##GENOME_BUILD=GRCh38
##CREATION_DATE=2023-05-17
##ANALYSISTYPE=GERMLINE_SINGLESAMPLE
##PIPELINE=megSAP 2023_04-16-g18cecd64
##SAMPLE=<ID=NA12878_03,Gender=female,ExternalSampleName=Coriell-DNA,IsTumor=no,IsFFPE=no,DiseaseGroup=Neoplasms,DiseaseStatus=affected>
##FILTER=off-target=Variant marked as 'off-target'.
##FILTER=low_mappability=Variants in reads with low mapping score.
##FILTER=mosaic=Putative mosaic variants.
##FILTER=low_conf_region=Variant marked as 'low_conf_region'.
##DESCRIPTION=NA12878_03=Genotype of variant in sample.
##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - variant quality (QUAL), depth (DP), quality divided by depth (QD), allele frequency (AF), mean mapping quality of alternate allele (MQM), probability of strand bias for alternate bases as phred score (SAP), probability of allele ballance as phred score (ABP)
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, ENST number, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=regulatory=Regulatory consequence details.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD project.
##DESCRIPTION=gnomAD_sub=Sub-population allele frequenciens (AFR,AMR,EAS,NFE,SAS) in gnomAD project.
##DESCRIPTION=gnomAD_hom_hemi=Homoyzgous counts and hemizygous counts of gnomAD project (genome data).
##DESCRIPTION=gnomAD_het=Heterozygous counts of the gnomAD project (genome data).
##DESCRIPTION=gnomAD_wt=Wildtype counts of the gnomAD project (genome data).
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=Sift=Sift effect prediction and score for each transcript: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen=PolyPhen (humVar) effect prediction and score for each transcript: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 10-20.
##DESCRIPTION=REVEL=REVEL pathogenicity prediction score. Deleterious threshold > 0.5.
##DESCRIPTION=MaxEntScan=MaxEntScan splicing prediction (reference bases score/alternate bases score).
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=SpliceAI=SpliceAI prediction of splice-site variations. Probability of the variant being splice-altering (range from 0-1). The score is the maximum value of acceptor/donor gain/loss of all effected genes.
##DESCRIPTION=PubMed=PubMed ids to publications on the given variant.
##DESCRIPTION=NGSD_hom=Homozygous variant count in NGSD.
##DESCRIPTION=NGSD_het=Heterozygous variant count in NGSD.
##DESCRIPTION=NGSD_group=Homozygous / heterozygous variant count in NGSD with the same disease group.
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validation=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Variant comments from the NGSD.
##DESCRIPTION=gene_info=Gene information from NGSD (inheritance mode, gnomAD o/e scores).
##FILTER=low_conf_region=Low confidence region for small variant calling based on gnomAD AC0/RF filters and IMGAG trio/twin data.
#chr	start	end	ref	obs	NA12878_03	filter	quality	gene	variant_type	coding_and_splicing	regulatory	OMIM	ClinVar	HGMD	RepeatMasker	dbSNP	gnomAD	gnomAD_sub	gnomAD_hom_hemi	gnomAD_het	gnomAD_wt	phyloP	Sift	PolyPhen	CADD	REVEL	MaxEntScan	COSMIC	SpliceAI	PubMed	NGSD_hom	NGSD_het	NGSD_group	classification	classification_comment	validation	comment	gene_info
chr1	27355949	27355949	-	G	het	off-target	QUAL=2491;DP=185;QD=13.46;AF=0.51;MQM=60;SAP=33;ABP=3;SAR=29;SAF=65	MAP3K6,SYTL1	intron,downstream_gene	MAP3K6:ENST00000357582.3:intron_variant:MODIFIER:intron27/28:c.3711+76_3711+77insC::,MAP3K6:ENST00000374040.7:intron_variant:MODIFIER:intron26/27:c.3687+76_3687+77insC::,SYTL1:ENST00000618673.4:downstream_gene_variant:MODIFIER::::,SYTL1:ENST00000318074.9:downstream_gene_variant:MODIFIER::::,SYTL1:ENST00000616558.5:downstream_gene_variant:MODIFIER::::,SYTL1:ENST00000543823.1:downstream_gene_variant:MODIFIER::::					L2 (LINE/L2)	rs36035221	0.42715	0.65670,0.34795,0.12510,0.36577,0.20108	15649,	33525	86933				12.93				0.04		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SYTL1 (inh=n/a oe_syn=0.98 oe_mis=0.79 oe_lof=0.73), MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58)
chr1	27355990	27355990	G	A	het	off-target	QUAL=2167;DP=164;QD=13.21;AF=0.51;MQM=60;SAP=15;ABP=3;SAR=31;SAF=52	MAP3K6,SYTL1	intron,downstream_gene	MAP3K6:ENST00000357582.3:intron_variant:MODIFIER:intron27/28:c.3711+36C>T::,MAP3K6:ENST00000374040.7:intron_variant:MODIFIER:intron26/27:c.3687+36C>T::,SYTL1:ENST00000618673.4:downstream_gene_variant:MODIFIER::::,SYTL1:ENST00000318074.9:downstream_gene_variant:MODIFIER::::,SYTL1:ENST00000616558.5:downstream_gene_variant:MODIFIER::::,SYTL1:ENST00000543823.1:downstream_gene_variant:MODIFIER::::						rs12569127	0.27140	0.21459,0.26063,0.12389,0.32157,0.15804	5878,	29481	110707	-0.4890			0.35			COSV58872155	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)				"sdsds"	SYTL1 (inh=n/a oe_syn=0.98 oe_mis=0.79 oe_lof=0.73), MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58)
chr1	27359572	27359572	G	C	hom	off-target	QUAL=6098;DP=195;QD=31.27;AF=1.00;MQM=60;SAP=4;ABP=0;SAR=103;SAF=92	MAP3K6	intron	MAP3K6:ENST00000357582.3:intron_variant:MODIFIER:intron17/28:c.2320-50C>G::,MAP3K6:ENST00000374040.7:intron_variant:MODIFIER:intron16/27:c.2296-50C>G::						rs7521552	0.98775	0.96526,0.99535,1.00000,0.99583,0.99669	74221,	1809	1863	-0.1950			3.40				0.79		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58)
chr1	27360975	27360975	G	T	het		QUAL=9693;DP=723;QD=13.41;AF=0.51;MQM=60;SAP=3;ABP=4;SAR=182;SAF=190	MAP3K6	missense	MAP3K6:ENST00000357582.3:missense_variant:MODERATE:exon14/29:c.1866C>A:p.Asn622Lys:,MAP3K6:ENST00000374040.7:missense_variant:MODERATE:exon13/28:c.1842C>A:p.Asn614Lys:	regulatory_region_variant:promoter		403071 [benign DISEASE=not specified];			rs35659744	0.21051	0.05785,0.19873,0.09606,0.30283,0.14694	4303,	23416	120092	0.1830	T(0.29),T(0.31)	B(0.02),B(0.04)	13.87	0.05		COSV62887042,COSV62889375	0	24033266,34059054	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahchera1 17.06.2021"		"3"	MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58)
chr1	27363272	27363272	C	T	het	off-target	QUAL=362;DP=33;QD=10.97;AF=0.48;MQM=60;SAP=8;ABP=3;SAR=5;SAF=11	MAP3K6	intron	MAP3K6:ENST00000357582.3:intron_variant:MODIFIER:intron6/28:c.971+170G>A::,MAP3K6:ENST00000374040.7:intron_variant:MODIFIER:intron5/27:c.947+170G>A::						rs4525067	0.22612	0.06203,0.23242,0.12138,0.32042,0.15729	4912,	24510	117504	-0.2130			2.99			COSV62890052	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58)
chr1	27363806	27363806	G	T	het	off-target	QUAL=548;DP=54;QD=10.15;AF=0.48;MQM=60;SAP=59;ABP=3;SAR=0;SAF=26	MAP3K6	intron	MAP3K6:ENST00000357582.3:intron_variant:MODIFIER:intron5/28:c.864+111C>A::,MAP3K6:ENST00000374040.7:intron_variant:MODIFIER:intron4/27:c.840+111C>A::					MIRb (SINE/MIR)	rs4075731	0.42472	0.67181,0.33421,0.12274,0.35594,0.19644	15775,	33037	87483	-0.5370			0.39			COSV62890056	0	23048207	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58)
chr1	27363868	27363868	T	C	het	off-target	QUAL=1447;DP=110;QD=13.15;AF=0.53;MQM=60;SAP=4;ABP=4;SAR=32;SAF=26	MAP3K6	intron	MAP3K6:ENST00000357582.3:intron_variant:MODIFIER:intron5/28:c.864+49A>G::,MAP3K6:ENST00000374040.7:intron_variant:MODIFIER:intron4/27:c.840+49A>G::					MIRb (SINE/MIR)	rs4307592	0.30437	0.32221,0.27704,0.12370,0.32366,0.16128	7286,	31722	105804	-0.0450			5.97			COSV62890059	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58)
chr1	27364153	27364153	A	G	het	off-target	QUAL=641;DP=85;QD=7.54;AF=0.35;MQM=60;SAP=4;ABP=19;SAR=13;SAF=17	MAP3K6,FCN3	intron,downstream_gene	MAP3K6:ENST00000357582.3:intron_variant:MODIFIER:intron4/28:c.695+51T>C::,MAP3K6:ENST00000374040.7:intron_variant:MODIFIER:intron3/27:c.671+51T>C::,FCN3:ENST00000270879.9:downstream_gene_variant:MODIFIER::::,FCN3:ENST00000354982.2:downstream_gene_variant:MODIFIER::::		604973_[GENE=FCN3_PHENOS=Immunodeficiency due to ficolin 3 deficiency, 613860 (3), Autosomal recessive]				rs12727507	0.42463	0.67108,0.33418,0.12389,0.35619,0.19723	15760,	33041	87479	0.0210			3.13			COSV54641801	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58), FCN3 (inh=AR oe_syn=0.74 oe_mis=0.91 oe_lof=0.45)
chr1	45330597	45330597	G	C	hom	off-target	QUAL=264;DP=10;QD=26.40;AF=1.00;MQM=60;SAP=25;ABP=0;SAR=0;SAF=10	MUTYH,HPDL	intron,downstream_gene	MUTYH:ENST00000529984.5:intron_variant:MODIFIER:intron5/6:c.478-40C>G::,MUTYH:ENST00000372104.5:intron_variant:MODIFIER:intron15/16:c.1393-40C>G::,MUTYH:ENST00000448481.5:intron_variant:MODIFIER:intron14/15:c.1426-40C>G::,MUTYH:ENST00000456914.7:intron_variant:MODIFIER:intron14/15:c.1393-40C>G::,MUTYH:ENST00000354383.10:intron_variant:MODIFIER:intron14/15:c.1396-40C>G::,MUTYH:ENST00000355498.6:intron_variant:MODIFIER:intron14/15:c.1393-40C>G::,MUTYH:ENST00000372098.7:intron_variant:MODIFIER:intron14/15:c.1468-40C>G::,MUTYH:ENST00000372110.7:intron_variant:MODIFIER:intron14/15:c.1438-40C>G::,MUTYH:ENST00000672818.3:intron_variant:MODIFIER:intron14/15:c.1468-40C>G::,MUTYH:ENST00000372115.7:intron_variant:MODIFIER:intron14/15:c.1435-40C>G::,MUTYH:ENST00000488731.6:intron_variant:MODIFIER:intron5/6:c.478-40C>G::,MUTYH:ENST00000531105.5:intron_variant:MODIFIER:intron2/2:c.116-1160C>G::,MUTYH:ENST00000528013.6:intron_variant:MODIFIER:intron14/15:c.1435-40C>G::,HPDL:ENST00000334815.6:downstream_gene_variant:MODIFIER::::		618994_[GENE=HPDL_PHENOS=Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities, 619026 (3), Autosomal recessive; Spastic paraplegia 83, autosomal recessive, 619027 (3), Autosomal recessive]&604933_[GENE=MUTYH_PHENOS=Adenomas, multiple colorectal, 608456 (3), Autosomal recessive; Gastric cancer, somatic, 613659 (3)]	439920 [benign DISEASE=not provided];			rs3219493	0.92948	0.95688,0.92907,0.90046,0.91103,0.92632	65830,	9767	10731	0.2630			4.74				0	27153553,26273655,28173856,22297469,24799981,17207658,32821650,33343895,34967580	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HPDL (inh=AR oe_syn=0.86 oe_mis=0.83 oe_lof=0.80), MUTYH (inh=AR oe_syn=1.01 oe_mis=1.03 oe_lof=0.88)
chr1	45331833	45331833	C	G	het		QUAL=3095;DP=229;QD=13.52;AF=0.51;MQM=60;SAP=4;ABP=3;SAR=62;SAF=54	MUTYH,HPDL	intron,missense,downstream_gene	MUTYH:ENST00000529984.5:intron_variant:MODIFIER:intron3/6:c.188-277G>C::,MUTYH:ENST00000372104.5:missense_variant:MODERATE:exon13/17:c.930G>C:p.Gln310His:,MUTYH:ENST00000448481.5:missense_variant:MODERATE:exon12/16:c.963G>C:p.Gln321His:,MUTYH:ENST00000456914.7:missense_variant:MODERATE:exon12/16:c.930G>C:p.Gln310His:,MUTYH:ENST00000354383.10:missense_variant:MODERATE:exon12/16:c.933G>C:p.Gln311His:,MUTYH:ENST00000355498.6:missense_variant:MODERATE:exon12/16:c.930G>C:p.Gln310His:,MUTYH:ENST00000372098.7:missense_variant:MODERATE:exon12/16:c.1005G>C:p.Gln335His:,MUTYH:ENST00000372110.7:missense_variant:MODERATE:exon12/16:c.975G>C:p.Gln325His:,MUTYH:ENST00000672818.3:missense_variant:MODERATE:exon12/16:c.1005G>C:p.Gln335His:,MUTYH:ENST00000372115.7:missense_variant:MODERATE:exon12/16:c.972G>C:p.Gln324His:,MUTYH:ENST00000488731.6:intron_variant:MODIFIER:intron3/6:c.188-277G>C::,MUTYH:ENST00000531105.5:intron_variant:MODIFIER:intron2/2:c.116-2396G>C::,MUTYH:ENST00000528013.6:missense_variant:MODERATE:exon12/16:c.972G>C:p.Gln324His:,HPDL:ENST00000334815.6:downstream_gene_variant:MODIFIER::::		618994_[GENE=HPDL_PHENOS=Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities, 619026 (3), Autosomal recessive; Spastic paraplegia 83, autosomal recessive, 619027 (3), Autosomal recessive]&604933_[GENE=MUTYH_PHENOS=Adenomas, multiple colorectal, 608456 (3), Autosomal recessive; Gastric cancer, somatic, 613659 (3)]	41767 [benign DISEASE=Carcinoma of colon,Familial adenomatous polyposis 2,Hereditary cancer-predisposing syndrome,Familial multiple polyposis syndrome,not specified,not provided];	CM083726 [CLASS=DFP MUT=ALT PHEN="Reduced activity" GENE=MUTYH];		rs3219489	0.26943	0.26360,0.39961,0.41167,0.24321,0.23757	5824,	29310	111058	-0.2650	 ,T(0.12),T(0.10),T(0.12),T(0.12),T(0.12),T(0.10),T(0.11),T(0.10),T(0.11), , ,T(0.10), 		8.88	0.04		COSV58343790	0.06	25741868,24728327,23946381,27713515,23757202,23202958,19536092,28391539,16465622,27588484,23565320,18547414,16774938,18271935,26900293,22703879,26273655,28173856,22297469,19443904,19902366,29458332,32072083,18823566,19781088,20149637,20843780,21195504,21777424,22466227,22469746,22641385,22720119,22922830,23443124,24039736,24799981,26074017,26159902,27217144,27471558,29664240,22926731,31374908,28749454,29445914,19888426,27105872,26528356,27209488,31027119,30271482,31924810,26511139,27081525,27324896,28599464,31031852,27630279,19161591,18848840,17055652,28628107,29844566,30564557,32821650,25998844,33942220,32265040,32461665,33240400,34295994,24058721,24377542,33343895,35117636,35628513	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)				"dfdfdfdf"	HPDL (inh=AR oe_syn=0.86 oe_mis=0.83 oe_lof=0.80), MUTYH (inh=AR oe_syn=1.01 oe_mis=1.03 oe_lof=0.88)
chr1	45332883	45332883	T	C	hom	off-target	QUAL=5816;DP=187;QD=31.10;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=92;SAF=95	MUTYH,HPDL	intron,downstream_gene	MUTYH:ENST00000529984.5:intron_variant:MODIFIER:intron2/6:c.116-49A>G::,MUTYH:ENST00000372104.5:intron_variant:MODIFIER:intron7/16:c.420+35A>G::,MUTYH:ENST00000448481.5:intron_variant:MODIFIER:intron6/15:c.453+35A>G::,MUTYH:ENST00000456914.7:intron_variant:MODIFIER:intron6/15:c.420+35A>G::,MUTYH:ENST00000354383.10:intron_variant:MODIFIER:intron6/15:c.423+35A>G::,MUTYH:ENST00000355498.6:intron_variant:MODIFIER:intron6/15:c.420+35A>G::,MUTYH:ENST00000372098.7:intron_variant:MODIFIER:intron6/15:c.495+35A>G::,MUTYH:ENST00000372110.7:intron_variant:MODIFIER:intron6/15:c.465+35A>G::,MUTYH:ENST00000672818.3:intron_variant:MODIFIER:intron6/15:c.495+35A>G::,MUTYH:ENST00000372115.7:intron_variant:MODIFIER:intron6/15:c.462+35A>G::,MUTYH:ENST00000488731.6:intron_variant:MODIFIER:intron2/6:c.116-49A>G::,MUTYH:ENST00000531105.5:intron_variant:MODIFIER:intron2/2:c.115+1508A>G::,MUTYH:ENST00000528013.6:intron_variant:MODIFIER:intron6/15:c.462+35A>G::,HPDL:ENST00000334815.6:downstream_gene_variant:MODIFIER::::		618994_[GENE=HPDL_PHENOS=Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities, 619026 (3), Autosomal recessive; Spastic paraplegia 83, autosomal recessive, 619027 (3), Autosomal recessive]&604933_[GENE=MUTYH_PHENOS=Adenomas, multiple colorectal, 608456 (3), Autosomal recessive; Gastric cancer, somatic, 613659 (3)]	257529 [benign DISEASE=not specified,not provided];			rs3219487	0.93264	0.96584,0.93218,0.90054,0.91151,0.92762	66268,	9336	10246	-1.2610			0.66			COSV58343750	0.01	25741868,23565320,22297469,30218772,24799981,17207658,23504502,31031852,32821650,33343895	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HPDL (inh=AR oe_syn=0.86 oe_mis=0.83 oe_lof=0.80), MUTYH (inh=AR oe_syn=1.01 oe_mis=1.03 oe_lof=0.88)
chr1	62238462	62238462	A	G	het	off-target	QUAL=2091;DP=134;QD=15.60;AF=0.59;MQM=60;SAP=4;ABP=12;SAR=36;SAF=43	KANK4	intron	KANK4:ENST00000371153.9:intron_variant:MODIFIER:intron9/9:c.2884-81T>C::,KANK4:ENST00000317477.8:intron_variant:MODIFIER:intron3/3:c.298-81T>C::,KANK4:ENST00000371150.5:intron_variant:MODIFIER:intron6/6:c.952-81T>C::,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron8/8:c.1000-81T>C::			1249680 [benign DISEASE=not provided];			rs41289438	0.35647	0.35365,0.33344,0.17233,0.37414,0.24513	9836,	34431	97673	-1.2140			0.91				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62247305	62247305	T	-	het	off-target	QUAL=94;DP=6;QD=15.67;AF=0.33;MQM=60;SAP=7;ABP=4;SAR=0;SAF=2	KANK4	intron	KANK4:ENST00000371153.9:intron_variant:MODIFIER:intron9/9:c.2883+167del::,KANK4:ENST00000317477.8:intron_variant:MODIFIER:intron3/3:c.297+167del::,KANK4:ENST00000371150.5:intron_variant:MODIFIER:intron6/6:c.951+167del::,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron8/8:c.999+167del::			1231277 [benign DISEASE=not provided];			rs371644915	0.07436	0.18821,0.04356,0.02697,0.02371,0.02139	673,	8764	125846	-0.9790			0.24				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62247305	62247306	TT	-	het	off-target	QUAL=94;DP=6;QD=15.67;AF=0.50;MQM=60;SAP=10;ABP=3;SAR=0;SAF=3	KANK4	intron	KANK4:ENST00000371153.9:intron_variant:MODIFIER:intron9/9:c.2883+166_2883+167del::,KANK4:ENST00000317477.8:intron_variant:MODIFIER:intron3/3:c.297+166_297+167del::,KANK4:ENST00000371150.5:intron_variant:MODIFIER:intron6/6:c.951+166_951+167del::,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron8/8:c.999+166_999+167del::					FLAM_C (SINE/Alu)	rs371644915	0.00063	0.00146,0.00039,0.00000,0.00025,0.00024	0,	86	136156	0.1070			0.79				0.01		1	2	0 / 1					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62247328	62247328	G	-	het	off-target	QUAL=42;DP=7;QD=6.00;AF=0.43;MQM=60;SAP=10;ABP=3;SAR=0;SAF=3	KANK4	intron	KANK4:ENST00000371153.9:intron_variant:MODIFIER:intron9/9:c.2883+144del::,KANK4:ENST00000317477.8:intron_variant:MODIFIER:intron3/3:c.297+144del::,KANK4:ENST00000371150.5:intron_variant:MODIFIER:intron6/6:c.951+144del::,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron8/8:c.999+144del::			1279369 [benign DISEASE=not provided];		FLAM_C (SINE/Alu)	rs111297754	0.43086	0.42851,0.40969,0.17250,0.45327,0.33701	13896,	35760	83950	0.1120			0.75				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62247552	62247552	C	G	hom		QUAL=1165;DP=37;QD=31.49;AF=1.00;MQM=60;SAP=4;ABP=0;SAR=21;SAF=16	KANK4	missense	KANK4:ENST00000371153.9:missense_variant:MODERATE:exon9/10:c.2803G>C:p.Val935Leu:PF13857 [Ankyrin repeats (many copies)],KANK4:ENST00000317477.8:missense_variant:MODERATE:exon3/4:c.217G>C:p.Val73Leu:PF13857 [Ankyrin repeats (many copies)],KANK4:ENST00000371150.5:missense_variant:MODERATE:exon6/7:c.871G>C:p.Val291Leu:PF13857 [Ankyrin repeats (many copies)],KANK4:ENST00000354381.3:missense_variant:MODERATE:exon8/9:c.919G>C:p.Val307Leu:PF13857 [Ankyrin repeats (many copies)]	regulatory_region_variant:open_chromatin_region		1257820 [benign DISEASE=not provided];			rs2941679	0.97672	0.99361,0.98305,0.99981,0.96323,0.97475	72601,	3418	3542	0.7870	T(0.44),T(0.61),T(0.55),T(0.56)	B(0.00),B(0.00),B(0.00),B(0.00)	14.11	0.04			0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62247574	62247574	G	A	het		QUAL=1316;DP=117;QD=11.25;AF=0.44;MQM=60;SAP=3;ABP=7;SAR=26;SAF=25	KANK4	synonymous	KANK4:ENST00000371153.9:synonymous_variant:LOW:exon9/10:c.2781C>T:p.His927=:PF13857 [Ankyrin repeats (many copies)],KANK4:ENST00000317477.8:synonymous_variant:LOW:exon3/4:c.195C>T:p.His65=:PF13857 [Ankyrin repeats (many copies)],KANK4:ENST00000371150.5:synonymous_variant:LOW:exon6/7:c.849C>T:p.His283=:PF13857 [Ankyrin repeats (many copies)],KANK4:ENST00000354381.3:synonymous_variant:LOW:exon8/9:c.897C>T:p.His299=:PF13857 [Ankyrin repeats (many copies)]	regulatory_region_variant:open_chromatin_region		1272744 [benign DISEASE=not provided];			rs10889315	0.38429	0.32405,0.36324,0.17217,0.42073,0.39400	11539,	35304	93540	-0.0850			0.70			COSV58092010	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)				"dfgdfgdfgdg"	KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62247797	62247797	T	C	het	off-target	QUAL=281;DP=40;QD=7.03;AF=0.43;MQM=60;SAP=40;ABP=5;SAR=17;SAF=0	KANK4	intron	KANK4:ENST00000371153.9:intron_variant:MODIFIER:intron8/9:c.2683-125A>G::,KANK4:ENST00000317477.8:intron_variant:MODIFIER:intron2/3:c.97-125A>G::,KANK4:ENST00000371150.5:intron_variant:MODIFIER:intron5/6:c.751-125A>G::,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron7/8:c.799-125A>G::			1243108 [benign DISEASE=not provided];			rs10789108	0.42916	0.43507,0.40578,0.17467,0.43928,0.42926	14118,	36697	86371	-0.1910			1.80				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62262956	62262956	C	T	het	off-target	QUAL=54;DP=14;QD=3.86;AF=0.29;MQM=60;SAP=3;ABP=9;SAR=2;SAF=2	KANK4	intron	KANK4:ENST00000371153.9:intron_variant:MODIFIER:intron7/9:c.2539+136G>A::,KANK4:ENST00000317477.8:intron_variant:MODIFIER:intron1/3:c.-48+136G>A::,KANK4:ENST00000371150.5:intron_variant:MODIFIER:intron4/6:c.607+136G>A::,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron6/8:c.655+136G>A::			1182710 [benign DISEASE=not provided];		L1PB3 (LINE/L1)	rs59025845	0.25259	0.12933,0.22469,0.13276,0.32425,0.28471	5445,	27508	113618	0.2060			3.74				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62263112	62263112	A	G	hom		QUAL=38141;DP=1196;QD=31.89;AF=1.00;MQM=60;SAP=5;ABP=0;SAR=581;SAF=615	KANK4	missense,5'UTR	KANK4:ENST00000371153.9:missense_variant:MODERATE:exon7/10:c.2519T>C:p.Val840Ala:PF00023 [Ankyrin repeat],KANK4:ENST00000317477.8:5_prime_UTR_variant:MODIFIER:exon1/4:c.-68T>C::,KANK4:ENST00000371150.5:missense_variant:MODERATE:exon4/7:c.587T>C:p.Val196Ala:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000354381.3:missense_variant:MODERATE:exon6/9:c.635T>C:p.Val212Ala:PF12796 [Ankyrin repeats (3 copies)]	regulatory_region_variant:enhancer		1239401 [benign DISEASE=not provided];			rs2666472	0.70434	0.55735,0.78890,0.83533,0.74088,0.72188	38394,	30196	44908	2.8390	T(1.00), ,T(0.55),T(0.49)	B(0.06), ,B(0.06),B(0.04)	9.67	0.16		COSV58093169	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62263166	62263166	T	C	hom		QUAL=35273;DP=1131;QD=31.19;AF=1.00;MQM=60;SAP=5;ABP=0;SAR=550;SAF=581	KANK4	missense,5'UTR	KANK4:ENST00000371153.9:missense_variant:MODERATE:exon7/10:c.2465A>G:p.His822Arg:,KANK4:ENST00000317477.8:5_prime_UTR_variant:MODIFIER:exon1/4:c.-122A>G::,KANK4:ENST00000371150.5:missense_variant:MODERATE:exon4/7:c.533A>G:p.His178Arg:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000354381.3:missense_variant:MODERATE:exon6/9:c.581A>G:p.His194Arg:PF12796 [Ankyrin repeats (3 copies)]	regulatory_region_variant:enhancer		1270534 [benign DISEASE=not provided];			rs2258470	0.70400	0.55645,0.78900,0.83553,0.74076,0.72111	38311,	30195	44911	2.7470	T(1.00), ,T(0.69),T(0.66)	B(0.00), ,B(0.00),B(0.00)	18.45	0.10			0	28487959	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62263189	62263189	T	C	hom		QUAL=35553;DP=1119;QD=31.77;AF=1.00;MQM=60;SAP=6;ABP=0;SAR=540;SAF=578	KANK4	synonymous,5'UTR	KANK4:ENST00000371153.9:synonymous_variant:LOW:exon7/10:c.2442A>G:p.Lys814=:,KANK4:ENST00000317477.8:5_prime_UTR_variant:MODIFIER:exon1/4:c.-145A>G::,KANK4:ENST00000371150.5:synonymous_variant:LOW:exon4/7:c.510A>G:p.Lys170=:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000354381.3:synonymous_variant:LOW:exon6/9:c.558A>G:p.Lys186=:PF12796 [Ankyrin repeats (3 copies)]	regulatory_region_variant:enhancer		1295500 [benign DISEASE=not provided];			rs2260581	0.70421	0.55703,0.78877,0.83483,0.74093,0.72121	38296,	30169	44843	0.5990			11.06				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62263246	62263246	G	A	hom		QUAL=5529;DP=181;QD=30.55;AF=1.00;MQM=60;SAP=34;ABP=0;SAR=65;SAF=116	KANK4	synonymous,5'UTR	KANK4:ENST00000371153.9:synonymous_variant:LOW:exon7/10:c.2385C>T:p.Pro795=:,KANK4:ENST00000317477.8:5_prime_UTR_variant:MODIFIER:exon1/4:c.-202C>T::,KANK4:ENST00000371150.5:synonymous_variant:LOW:exon4/7:c.453C>T:p.Pro151=:,KANK4:ENST00000354381.3:synonymous_variant:LOW:exon6/9:c.501C>T:p.Pro167=:	regulatory_region_variant:enhancer		1262248 [benign DISEASE=not provided];			rs2262110	0.70444	0.55732,0.78889,0.83554,0.74105,0.72183	38368,	30157	44849	-1.7700			0.77			COSV58094416	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62263343	62263343	G	A	hom	off-target	QUAL=7334;DP=221;QD=33.19;AF=1.00;MQM=60;SAP=11;ABP=0;SAR=125;SAF=96	KANK4	intron,5'UTR	KANK4:ENST00000371153.9:intron_variant:MODIFIER:intron6/9:c.2320-32C>T::,KANK4:ENST00000317477.8:5_prime_UTR_variant:MODIFIER:exon1/4:c.-299C>T::,KANK4:ENST00000371150.5:intron_variant:MODIFIER:intron3/6:c.388-32C>T::,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron5/8:c.436-32C>T::	regulatory_region_variant:enhancer		1295474 [benign DISEASE=not provided];			rs2262106	0.69634	0.52897,0.78707,0.83605,0.74082,0.72114	37689,	30335	46099	0.5880			13.85			COSV58091893	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62266749	62266749	T	C	het		QUAL=11401;DP=869;QD=13.12;AF=0.52;MQM=60;SAP=3;ABP=6;SAR=223;SAF=230	KANK4	missense,upstream_gene	KANK4:ENST00000371153.9:missense_variant:MODERATE:exon6/10:c.2302A>G:p.Thr768Ala:,KANK4:ENST00000371150.5:missense_variant:MODERATE:exon3/7:c.370A>G:p.Thr124Ala:,KANK4:ENST00000354381.3:missense_variant:MODERATE:exon5/9:c.418A>G:p.Thr140Ala:,KANK4:ENST00000317477.8:upstream_gene_variant:MODIFIER::::			1295514 [benign DISEASE=not provided];			rs11207949	0.26469	0.21373,0.34976,0.56209,0.25224,0.15471	5876,	28499	111819	2.3690	T(0.09),T(0.08),T(0.10), 	B(0.01),B(0.01),B(0.01), 	17.77	0.02			0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62268267	62268267	G	A	het	off-target	QUAL=1655;DP=148;QD=11.18;AF=0.46;MQM=60;SAP=3;ABP=5;SAR=33;SAF=35	KANK4	splice_region&intron,upstream_gene	KANK4:ENST00000371153.9:splice_region_variant&intron_variant:LOW:intron5/9:c.2231+20C>T::,KANK4:ENST00000371150.5:splice_region_variant&intron_variant:LOW:intron2/6:c.299+20C>T::,KANK4:ENST00000354381.3:splice_region_variant&intron_variant:LOW:intron4/8:c.347+20C>T::,KANK4:ENST00000317477.8:upstream_gene_variant:MODIFIER::::			1271177 [benign DISEASE=not provided];			rs11207950	0.45190	0.57506,0.39894,0.27287,0.40597,0.56642	16100,	36465	83281	-0.4840			0.35			COSV58092900	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62271700	62271700	A	C	het	off-target	QUAL=1498;DP=111;QD=13.50;AF=0.54;MQM=60;SAP=4;ABP=5;SAR=33;SAF=27	KANK4	intron,5'UTR	KANK4:ENST00000371153.9:intron_variant:MODIFIER:intron3/9:c.1901-111T>G::,KANK4:ENST00000371150.5:5_prime_UTR_variant:MODIFIER:exon1/7:c.-143T>G::,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-111T>G::	regulatory_region_variant:enhancer		1225071 [benign DISEASE=not provided];			rs4609464	0.39101	0.43132,0.35999,0.27255,0.37579,0.51645	11750,	35864	92460	0.2410			3.19			COSV62985665	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62273232	62273232	T	C	hom		QUAL=1844;DP=63;QD=29.27;AF=1.00;MQM=60;SAP=9;ABP=0;SAR=38;SAF=25	KANK4	synonymous,intron,upstream_gene	KANK4:ENST00000371153.9:synonymous_variant:LOW:exon3/10:c.1872A>G:p.Pro624=:,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-1643A>G::,KANK4:ENST00000371150.5:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer		1265012 [benign DISEASE=not provided];			rs7516290	0.75558	0.85960,0.76162,0.83771,0.68643,0.75187	43916,	27054	37164	-0.8210			1.88				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62273526	62273526	G	A	het		QUAL=1760;DP=140;QD=12.57;AF=0.49;MQM=60;SAP=10;ABP=3;SAR=42;SAF=27	KANK4	synonymous,intron,upstream_gene	KANK4:ENST00000371153.9:synonymous_variant:LOW:exon3/10:c.1578C>T:p.Ser526=:,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-1937C>T::,KANK4:ENST00000371150.5:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer		1270734 [benign DISEASE=not provided];			rs17855078	0.27830	0.18685,0.24708,0.13166,0.33082,0.40154	6374,	29522	109618	-1.1030			0.19			COSV62990033	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62274393	62274393	A	G	het		QUAL=1461;DP=120;QD=12.18;AF=0.49;MQM=60;SAP=4;ABP=3;SAR=32;SAF=27	KANK4	synonymous,intron,upstream_gene	KANK4:ENST00000371153.9:synonymous_variant:LOW:exon3/10:c.711T>C:p.Gly237=:,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-2804T>C::,KANK4:ENST00000371150.5:upstream_gene_variant:MODIFIER::::			1265023 [benign DISEASE=not provided];			rs12127930	0.48104	0.61928,0.40991,0.27359,0.43072,0.57066	18375,	36326	78836	-1.1560			0.28			COSV105915634,COSV62986848	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62274774	62274774	T	C	hom		QUAL=7435;DP=235;QD=31.64;AF=1.00;MQM=60;SAP=4;ABP=0;SAR=122;SAF=112	KANK4	synonymous,intron,upstream_gene	KANK4:ENST00000371153.9:synonymous_variant:LOW:exon3/10:c.330A>G:p.Pro110=:,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-3185A>G::,KANK4:ENST00000371150.5:upstream_gene_variant:MODIFIER::::			1262658 [benign DISEASE=not provided];			rs2666506	0.75568	0.85963,0.76139,0.85161,0.68611,0.75239	43743,	26964	37004	-0.6950			3.59			COSV62988812	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62274777	62274777	T	C	hom		QUAL=7435;DP=235;QD=31.64;AF=1.00;MQM=60;SAP=4;ABP=0;SAR=122;SAF=112	KANK4	synonymous,intron,upstream_gene	KANK4:ENST00000371153.9:synonymous_variant:LOW:exon3/10:c.327A>G:p.Ser109=:,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-3188A>G::,KANK4:ENST00000371150.5:upstream_gene_variant:MODIFIER::::			1182584 [benign DISEASE=not provided];			rs2666507	0.73196	0.77746,0.75262,0.85157,0.68591,0.75146	40797,	29256	40592	-2.2680			0.25			COSV62988817	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62275109	62275109	A	-	het	off-target;low_conf_region	QUAL=274;DP=114;QD=2.40;AF=0.20;MQM=60;SAP=3;ABP=91;SAR=11;SAF=12	KANK4	intron,upstream_gene	KANK4:ENST00000371153.9:intron_variant:MODIFIER:intron2/9:c.17-22del::,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-3520del::,KANK4:ENST00000371150.5:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region					rs761923018	0.00062	0.00106,0.00055,0.00020,0.00027,0.00000	0,	90	144528	0.0400			2.59				0.05		0	47	0 / 9					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	78112493	78112493	T	C	het		QUAL=4964;DP=410;QD=12.11;AF=0.45;MQM=60;SAP=4;ABP=11;SAR=97;SAF=89	GIPC2	intron	GIPC2:ENST00000370759.4:intron_variant:MODIFIER:intron3/5:c.608-6900T>C::	regulatory_region_variant:open_chromatin_region					rs6666954	0.37758	0.60779,0.29000,0.61023,0.27565,0.27953	12754,	31863	94575	-1.1960			0.35			COSV66129252	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GIPC2 (inh=n/a oe_syn=1.00 oe_mis=1.06 oe_lof=1.01)
chr1	119915381	119915381	A	T	het		QUAL=1758;DP=127;QD=13.84;AF=0.55;MQM=60;SAP=3;ABP=6;SAR=35;SAF=35	NOTCH2	synonymous	NOTCH2:ENST00000256646.7:synonymous_variant:LOW:exon34/34:c.7341T>A:p.Gly2447=:		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	261705 [benign DISEASE=Hajdu-Cheney syndrome,not specified,not provided];			rs6685892	0.16795	0.32566,0.10643,0.03172,0.10626,0.19077	2968,	19591	126467	-0.7840			5.31			COSV56683182	0	25741868,29593342,34737607	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119918630	119918630	C	T	het	off-target	QUAL=275;DP=20;QD=13.75;AF=0.70;MQM=60;SAP=33;ABP=10;SAR=14;SAF=0	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron31/33:c.5782-77G>A::		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1239541 [benign DISEASE=not provided];			rs2793829	0.16744	0.32493,0.10639,0.03194,0.10587,0.19028	2947,	19552	126522	1.7540			7.57			COSV104375006	0	30595370	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119921542	119921542	C	T	het	off-target	QUAL=2286;DP=225;QD=10.16;AF=0.52;MQM=60;SAP=255;ABP=3;SAR=0;SAF=116	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron29/33:c.5310+171G>A::		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1239830 [benign DISEASE=not provided];			rs835573	0.21853	0.42448,0.16232,0.09773,0.12550,0.30236	5047,	23123	118783	-0.3850			0.70			COSV56701749	0	28714469	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119923485	119923485	G	A	het	off-target	QUAL=2692;DP=416;QD=6.47;AF=0.46;MQM=60;SAP=420;ABP=8;SAR=0;SAF=192	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron26/33:c.4859+152C>T::		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1230128 [benign DISEASE=not provided];			rs2793830	0.30644	0.72723,0.19212,0.10624,0.12679,0.31498	12443,	21700	105436	-3.2970			0.00			COSV104375039	0	32341527	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119929234	119929234	C	T	het	off-target	QUAL=530;DP=29;QD=18.28;AF=0.69;MQM=60;SAP=5;ABP=12;SAR=12;SAF=8	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron22/33:c.3656-22G>A::		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1265981 [benign DISEASE=not provided];			rs2493392	0.16773	0.32532,0.10628,0.03189,0.10606,0.19255	2962,	19587	126581	0.4450			5.44			COSV56687338	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119935375	119935375	C	A	het	off-target	QUAL=290;DP=19;QD=15.26;AF=0.63;MQM=60;SAP=3;ABP=6;SAR=6;SAF=6	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron22/33:c.3655+97G>T::		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1179326 [benign DISEASE=not provided];			rs2453056	0.24421	0.51352,0.17178,0.09773,0.12590,0.30319	6810,	23505	114897	-0.0250			2.76			COSV104375007	0	29434720	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119935662	119935662	T	C	het	off-target	QUAL=11698;DP=878;QD=13.32;AF=0.52;MQM=60;SAP=3;ABP=6;SAR=230;SAF=225	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron21/33:c.3523-58A>G::		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1260068 [benign DISEASE=not provided];			rs5025718	0.66976	0.18973,0.80071,0.90189,0.87224,0.68427	40976,	19866	50204	-1.1160			5.22				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119938086	119938086	C	T	het	off-target	QUAL=4895;DP=360;QD=13.60;AF=0.52;MQM=60;SAP=3;ABP=4;SAR=93;SAF=94	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron19/33:c.3184-76G>A::		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1235242 [benign DISEASE=not provided];			rs2453058	0.16785	0.32565,0.10669,0.03195,0.10604,0.19153	2960,	19565	126343	-0.2200			1.90			COSV104375008	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119941798	119941798	G	A	het	off-target	QUAL=767;DP=65;QD=11.80;AF=0.49;MQM=60;SAP=3;ABP=3;SAR=16;SAF=16	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron17/33:c.2753-44C>T::		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1293670 [benign DISEASE=Hajdu-Cheney syndrome,Alagille syndrome due to a NOTCH2 point mutation,not provided];			rs2493420	0.21860	0.42471,0.16250,0.09715,0.12548,0.30306	5056,	23124	118802	-0.0270			5.76			COSV99862942	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119953496	119953496	A	T	het	off-target	QUAL=7144;DP=636;QD=11.23;AF=0.45;MQM=60;SAP=3;ABP=18;SAR=141;SAF=144	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron14/33:c.2365+47T>A::		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1265607 [benign DISEASE=not provided];			rs7534585	0.16690	0.32360,0.10639,0.03201,0.10561,0.19154	2891,	19570	126552	0.4620			3.55			COSV56685993	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119953504	119953504	A	C	het	off-target	QUAL=7115;DP=634;QD=11.22;AF=0.45;MQM=60;SAP=3;ABP=17;SAR=141;SAF=144	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron14/33:c.2365+39T>G::		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1245879 [benign DISEASE=not provided];			rs7534586	0.16684	0.32365,0.10639,0.03185,0.10553,0.19108	2888,	19561	126529	0.5980			5.95			COSV56686003	0.02	25135348	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119963373	119963373	G	C	het	off-target	QUAL=2546;DP=269;QD=9.46;AF=0.49;MQM=60;SAP=292;ABP=3;SAR=0;SAF=133	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron11/33:c.1915+201C>G::	regulatory_region_variant:enhancer	600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1274327 [benign DISEASE=not provided];			rs10923929	0.66576	0.17533,0.79898,0.90150,0.87255,0.68542	40882,	19505	50841	0.3540			2.89			COSV56681705	0	18179887,28666004,31217584,34107879	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119963485	119963485	G	A	het	off-target	QUAL=2791;DP=278;QD=10.04;AF=0.53;MQM=60;SAP=320;ABP=5;SAR=0;SAF=146	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron11/33:c.1915+89C>T::	regulatory_region_variant:enhancer	600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1276223 [benign DISEASE=not provided];			rs2934381	0.16757	0.32546,0.10624,0.03180,0.10578,0.19051	2959,	19554	126536	0.5720			1.51			COSV56687347	0	18372903,18591388,19056611,19794065,21124985,24932614,30328613	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119969481	119969481	T	C	hom	off-target	QUAL=17991;DP=570;QD=31.56;AF=1.00;MQM=60;SAP=4;ABP=0;SAR=294;SAF=276	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron6/33:c.1108+30A>G::		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1283582 [benign DISEASE=Hajdu-Cheney syndrome,Alagille syndrome due to a NOTCH2 point mutation,not provided];			rs2493409	0.97812	0.92359,0.99424,0.99981,0.99950,0.99855	72873,	3097	3329	-2.8650			0.02			COSV99862551	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119987127	119987127	A	C	het	off-target	QUAL=11316;DP=918;QD=12.33;AF=0.48;MQM=60;SAP=4;ABP=5;SAR=229;SAF=214	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron4/33:c.752-45T>G::	regulatory_region_variant:enhancer,TF_binding_site_variant	600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1283883 [benign DISEASE=not provided];			rs2453040	0.16515	0.31888,0.10523,0.03176,0.10482,0.19110	2870,	19374	126954	-0.0060			3.93			COSV56686013	0	28652462	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr2	17760156	17760156	T	G	hom	off-target	QUAL=977;DP=30;QD=32.57;AF=1.00;MQM=60;SAP=32;ABP=0;SAR=25;SAF=5	SMC6,GEN1	intron	SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-5-14205A>C::,GEN1:ENST00000317402.11:intron_variant:MODIFIER:intron2/13:c.161+52T>G::,GEN1:ENST00000381254.7:intron_variant:MODIFIER:intron2/13:c.161+52T>G::			1261547 [benign DISEASE=not provided];			rs2555072	0.61128	0.48559,0.72253,0.95519,0.61843,0.87064	29355,	34062	58996	-0.5730			0.32				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17761508	17761508	T	A	hom		QUAL=3025;DP=91;QD=33.24;AF=1.00;MQM=60;SAP=16;ABP=0;SAR=34;SAF=57	SMC6,GEN1	intron,missense	SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-5-15557A>T::,GEN1:ENST00000317402.11:missense_variant:MODERATE:exon3/14:c.274T>A:p.Ser92Thr:PF00752 [XPG N-terminal domain],GEN1:ENST00000381254.7:missense_variant:MODERATE:exon3/14:c.274T>A:p.Ser92Thr:PF00752 [XPG N-terminal domain]			1169875 [benign DISEASE=not provided];			rs1812152	0.69774	0.77013,0.75884,0.98556,0.62417,0.88680	37688,	30626	45920	0.6630	 ,T(0.19),T(0.19)	 ,B(0.00),B(0.00)	9.80	0.03			0.09	20512659	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17761748	17761748	T	C	hom	off-target	QUAL=583;DP=24;QD=24.29;AF=1.00;MQM=60;SAP=55;ABP=0;SAR=24;SAF=0	SMC6,GEN1	intron	SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-5-15797A>G::,GEN1:ENST00000317402.11:intron_variant:MODIFIER:intron3/13:c.348+166T>C::,GEN1:ENST00000381254.7:intron_variant:MODIFIER:intron3/13:c.348+166T>C::			1231264 [benign DISEASE=not provided];		MIRb (SINE/MIR)	rs2615047	0.69545	0.76221,0.75861,0.98540,0.62419,0.88677	37459,	30790	46292	-0.0400			3.38				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17772760	17772760	G	A	hom		QUAL=959;DP=29;QD=33.07;AF=1.00;MQM=60;SAP=20;ABP=0;SAR=7;SAF=22	SMC6,GEN1	intron,missense	SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-6+15055C>T::,GEN1:ENST00000317402.11:missense_variant:MODERATE:exon8/14:c.929G>A:p.Ser310Asn:,GEN1:ENST00000381254.7:missense_variant:MODERATE:exon8/14:c.929G>A:p.Ser310Asn:			1169876 [benign DISEASE=not provided];			rs300175	0.98691	0.95655,0.99613,1.00000,0.99990,0.97950	74046,	1920	1990	-2.3000	 ,T(1.00),T(1.00)	 ,B(0.00),B(0.00)	0.00	0.02			0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17772873	17772873	A	G	hom	off-target	QUAL=1069;DP=32;QD=33.41;AF=1.00;MQM=60;SAP=16;ABP=0;SAR=23;SAF=9	SMC6,GEN1	intron	SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-6+14942T>C::,GEN1:ENST00000317402.11:intron_variant:MODIFIER:intron8/13:c.953+89A>G::,GEN1:ENST00000381254.7:intron_variant:MODIFIER:intron8/13:c.953+89A>G::			1234610 [benign DISEASE=not provided];			rs300176	0.66231	0.64696,0.74458,0.98539,0.62414,0.88613	33858,	32731	51215	-0.4490			1.21				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17773154	17773154	C	G	hom	off-target	QUAL=2990;DP=92;QD=32.50;AF=1.00;MQM=60;SAP=5;ABP=0;SAR=42;SAF=50	SMC6,GEN1	intron	SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-6+14661G>C::,GEN1:ENST00000317402.11:intron_variant:MODIFIER:intron9/13:c.990+22C>G::,GEN1:ENST00000381254.7:intron_variant:MODIFIER:intron9/13:c.990+22C>G::			1276608 [benign DISEASE=not provided];			rs300177	0.69586	0.76253,0.75854,0.98537,0.62466,0.88624	37402,	30744	46132	-2.1750			0.06				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17773380	17773380	T	G	hom	off-target	QUAL=925;DP=30;QD=30.83;AF=1.00;MQM=60;SAP=8;ABP=0;SAR=19;SAF=11	SMC6,GEN1	intron	SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-6+14435A>C::,GEN1:ENST00000317402.11:intron_variant:MODIFIER:intron10/13:c.1071+81T>G::,GEN1:ENST00000381254.7:intron_variant:MODIFIER:intron10/13:c.1071+81T>G::			1280388 [benign DISEASE=not provided];			rs300178	0.65127	0.60985,0.73802,0.98535,0.62366,0.88619	32834,	33125	52901	-1.6090			0.24				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17779783	17779783	A	G	hom	off-target	QUAL=577;DP=23;QD=25.09;AF=1.00;MQM=60;SAP=53;ABP=0;SAR=0;SAF=23	SMC6,GEN1	intron	SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-6+8032T>C::,GEN1:ENST00000317402.11:intron_variant:MODIFIER:intron12/13:c.1265-195A>G::,GEN1:ENST00000381254.7:intron_variant:MODIFIER:intron12/13:c.1265-195A>G::			1249180 [benign DISEASE=not provided];		AluSg (SINE/Alu)	rs300167	0.69596	0.76303,0.75856,0.98535,0.62473,0.88613	37439,	30736	46138	-0.7300			1.22				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17781183	17781183	A	G	hom		QUAL=3044;DP=93;QD=32.73;AF=1.00;MQM=60;SAP=79;ABP=0;SAR=18;SAF=75	SMC6,GEN1	intron,synonymous	SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-6+6632T>C::,GEN1:ENST00000317402.11:synonymous_variant:LOW:exon14/14:c.1971A>G:p.Glu657=:,GEN1:ENST00000381254.7:synonymous_variant:LOW:exon14/14:c.1971A>G:p.Glu657=:			1169877 [benign DISEASE=not provided];			rs300168	0.46940	0.22978,0.61702,0.91901,0.51382,0.77868	19073,	33179	80625	0.7070			6.44			COSV58057416	0	20150382,20512659	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17781251	17781251	C	T	hom		QUAL=3585;DP=111;QD=32.30;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=54;SAF=57	SMC6,GEN1	intron,missense	SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-6+6564G>A::,GEN1:ENST00000317402.11:missense_variant:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile:,GEN1:ENST00000381254.7:missense_variant:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile:			1169878 [benign DISEASE=not provided];			rs300169	0.65079	0.60815,0.73797,0.98518,0.62364,0.88544	32837,	33200	53056	0.1650	 ,T(0.52),T(0.52)	 ,B(0.00),B(0.00)	4.92	0.05			0	20512659	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	47369714	47369714	-	G	het	off-target	QUAL=254;DP=35;QD=7.26;AF=0.40;MQM=60;SAP=4;ABP=6;SAR=8;SAF=6	EPCAM	intron	EPCAM:ENST00000405271.5:intron_variant:MODIFIER:intron2/9:c.160+481dup::,EPCAM:ENST00000263735.9:intron_variant:MODIFIER:intron1/8:c.76+135dup::	regulatory_region_variant:promoter	185535_[GENE=EPCAM_PHENOS=Diarrhea 5, with tufting enteropathy, congenital, 613217 (3), Autosomal recessive; Lynch syndrome 8, 613244 (3), Autosomal dominant]	1225956 [benign DISEASE=not provided];			rs144077629	0.09252	0.09941,0.11121,0.24525,0.07204,0.12117	786,	12505	138067				7.15				0.04		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EPCAM (inh=AR oe_syn=1.27 oe_mis=1.31 oe_lof=0.73)
chr2	47373967	47373967	T	C	het		QUAL=747;DP=41;QD=18.22;AF=0.73;MQM=60;SAP=3;ABP=22;SAR=15;SAF=15	EPCAM,MIR559	missense,upstream_gene	EPCAM:ENST00000405271.5:missense_variant:MODERATE:exon4/10:c.428T>C:p.Met143Thr:PF00086 [Thyroglobulin type-1 repeat],EPCAM:ENST00000263735.9:missense_variant:MODERATE:exon3/9:c.344T>C:p.Met115Thr:PF00086 [Thyroglobulin type-1 repeat],MIR559:ENST00000385188.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	185535_[GENE=EPCAM_PHENOS=Diarrhea 5, with tufting enteropathy, congenital, 613217 (3), Autosomal recessive; Lynch syndrome 8, 613244 (3), Autosomal dominant]	183700 [benign DISEASE=Lynch syndrome 1,Congenital diarrhea 5 with tufting enteropathy,Hereditary cancer-predisposing syndrome,Hereditary nonpolyposis colorectal neoplasms,not specified,not provided];			rs1126497	0.57686	0.83076,0.49368,0.81685,0.44256,0.49813	27689,	32169	64219	0.0500	T(1.00),T(1.00), 	B(0.00),B(0.00), 	11.74	0.18		COSV55392922	0.02	25741868,24033266,22938532,28652652,29458332,27900359,26318430,20683652,22322561,26115884,31511551,30089705,24304228,22781090,24718422,28366820,33240400,34573430,35070966	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EPCAM (inh=AR oe_syn=1.27 oe_mis=1.31 oe_lof=0.73), MIR559 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	47374118	47374118	T	C	het	off-target	QUAL=6205;DP=541;QD=11.47;AF=0.46;MQM=60;SAP=3;ABP=11;SAR=124;SAF=124	EPCAM,MIR559	intron,upstream_gene	EPCAM:ENST00000405271.5:intron_variant:MODIFIER:intron4/9:c.509+70T>C::,EPCAM:ENST00000263735.9:intron_variant:MODIFIER:intron3/8:c.425+70T>C::,MIR559:ENST00000385188.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	185535_[GENE=EPCAM_PHENOS=Diarrhea 5, with tufting enteropathy, congenital, 613217 (3), Autosomal recessive; Lynch syndrome 8, 613244 (3), Autosomal dominant]	1297204 [benign DISEASE=not provided];		L1ME4b (LINE/L1)	rs4399765	0.11217	0.08789,0.11577,0.25762,0.11001,0.12759	1057,	14937	134965	0.5230			11.74			COSV55394939	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EPCAM (inh=AR oe_syn=1.27 oe_mis=1.31 oe_lof=0.73), MIR559 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	47375102	47375102	T	C	het	off-target	QUAL=228;DP=27;QD=8.44;AF=0.48;MQM=60;SAP=31;ABP=3;SAR=0;SAF=13	EPCAM,MIR559	intron,upstream_gene	EPCAM:ENST00000405271.5:intron_variant:MODIFIER:intron4/9:c.510-132T>C::,EPCAM:ENST00000263735.9:intron_variant:MODIFIER:intron3/8:c.426-132T>C::,MIR559:ENST00000385188.1:upstream_gene_variant:MODIFIER::::		185535_[GENE=EPCAM_PHENOS=Diarrhea 5, with tufting enteropathy, congenital, 613217 (3), Autosomal recessive; Lynch syndrome 8, 613244 (3), Autosomal dominant]	1294299 [benign DISEASE=not provided];			rs35079997	0.10804	0.15748,0.10401,0.25385,0.07203,0.12116	1065,	14300	135638	-0.5780			0.34				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EPCAM (inh=AR oe_syn=1.27 oe_mis=1.31 oe_lof=0.73), MIR559 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	47379635	47379635	A	G	het	off-target	QUAL=92;DP=12;QD=7.67;AF=0.50;MQM=60;SAP=16;ABP=3;SAR=0;SAF=6	EPCAM,MIR559,Metazoa_SRP	intron,downstream_gene,upstream_gene	EPCAM:ENST00000405271.5:intron_variant:MODIFIER:intron7/9:c.742-134A>G::,EPCAM:ENST00000263735.9:intron_variant:MODIFIER:intron6/8:c.658-134A>G::,MIR559:ENST00000385188.1:downstream_gene_variant:MODIFIER::::,Metazoa_SRP:ENST00000622819.1:upstream_gene_variant:MODIFIER::::		185535_[GENE=EPCAM_PHENOS=Diarrhea 5, with tufting enteropathy, congenital, 613217 (3), Autosomal recessive; Lynch syndrome 8, 613244 (3), Autosomal dominant]	1292215 [benign DISEASE=not provided];			rs3923559	0.57173	0.83792,0.49324,0.81334,0.42921,0.48158	27505,	31881	65087	-0.5650			1.31				0	30089705	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EPCAM (inh=AR oe_syn=1.27 oe_mis=1.31 oe_lof=0.73), MIR559 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	47385017	47385017	A	G	het	off-target	QUAL=734;DP=74;QD=9.92;AF=0.43;MQM=60;SAP=5;ABP=6;SAR=13;SAF=19	EPCAM,Metazoa_SRP	intron,downstream_gene	EPCAM:ENST00000405271.5:intron_variant:MODIFIER:intron8/9:c.943-149A>G::,EPCAM:ENST00000263735.9:intron_variant:MODIFIER:intron7/8:c.859-149A>G::,Metazoa_SRP:ENST00000622819.1:downstream_gene_variant:MODIFIER::::		185535_[GENE=EPCAM_PHENOS=Diarrhea 5, with tufting enteropathy, congenital, 613217 (3), Autosomal recessive; Lynch syndrome 8, 613244 (3), Autosomal dominant]	1244355 [benign DISEASE=not provided];			rs4952886	0.10305	0.15260,0.10114,0.17238,0.07173,0.10941	917,	13838	136416	-0.2420			1.36				0	21093899	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EPCAM (inh=AR oe_syn=1.27 oe_mis=1.31 oe_lof=0.73)
chr2	47408384	47408384	-	T	het	off-target	QUAL=53;DP=17;QD=3.12;AF=0.35;MQM=60;SAP=16;ABP=6;SAR=6;SAF=0	MSH2	splice_region&intron	MSH2:ENST00000543555.6:splice_region_variant&intron_variant:LOW:intron2/16:c.14-4dup::,MSH2:ENST00000645506.1:splice_region_variant&intron_variant:LOW:intron1/16:c.212-4dup::,MSH2:ENST00000406134.5:splice_region_variant&intron_variant:LOW:intron1/15:c.212-4dup::,MSH2:ENST00000233146.7:splice_region_variant&intron_variant:LOW:intron1/15:c.212-4dup::		609309_[GENE=MSH2_PHENOS=Lynch syndrome 1, 120435 (3), Autosomal dominant; Muir-Torre syndrome, 158320 (3), Autosomal dominant; Mismatch repair cancer syndrome 2, 619096 (3), Autosomal recessive]	491795 [benign/likely benign DISEASE=Lynch syndrome 1,Hereditary cancer-predisposing syndrome,not specified,Breast and/or ovarian cancer];			rs746333570	0.00188	0.00053,0.00140,0.00040,0.00132,0.01149	1,	268	143532				5.55				0.01		0	163	0 / 8					MSH2 (inh=AR+AD oe_syn=1.18 oe_mis=1.31 oe_lof=0.19)
chr2	47412708	47412708	T	-	het	off-target	QUAL=80;DP=229;QD=0.35;AF=0.17;MQM=60;SAP=88;ABP=219;SAR=39;SAF=0	MSH2	intron	MSH2:ENST00000543555.6:intron_variant:MODIFIER:intron5/16:c.594+161del::,MSH2:ENST00000645506.1:intron_variant:MODIFIER:intron4/16:c.792+161del::,MSH2:ENST00000406134.5:intron_variant:MODIFIER:intron4/15:c.792+161del::,MSH2:ENST00000233146.7:intron_variant:MODIFIER:intron4/15:c.792+161del::		609309_[GENE=MSH2_PHENOS=Lynch syndrome 1, 120435 (3), Autosomal dominant; Muir-Torre syndrome, 158320 (3), Autosomal dominant; Mismatch repair cancer syndrome 2, 619096 (3), Autosomal recessive]			AluSp (SINE/Alu)	rs1236136541	0.00471	0.00210,0.00305,0.00121,0.00599,0.00155	3,	666	141898	0.1840			1.30				0.02		6	67	0 / 9					MSH2 (inh=AR+AD oe_syn=1.18 oe_mis=1.31 oe_lof=0.19)
chr2	47445430	47445430	G	A	het	off-target	QUAL=2067;DP=204;QD=10.13;AF=0.48;MQM=60;SAP=216;ABP=4;SAR=0;SAF=98	MSH2	intron	MSH2:ENST00000543555.6:intron_variant:MODIFIER:intron8/16:c.1079-118G>A::,MSH2:ENST00000645506.1:intron_variant:MODIFIER:intron7/16:c.1277-118G>A::,MSH2:ENST00000406134.5:intron_variant:MODIFIER:intron7/15:c.1277-118G>A::,MSH2:ENST00000233146.7:intron_variant:MODIFIER:intron7/15:c.1277-118G>A::		609309_[GENE=MSH2_PHENOS=Lynch syndrome 1, 120435 (3), Autosomal dominant; Muir-Torre syndrome, 158320 (3), Autosomal dominant; Mismatch repair cancer syndrome 2, 619096 (3), Autosomal recessive]	90599 [benign DISEASE=Lynch syndrome,not specified,not provided];			rs1981929	0.71882	0.90715,0.73010,0.85362,0.60338,0.70583	40656,	27960	42744	0.0930			0.91				0	29936769,23565320,20386703,21093899,19930554,28093084,27090025,24578158,24114314,21566726,32742474,32756484	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH2 (inh=AR+AD oe_syn=1.18 oe_mis=1.31 oe_lof=0.19)
chr2	47783349	47783349	G	A	het		QUAL=143;DP=14;QD=10.21;AF=0.50;MQM=60;SAP=3;ABP=3;SAR=3;SAF=4	MSH6,U6	intron,missense,downstream_gene	MSH6:ENST00000652107.1:intron_variant:MODIFIER:intron3/11:c.-37-7578G>A::,MSH6:ENST00000234420.11:missense_variant:MODERATE:exon1/10:c.116G>A:p.Gly39Glu:,MSH6:ENST00000700000.1:missense_variant:MODERATE:exon1/10:c.116G>A:p.Gly39Glu:,MSH6:ENST00000673637.1:intron_variant:MODIFIER:intron1/9:c.-38+118G>A::,MSH6:ENST00000700002.1:missense_variant:MODERATE:exon1/10:c.116G>A:p.Gly39Glu:,MSH6:ENST00000540021.6:missense_variant:MODERATE:exon1/8:c.116G>A:p.Gly39Glu:,U6:ENST00000636749.1:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	600678_[GENE=MSH6_PHENOS=Lynch syndrome 5, 614350 (3), Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; {Endometrial cancer, familial}, 608089 (3), Somatic mutation, Autosomal dominant]	36581 [benign DISEASE=Breast carcinoma,Carcinoma of colon,Lynch syndrome,Lynch syndrome 1,Lynch syndrome 5,Hereditary cancer-predisposing syndrome,Hereditary nonpolyposis colorectal neoplasms,not specified,not provided];	CM092149 [CLASS=DP MUT=ALT PHEN="Colorectal cancer association with" GENE=MSH6];		rs1042821	0.18880	0.21535,0.14547,0.24621,0.17996,0.20676	2796,	23113	123337	1.7840	 ,T(0.60),T(0.38), ,T(0.61),T(0.39), 	 , ,P(0.83), ,B(0.34), (0.00), 	16.79	0.16		COSV52274018	0	25741868,24033266,25491747,26811195,30337837,23757202,22623965,18701435,21700777,23720673,21036793,26900293,22703879,29458332,19781088,20149637,29616133,27900359,31374908,28749454,18523027,19389263,24689082,22294770,22949387,25023197,24383517,17108146,26027715,10507723,10537275,10699937,15805151,1958276,8838326,16203774,16270383,16771955,17205513,18355840,19582761,19685280,25938433,28481244,29365312,31031852,23436172,18851982,32773772,21286719,32957448,32756484,32053874,35541922,35868444	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34)
chr2	47790891	47790891	A	G	het	off-target	QUAL=10793;DP=923;QD=11.69;AF=0.46;MQM=60;SAP=3;ABP=14;SAR=214;SAF=214	MSH6,FBXO11	intron	MSH6:ENST00000652107.1:intron_variant:MODIFIER:intron3/11:c.-37-36A>G::,MSH6:ENST00000234420.11:intron_variant:MODIFIER:intron1/9:c.261-36A>G::,MSH6:ENST00000700000.1:intron_variant:MODIFIER:intron1/9:c.261-36A>G::,MSH6:ENST00000673637.1:intron_variant:MODIFIER:intron1/9:c.-37-36A>G::,MSH6:ENST00000700002.1:intron_variant:MODIFIER:intron1/9:c.261-36A>G::,MSH6:ENST00000540021.6:intron_variant:MODIFIER:intron1/7:c.237+7421A>G::,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.170-1451T>C::		600678_[GENE=MSH6_PHENOS=Lynch syndrome 5, 614350 (3), Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; {Endometrial cancer, familial}, 608089 (3), Somatic mutation, Autosomal dominant]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	89301 [benign DISEASE=Lynch syndrome,not specified,not provided];			rs1800931	0.03569	0.01069,0.03801,0.02288,0.05517,0.01698	131,	5170	146752	0.4140			13.73			COSV104579250	0		47	2135	11 / 433					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	47795761	47795761	A	G	hom	off-target	QUAL=179;DP=7;QD=25.57;AF=1.00;MQM=60;SAP=18;ABP=0;SAR=0;SAF=7	MSH6,FBXO11,RPL36AP15	intron,downstream_gene	MSH6:ENST00000652107.1:intron_variant:MODIFIER:intron4/11:c.161-133A>G::,MSH6:ENST00000234420.11:intron_variant:MODIFIER:intron2/9:c.458-133A>G::,MSH6:ENST00000700000.1:intron_variant:MODIFIER:intron2/9:c.458-133A>G::,MSH6:ENST00000673637.1:intron_variant:MODIFIER:intron2/9:c.161-133A>G::,MSH6:ENST00000700002.1:intron_variant:MODIFIER:intron2/9:c.458-133A>G::,MSH6:ENST00000540021.6:intron_variant:MODIFIER:intron1/7:c.238-2850A>G::,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.170-6321T>C::,RPL36AP15:ENST00000444514.1:downstream_gene_variant:MODIFIER::::		600678_[GENE=MSH6_PHENOS=Lynch syndrome 5, 614350 (3), Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; {Endometrial cancer, familial}, 608089 (3), Somatic mutation, Autosomal dominant]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	676475 [benign DISEASE=not provided];		AluSz (SINE/Alu)	rs3136316	0.79901	0.92841,0.74084,0.89089,0.74661,0.80941	48987,	23207	30483	-2.9530			1.09				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02), RPL36AP15 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	47795842	47795842	G	T	het	off-target	QUAL=281;DP=26;QD=10.81;AF=0.46;MQM=60;SAP=15;ABP=3;SAR=2;SAF=10	MSH6,FBXO11,RPL36AP15	intron,downstream_gene	MSH6:ENST00000652107.1:intron_variant:MODIFIER:intron4/11:c.161-52G>T::,MSH6:ENST00000234420.11:intron_variant:MODIFIER:intron2/9:c.458-52G>T::,MSH6:ENST00000700000.1:intron_variant:MODIFIER:intron2/9:c.458-52G>T::,MSH6:ENST00000673637.1:intron_variant:MODIFIER:intron2/9:c.161-52G>T::,MSH6:ENST00000700002.1:intron_variant:MODIFIER:intron2/9:c.458-52G>T::,MSH6:ENST00000540021.6:intron_variant:MODIFIER:intron1/7:c.238-2769G>T::,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.170-6402C>A::,RPL36AP15:ENST00000444514.1:downstream_gene_variant:MODIFIER::::		600678_[GENE=MSH6_PHENOS=Lynch syndrome 5, 614350 (3), Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; {Endometrial cancer, familial}, 608089 (3), Somatic mutation, Autosomal dominant]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	89532 [benign DISEASE=Lynch syndrome,not provided];		FLAM_C (SINE/Alu)	rs1800934	0.20843	0.29408,0.15689,0.25125,0.17416,0.20514	3539,	24576	120218	0.3750			2.12			COSV52273967	0	19906786,20386703,18723338,25329635,29290338,32858845	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02), RPL36AP15 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	47803319	47803319	G	C	hom	off-target	QUAL=2021;DP=66;QD=30.62;AF=1.00;MQM=60;SAP=37;ABP=0;SAR=17;SAF=49	MSH6,FBXO11	intron,downstream_gene	MSH6:ENST00000652107.1:intron_variant:MODIFIER:intron6/11:c.2876-101G>C::,MSH6:ENST00000234420.11:intron_variant:MODIFIER:intron4/9:c.3173-101G>C::,MSH6:ENST00000700000.1:intron_variant:MODIFIER:intron4/9:c.1607-101G>C::,MSH6:ENST00000673637.1:intron_variant:MODIFIER:intron4/9:c.2876-101G>C::,MSH6:ENST00000700002.1:intron_variant:MODIFIER:intron4/9:c.3179-101G>C::,MSH6:ENST00000540021.6:intron_variant:MODIFIER:intron2/7:c.2783-101G>C::,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.169+4876C>G::,FBXO11:ENST00000402508.5:downstream_gene_variant:MODIFIER::::,FBXO11:ENST00000403359.8:downstream_gene_variant:MODIFIER::::,FBXO11:ENST00000683894.1:downstream_gene_variant:MODIFIER::::		600678_[GENE=MSH6_PHENOS=Lynch syndrome 5, 614350 (3), Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; {Endometrial cancer, familial}, 608089 (3), Somatic mutation, Autosomal dominant]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	89345 [benign DISEASE=Lynch syndrome,not specified,not provided];			rs2072447	0.78316	0.92121,0.72157,0.87891,0.73047,0.76328	47310,	24403	32955	-0.4200			1.43				0.01	27090025,18851982	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	47803553	47803553	T	A	het		QUAL=247;DP=17;QD=14.53;AF=0.65;MQM=60;SAP=27;ABP=6;SAR=0;SAF=11	MSH6,FBXO11	synonymous,intron,downstream_gene	MSH6:ENST00000652107.1:synonymous_variant:LOW:exon7/12:c.3009T>A:p.Thr1003=:,MSH6:ENST00000234420.11:synonymous_variant:LOW:exon5/10:c.3306T>A:p.Thr1102=:,MSH6:ENST00000700000.1:synonymous_variant:LOW:exon5/10:c.1740T>A:p.Thr580=:,MSH6:ENST00000673637.1:synonymous_variant:LOW:exon5/10:c.3009T>A:p.Thr1003=:,MSH6:ENST00000700002.1:synonymous_variant:LOW:exon5/10:c.3312T>A:p.Thr1104=:,MSH6:ENST00000540021.6:synonymous_variant:LOW:exon3/8:c.2916T>A:p.Thr972=:,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.169+4642A>T::,FBXO11:ENST00000402508.5:downstream_gene_variant:MODIFIER::::,FBXO11:ENST00000403359.8:downstream_gene_variant:MODIFIER::::,FBXO11:ENST00000683894.1:downstream_gene_variant:MODIFIER::::		600678_[GENE=MSH6_PHENOS=Lynch syndrome 5, 614350 (3), Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; {Endometrial cancer, familial}, 608089 (3), Somatic mutation, Autosomal dominant]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	36589 [benign DISEASE=Carcinoma of colon,Lynch syndrome,Lynch syndrome 5,Hereditary cancer-predisposing syndrome,Hereditary nonpolyposis colorectal neoplasms,not specified,not provided];			rs2020910	0.01153	0.00710,0.00708,0.19722,0.00163,0.01328	112,	1529	150327	-2.3440			0.17			COSV52275019	0.02	25741868,23757202,26900293,28093084,29434720,10537275,15805151,10413423,16010685,16638864,19685281,31660093,32742474	9	294	1 / 57	1	"[1] Ilnaz Sepahi 29-03-2016 batch import"			MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	47803699	47803699	A	T	het	off-target	QUAL=2490;DP=238;QD=10.46;AF=0.49;MQM=60;SAP=208;ABP=3;SAR=6;SAF=111	MSH6,FBXO11	splice_region&intron,intron,downstream_gene	MSH6:ENST00000652107.1:splice_region_variant&intron_variant:LOW:intron7/11:c.3141+14A>T::,MSH6:ENST00000234420.11:splice_region_variant&intron_variant:LOW:intron5/9:c.3438+14A>T::,MSH6:ENST00000700000.1:splice_region_variant&intron_variant:LOW:intron5/9:c.1872+14A>T::,MSH6:ENST00000673637.1:splice_region_variant&intron_variant:LOW:intron5/9:c.3141+14A>T::,MSH6:ENST00000700002.1:splice_region_variant&intron_variant:LOW:intron5/9:c.3444+14A>T::,MSH6:ENST00000540021.6:splice_region_variant&intron_variant:LOW:intron3/7:c.3048+14A>T::,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.169+4496T>A::,FBXO11:ENST00000402508.5:downstream_gene_variant:MODIFIER::::,FBXO11:ENST00000403359.8:downstream_gene_variant:MODIFIER::::,FBXO11:ENST00000683894.1:downstream_gene_variant:MODIFIER::::		600678_[GENE=MSH6_PHENOS=Lynch syndrome 5, 614350 (3), Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; {Endometrial cancer, familial}, 608089 (3), Somatic mutation, Autosomal dominant]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	42471 [benign DISEASE=Endometrial carcinoma,Lynch syndrome,Lynch syndrome 5,Hereditary cancer-predisposing syndrome,Mismatch repair cancer syndrome 3,Hereditary nonpolyposis colorectal neoplasms,not specified,Breast and/or ovarian cancer,not provided];			rs2020911	0.33434	0.17502,0.43500,0.61818,0.37396,0.49399	9379,	32037	101131	-0.0370			3.84			COSV52273834	0	25741868,24033266,23757202,20386703,24689082,16847180,25938433,28481244,31660093	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	47805736	47805739	CTAT	-	het	off-target	QUAL=598;DP=43;QD=13.91;AF=0.58;MQM=60;SAP=7;ABP=5;SAR=9;SAF=16	MSH6,FBXO11	intron,downstream_gene	MSH6:ENST00000652107.1:intron_variant:MODIFIER:intron9/11:c.3349+35_3349+38del::,MSH6:ENST00000234420.11:intron_variant:MODIFIER:intron7/9:c.3646+35_3646+38del::,MSH6:ENST00000700000.1:intron_variant:MODIFIER:intron7/9:c.2080+35_2080+38del::,MSH6:ENST00000673637.1:intron_variant:MODIFIER:intron7/9:c.3349+35_3349+38del::,MSH6:ENST00000700002.1:intron_variant:MODIFIER:intron7/9:c.3652+35_3652+38del::,MSH6:ENST00000540021.6:intron_variant:MODIFIER:intron5/7:c.3256+35_3256+38del::,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.169+2456_169+2459del::,FBXO11:ENST00000402508.5:downstream_gene_variant:MODIFIER::::,FBXO11:ENST00000403359.8:downstream_gene_variant:MODIFIER::::,FBXO11:ENST00000683894.1:downstream_gene_variant:MODIFIER::::		600678_[GENE=MSH6_PHENOS=Lynch syndrome 5, 614350 (3), Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; {Endometrial cancer, familial}, 608089 (3), Somatic mutation, Autosomal dominant]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	89429 [benign DISEASE=Lynch syndrome,not specified,not provided];			rs1805181	0.70636	0.79686,0.59945,0.85892,0.67001,0.74086	38205,	30586	44480	1.3380			1.21				0	28481244	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	47805798	47805798	T	C	hom	off-target	QUAL=1373;DP=44;QD=31.20;AF=1.00;MQM=60;SAP=13;ABP=0;SAR=15;SAF=29	MSH6,FBXO11	intron,downstream_gene	MSH6:ENST00000652107.1:intron_variant:MODIFIER:intron9/11:c.3349+91T>C::,MSH6:ENST00000234420.11:intron_variant:MODIFIER:intron7/9:c.3646+91T>C::,MSH6:ENST00000700000.1:intron_variant:MODIFIER:intron7/9:c.2080+91T>C::,MSH6:ENST00000673637.1:intron_variant:MODIFIER:intron7/9:c.3349+91T>C::,MSH6:ENST00000700002.1:intron_variant:MODIFIER:intron7/9:c.3652+91T>C::,MSH6:ENST00000540021.6:intron_variant:MODIFIER:intron5/7:c.3256+91T>C::,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.169+2397A>G::,FBXO11:ENST00000402508.5:downstream_gene_variant:MODIFIER::::,FBXO11:ENST00000403359.8:downstream_gene_variant:MODIFIER::::,FBXO11:ENST00000683894.1:downstream_gene_variant:MODIFIER::::		600678_[GENE=MSH6_PHENOS=Lynch syndrome 5, 614350 (3), Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; {Endometrial cancer, familial}, 608089 (3), Somatic mutation, Autosomal dominant]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	89432 [benign DISEASE=Lynch syndrome,Hereditary nonpolyposis colorectal neoplasms,not specified,not provided];	CS1714498 [CLASS=R MUT=ALT PHEN="Lynch syndrome" GENE=MSH6];		rs3136359	0.77765	0.91925,0.66669,0.86407,0.73012,0.75901	46722,	24774	33802	-2.1920			1.40			COSV52273843	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	47806412	47806412	C	G	hom	off-target	QUAL=1514;DP=48;QD=31.54;AF=1.00;MQM=60;SAP=5;ABP=0;SAR=27;SAF=21	MSH6,FBXO11	intron,downstream_gene	MSH6:ENST00000652107.1:intron_variant:MODIFIER:intron10/11:c.3505-40C>G::,MSH6:ENST00000234420.11:intron_variant:MODIFIER:intron8/9:c.3802-40C>G::,MSH6:ENST00000700000.1:intron_variant:MODIFIER:intron8/9:c.2236-40C>G::,MSH6:ENST00000673637.1:intron_variant:MODIFIER:intron8/9:c.3505-40C>G::,MSH6:ENST00000700002.1:intron_variant:MODIFIER:intron8/9:c.3808-40C>G::,MSH6:ENST00000540021.6:intron_variant:MODIFIER:intron6/7:c.3412-40C>G::,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.169+1783G>C::,FBXO11:ENST00000402508.5:downstream_gene_variant:MODIFIER::::,FBXO11:ENST00000403359.8:downstream_gene_variant:MODIFIER::::,FBXO11:ENST00000683894.1:downstream_gene_variant:MODIFIER::::		600678_[GENE=MSH6_PHENOS=Lynch syndrome 5, 614350 (3), Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; {Endometrial cancer, familial}, 608089 (3), Somatic mutation, Autosomal dominant]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	36594 [benign DISEASE=Lynch syndrome,Lynch syndrome 5,not specified,not provided];			rs3136367	0.77247	0.91481,0.66041,0.87505,0.72530,0.75497	46108,	25180	34578	-1.0020			0.34			COSV52273637	0	25741868,16847180,10699937,14520694,11807791,21155762	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	47806752	47806752	T	-	het	off-target;low_conf_region	QUAL=238;DP=27;QD=8.81;AF=0.41;MQM=60;SAP=13;ABP=5;SAR=2;SAF=9	MSH6,FBXO11	splice_region&intron,intron,downstream_gene	MSH6:ENST00000652107.1:splice_region_variant&intron_variant:LOW:intron11/11:c.3705-10del::,MSH6:ENST00000234420.11:splice_region_variant&intron_variant:LOW:intron9/9:c.4002-10del::,MSH6:ENST00000700000.1:splice_region_variant&intron_variant:LOW:intron9/9:c.2436-10del::,MSH6:ENST00000673637.1:splice_region_variant&intron_variant:LOW:intron9/9:c.3705-10del::,MSH6:ENST00000700002.1:splice_region_variant&intron_variant:LOW:intron9/9:c.4008-10del::,MSH6:ENST00000540021.6:splice_region_variant&intron_variant:LOW:intron7/7:c.3612-10del::,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.169+1443del::,FBXO11:ENST00000402508.5:downstream_gene_variant:MODIFIER::::,FBXO11:ENST00000403359.8:downstream_gene_variant:MODIFIER::::,FBXO11:ENST00000683894.1:downstream_gene_variant:MODIFIER::::		600678_[GENE=MSH6_PHENOS=Lynch syndrome 5, 614350 (3), Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; {Endometrial cancer, familial}, 608089 (3), Somatic mutation, Autosomal dominant]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	89508 [likely benign DISEASE=Lynch syndrome,Lynch syndrome 5,not specified,Breast and/or ovarian cancer,not provided];		(T)n (Simple_repeat)	rs59056100	0.27616	0.30168,0.19999,0.23913,0.28062,0.21725	4785,	28616	100088	-1.0800			0.01				0.04		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	146839405	146839405	A	G	het		QUAL=10814;DP=814;QD=13.29;AF=0.51;MQM=60;SAP=3;ABP=4;SAR=211;SAF=204	LINC01911	intron&non_coding_transcript	LINC01911:ENST00000696349.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.259-7224A>G::,LINC01911:ENST00000656564.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.320+1359A>G::,LINC01911:ENST00000450667.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/10:n.229+1200A>G::,LINC01911:ENST00000670621.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.291+1359A>G::,LINC01911:ENST00000669097.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/8:n.280+1359A>G::,LINC01911:ENST00000696350.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/11:n.77+1200A>G::						rs4411641	0.48136	0.63712,0.52039,0.45595,0.39978,0.43527	18524,	36016	78722	0.2300			3.78						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LINC01911 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	189805813	189805813	-	A	het	off-target	QUAL=41;DP=43;QD=0.95;AF=0.19;MQM=60;SAP=20;ABP=40;SAR=0;SAF=8	PMS1	intron,frameshift	PMS1:ENST00000418224.7:intron_variant:MODIFIER:intron4/10:c.418+70dup::,PMS1:ENST00000432292.7:intron_variant:MODIFIER:intron2/10:c.-110-12193dup::,PMS1:ENST00000618056.4:intron_variant:MODIFIER:intron4/5:c.418+70dup::,PMS1:ENST00000624204.3:intron_variant:MODIFIER:intron3/11:c.-111+9873dup::,PMS1:ENST00000409985.5:frameshift_variant:HIGH:exon4/4:c.488dup:p.Leu164ValfsTer4:,PMS1:ENST00000441310.7:intron_variant:MODIFIER:intron4/12:c.418+70dup::,PMS1:ENST00000409823.7:intron_variant:MODIFIER:intron4/11:c.418+70dup::,PMS1:ENST00000374826.8:intron_variant:MODIFIER:intron4/4:c.418+70dup::,PMS1:ENST00000447232.6:intron_variant:MODIFIER:intron4/11:c.418+70dup::			1228750 [benign DISEASE=not provided];	CI229062 [CLASS=DM MUT=ALT PHEN="Constitutional mismatch repair deficiency syndrome" GENE=PMS1];		rs3214425	0.22847	0.28964,0.25242,0.22950,0.19875,0.12356	3953,	26107	114859				1.27				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS1 (inh=AD oe_syn=0.84 oe_mis=0.92 oe_lof=0.76)
chr2	189817906	189817906	G	C	het	off-target	QUAL=2280;DP=304;QD=7.50;AF=0.50;MQM=60;SAP=335;ABP=3;SAR=0;SAF=153	PMS1	intron	PMS1:ENST00000418224.7:intron_variant:MODIFIER:intron4/10:c.419-111G>C::,PMS1:ENST00000432292.7:intron_variant:MODIFIER:intron2/10:c.-110-111G>C::,PMS1:ENST00000618056.4:intron_variant:MODIFIER:intron4/5:c.419-111G>C::,PMS1:ENST00000624204.3:intron_variant:MODIFIER:intron3/11:c.-110-111G>C::,PMS1:ENST00000441310.7:intron_variant:MODIFIER:intron4/12:c.419-111G>C::,PMS1:ENST00000409823.7:intron_variant:MODIFIER:intron4/11:c.419-111G>C::,PMS1:ENST00000447232.6:intron_variant:MODIFIER:intron4/11:c.419-111G>C::			1283805 [benign DISEASE=not provided];			rs3791773	0.22463	0.28365,0.24951,0.22641,0.19657,0.12080	4027,	26064	117770	0.7580			8.80				0	25162662	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS1 (inh=AD oe_syn=0.84 oe_mis=0.92 oe_lof=0.76)
chr2	214728509	214728509	T	C	het	off-target	QUAL=1777;DP=201;QD=8.84;AF=0.46;MQM=60;SAP=205;ABP=5;SAR=0;SAF=93	BARD1	3'UTR,downstream_gene	BARD1:ENST00000260947.9:3_prime_UTR_variant:MODIFIER:exon11/11:c.*167A>G::,BARD1:ENST00000619009.5:downstream_gene_variant:MODIFIER::::,BARD1:ENST00000617164.5:downstream_gene_variant:MODIFIER::::,BARD1:ENST00000613374.5:downstream_gene_variant:MODIFIER::::,BARD1:ENST00000613706.5:downstream_gene_variant:MODIFIER::::,BARD1:ENST00000421162.2:downstream_gene_variant:MODIFIER::::,BARD1:ENST00000620057.4:downstream_gene_variant:MODIFIER::::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	1222105 [benign DISEASE=not provided];			rs5020511	0.64547	0.77044,0.54561,0.44359,0.61216,0.58183	31782,	33099	53093	-1.4770			1.18				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214728537	214728537	-	T	het	off-target	QUAL=1768;DP=264;QD=6.70;AF=0.30;MQM=60;SAP=86;ABP=95;SAR=12;SAF=67	BARD1	3'UTR,downstream_gene	BARD1:ENST00000260947.9:3_prime_UTR_variant:MODIFIER:exon11/11:c.*138dup::,BARD1:ENST00000619009.5:downstream_gene_variant:MODIFIER::::,BARD1:ENST00000617164.5:downstream_gene_variant:MODIFIER::::,BARD1:ENST00000613374.5:downstream_gene_variant:MODIFIER::::,BARD1:ENST00000613706.5:downstream_gene_variant:MODIFIER::::,BARD1:ENST00000421162.2:downstream_gene_variant:MODIFIER::::,BARD1:ENST00000620057.4:downstream_gene_variant:MODIFIER::::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	1292322 [benign DISEASE=not provided];			rs113789798	0.38741	0.26509,0.47675,0.64494,0.41576,0.48017	11461,	32819	88141				0.34				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214729127	214729127	G	C	het	off-target	QUAL=477;DP=46;QD=10.37;AF=0.48;MQM=60;SAP=13;ABP=3;SAR=16;SAF=6	BARD1	intron	BARD1:ENST00000260947.9:intron_variant:MODIFIER:intron10/10:c.2002-119C>G::,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron4/4:c.463-119C>G::,BARD1:ENST00000617164.5:intron_variant:MODIFIER:intron9/9:c.1945-119C>G::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron5/5:c.592-119C>G::,BARD1:ENST00000613706.5:intron_variant:MODIFIER:intron10/10:c.1594-119C>G::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron6/6:c.649-119C>G::,BARD1:ENST00000620057.4:intron_variant:MODIFIER:intron9/9:c.*668-119C>G::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	1292323 [benign DISEASE=not provided];		Tigger4b (DNA/TcMar-Tigger)	rs2075623	0.64163	0.76484,0.53724,0.43417,0.61129,0.57593	31964,	33572	54458	-0.8080			0.58				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214729147	214729147	T	G	het	off-target	QUAL=493;DP=46;QD=10.72;AF=0.48;MQM=60;SAP=13;ABP=3;SAR=16;SAF=6	BARD1	intron	BARD1:ENST00000260947.9:intron_variant:MODIFIER:intron10/10:c.2002-139A>C::,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron4/4:c.463-139A>C::,BARD1:ENST00000617164.5:intron_variant:MODIFIER:intron9/9:c.1945-139A>C::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron5/5:c.592-139A>C::,BARD1:ENST00000613706.5:intron_variant:MODIFIER:intron10/10:c.1594-139A>C::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron6/6:c.649-139A>C::,BARD1:ENST00000620057.4:intron_variant:MODIFIER:intron9/9:c.*668-139A>C::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	1292324 [benign DISEASE=not provided];		Tigger4b (DNA/TcMar-Tigger)	rs2075622	0.64167	0.76487,0.53728,0.43328,0.61148,0.57560	31984,	33574	54470	-0.2930			0.73				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214730440	214730440	G	A	het		QUAL=261;DP=27;QD=9.67;AF=0.44;MQM=60;SAP=4;ABP=4;SAR=7;SAF=5	BARD1	missense,3'UTR	BARD1:ENST00000260947.9:missense_variant:MODERATE:exon10/11:c.1972C>T:p.Arg658Cys:,BARD1:ENST00000619009.5:missense_variant:MODERATE:exon4/5:c.433C>T:p.Arg145Cys:,BARD1:ENST00000617164.5:missense_variant:MODERATE:exon9/10:c.1915C>T:p.Arg639Cys:,BARD1:ENST00000613374.5:missense_variant:MODERATE:exon5/6:c.562C>T:p.Arg188Cys:,BARD1:ENST00000613706.5:missense_variant:MODERATE:exon10/11:c.1564C>T:p.Arg522Cys:,BARD1:ENST00000421162.2:missense_variant:MODERATE:exon6/7:c.619C>T:p.Arg207Cys:,BARD1:ENST00000620057.4:3_prime_UTR_variant:MODIFIER:exon9/10:c.*638C>T::	regulatory_region_variant:enhancer	601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	136500 [benign(replaced by megSAP based on classifications:10x1,3x2,1x3) DISEASE=Hereditary breast ovarian cancer syndrome,Malignant tumor of breast,Hereditary cancer-predisposing syndrome,Familial cancer of breast,Triple-Negative Breast Cancer Finding,not specified,not provided];	CM067650 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=BARD1];		rs3738888	0.00733	0.00220,0.00661,0.00984,0.00846,0.00394	15,	1084	150936	5.2690	D(0.00),D(0.00),D(0.00),D(0.00),D(0.00),D(0.00), 	D(0.92),D(1.00),D(0.94),D(0.99),D(1.00),D(0.99), 	24.30	0.10		COSV53616840	0.01	25741868,29458332,27153395,32039725,16741161,19584272,23056176,26315354,19412175,31258718,16061562,20077502,9425226,15342711,16333312,25994375,26350354,26307947,26329992,26010302,32708251,35650591	2	365	0 / 67	2	"[2] Ilnaz Sepahi 29-03-2016 batch import"			BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214745589	214745589	G	T	het	off-target	QUAL=643;DP=57;QD=11.28;AF=0.53;MQM=60;SAP=45;ABP=3;SAR=27;SAF=3	BARD1	intron	BARD1:ENST00000260947.9:intron_variant:MODIFIER:intron8/10:c.1810+133C>A::,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.365-15081C>A::,BARD1:ENST00000617164.5:intron_variant:MODIFIER:intron7/9:c.1753+133C>A::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron3/5:c.400+133C>A::,BARD1:ENST00000613706.5:intron_variant:MODIFIER:intron8/10:c.1402+133C>A::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron4/6:c.457+133C>A::,BARD1:ENST00000620057.4:intron_variant:MODIFIER:intron7/9:c.*476+133C>A::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	1251354 [benign DISEASE=not provided];			rs6730040	0.48888	0.51784,0.53881,0.56581,0.46859,0.45859	18297,	37640	77612	-0.5570			0.09				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214745914	214745914	A	G	het	off-target	QUAL=3811;DP=271;QD=14.06;AF=0.51;MQM=60;SAP=3;ABP=3;SAR=70;SAF=69	BARD1	intron	BARD1:ENST00000260947.9:intron_variant:MODIFIER:intron7/10:c.1678-60T>C::,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.365-15406T>C::,BARD1:ENST00000617164.5:intron_variant:MODIFIER:intron6/9:c.1621-60T>C::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron2/5:c.268-60T>C::,BARD1:ENST00000613706.5:intron_variant:MODIFIER:intron7/10:c.1270-60T>C::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron3/6:c.325-60T>C::,BARD1:ENST00000620057.4:intron_variant:MODIFIER:intron6/9:c.*344-60T>C::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	676478 [likely benign DISEASE=Hereditary breast ovarian cancer syndrome,not provided];			rs4986842	0.00700	0.00222,0.00668,0.00115,0.00841,0.00352	15,	1036	151182	-1.4830			0.34				0		2	354	0 / 62					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214767401	214767402	TT	-	het	off-target	QUAL=1438;DP=104;QD=13.83;AF=0.55;MQM=60;SAP=6;ABP=5;SAR=33;SAF=24	BARD1	intron	BARD1:ENST00000260947.9:intron_variant:MODIFIER:intron6/10:c.1568+80_1568+81del::,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.364+24895_364+24896del::,BARD1:ENST00000617164.5:intron_variant:MODIFIER:intron5/9:c.1511+80_1511+81del::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron1/5:c.159-14847_159-14846del::,BARD1:ENST00000613706.5:intron_variant:MODIFIER:intron6/10:c.1160+80_1160+81del::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron2/6:c.216-14847_216-14846del::,BARD1:ENST00000620057.4:intron_variant:MODIFIER:intron5/9:c.*234+80_*234+81del::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	1292325 [benign DISEASE=not provided];			rs5031008	0.37106	0.37085,0.31848,0.37143,0.36410,0.41131	10564,	35191	95459	0.6430			2.39				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214767431	214767431	T	C	het	off-target	QUAL=1546;DP=108;QD=14.31;AF=0.56;MQM=60;SAP=6;ABP=7;SAR=35;SAF=26	BARD1	intron	BARD1:ENST00000260947.9:intron_variant:MODIFIER:intron6/10:c.1568+51A>G::,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.364+24866A>G::,BARD1:ENST00000617164.5:intron_variant:MODIFIER:intron5/9:c.1511+51A>G::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron1/5:c.159-14876A>G::,BARD1:ENST00000613706.5:intron_variant:MODIFIER:intron6/10:c.1160+51A>G::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron2/6:c.216-14876A>G::,BARD1:ENST00000620057.4:intron_variant:MODIFIER:intron5/9:c.*234+51A>G::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	1230936 [benign DISEASE=Hereditary breast ovarian cancer syndrome,not provided];			rs5031009	0.37124	0.37059,0.31873,0.37182,0.36429,0.41053	10628,	35086	95424	-3.4800			0.07			COSV53611189	0	29879995	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2022-06-22 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2021-03-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214767468	214767468	G	A	het	off-target	QUAL=1792;DP=112;QD=16.00;AF=0.58;MQM=60;SAP=4;ABP=9;SAR=35;SAF=30	BARD1	splice_region&intron,intron	BARD1:ENST00000260947.9:splice_region_variant&intron_variant:LOW:intron6/10:c.1568+14C>T::,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.364+24829C>T::,BARD1:ENST00000617164.5:splice_region_variant&intron_variant:LOW:intron5/9:c.1511+14C>T::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron1/5:c.159-14913C>T::,BARD1:ENST00000613706.5:splice_region_variant&intron_variant:LOW:intron6/10:c.1160+14C>T::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron2/6:c.216-14913C>T::,BARD1:ENST00000620057.4:splice_region_variant&intron_variant:LOW:intron5/9:c.*234+14C>T::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	256214 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];			rs5031011	0.35073	0.34565,0.30468,0.37267,0.34174,0.40407	9506,	34214	98534	-0.2950			1.75			COSV53615058	0.01	25741868,24033266,29879995	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214767531	214767531	C	T	het		QUAL=3056;DP=110;QD=27.78;AF=0.55;MQM=60;SAP=29;ABP=6;SAR=44;SAF=17	BARD1	missense,intron,3'UTR	BARD1:ENST00000260947.9:missense_variant:MODERATE:exon6/11:c.1519G>A:p.Val507Met:PF12796 [Ankyrin repeats (3 copies)],BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.364+24766G>A::,BARD1:ENST00000617164.5:missense_variant:MODERATE:exon5/10:c.1462G>A:p.Val488Met:PF12796 [Ankyrin repeats (3 copies)],BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron1/5:c.159-14976G>A::,BARD1:ENST00000613706.5:missense_variant:MODERATE:exon6/11:c.1111G>A:p.Val371Met:PF12796 [Ankyrin repeats (3 copies)],BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron2/6:c.216-14976G>A::,BARD1:ENST00000620057.4:3_prime_UTR_variant:MODIFIER:exon5/10:c.*185G>A::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	140757 [benign/likely benign DISEASE=Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];	CM034384 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=BARD1];		rs2070094	0.37121	0.37076,0.31899,0.37157,0.36392,0.41156	10590,	35226	95544	-5.2200	T(0.10), ,T(0.12), ,T(0.06), , 	B(0.02), ,B(0.00), ,B(0.03), , 	0.01	0.11		COSV53610001	0	25741868,23222812,29458332,29879995,19482343,19412175,25785002,14550946,17399677,33623049,23966609,33240400,35768791	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214767532	214767532	A	G	hom		QUAL=3056;DP=110;QD=27.78;AF=0.55;MQM=60;SAP=18;ABP=9;SAR=32;SAF=14	BARD1	synonymous,intron,3'UTR	BARD1:ENST00000260947.9:synonymous_variant:LOW:exon6/11:c.1518T>C:p.His506=:PF12796 [Ankyrin repeats (3 copies)],BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.364+24765T>C::,BARD1:ENST00000617164.5:synonymous_variant:LOW:exon5/10:c.1461T>C:p.His487=:PF12796 [Ankyrin repeats (3 copies)],BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron1/5:c.159-14977T>C::,BARD1:ENST00000613706.5:synonymous_variant:LOW:exon6/11:c.1110T>C:p.His370=:PF12796 [Ankyrin repeats (3 copies)],BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron2/6:c.216-14977T>C::,BARD1:ENST00000620057.4:3_prime_UTR_variant:MODIFIER:exon5/10:c.*184T>C::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	183704 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];			rs2070093	0.75575	0.59942,0.75426,0.94869,0.80486,0.83996	44222,	26415	37121	-0.2410			4.69			COSV53617490	0	25741868,24033266,19536092,17399677	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214769331	214769331	C	T	het	off-target	QUAL=2564;DP=270;QD=9.50;AF=0.47;MQM=60;SAP=262;ABP=5;SAR=125;SAF=2	BARD1	splice_region&intron,intron	BARD1:ENST00000260947.9:splice_region_variant&intron_variant:LOW:intron4/10:c.1315-19G>A::,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.364+22966G>A::,BARD1:ENST00000617164.5:splice_region_variant&intron_variant:LOW:intron3/9:c.1258-19G>A::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron1/5:c.159-16776G>A::,BARD1:ENST00000613706.5:splice_region_variant&intron_variant:LOW:intron4/10:c.907-19G>A::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron2/6:c.216-16776G>A::,BARD1:ENST00000620057.4:splice_region_variant&intron_variant:LOW:intron3/9:c.365-19G>A::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	256213 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];			rs6704780	0.37147	0.37128,0.31932,0.37153,0.36430,0.40835	10597,	35220	95452	0.1260			0.84		10.09>9.72	COSV53612311	0.01	25741868,29879995	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214780740	214780740	C	G	het		QUAL=1090;DP=79;QD=13.80;AF=0.53;MQM=60;SAP=8;ABP=4;SAR=26;SAF=16	BARD1	missense,intron	BARD1:ENST00000260947.9:missense_variant:MODERATE:exon4/11:c.1134G>C:p.Arg378Ser:,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.364+11557G>C::,BARD1:ENST00000617164.5:missense_variant:MODERATE:exon3/10:c.1077G>C:p.Arg359Ser:,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron1/5:c.159-28185G>C::,BARD1:ENST00000613706.5:intron_variant:MODIFIER:intron4/10:c.906+228G>C::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron2/6:c.215+16321G>C::,BARD1:ENST00000620057.4:intron_variant:MODIFIER:intron3/9:c.365-11428G>C::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	142769 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];	CM076014 [CLASS=DP MUT=ALT PHEN="Breast cancer reduced risk association with" GENE=BARD1];		rs2229571	0.53023	0.39854,0.47001,0.37291,0.61173,0.48196	22188,	36087	71287	-0.3950	T(0.39), ,T(0.33), , , , 	B(0.02), ,B(0.02), , , , 	4.32	0.11		COSV53612030	0.01	25741868,23554684,23222812,29458332,29879995,19482343,23056176,19412175,25785002,31258718,30071039,17028982,18059179,33623049,30976110,23966609,33603458,32708251,33240400,35084806,35650591,35768791	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214792151	214792151	A	-	het	off-target	QUAL=231;DP=41;QD=5.63;AF=0.27;MQM=60;SAP=3;ABP=22;SAR=6;SAF=5	BARD1	intron	BARD1:ENST00000260947.9:intron_variant:MODIFIER:intron3/10:c.364+146del::,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.364+146del::,BARD1:ENST00000617164.5:intron_variant:MODIFIER:intron2/9:c.307+146del::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron1/5:c.158+17261del::,BARD1:ENST00000613706.5:intron_variant:MODIFIER:intron3/10:c.364+146del::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron2/6:c.215+4910del::,BARD1:ENST00000620057.4:intron_variant:MODIFIER:intron3/9:c.364+146del::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]			FLAM_A (SINE/Alu)	rs536345234	0.00555	0.00831,0.00345,0.00133,0.00480,0.00101	0,	705	126261	0.6330			1.05			COSV53611842	0		8	361	0 / 105					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214809366	214809366	T	G	hom	off-target	QUAL=3841;DP=118;QD=32.55;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=60;SAF=58	BARD1,SNHG31	intron,upstream_gene	BARD1:ENST00000260947.9:intron_variant:MODIFIER:intron1/10:c.158+46A>C::,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron1/4:c.158+46A>C::,BARD1:ENST00000617164.5:intron_variant:MODIFIER:intron1/9:c.158+46A>C::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron1/5:c.158+46A>C::,BARD1:ENST00000613706.5:intron_variant:MODIFIER:intron1/10:c.158+46A>C::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron1/6:c.158+46A>C::,BARD1:ENST00000620057.4:intron_variant:MODIFIER:intron1/9:c.158+46A>C::,SNHG31:ENST00000670391.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	1174423 [benign DISEASE=Hereditary breast ovarian cancer syndrome,not provided];			rs35933323	0.73732	0.75970,0.78334,0.80510,0.71116,0.66743	41393,	29317	39939	0.1910			9.02				0	22328350,35131881	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2022-06-22 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2021-03-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03), SNHG31 (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	214809500	214809500	G	A	het		QUAL=8449;DP=776;QD=10.89;AF=0.49;MQM=60;SAP=3;ABP=4;SAR=192;SAF=188	BARD1,SNHG31	missense,upstream_gene	BARD1:ENST00000260947.9:missense_variant:MODERATE:exon1/11:c.70C>T:p.Pro24Ser:,BARD1:ENST00000619009.5:missense_variant:MODERATE:exon1/5:c.70C>T:p.Pro24Ser:,BARD1:ENST00000617164.5:missense_variant:MODERATE:exon1/10:c.70C>T:p.Pro24Ser:,BARD1:ENST00000613374.5:missense_variant:MODERATE:exon1/6:c.70C>T:p.Pro24Ser:,BARD1:ENST00000613706.5:missense_variant:MODERATE:exon1/11:c.70C>T:p.Pro24Ser:,BARD1:ENST00000421162.2:missense_variant:MODERATE:exon1/7:c.70C>T:p.Pro24Ser:,BARD1:ENST00000620057.4:missense_variant:MODERATE:exon1/10:c.70C>T:p.Pro24Ser:,SNHG31:ENST00000670391.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	183698 [benign DISEASE=Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];	CM076015 [CLASS=DP MUT=ALT PHEN="Breast cancer reduced risk association with" GENE=BARD1];		rs1048108	0.33277	0.21226,0.38560,0.36075,0.36986,0.40907	8911,	32768	101438	0.9900	T(0.11),D(0.03),T(0.10),D(0.01),T(0.61),T(0.06),T(0.08), 	B(0.06),P(0.81),B(0.01),P(0.81),P(0.81),P(0.81),B(0.01), 	19.26	0.26		COSV53608734	0	25741868,23554684,21514219,23222812,29484706,29458332,29879995,19482343,23056176,24293394,30132831,19412175,25785002,31258718,33623049,23966609,32708251,34094541,35768791	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03), SNHG31 (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	214809599	214809599	C	G	hom	off-target	QUAL=3232;DP=105;QD=30.78;AF=1.00;MQM=60;SAP=12;ABP=0;SAR=63;SAF=42	BARD1,SNHG31	5'UTR,upstream_gene	BARD1:ENST00000260947.9:5_prime_UTR_variant:MODIFIER:exon1/11:c.-30G>C::,BARD1:ENST00000617164.5:5_prime_UTR_variant:MODIFIER:exon1/10:c.-30G>C::,BARD1:ENST00000613374.5:5_prime_UTR_variant:MODIFIER:exon1/6:c.-30G>C::,BARD1:ENST00000613706.5:5_prime_UTR_variant:MODIFIER:exon1/11:c.-30G>C::,BARD1:ENST00000620057.4:5_prime_UTR_variant:MODIFIER:exon1/10:c.-30G>C::,BARD1:ENST00000619009.5:upstream_gene_variant:MODIFIER::::,BARD1:ENST00000421162.2:upstream_gene_variant:MODIFIER::::,SNHG31:ENST00000670391.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	334199 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Familial cancer of breast,not provided];			rs1129804	0.73675	0.75894,0.78349,0.80039,0.71091,0.66687	41325,	29344	40016	-0.2340			8.10				0	19252927,31258718	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03), SNHG31 (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	214809617	214809617	A	G	hom	off-target	QUAL=3155;DP=105;QD=30.05;AF=1.00;MQM=60;SAP=14;ABP=0;SAR=64;SAF=41	BARD1,SNHG31	5'UTR,upstream_gene	BARD1:ENST00000260947.9:5_prime_UTR_variant:MODIFIER:exon1/11:c.-48T>C::,BARD1:ENST00000617164.5:5_prime_UTR_variant:MODIFIER:exon1/10:c.-48T>C::,BARD1:ENST00000613374.5:5_prime_UTR_variant:MODIFIER:exon1/6:c.-48T>C::,BARD1:ENST00000613706.5:5_prime_UTR_variant:MODIFIER:exon1/11:c.-48T>C::,BARD1:ENST00000620057.4:5_prime_UTR_variant:MODIFIER:exon1/10:c.-48T>C::,BARD1:ENST00000619009.5:upstream_gene_variant:MODIFIER::::,BARD1:ENST00000421162.2:upstream_gene_variant:MODIFIER::::,SNHG31:ENST00000670391.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	334200 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Familial cancer of breast,not provided];			rs17489363	0.73688	0.75897,0.78334,0.80356,0.71094,0.66667	41341,	29332	39998	-2.5770			3.11				0	23056176,30132831,31258718,32021290,30793172,32708251,35650591,35768791	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03), SNHG31 (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	214809647	214809647	C	T	hom	off-target	QUAL=255;DP=9;QD=28.33;AF=1.00;MQM=60;SAP=9;ABP=0;SAR=2;SAF=7	BARD1,SNHG31	5'UTR,upstream_gene	BARD1:ENST00000260947.9:5_prime_UTR_variant:MODIFIER:exon1/11:c.-78G>A::,BARD1:ENST00000613706.5:5_prime_UTR_variant:MODIFIER:exon1/11:c.-78G>A::,BARD1:ENST00000619009.5:upstream_gene_variant:MODIFIER::::,BARD1:ENST00000617164.5:upstream_gene_variant:MODIFIER::::,BARD1:ENST00000613374.5:upstream_gene_variant:MODIFIER::::,BARD1:ENST00000421162.2:upstream_gene_variant:MODIFIER::::,BARD1:ENST00000620057.4:upstream_gene_variant:MODIFIER::::,SNHG31:ENST00000670391.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	334201 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Familial cancer of breast,not provided];			rs34732883	0.63842	0.60673,0.66933,0.80217,0.63189,0.60870	31126,	34847	54993	-0.0320			9.70				0	31258718	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03), SNHG31 (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	219550874	219550875	GA	-	hom	off-target	QUAL=4744;DP=148;QD=32.05;AF=0.99;MQM=60;SAP=4;ABP=0;SAR=77;SAF=69	OBSL1,TMEM198,MIR3132	intron,downstream_gene,upstream_gene	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron20/20:c.5684-33_5684-32del::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron19/19:c.5408-33_5408-32del::,TMEM198:ENST00000344458.6:downstream_gene_variant:MODIFIER::::,TMEM198:ENST00000373883.4:downstream_gene_variant:MODIFIER::::,MIR3132:ENST00000581997.1:upstream_gene_variant:MODIFIER::::,OBSL1:ENST00000603926.5:downstream_gene_variant:MODIFIER::::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1276422 [benign DISEASE=3M syndrome 2,not provided];			rs146790993	0.43774	0.40125,0.48254,0.40241,0.45944,0.25155	14809,	36788	85296	1.2180			17.26				0.22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219550924	219550924	T	C	hom	off-target	QUAL=4779;DP=158;QD=30.25;AF=0.99;MQM=60;SAP=3;ABP=0;SAR=77;SAF=79	OBSL1,TMEM198,MIR3132	intron,downstream_gene,upstream_gene	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron20/20:c.5684-82A>G::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron19/19:c.5408-82A>G::,TMEM198:ENST00000344458.6:downstream_gene_variant:MODIFIER::::,TMEM198:ENST00000373883.4:downstream_gene_variant:MODIFIER::::,MIR3132:ENST00000581997.1:upstream_gene_variant:MODIFIER::::,OBSL1:ENST00000603926.5:downstream_gene_variant:MODIFIER::::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1287989 [benign DISEASE=not provided];			rs1043582	0.43851	0.40209,0.48328,0.40606,0.45981,0.25155	14874,	36783	85191	0.2580			5.17			COSV54706169	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219551442	219551442	T	C	hom	off-target	QUAL=2746;DP=91;QD=30.18;AF=1.00;MQM=60;SAP=4;ABP=0;SAR=48;SAF=43	OBSL1,TMEM198,MIR3132	intron,downstream_gene,upstream_gene	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron20/20:c.5683+87A>G::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron19/19:c.5407+87A>G::,TMEM198:ENST00000344458.6:downstream_gene_variant:MODIFIER::::,TMEM198:ENST00000373883.4:downstream_gene_variant:MODIFIER::::,MIR3132:ENST00000581997.1:upstream_gene_variant:MODIFIER::::,OBSL1:ENST00000603926.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1247466 [benign DISEASE=not provided];			rs6761575	0.93992	0.80921,0.96392,0.99981,0.99334,0.99938	67547,	7654	9124	-1.7350			1.85				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219551848	219551848	C	T	hom	off-target	QUAL=341;DP=13;QD=26.23;AF=1.00;MQM=60;SAP=31;ABP=0;SAR=13;SAF=0	OBSL1,TMEM198,MIR3132	intron,downstream_gene,upstream_gene	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron19/20:c.5414-50G>A::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron18/19:c.5138-50G>A::,TMEM198:ENST00000344458.6:downstream_gene_variant:MODIFIER::::,TMEM198:ENST00000373883.4:downstream_gene_variant:MODIFIER::::,MIR3132:ENST00000581997.1:upstream_gene_variant:MODIFIER::::,OBSL1:ENST00000603926.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1274171 [benign DISEASE=not provided];			rs4672931	0.93101	0.77888,0.95956,0.99981,0.99319,0.99876	66559,	8500	10494	-0.4130			6.49				0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219551869	219551869	C	T	hom	off-target	QUAL=331;DP=13;QD=25.46;AF=1.00;MQM=60;SAP=31;ABP=0;SAR=13;SAF=0	OBSL1,TMEM198,MIR3132	intron,downstream_gene,upstream_gene	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron19/20:c.5414-71G>A::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron18/19:c.5138-71G>A::,TMEM198:ENST00000344458.6:downstream_gene_variant:MODIFIER::::,TMEM198:ENST00000373883.4:downstream_gene_variant:MODIFIER::::,MIR3132:ENST00000581997.1:upstream_gene_variant:MODIFIER::::,OBSL1:ENST00000603926.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1229527 [benign DISEASE=not provided];			rs4672932	0.93102	0.77892,0.95957,0.99981,0.99319,0.99897	66572,	8498	10494	0.6000			14.81				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219552081	219552081	A	T	hom	off-target	QUAL=37417;DP=1138;QD=32.88;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=568;SAF=570	OBSL1,TMEM198,MIR3132	intron,downstream_gene,upstream_gene	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron19/20:c.5413+31T>A::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron18/19:c.5137+31T>A::,TMEM198:ENST00000344458.6:downstream_gene_variant:MODIFIER::::,TMEM198:ENST00000373883.4:downstream_gene_variant:MODIFIER::::,MIR3132:ENST00000581997.1:upstream_gene_variant:MODIFIER::::,OBSL1:ENST00000603926.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1261356 [benign DISEASE=3M syndrome 2,not provided];			rs4672933	0.98169	0.93888,0.98771,1.00000,0.99957,1.00000	73419,	2628	2788	-0.6360			5.23				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219552220	219552220	G	C	hom		QUAL=1036;DP=33;QD=31.39;AF=1.00;MQM=60;SAP=32;ABP=0;SAR=6;SAF=27	OBSL1,TMEM198,MIR3132	splice_region&intron,downstream_gene,upstream_gene	OBSL1:ENST00000404537.6:splice_region_variant&intron_variant:LOW:intron18/20:c.5309-4C>G::,OBSL1:ENST00000373876.5:splice_region_variant&intron_variant:LOW:intron17/19:c.5033-4C>G::,TMEM198:ENST00000344458.6:downstream_gene_variant:MODIFIER::::,TMEM198:ENST00000373883.4:downstream_gene_variant:MODIFIER::::,MIR3132:ENST00000581997.1:upstream_gene_variant:MODIFIER::::,OBSL1:ENST00000603926.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	194972 [benign DISEASE=3M syndrome 2,not specified,not provided];			rs34490902	0.44500	0.40352,0.48738,0.40440,0.46688,0.25373	15411,	36894	84454	-0.2900			10.06		6.86>7.91	COSV54703179	0.24		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219552506	219552506	G	T	hom	off-target	QUAL=2373;DP=79;QD=30.04;AF=1.00;MQM=60;SAP=166;ABP=0;SAR=78;SAF=1	OBSL1,TMEM198,MIR3132	intron,downstream_gene,upstream_gene	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron18/20:c.5308+30C>A::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron17/19:c.5032+30C>A::,TMEM198:ENST00000344458.6:downstream_gene_variant:MODIFIER::::,TMEM198:ENST00000373883.4:downstream_gene_variant:MODIFIER::::,MIR3132:ENST00000581997.1:upstream_gene_variant:MODIFIER::::,OBSL1:ENST00000603926.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1269748 [benign DISEASE=not provided];			rs60549465	0.40146	0.25392,0.47051,0.40511,0.46548,0.25125	13124,	34652	90796	0.1300			10.68				0.07		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219552544	219552544	C	T	hom		QUAL=4413;DP=145;QD=30.43;AF=1.00;MQM=60;SAP=92;ABP=0;SAR=111;SAF=34	OBSL1,TMEM198,MIR3132	missense,downstream_gene,upstream_gene	OBSL1:ENST00000404537.6:missense_variant:MODERATE:exon18/21:c.5300G>A:p.Arg1767Gln:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373876.5:missense_variant:MODERATE:exon17/20:c.5024G>A:p.Arg1675Gln:PF07679 [Immunoglobulin I-set domain],TMEM198:ENST00000344458.6:downstream_gene_variant:MODIFIER::::,TMEM198:ENST00000373883.4:downstream_gene_variant:MODIFIER::::,MIR3132:ENST00000581997.1:upstream_gene_variant:MODIFIER::::,OBSL1:ENST00000603926.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	288014 [benign DISEASE=3M syndrome 2,not specified,not provided];			rs59332477	0.43189	0.37848,0.48238,0.40473,0.45978,0.25062	14500,	36601	86293	1.1840	T(0.05),T(0.45), , , , 		25.60	0.24		COSV54703732	0.02	33230300	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219553189	219553189	T	C	hom	off-target	QUAL=104;DP=4;QD=26.00;AF=1.00;MQM=60;SAP=12;ABP=0;SAR=4;SAF=0	OBSL1,TMEM198,MIR3132	intron,downstream_gene,upstream_gene	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron16/20:c.4990-165A>G::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron15/19:c.4714-165A>G::,TMEM198:ENST00000344458.6:downstream_gene_variant:MODIFIER::::,TMEM198:ENST00000373883.4:downstream_gene_variant:MODIFIER::::,MIR3132:ENST00000581997.1:upstream_gene_variant:MODIFIER::::,OBSL1:ENST00000603926.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1257901 [benign DISEASE=not provided];			rs6436157	0.94211	0.81683,0.96592,0.99981,0.99327,0.99897	67938,	7464	8808	0.0930			9.45				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219553844	219553844	T	G	hom	off-target;low_conf_region	QUAL=70;DP=3;QD=23.33;AF=1.00;MQM=59;SAP=10;ABP=0;SAR=3;SAF=0	OBSL1,TMEM198,MIR3132	intron,downstream_gene,upstream_gene	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron15/20:c.4877-158A>C::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron14/19:c.4601-158A>C::,TMEM198:ENST00000344458.6:downstream_gene_variant:MODIFIER::::,TMEM198:ENST00000373883.4:downstream_gene_variant:MODIFIER::::,MIR3132:ENST00000581997.1:upstream_gene_variant:MODIFIER::::,OBSL1:ENST00000603926.5:downstream_gene_variant:MODIFIER::::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]				rs1390279179	0.04451	0.04903,0.03709,0.03591,0.04709,0.05124	0,	836	17946	-1.7670			1.70				0		2	47	0 / 2					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219554514	219554514	T	C	hom		QUAL=14170;DP=461;QD=30.74;AF=1.00;MQM=60;SAP=507;ABP=0;SAR=67;SAF=394	OBSL1,TMEM198	synonymous,downstream_gene	OBSL1:ENST00000404537.6:synonymous_variant:LOW:exon15/21:c.4836A>G:p.Thr1612=:,OBSL1:ENST00000373876.5:synonymous_variant:LOW:exon14/20:c.4560A>G:p.Thr1520=:,TMEM198:ENST00000344458.6:downstream_gene_variant:MODIFIER::::,TMEM198:ENST00000373883.4:downstream_gene_variant:MODIFIER::::,OBSL1:ENST00000603926.5:downstream_gene_variant:MODIFIER::::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	334466 [benign DISEASE=3M syndrome 2,not specified,not provided];			rs10932813	0.98829	0.96174,0.99065,1.00000,0.99966,1.00000	74351,	1734	1782	-3.9870			2.14				0.11		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219554617	219554617	T	C	hom		QUAL=21571;DP=692;QD=31.17;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=344;SAF=348	OBSL1,TMEM198	missense,downstream_gene	OBSL1:ENST00000404537.6:missense_variant:MODERATE:exon15/21:c.4733A>G:p.Gln1578Arg:,OBSL1:ENST00000373876.5:missense_variant:MODERATE:exon14/20:c.4457A>G:p.Gln1486Arg:,TMEM198:ENST00000344458.6:downstream_gene_variant:MODIFIER::::,TMEM198:ENST00000373883.4:downstream_gene_variant:MODIFIER::::,OBSL1:ENST00000603926.5:downstream_gene_variant:MODIFIER::::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	334469 [benign DISEASE=3M syndrome 2,not specified,not provided];			rs10932814	0.96354	0.88971,0.97716,1.00000,0.99366,0.99938	70786,	5015	5547	0.1340	T(1.00),T(0.53), , , 		7.41	0.09			0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219556234	219556234	A	G	hom		QUAL=1331;DP=50;QD=26.62;AF=1.00;MQM=60;SAP=103;ABP=0;SAR=1;SAF=49	OBSL1	synonymous	OBSL1:ENST00000404537.6:synonymous_variant:LOW:exon14/21:c.4395T>C:p.Asp1465=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373876.5:synonymous_variant:LOW:exon13/20:c.4119T>C:p.Asp1373=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926.5:synonymous_variant:LOW:exon14/14:c.4395T>C:p.Asp1465=:PF07679 [Immunoglobulin I-set domain]		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	334475 [benign DISEASE=3M syndrome 2,not specified,not provided];			rs10932816	0.97063	0.90064,0.98293,1.00000,0.99941,1.00000	71824,	4055	4469	-3.1400			0.29	0.10		COSV54708888	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219556695	219556695	C	G	hom		QUAL=23333;DP=727;QD=32.09;AF=1.00;MQM=60;SAP=11;ABP=0;SAR=390;SAF=337	OBSL1	missense	OBSL1:ENST00000404537.6:missense_variant:MODERATE:exon13/21:c.4095G>C:p.Glu1365Asp:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373876.5:missense_variant:MODERATE:exon12/20:c.3819G>C:p.Glu1273Asp:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926.5:missense_variant:MODERATE:exon13/14:c.4095G>C:p.Glu1365Asp:PF07679 [Immunoglobulin I-set domain]		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	334483 [benign DISEASE=3M syndrome 2,not specified,not provided];			rs1983210	0.70293	0.62224,0.68060,0.71763,0.73723,0.89482	37847,	31118	45140	0.6310	T(0.09),T(0.96),T(0.13)	 , ,B(0.44)	22.50	0.17		COSV54706342	0.01	30400783	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219556734	219556734	C	A	hom	off-target	QUAL=22496;DP=671;QD=33.53;AF=1.00;MQM=60;SAP=40;ABP=0;SAR=389;SAF=282	OBSL1	splice_region&intron,downstream_gene	OBSL1:ENST00000404537.6:splice_region_variant&intron_variant:LOW:intron12/20:c.4067-11G>T::,OBSL1:ENST00000373876.5:splice_region_variant&intron_variant:LOW:intron11/19:c.3791-11G>T::,OBSL1:ENST00000603926.5:splice_region_variant&intron_variant:LOW:intron12/13:c.4067-11G>T::,OBSL1:ENST00000373873.8:downstream_gene_variant:MODIFIER::::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	334484 [benign DISEASE=3M syndrome 2,not provided];			rs1983211	0.13794	0.03611,0.17852,0.12423,0.18264,0.14629	1807,	17361	131079	-0.6670			0.45		7.34>8.35	COSV54703188	0.08		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219557307	219557307	G	A	hom	off-target	QUAL=4706;DP=160;QD=29.41;AF=1.00;MQM=60;SAP=6;ABP=0;SAR=88;SAF=72	OBSL1	intron,downstream_gene	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron12/20:c.4066+36C>T::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron11/19:c.3790+516C>T::,OBSL1:ENST00000603926.5:intron_variant:MODIFIER:intron12/13:c.4066+36C>T::,OBSL1:ENST00000373873.8:downstream_gene_variant:MODIFIER::::,OBSL1:ENST00000289656.3:downstream_gene_variant:MODIFIER::::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1286959 [benign DISEASE=not provided];			rs55873563	0.13813	0.03648,0.17866,0.12264,0.18309,0.14721	1820,	17373	131113	-0.1870			9.37				0.01	34610981	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219557678	219557678	C	G	hom	off-target	QUAL=10226;DP=365;QD=28.02;AF=1.00;MQM=60;SAP=440;ABP=0;SAR=47;SAF=318	OBSL1	intron,downstream_gene	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron11/20:c.3791-60G>C::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron11/19:c.3790+145G>C::,OBSL1:ENST00000603926.5:intron_variant:MODIFIER:intron11/13:c.3791-60G>C::,OBSL1:ENST00000373873.8:downstream_gene_variant:MODIFIER::::,OBSL1:ENST00000289656.3:downstream_gene_variant:MODIFIER::::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1286818 [benign DISEASE=not provided];			rs2278200	0.45577	0.49540,0.49738,0.40678,0.44319,0.25279	16092,	37053	82675	-0.4970			2.35			COSV54704518,COSV54704992	0	30400783	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219557964	219557964	C	T	het		QUAL=529;DP=61;QD=8.67;AF=0.44;MQM=60;SAP=38;ABP=5;SAR=24;SAF=3	OBSL1	missense,downstream_gene	OBSL1:ENST00000404537.6:missense_variant:MODERATE:exon11/21:c.3649G>A:p.Glu1217Lys:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373876.5:missense_variant:MODERATE:exon11/20:c.3649G>A:p.Glu1217Lys:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926.5:missense_variant:MODERATE:exon11/14:c.3649G>A:p.Glu1217Lys:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373873.8:downstream_gene_variant:MODIFIER::::,OBSL1:ENST00000289656.3:downstream_gene_variant:MODIFIER::::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	193901 [benign/likely benign DISEASE=3M syndrome 2,not specified,not provided];			rs72957510	0.00711	0.01380,0.00235,0.00000,0.00612,0.00269	3,	1076	151114	0.7730	T(0.19),T(0.17),T(0.17), , 	 , ,B(0.25), , 	15.09	0.03		COSV105026433	0	25741868	5	385	2 / 81					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219558052	219558052	A	G	hom		QUAL=23923;DP=749;QD=31.94;AF=1.00;MQM=60;SAP=8;ABP=0;SAR=354;SAF=395	OBSL1	synonymous,downstream_gene	OBSL1:ENST00000404537.6:synonymous_variant:LOW:exon11/21:c.3561T>C:p.Pro1187=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373876.5:synonymous_variant:LOW:exon11/20:c.3561T>C:p.Pro1187=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926.5:synonymous_variant:LOW:exon11/14:c.3561T>C:p.Pro1187=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373873.8:downstream_gene_variant:MODIFIER::::,OBSL1:ENST00000289656.3:downstream_gene_variant:MODIFIER::::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	334496 [benign DISEASE=3M syndrome 2,not specified,not provided];			rs2278201	0.46485	0.52651,0.50281,0.40617,0.44329,0.25321	16868,	36976	81406	-4.6040			0.08	0.23		COSV54706224	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219563274	219563274	T	C	hom	off-target	QUAL=3197;DP=106;QD=30.16;AF=1.00;MQM=60;SAP=10;ABP=0;SAR=62;SAF=44	OBSL1	intron	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron7/20:c.2680+81A>G::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron7/19:c.2680+81A>G::,OBSL1:ENST00000603926.5:intron_variant:MODIFIER:intron7/13:c.2680+81A>G::,OBSL1:ENST00000373873.8:intron_variant:MODIFIER:intron7/8:c.2680+81A>G::,OBSL1:ENST00000289656.3:intron_variant:MODIFIER:intron7/8:c.1441+81A>G::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1286679 [benign DISEASE=not provided];			rs11904583	0.97910	0.93058,0.98652,1.00000,0.99949,0.99938	72965,	3011	3179	-2.5490			0.18				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219563659	219563659	A	T	het	off-target	QUAL=3410;DP=277;QD=12.31;AF=0.45;MQM=60;SAP=15;ABP=8;SAR=76;SAF=50	OBSL1	intron	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron6/20:c.2408-32T>A::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron6/19:c.2408-32T>A::,OBSL1:ENST00000603926.5:intron_variant:MODIFIER:intron6/13:c.2408-32T>A::,OBSL1:ENST00000373873.8:intron_variant:MODIFIER:intron6/8:c.2408-32T>A::,OBSL1:ENST00000289656.3:intron_variant:MODIFIER:intron6/8:c.1169-32T>A::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1226510 [benign DISEASE=3M syndrome 2,not provided];			rs2303543	0.56624	0.30504,0.54398,0.67622,0.67794,0.75000	26428,	33008	65776	0.9790			7.05				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219565481	219565481	C	T	hom		QUAL=23630;DP=731;QD=32.33;AF=1.00;MQM=60;SAP=16;ABP=0;SAR=399;SAF=332	OBSL1	missense	OBSL1:ENST00000404537.6:missense_variant:MODERATE:exon6/21:c.2168G>A:p.Arg723Lys:,OBSL1:ENST00000373876.5:missense_variant:MODERATE:exon6/20:c.2168G>A:p.Arg723Lys:,OBSL1:ENST00000603926.5:missense_variant:MODERATE:exon6/14:c.2168G>A:p.Arg723Lys:,OBSL1:ENST00000373873.8:missense_variant:MODERATE:exon6/9:c.2168G>A:p.Arg723Lys:,OBSL1:ENST00000289656.3:missense_variant:MODERATE:exon6/9:c.929G>A:p.Arg310Lys:	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	334508 [benign DISEASE=3M syndrome 2,not specified,not provided];			rs1039898	0.82115	0.63515,0.83384,0.90397,0.90447,0.83638	52358,	20137	27193	-0.3080	T(1.00),T(1.00),T(1.00),T(1.00),T(0.68)	 , ,B(0.00), , 	0.53	0.05		COSV54726542,COSV54731761	0.01	22371699,30400783	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219567197	219567197	A	G	hom	off-target	QUAL=2105;DP=69;QD=30.51;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=33;SAF=36	OBSL1	intron	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron4/20:c.1838-71T>C::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron4/19:c.1838-71T>C::,OBSL1:ENST00000603926.5:intron_variant:MODIFIER:intron4/13:c.1838-71T>C::,OBSL1:ENST00000373873.8:intron_variant:MODIFIER:intron4/8:c.1838-71T>C::,OBSL1:ENST00000289656.3:intron_variant:MODIFIER:intron4/8:c.599-71T>C::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1242247 [benign DISEASE=not provided];			rs4674412	0.97926	0.92928,0.98882,1.00000,0.99974,1.00000	73046,	2977	3157	0.2210			3.68				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219567987	219567987	A	T	het	off-target	QUAL=9101;DP=711;QD=12.80;AF=0.48;MQM=60;SAP=3;ABP=5;SAR=172;SAF=170	OBSL1,INHA	splice_region&intron,upstream_gene	OBSL1:ENST00000404537.6:splice_region_variant&intron_variant:LOW:intron2/20:c.1283-18T>A::,OBSL1:ENST00000373876.5:splice_region_variant&intron_variant:LOW:intron2/19:c.1283-18T>A::,OBSL1:ENST00000603926.5:splice_region_variant&intron_variant:LOW:intron2/13:c.1283-18T>A::,OBSL1:ENST00000373873.8:splice_region_variant&intron_variant:LOW:intron2/8:c.1283-18T>A::,OBSL1:ENST00000289656.3:splice_region_variant&intron_variant:LOW:intron2/8:c.44-18T>A::,INHA:ENST00000243786.3:upstream_gene_variant:MODIFIER::::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1174895 [benign DISEASE=3M syndrome 2,not specified,not provided];			rs2292360	0.37193	0.18816,0.36572,0.49864,0.45158,0.43166	11489,	33526	95416	-1.0910			2.08		6.52>5.43	COSV54726835	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70), INHA (inh=n/a oe_syn=1.26 oe_mis=0.91 oe_lof=0.48)
chr2	219570312	219570312	A	G	hom		QUAL=20220;DP=635;QD=31.84;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=318;SAF=317	OBSL1,INHA	synonymous,intron,upstream_gene	OBSL1:ENST00000404537.6:synonymous_variant:LOW:exon1/21:c.921T>C:p.Leu307=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373876.5:synonymous_variant:LOW:exon1/20:c.921T>C:p.Leu307=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926.5:synonymous_variant:LOW:exon1/14:c.921T>C:p.Leu307=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373873.8:synonymous_variant:LOW:exon1/9:c.921T>C:p.Leu307=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000289656.3:intron_variant:MODIFIER:intron1/8:c.-228+1082T>C::,INHA:ENST00000243786.3:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	193382 [benign DISEASE=3M syndrome 2,not specified,not provided];			rs10180675	0.81406	0.61120,0.82993,0.90508,0.90440,0.83437	51711,	20423	28287	-0.3330			13.57			COSV54725784	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70), INHA (inh=n/a oe_syn=1.26 oe_mis=0.91 oe_lof=0.48)
chr2	219570653	219570653	G	A	het		QUAL=384;DP=19;QD=20.21;AF=0.84;MQM=60;SAP=4;ABP=22;SAR=7;SAF=9	OBSL1,INHA	synonymous,intron,upstream_gene	OBSL1:ENST00000404537.6:synonymous_variant:LOW:exon1/21:c.580C>T:p.Leu194=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373876.5:synonymous_variant:LOW:exon1/20:c.580C>T:p.Leu194=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926.5:synonymous_variant:LOW:exon1/14:c.580C>T:p.Leu194=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373873.8:synonymous_variant:LOW:exon1/9:c.580C>T:p.Leu194=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000289656.3:intron_variant:MODIFIER:intron1/8:c.-228+741C>T::,INHA:ENST00000243786.3:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	290129 [benign DISEASE=3M syndrome 2,not specified,not provided];			rs1061399	0.36306	0.16294,0.36176,0.49368,0.44889,0.43044	11133,	32699	96431	3.2570			13.56			COSV54727864	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70), INHA (inh=n/a oe_syn=1.26 oe_mis=0.91 oe_lof=0.48)
chr3	10034299	10034299	T	C	het	off-target	QUAL=2176;DP=211;QD=10.31;AF=0.45;MQM=60;SAP=211;ABP=7;SAR=0;SAF=96	FANCD2,RNU6-670P	intron,downstream_gene,upstream_gene	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron3/42:c.206-170T>C::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron3/43:c.206-170T>C::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron3/43:c.206-170T>C::,FANCD2:ENST00000431693.1:intron_variant:MODIFIER:intron2/7:c.206-170T>C::,FANCD2:ENST00000625535.1:downstream_gene_variant:MODIFIER::::,RNU6-670P:ENST00000364312.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1286016 [benign DISEASE=not provided];		AluSc8 (SINE/Alu)	rs113771705	0.20839	0.33992,0.18178,0.06837,0.16513,0.16390	3039,	21106	103266	0.7930			5.02				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10034307	10034307	A	G	het	off-target	QUAL=1991;DP=206;QD=9.67;AF=0.45;MQM=60;SAP=205;ABP=7;SAR=0;SAF=93	FANCD2,RNU6-670P	intron,downstream_gene,upstream_gene	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron3/42:c.206-162A>G::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron3/43:c.206-162A>G::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron3/43:c.206-162A>G::,FANCD2:ENST00000431693.1:intron_variant:MODIFIER:intron2/7:c.206-162A>G::,FANCD2:ENST00000625535.1:downstream_gene_variant:MODIFIER::::,RNU6-670P:ENST00000364312.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1251762 [benign DISEASE=not provided];		AluSc8 (SINE/Alu)	rs111392584	0.18303	0.29745,0.13063,0.05887,0.15742,0.14678	2950,	20664	118568	-0.9310			1.85				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10034325	10034325	A	-	het	off-target	QUAL=221;DP=82;QD=2.70;AF=0.17;MQM=60;SAP=33;ABP=80;SAR=0;SAF=14	FANCD2,RNU6-670P	intron,downstream_gene,upstream_gene	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron3/42:c.206-124del::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron3/43:c.206-124del::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron3/43:c.206-124del::,FANCD2:ENST00000431693.1:intron_variant:MODIFIER:intron2/7:c.206-124del::,FANCD2:ENST00000625535.1:downstream_gene_variant:MODIFIER::::,RNU6-670P:ENST00000364312.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1219567 [likely benign DISEASE=not provided];		AluSc8 (SINE/Alu)	rs879221957	0.01678	0.02436,0.00757,0.00585,0.01281,0.04558	2,	881	51853	1.2420			3.65				0		54	499	4 / 62					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10035159	10035160	TT	-	het	off-target	QUAL=1933;DP=167;QD=11.57;AF=0.44;MQM=60;SAP=9;ABP=8;SAR=44;SAF=30	FANCD2,RNU6-670P	splice_region&intron,downstream_gene,upstream_gene	FANCD2:ENST00000287647.7:splice_region_variant&intron_variant:LOW:intron5/42:c.378-6_378-5del::,FANCD2:ENST00000675286.1:splice_region_variant&intron_variant:LOW:intron5/43:c.378-6_378-5del::,FANCD2:ENST00000419585.5:splice_region_variant&intron_variant:LOW:intron5/43:c.378-6_378-5del::,FANCD2:ENST00000431693.1:splice_region_variant&intron_variant:LOW:intron4/7:c.378-6_378-5del::,FANCD2:ENST00000625535.1:downstream_gene_variant:MODIFIER::::,RNU6-670P:ENST00000364312.1:upstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	342255 [benign/likely benign DISEASE=Fanconi anemia complementation group D2,Fanconi anemia,not provided];			rs55973240	0.22891	0.42254,0.15838,0.06628,0.16410,0.16490	4993,	24249	115323	0.3340			4.32				0.11	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10035291	10035291	A	C	het	off-target	QUAL=1279;DP=99;QD=12.92;AF=0.48;MQM=60;SAP=12;ABP=3;SAR=17;SAF=31	FANCD2,RNU6-670P	intron,downstream_gene,upstream_gene	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron6/42:c.438+58A>C::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron6/43:c.438+58A>C::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron6/43:c.438+58A>C::,FANCD2:ENST00000431693.1:intron_variant:MODIFIER:intron5/7:c.438+58A>C::,FANCD2:ENST00000625535.1:downstream_gene_variant:MODIFIER::::,RNU6-670P:ENST00000364312.1:upstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1271812 [benign DISEASE=not provided];			rs17032276	0.19694	0.31968,0.14538,0.06505,0.16190,0.15990	3454,	23022	122042	2.2790			14.26				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10035339	10035339	T	C	het	off-target	QUAL=1111;DP=93;QD=11.95;AF=0.49;MQM=60;SAP=12;ABP=3;SAR=16;SAF=30	FANCD2,RNU6-670P	intron,downstream_gene,upstream_gene	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron6/42:c.438+106T>C::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron6/43:c.438+106T>C::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron6/43:c.438+106T>C::,FANCD2:ENST00000431693.1:intron_variant:MODIFIER:intron5/7:c.438+106T>C::,FANCD2:ENST00000625535.1:downstream_gene_variant:MODIFIER::::,RNU6-670P:ENST00000364312.1:upstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1259039 [benign DISEASE=not provided];			rs17032277	0.19712	0.31988,0.14552,0.06614,0.16193,0.16009	3457,	23020	121924	0.2960			8.18				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10036271	10036271	A	G	het	off-target	QUAL=552;DP=45;QD=12.27;AF=0.62;MQM=60;SAP=64;ABP=9;SAR=0;SAF=28	FANCD2,RNU6-670P	splice_region&intron,downstream_gene,upstream_gene	FANCD2:ENST00000287647.7:splice_region_variant&intron_variant:LOW:intron6/42:c.439-16A>G::,FANCD2:ENST00000675286.1:splice_region_variant&intron_variant:LOW:intron6/43:c.439-16A>G::,FANCD2:ENST00000419585.5:splice_region_variant&intron_variant:LOW:intron6/43:c.439-16A>G::,FANCD2:ENST00000431693.1:splice_region_variant&intron_variant:LOW:intron5/7:c.439-16A>G::,FANCD2:ENST00000625535.1:downstream_gene_variant:MODIFIER::::,RNU6-670P:ENST00000364312.1:upstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257083 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D2,Fanconi anemia,not specified,not provided];			rs17032278	0.19654	0.32009,0.14457,0.06547,0.16128,0.15887	3419,	22844	121338	-0.7230			0.15		10.11>10.91		0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10039861	10039861	G	C	het	off-target	QUAL=5185;DP=480;QD=10.80;AF=0.48;MQM=60;SAP=3;ABP=6;SAR=114;SAF=114	FANCD2,RNU6-670P	splice_region&intron,synonymous,downstream_gene	FANCD2:ENST00000287647.7:splice_region_variant&intron_variant:LOW:intron9/42:c.695+16G>C::,FANCD2:ENST00000675286.1:splice_region_variant&intron_variant:LOW:intron9/43:c.695+16G>C::,FANCD2:ENST00000419585.5:splice_region_variant&intron_variant:LOW:intron9/43:c.695+16G>C::,FANCD2:ENST00000431693.1:synonymous_variant:LOW:exon8/8:c.711G>C:p.Leu237=:,RNU6-670P:ENST00000364312.1:downstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257086 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D2,Fanconi anemia,not specified,not provided];			rs17032283	0.19705	0.31991,0.14502,0.06561,0.16184,0.15988	3453,	22994	121836	-0.1270			2.65			COSV55047412	0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10041485	10041485	C	T	het	off-target	QUAL=671;DP=118;QD=5.69;AF=0.36;MQM=60;SAP=94;ABP=24;SAR=0;SAF=42	FANCD2,RNU6-670P	intron,3'UTR,downstream_gene	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron9/42:c.696-138C>T::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron9/43:c.696-138C>T::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron9/43:c.696-138C>T::,FANCD2:ENST00000431693.1:3_prime_UTR_variant:MODIFIER:exon8/8:c.*1609C>T::,RNU6-670P:ENST00000364312.1:downstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	439691 [benign DISEASE=not specified,not provided];			rs35220123	0.19704	0.31940,0.14523,0.06543,0.16203,0.16058	3445,	23048	122000	-1.3410			0.19				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10041843	10041844	TT	-	het	off-target	QUAL=119;DP=21;QD=5.67;AF=0.33;MQM=60;SAP=11;ABP=8;SAR=1;SAF=6	FANCD2,RNU6-670P	intron,downstream_gene	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron10/42:c.783+146_783+147del::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron10/43:c.783+146_783+147del::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron10/43:c.783+146_783+147del::,FANCD2:ENST00000431693.1:downstream_gene_variant:MODIFIER::::,RNU6-670P:ENST00000364312.1:downstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1251282 [benign DISEASE=not provided];			rs201603399	0.22871	0.42110,0.15836,0.06638,0.16697,0.16674	4579,	23037	108571	0.0510			0.54				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10042540	10042540	C	T	het	off-target	QUAL=14431;DP=1012;QD=14.26;AF=0.53;MQM=60;SAP=3;ABP=13;SAR=270;SAF=270	FANCD2,RNU6-670P	splice_region&intron,downstream_gene	FANCD2:ENST00000287647.7:splice_region_variant&intron_variant:LOW:intron10/42:c.784-19C>T::,FANCD2:ENST00000675286.1:splice_region_variant&intron_variant:LOW:intron10/43:c.784-19C>T::,FANCD2:ENST00000419585.5:splice_region_variant&intron_variant:LOW:intron10/43:c.784-19C>T::,FANCD2:ENST00000431693.1:downstream_gene_variant:MODIFIER::::,RNU6-670P:ENST00000364312.1:downstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257087 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D2,Fanconi anemia,not specified,not provided];			rs9879080	0.22573	0.41916,0.15585,0.06551,0.16231,0.16052	5005,	24289	117647	0.8720			7.43		12.10>11.70	COSV55047416	0	25741868,21766209	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10043351	10043351	G	T	hom	off-target	QUAL=1694;DP=59;QD=28.71;AF=1.00;MQM=60;SAP=59;ABP=0;SAR=49;SAF=10	FANCD2	intron,downstream_gene	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron12/42:c.990-133G>T::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron12/43:c.990-133G>T::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron12/43:c.990-133G>T::,FANCD2:ENST00000431693.1:downstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1226898 [benign DISEASE=not provided];			rs803335	0.93791	0.97378,0.92874,0.99808,0.91068,0.92372	67034,	8640	9448	0.2170			3.46				0.11		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10043446	10043446	C	G	het	off-target	QUAL=62;DP=10;QD=6.20;AF=0.40;MQM=60;SAP=12;ABP=4;SAR=4;SAF=0	FANCD2	intron,downstream_gene	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron12/42:c.990-38C>G::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron12/43:c.990-38C>G::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron12/43:c.990-38C>G::,FANCD2:ENST00000431693.1:downstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257088 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D2,not specified,not provided];			rs9809061	0.22609	0.42035,0.15587,0.06539,0.16224,0.16197	5019,	24290	117508	-0.9250			4.88				0.05	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10043852	10043852	A	G	het		QUAL=2154;DP=291;QD=7.40;AF=0.43;MQM=60;SAP=182;ABP=14;SAR=114;SAF=12	FANCD2	synonymous,downstream_gene	FANCD2:ENST00000287647.7:synonymous_variant:LOW:exon14/43:c.1122A>G:p.Val374=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000675286.1:synonymous_variant:LOW:exon14/44:c.1122A>G:p.Val374=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000419585.5:synonymous_variant:LOW:exon14/44:c.1122A>G:p.Val374=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000431693.1:downstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257065 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D2,Fanconi anemia complementation group A,Fanconi anemia,not specified,not provided];			rs34046352	0.19293	0.33537,0.14093,0.06038,0.14821,0.14711	235,	28739	122185	-0.0460			1.33			COSV55037937	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10046838	10046838	G	A	het	off-target	QUAL=182;DP=34;QD=5.35;AF=0.41;MQM=36;SAP=33;ABP=5;SAR=14;SAF=0	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron15/42:c.1278+115G>A::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron15/43:c.1278+115G>A::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron15/43:c.1278+115G>A::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1679038 [benign DISEASE=Hereditary breast ovarian cancer syndrome];		L3 (LINE/CR1)	rs9825871	0.50887	0.58312,0.46034,0.42997,0.48924,0.45229	5052,	64405	71911	-0.3220			3.75				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10048039	10048039	G	A	het		QUAL=46;DP=134;QD=0.34;AF=0.15;MQM=56;SAP=3;ABP=146;SAR=10;SAF=10	FANCD2	synonymous	FANCD2:ENST00000287647.7:synonymous_variant:LOW:exon16/43:c.1401G>A:p.Thr467=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000675286.1:synonymous_variant:LOW:exon16/44:c.1401G>A:p.Thr467=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000419585.5:synonymous_variant:LOW:exon16/44:c.1401G>A:p.Thr467=:PF14631 [Fanconi anaemia protein FancD2 nuclease]		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	342267 [benign/likely benign DISEASE=Fanconi anemia complementation group D2,not specified,not provided];			rs12330369	0.46103	0.48024,0.42498,0.41333,0.46393,0.41234	0,	66829	78127	0.0140			4.83			COSV55032260	0.1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10048089	10048089	A	C	het	off-target;low_conf_region	QUAL=1149;DP=106;QD=10.84;AF=0.45;MQM=60;SAP=25;ABP=5;SAR=13;SAF=35	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron16/42:c.1413+38A>C::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron16/43:c.1413+38A>C::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron16/43:c.1413+38A>C::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257067 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D2,not specified];			rs7615646	0.10744	0.16510,0.09139,0.04298,0.08843,0.10610	217,	15788	134762	0.4020			7.18			COSV55031871	0.03	25741868,22585858	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10049469	10049469	C	T	het	low_conf_region	QUAL=153;DP=27;QD=5.67;AF=0.41;MQM=40;SAP=27;ABP=5;SAR=0;SAF=11	FANCD2	synonymous	FANCD2:ENST00000287647.7:synonymous_variant:LOW:exon17/43:c.1509C>T:p.Asn503=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000675286.1:synonymous_variant:LOW:exon17/44:c.1509C>T:p.Asn503=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000419585.5:synonymous_variant:LOW:exon17/44:c.1509C>T:p.Asn503=:PF14631 [Fanconi anaemia protein FancD2 nuclease]		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257070 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D2,Fanconi anemia,not specified,not provided];			rs6785756	0.15915	0.26142,0.11786,0.05201,0.13210,0.14241	1066,	18897	111105	0.8720			5.83			COSV55032395	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10049715	10049715	C	G	het	off-target	QUAL=149;DP=25;QD=5.96;AF=0.40;MQM=60;SAP=25;ABP=5;SAR=10;SAF=0	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron17/42:c.1545+210C>G::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron17/43:c.1545+210C>G::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron17/43:c.1545+210C>G::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1244631 [benign DISEASE=not provided];		L2c (LINE/L2)	rs17032306	0.22579	0.41962,0.15562,0.06591,0.16213,0.16170	5011,	24303	117699	-0.0100			1.59				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10052522	10052522	-	T	het	off-target	QUAL=108;DP=23;QD=4.70;AF=0.35;MQM=60;SAP=20;ABP=8;SAR=8;SAF=0	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron18/42:c.1656+38dup::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron18/43:c.1656+38dup::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron18/43:c.1656+38dup::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1294503 [benign DISEASE=not provided];			rs544799101	0.17369	0.33502,0.12804,0.00774,0.12199,0.10026	2965,	19497	120967				2.30				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10060167	10060167	-	A	het	off-target	QUAL=137;DP=51;QD=2.69;AF=0.22;MQM=60;SAP=13;ABP=39;SAR=2;SAF=9	FANCD2,CYCSP11	intron,upstream_gene	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron18/42:c.1657-112dup::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron18/43:c.1657-112dup::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron18/43:c.1657-112dup::,CYCSP11:ENST00000436426.1:upstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1279487 [benign DISEASE=not provided];		AluSq2 (SINE/Alu)	rs111589951	0.21921	0.35056,0.18090,0.01671,0.17137,0.15974	2414,	18439	82875				1.00				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), CYCSP11 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10062350	10062350	C	T	het	off-target	QUAL=401;DP=47;QD=8.53;AF=0.40;MQM=60;SAP=3;ABP=7;SAR=10;SAF=9	FANCD2,CYCSP11	intron,upstream_gene	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron20/42:c.1827+139C>T::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron20/43:c.1827+139C>T::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron20/43:c.1827+139C>T::,CYCSP11:ENST00000436426.1:upstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1251257 [benign DISEASE=not provided];		AluSz (SINE/Alu)	rs6804967	0.22399	0.41410,0.15547,0.06531,0.16185,0.16085	4889,	24163	117587	-0.2030			0.90				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), CYCSP11 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10064848	10064848	C	T	het		QUAL=1266;DP=73;QD=17.34;AF=0.64;MQM=60;SAP=4;ABP=16;SAR=26;SAF=21	FANCD2	missense	FANCD2:ENST00000287647.7:missense_variant:MODERATE:exon23/43:c.2141C>T:p.Pro714Leu:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000675286.1:missense_variant:MODERATE:exon23/44:c.2141C>T:p.Pro714Leu:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000419585.5:missense_variant:MODERATE:exon23/44:c.2141C>T:p.Pro714Leu:PF14631 [Fanconi anaemia protein FancD2 nuclease]		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	134315 [benign/likely benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D2,Fanconi anemia complementation group A,Fanconi anemia,not specified,not provided];	CM1814115 [CLASS=DM? MUT=ALT PHEN="Fanconi anaemia" GENE=FANCD2];		rs3864017	0.18804	0.28377,0.14306,0.06257,0.16252,0.16065	1866,	23913	119371	-0.0900	T(0.28),T(0.27),T(0.27)	B(0.00),B(0.00),B(0.00)	0.88	0.03		COSV55033303	0	25741868,24728327,26822197,32107087	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10065836	10065836	G	T	het	off-target	QUAL=12183;DP=1003;QD=12.15;AF=0.48;MQM=60;SAP=3;ABP=7;SAR=241;SAF=240	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron24/42:c.2270-28G>T::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron24/43:c.2270-28G>T::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron24/43:c.2270-28G>T::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257074 [benign DISEASE=Fanconi anemia complementation group D2,not specified,not provided];			rs34608006	0.19371	0.30785,0.14422,0.06407,0.16175,0.16377	3256,	22927	122535	1.0360			8.29				0.04	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10073118	10073118	T	C	het	off-target	QUAL=121;DP=11;QD=11.00;AF=0.64;MQM=60;SAP=18;ABP=5;SAR=0;SAF=7	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron27/42:c.2606-135T>C::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron27/43:c.2606-135T>C::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron27/43:c.2606-135T>C::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1252243 [benign DISEASE=not provided];			rs9824585	0.23398	0.44788,0.15918,0.06543,0.16210,0.16549	5540,	24486	116438	-0.7750			0.32			COSV55040085	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10077919	10077919	C	A	het	off-target	QUAL=246;DP=21;QD=11.71;AF=0.67;MQM=60;SAP=33;ABP=8;SAR=0;SAF=14	FANCD2,FANCD2OS	intron,downstream_gene	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron29/42:c.2860-162C>A::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron29/43:c.2860-162C>A::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron29/43:c.2860-162C>A::,FANCD2OS:ENST00000524279.1:downstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1183813 [benign DISEASE=not provided];		AluJr (SINE/Alu)	rs6792951	0.23484	0.44928,0.15988,0.06685,0.16265,0.16542	5551,	24451	115839	-0.2140			2.26			COSV55037211	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10078233	10078233	T	C	het	off-target	QUAL=737;DP=70;QD=10.53;AF=0.46;MQM=60;SAP=3;ABP=4;SAR=15;SAF=17	FANCD2,FANCD2OS	intron,downstream_gene	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron30/42:c.2976+36T>C::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron30/43:c.2976+36T>C::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron30/43:c.2976+36T>C::,FANCD2OS:ENST00000524279.1:downstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257077 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D2,not specified,not provided];			rs6805869	0.22584	0.41964,0.15602,0.06583,0.16214,0.16438	5011,	24274	117562	0.3540			6.45			COSV55037214	0	25741868,21766209	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10086951	10086951	A	G	het	off-target	QUAL=131;DP=37;QD=3.54;AF=0.30;MQM=60;SAP=27;ABP=16;SAR=0;SAF=11	FANCD2,FANCD2OS	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron33/42:c.3336-183A>G::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron33/43:c.3336-183A>G::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron33/43:c.3336-183A>G::,FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*44-5420T>C::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1231027 [benign DISEASE=not provided];			rs33972700	0.06593	0.02456,0.05903,0.00116,0.09634,0.05174	435,	9157	142055	0.3280			4.10				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10087281	10087281	-	T	het	off-target;low_conf_region	QUAL=92;DP=29;QD=3.17;AF=0.21;MQM=60;SAP=16;ABP=25;SAR=0;SAF=6	FANCD2,FANCD2OS	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron34/42:c.3466+36dup::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron34/43:c.3466+36dup::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron34/43:c.3466+36dup::,FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*44-5751dup::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1206308 [benign DISEASE=not specified,not provided];			rs371321981	0.03513	0.01975,0.03177,0.01409,0.04389,0.07434	94,	3989	114713				4.26				0.05		3	131	0 / 7					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10090443	10090443	A	T	het	off-target;low_conf_region	QUAL=58;DP=10;QD=5.80;AF=0.50;MQM=60;SAP=14;ABP=3;SAR=5;SAF=0	FANCD2,FANCD2OS	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron37/42:c.3777+58A>T::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron37/43:c.3777+58A>T::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron37/43:c.3777+58A>T::,FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*44-8912T>A::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]				rs1276937447	0.00056	0.00030,0.00076,0.00065,0.00049,0.00113	0,	49	86991	-0.2200			1.84				0.01		11	57	3 / 29					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10092265	10092265	A	G	het	off-target	QUAL=2559;DP=173;QD=14.79;AF=0.55;MQM=60;SAP=6;ABP=7;SAR=53;SAF=42	FANCD2,FANCD2OS	splice_region&intron,intron	FANCD2:ENST00000287647.7:splice_region_variant&intron_variant:LOW:intron38/42:c.3849+13A>G::,FANCD2:ENST00000675286.1:splice_region_variant&intron_variant:LOW:intron38/43:c.3849+13A>G::,FANCD2:ENST00000419585.5:splice_region_variant&intron_variant:LOW:intron38/43:c.3849+13A>G::,FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*44-10734T>C::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257079 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D2,Fanconi anemia,not specified,not provided];			rs9811771	0.24904	0.48604,0.17664,0.08931,0.16261,0.21948	6440,	24925	113999	0.7300			15.61			COSV55047434	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10094466	10094466	C	T	het	off-target	QUAL=346;DP=30;QD=11.53;AF=0.60;MQM=60;SAP=42;ABP=6;SAR=18;SAF=0	FANCD2,FANCD2OS	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron40/42:c.3963+103C>T::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron40/43:c.3963+103C>T::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron40/43:c.3963+103C>T::,FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*43+9732G>A::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1235228 [benign DISEASE=not provided];			rs7610821	0.24199	0.46423,0.17362,0.09049,0.16228,0.20154	5953,	24840	115106	-0.0590			3.07				0	21766209	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10096385	10096385	T	G	het		QUAL=9046;DP=768;QD=11.78;AF=0.47;MQM=60;SAP=3;ABP=10;SAR=182;SAF=178	FANCD2,FANCD2OS	synonymous,intron	FANCD2:ENST00000287647.7:synonymous_variant:LOW:exon42/43:c.4098T>G:p.Leu1366=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000675286.1:synonymous_variant:LOW:exon42/44:c.4098T>G:p.Leu1366=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000419585.5:synonymous_variant:LOW:exon42/44:c.4098T>G:p.Leu1366=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*43+7813A>C::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257081 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D2,Fanconi anemia,not specified,not provided];	CM066071 [CLASS=DP MUT=ALT PHEN="Breast cancer increased risk association with" GENE=FANCD2];		rs2272125	0.24174	0.46310,0.17344,0.08960,0.16223,0.20187	5942,	24861	115257	1.9740			7.05			COSV55037985	0	25741868,21766209,16679306	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10096505	10096505	T	C	het	off-target	QUAL=2771;DP=202;QD=13.72;AF=0.52;MQM=60;SAP=4;ABP=4;SAR=56;SAF=50	FANCD2,FANCD2OS	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron42/42:c.4185+33T>C::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron42/43:c.4185+33T>C::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron42/43:c.4185+33T>C::,FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*43+7693A>G::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257082 [benign DISEASE=Hereditary breast ovarian cancer syndrome,not specified,not provided];			rs2272124	0.24170	0.46332,0.17345,0.08954,0.16230,0.20100	5940,	24844	115214	-0.0720			4.69			COSV55047440	0.03	25741868,21766209	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10098987	10098987	G	A	het	off-target	QUAL=10272;DP=673;QD=15.26;AF=0.54;MQM=60;SAP=3;ABP=14;SAR=180;SAF=186	FANCD2,FANCD2OS	3'UTR,intron,downstream_gene	FANCD2:ENST00000287647.7:3_prime_UTR_variant:MODIFIER:exon43/43:c.*37G>A::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron43/43:c.4281+172G>A::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron43/43:c.4281+172G>A::,FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*43+5211C>T::,FANCD2OS:ENST00000450660.3:downstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	342381 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D2,not provided];			rs7626117	0.33721	0.74793,0.22061,0.08979,0.18258,0.22844	13612,	24011	100701	-0.0220			3.53			COSV55047455	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10099012	10099012	A	G	het	off-target	QUAL=7691;DP=551;QD=13.96;AF=0.54;MQM=60;SAP=3;ABP=11;SAR=148;SAF=150	FANCD2,FANCD2OS	3'UTR,intron,downstream_gene	FANCD2:ENST00000287647.7:3_prime_UTR_variant:MODIFIER:exon43/43:c.*62A>G::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron43/43:c.4281+197A>G::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron43/43:c.4281+197A>G::,FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*43+5186T>C::,FANCD2OS:ENST00000450660.3:downstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	342383 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D2,not provided];			rs7647987	0.24197	0.46337,0.17377,0.08994,0.16247,0.20125	5944,	24849	115091	-0.4240			0.70			COSV55047463	0	21766209,29156695	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10101066	10101066	A	-	het	off-target	QUAL=942;DP=89;QD=10.58;AF=0.44;MQM=60;SAP=3;ABP=6;SAR=19;SAF=20	FANCD2,FANCD2OS	intron,downstream_gene	FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron43/43:c.4282-109del::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron43/43:c.4282-109del::,FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*43+3132del::,FANCD2:ENST00000287647.7:downstream_gene_variant:MODIFIER::::,FANCD2OS:ENST00000450660.3:downstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1234759 [benign DISEASE=not provided];		AluSx (SINE/Alu)	rs78434344	0.22595	0.38980,0.16510,0.06850,0.16946,0.18333	4304,	24090	112018	-1.0440			0.05			COSV55044503	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	36993455	36993455	G	A	het	off-target	QUAL=493;DP=48;QD=10.27;AF=0.48;MQM=60;SAP=5;ABP=3;SAR=9;SAF=14	MLH1,EPM2AIP1	5'UTR,upstream_gene	MLH1:ENST00000536378.5:5_prime_UTR_variant:MODIFIER:exon1/18:c.-725G>A::,EPM2AIP1:ENST00000322716.8:upstream_gene_variant:MODIFIER::::,MLH1:ENST00000673899.1:upstream_gene_variant:MODIFIER::::,MLH1:ENST00000231790.8:upstream_gene_variant:MODIFIER::::,MLH1:ENST00000673715.1:upstream_gene_variant:MODIFIER::::,MLH1:ENST00000674019.1:upstream_gene_variant:MODIFIER::::,MLH1:ENST00000458205.6:upstream_gene_variant:MODIFIER::::,MLH1:ENST00000455445.6:upstream_gene_variant:MODIFIER::::,MLH1:ENST00000539477.6:upstream_gene_variant:MODIFIER::::,MLH1:ENST00000435176.5:upstream_gene_variant:MODIFIER::::,MLH1:ENST00000441265.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	120436_[GENE=MLH1_PHENOS=Lynch syndrome 2, 609310 (3); Muir-Torre syndrome, 158320 (3), Autosomal dominant; Mismatch repair cancer syndrome 1, 276300 (3), Autosomal recessive]	89600 [benign DISEASE=Lynch syndrome,Muir-Torre syndrome,Turcot syndrome,Colorectal cancer, hereditary nonpolyposis, type 2,Hereditary cancer-predisposing syndrome,Hereditary nonpolyposis colorectal neoplasms,not specified,not provided];	CR045225 [CLASS=DFP MUT=ALT PHEN="Lung cancer risk association with" GENE=MLH1];		rs1800734	0.23189	0.17216,0.27408,0.55414,0.21544,0.38369	4667,	25944	116852	-0.7370			3.89			COSV99212309	0.09	25741868,24944790,23946381,30038702,28827732,22623965,26724419,30989434,23720673,29399184,23565320,21036793,21738611,24515656,29664240,24205329,29156846,29108386,21093899,20967208,23240038,21980013,25047469,19930554,17870204,18523027,18723338,20473912,20860725,22136435,22174852,22740958,24689082,25986311,26275295,29190978,17230510,17301300,17959715,18712731,21093954,21565826,22294770,22371642,22927776,24325908,25115745,25252909,26911399,26987333,28195176,28293327,28304185,28791697,29181059,29304767,30519050,30952131,31035658,31209889,31273068,31342644,31530880,31953835,19888426,25938433,24073290,23112559,26187503,22935517,18022218,25519377,25252713,31779681,20444249,31742432,25421847,25355167,26512054,18588460,29341452,31031852,22763379,19494183,18615680,27630279,30283143,18851982,24084575,22144422,32641106,32742474,33794988,32161499,34540665,27895767,34540891,32756484,33462484,33567514,26086992,33632709,25804231,25328415,33534415,33931130,30256891,34383893,35055016,35541922	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EPM2AIP1 (inh=n/a oe_syn=1.18 oe_mis=0.77 oe_lof=0.20), MLH1 (inh=AR+AD oe_syn=1.09 oe_mis=1.04 oe_lof=0.37)
chr3	37006802	37006802	A	-	het	off-target;low_conf_region	QUAL=128;DP=118;QD=1.08;AF=0.16;MQM=60;SAP=44;ABP=121;SAR=0;SAF=19	MLH1	intron	MLH1:ENST00000536378.5:intron_variant:MODIFIER:intron3/17:c.-343-176del::,MLH1:ENST00000673899.1:intron_variant:MODIFIER:intron4/14:c.381-176del::,MLH1:ENST00000231790.8:intron_variant:MODIFIER:intron4/18:c.381-176del::,MLH1:ENST00000673715.1:intron_variant:MODIFIER:intron4/15:c.381-176del::,MLH1:ENST00000674019.1:intron_variant:MODIFIER:intron5/19:c.-343-176del::,MLH1:ENST00000458205.6:intron_variant:MODIFIER:intron5/19:c.-343-176del::,MLH1:ENST00000455445.6:intron_variant:MODIFIER:intron4/18:c.-343-176del::,MLH1:ENST00000539477.6:intron_variant:MODIFIER:intron4/17:c.-251-176del::,MLH1:ENST00000435176.5:intron_variant:MODIFIER:intron4/18:c.87-176del::,MLH1:ENST00000441265.6:intron_variant:MODIFIER:intron4/14:c.-343-176del::		120436_[GENE=MLH1_PHENOS=Lynch syndrome 2, 609310 (3); Muir-Torre syndrome, 158320 (3), Autosomal dominant; Mismatch repair cancer syndrome 1, 276300 (3), Autosomal recessive]			AluSq2 (SINE/Alu)	rs35239510	0.02083	0.04090,0.01870,0.00029,0.01397,0.00781	16,	1947	93025	-0.2960			0.37				0		3	49	0 / 7					MLH1 (inh=AR+AD oe_syn=1.09 oe_mis=1.04 oe_lof=0.37)
chr3	37025606	37025606	A	T	het	off-target;low_conf_region	QUAL=1233;DP=227;QD=5.43;AF=0.26;MQM=60;SAP=36;ABP=113;SAR=15;SAF=45	MLH1	intron	MLH1:ENST00000536378.5:intron_variant:MODIFIER:intron10/17:c.316-31A>T::,MLH1:ENST00000673899.1:intron_variant:MODIFIER:intron8/14:c.678-3178A>T::,MLH1:ENST00000231790.8:intron_variant:MODIFIER:intron11/18:c.1039-31A>T::,MLH1:ENST00000673715.1:intron_variant:MODIFIER:intron11/15:c.1039-31A>T::,MLH1:ENST00000674019.1:intron_variant:MODIFIER:intron12/19:c.316-31A>T::,MLH1:ENST00000458205.6:intron_variant:MODIFIER:intron12/19:c.316-31A>T::,MLH1:ENST00000455445.6:intron_variant:MODIFIER:intron11/18:c.316-31A>T::,MLH1:ENST00000539477.6:intron_variant:MODIFIER:intron10/17:c.316-31A>T::,MLH1:ENST00000435176.5:intron_variant:MODIFIER:intron11/18:c.745-31A>T::,MLH1:ENST00000441265.6:intron_variant:MODIFIER:intron11/14:c.316-31A>T::	regulatory_region_variant:enhancer	120436_[GENE=MLH1_PHENOS=Lynch syndrome 2, 609310 (3); Muir-Torre syndrome, 158320 (3), Autosomal dominant; Mismatch repair cancer syndrome 1, 276300 (3), Autosomal recessive]	629888 [benign/likely benign DISEASE=Hereditary cancer-predisposing syndrome,not specified,not provided];		(TA)n (Simple_repeat)	rs59684491	0.33157	0.32844,0.30016,0.36375,0.34306,0.29907	1748,	14006	35284	-0.4710			1.11			COSV51624244	0.03	29434720	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MLH1 (inh=AR+AD oe_syn=1.09 oe_mis=1.04 oe_lof=0.37)
chr3	37025608	37025608	A	T	het	off-target;low_conf_region	QUAL=1233;DP=227;QD=5.43;AF=0.26;MQM=60;SAP=36;ABP=113;SAR=15;SAF=45	MLH1	intron	MLH1:ENST00000536378.5:intron_variant:MODIFIER:intron10/17:c.316-29A>T::,MLH1:ENST00000673899.1:intron_variant:MODIFIER:intron8/14:c.678-3176A>T::,MLH1:ENST00000231790.8:intron_variant:MODIFIER:intron11/18:c.1039-29A>T::,MLH1:ENST00000673715.1:intron_variant:MODIFIER:intron11/15:c.1039-29A>T::,MLH1:ENST00000674019.1:intron_variant:MODIFIER:intron12/19:c.316-29A>T::,MLH1:ENST00000458205.6:intron_variant:MODIFIER:intron12/19:c.316-29A>T::,MLH1:ENST00000455445.6:intron_variant:MODIFIER:intron11/18:c.316-29A>T::,MLH1:ENST00000539477.6:intron_variant:MODIFIER:intron10/17:c.316-29A>T::,MLH1:ENST00000435176.5:intron_variant:MODIFIER:intron11/18:c.745-29A>T::,MLH1:ENST00000441265.6:intron_variant:MODIFIER:intron11/14:c.316-29A>T::	regulatory_region_variant:enhancer	120436_[GENE=MLH1_PHENOS=Lynch syndrome 2, 609310 (3); Muir-Torre syndrome, 158320 (3), Autosomal dominant; Mismatch repair cancer syndrome 1, 276300 (3), Autosomal recessive]	629889 [benign DISEASE=Hereditary cancer-predisposing syndrome,not specified,not provided];		(TA)n (Simple_repeat)	rs6771325	0.48267	0.48177,0.46028,0.47723,0.49433,0.38992	4172,	14524	24510	0.1950			1.14			COSV51617601	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	2	"[2] auto-classification 24.10.2017  "			MLH1 (inh=AR+AD oe_syn=1.09 oe_mis=1.04 oe_lof=0.37)
chr3	142449489	142449489	C	T	hom		QUAL=1580;DP=48;QD=32.92;AF=1.00;MQM=60;SAP=5;ABP=0;SAR=21;SAF=27	ATR,XRN1	synonymous,upstream_gene	ATR:ENST00000350721.9:synonymous_variant:LOW:exon47/47:c.7875G>A:p.Gln2625=:PF02260 [FATC domain],ATR:ENST00000661310.1:synonymous_variant:LOW:exon46/46:c.7683G>A:p.Gln2561=:PF02260 [FATC domain],XRN1:ENST00000264951.8:upstream_gene_variant:MODIFIER::::,XRN1:ENST00000392981.7:upstream_gene_variant:MODIFIER::::,XRN1:ENST00000463916.5:upstream_gene_variant:MODIFIER::::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	93669 [benign/likely benign DISEASE=Seckel syndrome 1,not specified,not provided];			rs1802904	0.88662	0.96953,0.80664,0.92890,0.86649,0.93840	60074,	14732	17248	1.2390			6.93			COSV99377126	0	24033266,18414213,23757202,17010193,23844225,32724790	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					XRN1 (inh=n/a oe_syn=0.94 oe_mis=0.80 oe_lof=0.12), ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142459302	142459302	C	T	het		QUAL=1052;DP=77;QD=13.66;AF=0.55;MQM=60;SAP=8;ABP=4;SAR=26;SAF=16	ATR	missense	ATR:ENST00000350721.9:missense_variant:MODERATE:exon43/47:c.7274G>A:p.Arg2425Gln:PF00454 [Phosphatidylinositol 3- and 4-kinase],ATR:ENST00000661310.1:missense_variant:MODERATE:exon42/46:c.7082G>A:p.Arg2361Gln:PF00454 [Phosphatidylinositol 3- and 4-kinase]		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	136470 [benign DISEASE=Seckel syndrome 1,Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome,not specified,not provided];	CM1010619 [CLASS=DP MUT=ALT PHEN="Acute rejection in kidney transplantation association with" GENE=ATR];		rs2229032	0.12746	0.08102,0.10984,0.10132,0.16025,0.09818	1340,	16694	132628	0.0370	T(0.17),T(0.15)	B(0.00),B(0.00)	0.70	0.17		COSV63383988	0	24033266,18414213,21085059,17010193,23313170,27905519,32597209	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142465321	142465321	-	A	het	off-target	QUAL=24;DP=41;QD=0.59;AF=0.15;MQM=60;SAP=3;ABP=48;SAR=3;SAF=3	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron40/46:c.6898-82dup::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron39/45:c.6706-82dup::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	1216707 [likely benign DISEASE=not provided];			rs78538255	0.00532	0.01302,0.00270,0.00425,0.00177,0.00784	8,	735	140343				3.64				0		0	45	0 / 8					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142469495	142469495	A	C	het		QUAL=9939;DP=680;QD=14.62;AF=0.56;MQM=60;SAP=4;ABP=27;SAR=197;SAF=186	ATR	missense	ATR:ENST00000350721.9:missense_variant:MODERATE:exon38/47:c.6394T>G:p.Tyr2132Asp:,ATR:ENST00000661310.1:missense_variant:MODERATE:exon37/46:c.6202T>G:p.Tyr2068Asp:		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	158000 [benign/likely benign DISEASE=Seckel syndrome 1,Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome,not specified,not provided];	CM1725174 [CLASS=DP MUT=ALT PHEN="Haematological traits association with" GENE=ATR];		rs28910273	0.00341	0.00150,0.00144,0.00000,0.00606,0.00186	0,	519	151695	2.4040	D(0.03),D(0.03)	B(0.01),B(0.01)	20.90	0.05		COSV63384218	0.03	25741868,18414213,17010193,28787443,30595370,32888494	0	284	0 / 57	2	"[2] Ilnaz Sepahi 29-03-2016 batch import"			ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142496279	142496279	T	A	het	off-target;low_conf_region	QUAL=97;DP=10;QD=9.70;AF=0.60;MQM=60;SAP=16;ABP=4;SAR=0;SAF=6	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron34/46:c.5898+82A>T::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron33/45:c.5706+82A>T::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	1264913 [benign DISEASE=not provided];		(TA)n (Simple_repeat)	rs73864545	0.57878	0.65826,0.50681,0.54183,0.56033,0.53535	1369,	5880	6272	0.4140			2.48			COSV63385549,COSV63393775	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142496280	142496280	A	T	het	off-target;low_conf_region	QUAL=97;DP=10;QD=9.70;AF=0.60;MQM=60;SAP=16;ABP=4;SAR=0;SAF=6	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron34/46:c.5898+81T>A::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron33/45:c.5706+81T>A::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	1288139 [benign DISEASE=not provided];		(TA)n (Simple_repeat)	rs201323437	0.56280	0.64509,0.46739,0.52037,0.55092,0.50718	1299,	5871	6579	0.3350			1.49			COSV63385552	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142496329	142496329	T	C	het	off-target;low_conf_region	QUAL=124;DP=8;QD=15.50;AF=0.75;MQM=60;SAP=16;ABP=7;SAR=6;SAF=0	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron34/46:c.5898+32A>G::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron33/45:c.5706+32A>G::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	157998 [likely benign DISEASE=not specified];		(TA)n (Simple_repeat)	rs11719960	0.04387	0.00926,0.03064,0.03270,0.06903,0.03315	404,	3405	91821	-1.5210			0.12			COSV63384221	0.01		434	4353	76 / 829					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142496336	142496336	A	C	het	off-target;low_conf_region	QUAL=124;DP=8;QD=15.50;AF=0.75;MQM=60;SAP=16;ABP=7;SAR=6;SAF=0	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron34/46:c.5898+25T>G::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron33/45:c.5706+25T>G::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	157997 [benign DISEASE=Seckel syndrome 1,not specified,not provided];		(TA)n (Simple_repeat)	rs7620648	0.63268	0.79417,0.58156,0.51514,0.59021,0.44044	17182,	16191	29351	-0.6440			0.33			COSV63391396	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142498695	142498695	A	G	het		QUAL=3568;DP=347;QD=10.28;AF=0.51;MQM=60;SAP=343;ABP=3;SAR=5;SAF=171	ATR	synonymous	ATR:ENST00000350721.9:synonymous_variant:LOW:exon32/47:c.5460T>C:p.Tyr1820=:PF02259 [FAT domain],ATR:ENST00000661310.1:synonymous_variant:LOW:exon31/46:c.5268T>C:p.Tyr1756=:PF02259 [FAT domain]	regulatory_region_variant:open_chromatin_region,regulatory_region_variant:CTCF_binding_site	601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	136471 [benign/likely benign DISEASE=Seckel syndrome 1,Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome,not specified,not provided];			rs2227932	0.07866	0.01979,0.05816,0.00308,0.11189,0.15389	669,	10628	140166	1.4980			9.41			COSV100637634	0	18414213,17010193,23844225	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142512220	142512220	-	A	het	off-target;low_conf_region	QUAL=19;DP=16;QD=1.19;AF=0.25;MQM=60;SAP=12;ABP=12;SAR=4;SAF=0	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron27/46:c.4852+39dup::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron26/45:c.4660+39dup::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	1269319 [benign DISEASE=not provided];			rs74269486	0.46046	0.53839,0.42179,0.38254,0.44097,0.33351	12436,	32953	67757				0.18				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142536248	142536248	T	C	het	off-target	QUAL=1299;DP=110;QD=11.81;AF=0.45;MQM=60;SAP=7;ABP=5;SAR=30;SAF=20	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron19/46:c.3726-47A>G::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron18/45:c.3534-47A>G::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	157979 [benign DISEASE=not specified,not provided];			rs73240314	0.13779	0.11618,0.11610,0.10112,0.16045,0.09909	1474,	17996	131060	-0.2480			10.30			COSV63384224	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142540865	142540865	A	-	het	off-target;low_conf_region	QUAL=9061;DP=851;QD=10.65;AF=0.43;MQM=60;SAP=4;ABP=37;SAR=178;SAF=190	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron18/46:c.3581+39del::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron17/45:c.3389+39del::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	1225553 [benign DISEASE=not provided];			rs201551475	0.16067	0.15725,0.13340,0.11034,0.17384,0.11025	1543,	18956	115150	3.0930			8.47				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142553472	142553472	G	A	het	off-target	QUAL=106;DP=11;QD=9.64;AF=0.64;MQM=60;SAP=18;ABP=5;SAR=7;SAF=0	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron12/46:c.2634-74C>T::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron11/45:c.2442-74C>T::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	670440 [benign DISEASE=not provided];			rs9869842	0.62660	0.79312,0.53525,0.46770,0.58706,0.44502	30660,	33609	56569	-1.7890			0.05			COSV63385113	0	17010193	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142555897	142555897	-	T	het	mosaic	QUAL=2;DP=100;QD=0.02;AF=0.10;MQM=60;SAP=3;ABP=142;SAR=5;SAF=5	ATR	frameshift	ATR:ENST00000350721.9:frameshift_variant:HIGH:exon10/47:c.2320dup:p.Ile774AsnfsTer3:,ATR:ENST00000661310.1:frameshift_variant:HIGH:exon9/46:c.2128dup:p.Ile710AsnfsTer3:		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	938417 [pathogenic/likely pathogenic DISEASE=Seckel syndrome 1,not provided];	CI1925995 [CLASS=DM MUT=ALT PHEN="Breast cancer" GENE=ATR];		rs757500301	0.00004	0.00005,0.00000,0.00000,0.00004,0.00000	0,	6	150360				21.80				0.01	21228398,23144622,19470935	0	32	0 / 6					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142558523	142558523	-	AAAT	het	off-target	QUAL=2878;DP=308;QD=9.34;AF=0.44;MQM=60;SAP=301;ABP=11;SAR=0;SAF=137	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron8/46:c.1885+97_1885+100dup::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron7/45:c.1693+97_1693+100dup::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	1248576 [benign DISEASE=not provided];		AluSz (SINE/Alu)	rs56661838	0.09742	0.09262,0.08297,0.10579,0.10438,0.08820	651,	12695	129687				1.83				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142558585	142558585	A	G	het	off-target;low_conf_region	QUAL=6961;DP=584;QD=11.92;AF=0.47;MQM=60;SAP=5;ABP=7;SAR=145;SAF=131	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron8/46:c.1885+39T>C::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron7/45:c.1693+39T>C::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	157967 [benign DISEASE=not specified,not provided];		(TAGA)n (Simple_repeat)	rs73240318	0.10557	0.07287,0.08613,0.09360,0.12792,0.09497	832,	13594	129274	-0.5170			0.26			COSV63383992	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142558733	142558733	A	T	het		QUAL=3142;DP=268;QD=11.72;AF=0.47;MQM=60;SAP=12;ABP=6;SAR=51;SAF=74	ATR	synonymous	ATR:ENST00000350721.9:synonymous_variant:LOW:exon8/47:c.1776T>A:p.Gly592=:,ATR:ENST00000661310.1:synonymous_variant:LOW:exon7/46:c.1584T>A:p.Gly528=:		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	157965 [benign/likely benign DISEASE=Seckel syndrome 1,not specified,not provided];			rs2227930	0.62631	0.79394,0.53411,0.46503,0.58663,0.44385	30738,	33590	56722	-0.2640			7.02			COSV63383320	0.34	24033266,18414213,17010193,27863252,29403010,32888493	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142562770	142562770	A	G	het		QUAL=6530;DP=524;QD=12.46;AF=0.48;MQM=60;SAP=3;ABP=4;SAR=125;SAF=129	ATR	missense	ATR:ENST00000350721.9:missense_variant:MODERATE:exon4/47:c.632T>C:p.Met211Thr:,ATR:ENST00000661310.1:missense_variant:MODERATE:exon4/46:c.632T>C:p.Met211Thr:		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	93668 [benign/likely benign DISEASE=Seckel syndrome 1,not specified,not provided];			rs2227928	0.62547	0.79034,0.53447,0.46444,0.58710,0.44348	30655,	33712	56898	1.4770	T(0.84),T(1.00)	B(0.00),B(0.00)	14.16	0.09		COSV63383325	0	24033266,22938532,18414213,26743341,23757202,18191955,28415781,18551366,26920143,17010193,28238063,23313170,22767148,27905519,32597209,34594039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	156677540	156677540	G	T	het	off-target	QUAL=39;DP=19;QD=2.05;AF=0.26;MQM=60;SAP=14;ABP=12;SAR=0;SAF=5	TIPARP,TIPARP-AS1	intron,upstream_gene	TIPARP:ENST00000486483.5:intron_variant:MODIFIER:intron1/5:c.-41-117G>T::,TIPARP:ENST00000295924.12:intron_variant:MODIFIER:intron1/5:c.-41-117G>T::,TIPARP:ENST00000461166.5:intron_variant:MODIFIER:intron1/5:c.-41-117G>T::,TIPARP:ENST00000542783.5:intron_variant:MODIFIER:intron1/5:c.-41-117G>T::,TIPARP-AS1:ENST00000478005.1:upstream_gene_variant:MODIFIER::::,TIPARP-AS1:ENST00000463449.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter					rs345986	0.35920	0.27539,0.31542,0.10994,0.42265,0.43390	10394,	33777	97341	0.3640			8.74				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TIPARP-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), TIPARP (inh=n/a oe_syn=1.12 oe_mis=0.74 oe_lof=0.00)
chr3	156696129	156696129	T	C	hom	off-target	QUAL=17640;DP=559;QD=31.56;AF=1.00;MQM=60;SAP=5;ABP=0;SAR=291;SAF=268	TIPARP	intron	TIPARP:ENST00000486483.5:intron_variant:MODIFIER:intron4/5:c.1247+104T>C::,TIPARP:ENST00000295924.12:intron_variant:MODIFIER:intron4/5:c.1247+104T>C::,TIPARP:ENST00000461166.5:intron_variant:MODIFIER:intron4/5:c.1247+104T>C::,TIPARP:ENST00000542783.5:intron_variant:MODIFIER:intron4/5:c.1247+104T>C::						rs344016	0.95507	0.93463,0.96987,0.96423,0.96672,0.90917	69403,	6487	6835	-1.2670			1.55				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TIPARP (inh=n/a oe_syn=1.12 oe_mis=0.74 oe_lof=0.00)
chr3	156703736	156703736	G	T	het	off-target	QUAL=5954;DP=465;QD=12.80;AF=0.51;MQM=60;SAP=3;ABP=4;SAR=118;SAF=120	TIPARP	intron	TIPARP:ENST00000486483.5:intron_variant:MODIFIER:intron5/5:c.1526+34G>T::,TIPARP:ENST00000295924.12:intron_variant:MODIFIER:intron5/5:c.1526+34G>T::,TIPARP:ENST00000461166.5:intron_variant:MODIFIER:intron5/5:c.1526+34G>T::,TIPARP:ENST00000542783.5:intron_variant:MODIFIER:intron5/5:c.1526+34G>T::	regulatory_region_variant:enhancer				AluYm1 (SINE/Alu)	rs34277251	0.33784	0.08497,0.50052,0.71137,0.40830,0.38294	10993,	29352	100622	-0.1810			1.04				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TIPARP (inh=n/a oe_syn=1.12 oe_mis=0.74 oe_lof=0.00)
chr3	156705283	156705283	A	T	het	off-target	QUAL=83;DP=8;QD=10.38;AF=0.63;MQM=60;SAP=14;ABP=4;SAR=5;SAF=0	TIPARP	3'UTR,downstream_gene	TIPARP:ENST00000295924.12:3_prime_UTR_variant:MODIFIER:exon6/6:c.*152A>T::,TIPARP:ENST00000461166.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*152A>T::,TIPARP:ENST00000542783.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*152A>T::,TIPARP:ENST00000486483.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer					rs346003	0.35559	0.25184,0.31485,0.11193,0.42762,0.42339	10102,	33221	96817	0.2400			1.58						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TIPARP (inh=n/a oe_syn=1.12 oe_mis=0.74 oe_lof=0.00)
chr3	179199217	179199217	A	G	het	off-target	QUAL=843;DP=53;QD=15.91;AF=0.62;MQM=60;SAP=3;ABP=10;SAR=16;SAF=17	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron2/20:c.352+40A>G::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron2/21:c.352+40A>G::		171834_[GENE=PIK3CA_PHENOS=CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	873175 [benign DISEASE=Squamous cell lung carcinoma,not provided];			rs3729674	0.25663	0.42312,0.22776,0.10361,0.18873,0.24078	5940,	27125	112985	0.6980			7.27			COSV55876899	0.01	26587011,30569174,32368160	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179201605	179201605	C	T	hom	off-target	QUAL=53;DP=3;QD=17.67;AF=1.00;MQM=49;SAP=10;ABP=0;SAR=3;SAF=0	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron4/20:c.813+65C>T::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron4/21:c.813+65C>T::		171834_[GENE=PIK3CA_PHENOS=CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]					0.00000	0.00000,0.00000,0.00000,0.00000,0.00000	0,	0	125566	-2.0650			0.01				0		20	275	20 / 254					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179203370	179203370	G	A	het	off-target	QUAL=31;DP=8;QD=3.88;AF=0.38;MQM=60;SAP=10;ABP=4;SAR=0;SAF=3	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron4/20:c.814-174G>A::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron4/21:c.814-174G>A::		171834_[GENE=PIK3CA_PHENOS=CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	1228928 [benign DISEASE=not provided];			rs7623154	0.24074	0.38956,0.22546,0.10027,0.18467,0.10766	5154,	26268	115358	-0.0980			1.61			COSV104380944	0	31709530	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179203465	179203465	-	TAAA	het	off-target	QUAL=74;DP=16;QD=4.63;AF=0.31;MQM=60;SAP=7;ABP=8;SAR=4;SAF=1	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron4/20:c.814-77_814-76insAATA::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron4/21:c.814-77_814-76insAATA::		171834_[GENE=PIK3CA_PHENOS=CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	1275985 [benign DISEASE=not provided];			rs17550640	0.25592	0.42174,0.22765,0.10331,0.18840,0.24110	5866,	27127	112981				4.51				0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179203851	179203851	C	A	hom	off-target	QUAL=2511;DP=75;QD=33.48;AF=1.00;MQM=60;SAP=31;ABP=0;SAR=53;SAF=22	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron5/20:c.1059+62C>A::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron5/21:c.1059+62C>A::		171834_[GENE=PIK3CA_PHENOS=CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	1227071 [benign DISEASE=not provided];			rs2699895	0.57328	0.76073,0.50950,0.22254,0.52630,0.46884	26215,	34645	64815	-0.2870			0.75			COSV55874922	0	30867801	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179204434	179204434	G	T	het	off-target	QUAL=5339;DP=474;QD=11.26;AF=0.50;MQM=60;SAP=325;ABP=3;SAR=213;SAF=25	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron5/20:c.1060-69G>T::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron5/21:c.1060-69G>T::		171834_[GENE=PIK3CA_PHENOS=CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	1248893 [benign DISEASE=not provided];			rs3729676	0.25651	0.42299,0.22781,0.10389,0.18865,0.24036	5922,	27117	112927	0.9590			6.81			COSV55898889	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179204486	179204486	C	A	hom	off-target	QUAL=13651;DP=476;QD=28.68;AF=1.00;MQM=60;SAP=641;ABP=0;SAR=425;SAF=51	PIK3CA	splice_region&intron	PIK3CA:ENST00000263967.4:splice_region_variant&intron_variant:LOW:intron5/20:c.1060-17C>A::,PIK3CA:ENST00000643187.1:splice_region_variant&intron_variant:LOW:intron5/21:c.1060-17C>A::		171834_[GENE=PIK3CA_PHENOS=CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	259957 [benign DISEASE=Cowden syndrome,not specified,not provided];			rs2699896	0.63681	0.85736,0.54774,0.25917,0.58004,0.55182	32547,	31671	55189	-0.5230			0.61		11.00>10.43	COSV55874930	0.04	25741868,28833756	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179204642	179204642	A	G	hom	off-target	QUAL=1889;DP=60;QD=31.48;AF=1.00;MQM=60;SAP=7;ABP=0;SAR=35;SAF=25	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron6/20:c.1145+54A>G::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron6/21:c.1145+54A>G::		171834_[GENE=PIK3CA_PHENOS=CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	1236289 [benign DISEASE=not provided];			rs3729679	0.57252	0.75607,0.51050,0.22250,0.52729,0.46826	26093,	34701	64875	-1.2590			0.67			COSV55874940	0	26585822	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179210061	179210061	T	-	hom	off-target	QUAL=2805;DP=130;QD=21.58;AF=0.88;MQM=60;SAP=217;ABP=0;SAR=4;SAF=110	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron7/20:c.1252-114del::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron7/21:c.1252-114del::		171834_[GENE=PIK3CA_PHENOS=CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	1278006 [benign DISEASE=not provided];			rs67871207	0.24519	0.39281,0.22969,0.10129,0.18764,0.10969	5080,	26194	111912	0.3330			4.94				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179218439	179218439	T	G	het	off-target	QUAL=2983;DP=232;QD=12.86;AF=0.50;MQM=60;SAP=3;ABP=3;SAR=58;SAF=59	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron10/20:c.1664+105T>G::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron10/21:c.1664+105T>G::		171834_[GENE=PIK3CA_PHENOS=CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	1274886 [benign DISEASE=not provided];			rs17849071	0.07968	0.10421,0.09159,0.09908,0.06369,0.08071	513,	11084	139864	0.3970			1.23			COSV104381265	0	24908061,26453385,23185308,26823876,20416519,33182378,31905960	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179220959	179220959	A	T	het	off-target;low_conf_region	QUAL=4420;DP=374;QD=11.82;AF=0.47;MQM=55;SAP=9;ABP=6;SAR=99;SAF=77	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron13/20:c.2016-27A>T::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron13/21:c.2016-27A>T::		171834_[GENE=PIK3CA_PHENOS=CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	1229619 [benign DISEASE=not provided];			rs6443625	0.25627	0.42156,0.22742,0.10328,0.18885,0.24481	5907,	27091	112905	-0.4160			0.12			COSV55887980	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179224643	179224643	C	G	hom	off-target	QUAL=183;DP=7;QD=26.14;AF=1.00;MQM=60;SAP=18;ABP=0;SAR=7;SAF=0	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron15/20:c.2295-57C>G::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron15/21:c.2295-57C>G::		171834_[GENE=PIK3CA_PHENOS=CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	1281921 [benign DISEASE=not provided];			rs2699889	0.66839	0.91307,0.57257,0.28337,0.59971,0.61955	36073,	29271	50317	0.2750			5.62			COSV55874955	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr4	185078433	185078433	T	A	het	off-target	QUAL=686;DP=71;QD=9.66;AF=0.46;MQM=60;SAP=75;ABP=4;SAR=0;SAF=33	LINC02436	intron&non_coding_transcript,downstream_gene	LINC02436:ENST00000509017.6:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/9:n.1499+6360T>A::,LINC02436:ENST00000671007.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/9:n.490-2665T>A::,LINC02436:ENST00000655383.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/9:n.1001+6360T>A::,LINC02436:ENST00000658467.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/5:n.1129-2665T>A::,LINC02436:ENST00000653833.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/9:n.889+6360T>A::,LINC02436:ENST00000669078.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/8:n.638+6360T>A::,LINC02436:ENST00000668759.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/7:n.529+6360T>A::,LINC02436:ENST00000655167.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/11:n.959+6360T>A::,LINC02436:ENST00000653945.1:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer					rs6818170	0.69875	0.82994,0.62641,0.43221,0.67047,0.65168	37911,	30376	45786	0.1640			3.91						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LINC02436 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr5	58321576	58321576	G	C	het		QUAL=11953;DP=931;QD=12.84;AF=0.50;MQM=60;SAP=3;ABP=3;SAR=232;SAF=233		intergenic	::intergenic_variant:MODIFIER::::	regulatory_region_variant:enhancer				MLT1E1A (LTR/ERVL-MaLR)	rs37535	0.59198	0.64335,0.56961,0.49613,0.59295,0.48652	26748,	36369	61939	0.8590			3.18						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr5	80654689	80654689	C	T	hom	off-target	QUAL=3018;DP=108;QD=27.94;AF=1.00;MQM=60;SAP=5;ABP=0;SAR=49;SAF=59	DHFR,MSH3	5'UTR,upstream_gene	DHFR:ENST00000439211.7:5_prime_UTR_variant:MODIFIER:exon1/6:c.-200G>A::,MSH3:ENST00000265081.7:5_prime_UTR_variant:MODIFIER:exon1/24:c.-39C>T::,DHFR:ENST00000505337.5:upstream_gene_variant:MODIFIER::::,DHFR:ENST00000511032.5:upstream_gene_variant:MODIFIER::::,DHFR:ENST00000504396.1:upstream_gene_variant:MODIFIER::::,MSH3:ENST00000667069.1:upstream_gene_variant:MODIFIER::::,MSH3:ENST00000658259.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	126060_[GENE=DHFR_PHENOS=Megaloblastic anemia due to dihydrofolate reductase deficiency, 613839 (3), Autosomal recessive]&600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	1220684 [benign DISEASE=not provided];			rs1105525	0.13383	0.04785,0.11271,0.06772,0.17828,0.24054	1639,	16986	131158	-0.0080			8.40			COSV54143671	0	21629435,30967127,33256598,21317831	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHFR (inh=AR oe_syn=0.88 oe_mis=0.71 oe_lof=0.39), MSH3 (inh=AR+AD oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80654693	80654693	A	G	hom	off-target	QUAL=3018;DP=108;QD=27.94;AF=1.00;MQM=60;SAP=5;ABP=0;SAR=49;SAF=59	DHFR,MSH3	5'UTR,upstream_gene	DHFR:ENST00000439211.7:5_prime_UTR_variant:MODIFIER:exon1/6:c.-204T>C::,MSH3:ENST00000265081.7:5_prime_UTR_variant:MODIFIER:exon1/24:c.-35A>G::,DHFR:ENST00000505337.5:upstream_gene_variant:MODIFIER::::,DHFR:ENST00000511032.5:upstream_gene_variant:MODIFIER::::,DHFR:ENST00000504396.1:upstream_gene_variant:MODIFIER::::,MSH3:ENST00000667069.1:upstream_gene_variant:MODIFIER::::,MSH3:ENST00000658259.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	126060_[GENE=DHFR_PHENOS=Megaloblastic anemia due to dihydrofolate reductase deficiency, 613839 (3), Autosomal recessive]&600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	1237508 [benign DISEASE=not provided];			rs1105524	0.72436	0.91869,0.63097,0.39269,0.66678,0.75135	40944,	27505	41627	-4.8940			3.10			COSV54143681	0	31216018,25966119,32756484	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHFR (inh=AR oe_syn=0.88 oe_mis=0.71 oe_lof=0.39), MSH3 (inh=AR+AD oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80654962	80654962	A	G	het		QUAL=420;DP=38;QD=11.05;AF=0.47;MQM=60;SAP=27;ABP=3;SAR=2;SAF=16	DHFR,MSH3	5'UTR,missense&splice_region,upstream_gene	DHFR:ENST00000439211.7:5_prime_UTR_variant:MODIFIER:exon1/6:c.-473T>C::,MSH3:ENST00000265081.7:missense_variant&splice_region_variant:MODERATE:exon1/24:c.235A>G:p.Ile79Val:,MSH3:ENST00000667069.1:missense_variant&splice_region_variant:MODERATE:exon1/22:c.235A>G:p.Ile79Val:,DHFR:ENST00000505337.5:upstream_gene_variant:MODIFIER::::,DHFR:ENST00000511032.5:upstream_gene_variant:MODIFIER::::,DHFR:ENST00000504396.1:upstream_gene_variant:MODIFIER::::,MSH3:ENST00000658259.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	126060_[GENE=DHFR_PHENOS=Megaloblastic anemia due to dihydrofolate reductase deficiency, 613839 (3), Autosomal recessive]&600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	402591 [benign DISEASE=Constitutional megaloblastic anemia with severe neurologic disease,Hereditary cancer-predisposing syndrome,not specified,not provided];			rs1650697	0.79393	0.91281,0.76418,0.66907,0.75657,0.69597	48045,	24021	31175	-0.2430	 ,T(1.00),T(1.00), , , , 	 ,B(0.00),B(0.00), , , , 	3.55	0.24	4.07>2.71	COSV54144023	0.43	24033266,26811195,19493349,20472929,22495907,28266606,22103680,24846176,25759212,20737570,18551366,23313170,21629435,22450926,24732178,30583708,31216018,29844566,34354741,25966119,21317831,32756484,34050153,25592580,34881269,34910505	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHFR (inh=AR oe_syn=0.88 oe_mis=0.71 oe_lof=0.39), MSH3 (inh=AR+AD oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80670359	80670359	G	A	het	off-target;low_conf_region	QUAL=5451;DP=413;QD=13.20;AF=0.50;MQM=60;SAP=3;ABP=3;SAR=105;SAF=100	MSH3	intron	MSH3:ENST00000265081.7:intron_variant:MODIFIER:intron4/23:c.792+50G>A::,MSH3:ENST00000667069.1:intron_variant:MODIFIER:intron4/21:c.792+50G>A::,MSH3:ENST00000658259.1:intron_variant:MODIFIER:intron4/23:c.624+50G>A::		600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	1288145 [benign DISEASE=not specified,not provided];			rs6151630	0.03829	0.01205,0.02868,0.00077,0.05458,0.03975	141,	5542	146296	0.0690			11.74			COSV54144136	0		71	2176	12 / 444					MSH3 (inh=AR+AD oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80678827	80678827	T	C	hom	off-target	QUAL=3566;DP=115;QD=31.01;AF=1.00;MQM=60;SAP=45;ABP=0;SAR=81;SAF=34	MSH3	intron	MSH3:ENST00000265081.7:intron_variant:MODIFIER:intron7/23:c.1174-100T>C::,MSH3:ENST00000667069.1:intron_variant:MODIFIER:intron7/21:c.1174-100T>C::,MSH3:ENST00000658259.1:intron_variant:MODIFIER:intron7/23:c.1006-100T>C::		600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	1244295 [benign DISEASE=not provided];			rs836807	0.99881	0.99947,0.99961,1.00000,0.99787,0.99896	75940,	181	181	-0.5450			0.38				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH3 (inh=AR+AD oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80787812	80787812	G	A	hom	off-target	QUAL=938;DP=36;QD=26.06;AF=1.00;MQM=60;SAP=81;ABP=0;SAR=36;SAF=0	MSH3	intron	MSH3:ENST00000265081.7:intron_variant:MODIFIER:intron18/23:c.2543+140G>A::,MSH3:ENST00000667069.1:intron_variant:MODIFIER:intron16/21:c.2348+140G>A::,MSH3:ENST00000658259.1:intron_variant:MODIFIER:intron18/23:c.2375+140G>A::		600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	1251794 [benign DISEASE=not provided];			rs33010	0.84561	0.83889,0.85862,0.99885,0.83316,0.86661	54420,	19812	23490	0.4410			6.35				0	17903301	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH3 (inh=AR+AD oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80792643	80792644	AG	-	hom	off-target	QUAL=3983;DP=156;QD=25.53;AF=1.00;MQM=60;SAP=342;ABP=0;SAR=0;SAF=156	MSH3	intron	MSH3:ENST00000265081.7:intron_variant:MODIFIER:intron18/23:c.2544-88_2544-87del::,MSH3:ENST00000667069.1:intron_variant:MODIFIER:intron16/21:c.2349-88_2349-87del::,MSH3:ENST00000658259.1:intron_variant:MODIFIER:intron18/23:c.2376-88_2376-87del::		600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	1262383 [benign DISEASE=not provided];			rs3830224	0.33016	0.20512,0.34237,0.36429,0.37943,0.41778	8682,	32647	101463	1.7540			4.57				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH3 (inh=AR+AD oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80854162	80854162	A	G	hom		QUAL=27934;DP=894;QD=31.25;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=444;SAF=450	MSH3	missense	MSH3:ENST00000265081.7:missense_variant:MODERATE:exon21/24:c.2846A>G:p.Gln949Arg:PF00488 [MutS domain V],MSH3:ENST00000667069.1:missense_variant:MODERATE:exon19/22:c.2651A>G:p.Gln884Arg:PF00488 [MutS domain V],MSH3:ENST00000658259.1:missense_variant:MODERATE:exon21/24:c.2678A>G:p.Gln893Arg:PF00488 [MutS domain V]		600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	821892 [benign DISEASE=Hereditary cancer-predisposing syndrome,not provided];			rs184967	0.86706	0.89201,0.86666,0.99865,0.84294,0.88487	57227,	17320	20204	0.4290	T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	4.96	0.28		COSV54143790	0	23946381,25491747,26811195,18701435,21700777,20386703,28415781,19781088,31374908,25023197,23313170,23755158,27630279,32756484	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH3 (inh=AR+AD oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80864778	80864781	AATG	-	het	off-target	QUAL=54;DP=15;QD=3.60;AF=0.33;MQM=60;SAP=14;ABP=7;SAR=0;SAF=5	MSH3	intron	MSH3:ENST00000265081.7:intron_variant:MODIFIER:intron21/23:c.3001-33_3001-30del::,MSH3:ENST00000667069.1:intron_variant:MODIFIER:intron19/21:c.2806-33_2806-30del::,MSH3:ENST00000658259.1:intron_variant:MODIFIER:intron21/23:c.2833-33_2833-30del::		600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	1258155 [benign DISEASE=not provided];			rs3991216	0.44850	0.24081,0.40869,0.37461,0.55984,0.53904	16672,	34663	83625	3.5250			6.79				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH3 (inh=AR+AD oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80873118	80873118	G	A	hom		QUAL=3732;DP=111;QD=33.62;AF=1.00;MQM=60;SAP=13;ABP=0;SAR=67;SAF=44	MSH3	missense&splice_region	MSH3:ENST00000265081.7:missense_variant&splice_region_variant:MODERATE:exon23/24:c.3133G>A:p.Ala1045Thr:PF00488 [MutS domain V],MSH3:ENST00000667069.1:missense_variant&splice_region_variant:MODERATE:exon21/22:c.2938G>A:p.Ala980Thr:PF00488 [MutS domain V],MSH3:ENST00000658259.1:missense_variant&splice_region_variant:MODERATE:exon23/24:c.2965G>A:p.Ala989Thr:PF00488 [MutS domain V]		600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	822964 [benign DISEASE=Hereditary cancer-predisposing syndrome,not provided];			rs26279	0.70598	0.66825,0.70253,0.75385,0.71615,0.79602	37881,	31524	44682	1.9220	T(0.47),T(0.43),T(0.48)	B(0.03),B(0.02),B(0.05)	6.56	0.11	10.88>10.94	COSV54143807	0.02	21514219,23946381,25491747,26811195,30038702,22454423,31428123,24086368,22623965,18701435,21700777,20386703,19781088,29616133,21974800,31374908,22294770,31035658,31342644,31953835,23313170,18364438,26027715,27335251,18355840,27902597,31114287,30271482,23755158,26617824,31216018,31031852,25586538,27630279,18851982,25966119,32957448,32756484,25592580,31973052	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH3 (inh=AR+AD oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80873351	80873351	G	A	het	off-target	QUAL=1058;DP=59;QD=17.93;AF=0.66;MQM=60;SAP=3;ABP=16;SAR=20;SAF=19	MSH3	intron	MSH3:ENST00000265081.7:intron_variant:MODIFIER:intron23/23:c.3302+64G>A::,MSH3:ENST00000667069.1:intron_variant:MODIFIER:intron21/21:c.3107+64G>A::,MSH3:ENST00000658259.1:intron_variant:MODIFIER:intron23/23:c.3134+64G>A::		600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	1244496 [benign DISEASE=not provided];			rs6151928	0.02381	0.00784,0.02062,0.00000,0.03093,0.01242	67,	3490	148552	0.8450			7.13				0		28	1085	2 / 181					MSH3 (inh=AR+AD oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	112781076	112781076	A	G	het	off-target	QUAL=35;DP=7;QD=5.00;AF=0.43;MQM=60;SAP=10;ABP=3;SAR=3;SAF=0	APC,CBX3P3,RNU6-482P	intron,upstream_gene,downstream_gene	APC:ENST00000257430.9:intron_variant:MODIFIER:intron6/15:c.645+173A>G::,APC:ENST00000508376.6:intron_variant:MODIFIER:intron7/16:c.645+173A>G::,CBX3P3:ENST00000508108.2:upstream_gene_variant:MODIFIER::::,RNU6-482P:ENST00000391068.1:downstream_gene_variant:MODIFIER::::		611731_[GENE=APC_PHENOS=Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenoma, periampullary, somatic, 175100 (3); Hepatoblastoma, somatic, 114550 (3); Gastric cancer, somatic, 613659 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant]	82939 [benign DISEASE=Familial colorectal cancer,not provided];			rs2289484	0.42338	0.16130,0.57236,0.66859,0.50933,0.56147	15896,	32561	87645	-0.8280			0.15				0	29050326	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10), CBX3P3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), RNU6-482P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr5	112818847	112818847	-	G	het	off-target;low_conf_region	QUAL=24;DP=7;QD=3.43;AF=0.43;MQM=60;SAP=10;ABP=3;SAR=0;SAF=3	APC	intron	APC:ENST00000257430.9:intron_variant:MODIFIER:intron9/15:c.934-111dup::,APC:ENST00000508376.6:intron_variant:MODIFIER:intron10/16:c.934-111dup::		611731_[GENE=APC_PHENOS=Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenoma, periampullary, somatic, 175100 (3); Hepatoblastoma, somatic, 114550 (3); Gastric cancer, somatic, 613659 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant]	1292418 [benign DISEASE=not provided];			rs71590728	0.39507	0.13961,0.54426,0.64432,0.47988,0.53282	12040,	26901	78063				0.58				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112827157	112827157	T	C	het		QUAL=1661;DP=182;QD=9.13;AF=0.41;MQM=60;SAP=57;ABP=15;SAR=16;SAF=59	APC	synonymous	APC:ENST00000257430.9:synonymous_variant:LOW:exon12/16:c.1458T>C:p.Tyr486=:,APC:ENST00000508376.6:synonymous_variant:LOW:exon13/17:c.1458T>C:p.Tyr486=:		611731_[GENE=APC_PHENOS=Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenoma, periampullary, somatic, 175100 (3); Hepatoblastoma, somatic, 114550 (3); Gastric cancer, somatic, 613659 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant]	42238 [benign DISEASE=Hepatocellular carcinoma,Neoplasm of stomach,Carcinoma of colon,Hereditary cancer-predisposing syndrome,Familial adenomatous polyposis 1,Familial colorectal cancer,Desmoid disease, hereditary,not specified,APC-Associated Polyposis Disorders,not provided];	CS1822474 [CLASS=DFP MUT=ALT PHEN="Adenomatous polyposis coli predisposition to" GENE=APC];		rs2229992	0.48223	0.20638,0.62253,0.67188,0.58594,0.64567	20034,	33194	78662	1.2980			8.94			COSV57321592	0	25741868,20844743,25324626,23757202,17267408,23940558,22532847,27217144,18849522,18708403,26493165,16569251,20333795,20510605,21995949,27028212,27087319,15768050,17221838,21279955,29050326,29434720,17963004,20685668,9487968,20434453,7959691,26092435,22528324,30809121,26511139,28010732,24666523,24403877,25992589,31383941,33352971,35422484	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112828864	112828864	G	A	het		QUAL=2508;DP=177;QD=14.17;AF=0.51;MQM=60;SAP=3;ABP=3;SAR=44;SAF=46	APC	synonymous	APC:ENST00000257430.9:synonymous_variant:LOW:exon14/16:c.1635G>A:p.Ala545=:PF00514 [Armadillo/beta-catenin-like repeat],APC:ENST00000508376.6:synonymous_variant:LOW:exon15/17:c.1635G>A:p.Ala545=:PF00514 [Armadillo/beta-catenin-like repeat]		611731_[GENE=APC_PHENOS=Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenoma, periampullary, somatic, 175100 (3); Hepatoblastoma, somatic, 114550 (3); Gastric cancer, somatic, 613659 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant]	42239 [benign DISEASE=Carcinoma of colon,Hereditary cancer-predisposing syndrome,Familial adenomatous polyposis 1,Familial colorectal cancer,not specified,APC-Associated Polyposis Disorders,not provided];			rs351771	0.60137	0.53384,0.66854,0.81935,0.61266,0.73231	27971,	35448	60580	1.6090			11.07			COSV57321606	0	25741868,20844743,23757202,23940558,27217144,18849522,24078348,16569251,20333795,21995949,27028212,27087319,14616385,27081525,33352971,35075162	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112837409	112837409	-	AGAA	het	off-target	QUAL=1216;DP=137;QD=8.88;AF=0.49;MQM=60;SAP=148;ABP=3;SAR=0;SAF=67	APC	intron	APC:ENST00000257430.9:intron_variant:MODIFIER:intron15/15:c.1959-143_1959-140dup::,APC:ENST00000508376.6:intron_variant:MODIFIER:intron16/16:c.1959-143_1959-140dup::		611731_[GENE=APC_PHENOS=Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenoma, periampullary, somatic, 175100 (3); Hepatoblastoma, somatic, 114550 (3); Gastric cancer, somatic, 613659 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant]	1265993 [benign DISEASE=not provided];			rs3839284	0.61295	0.54379,0.68610,0.82211,0.62627,0.73537	28865,	35109	58623				9.66				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112840073	112840073	G	A	het		QUAL=5139;DP=417;QD=12.32;AF=0.49;MQM=60;SAP=3;ABP=4;SAR=102;SAF=101	APC	synonymous	APC:ENST00000257430.9:synonymous_variant:LOW:exon16/16:c.4479G>A:p.Thr1493=:PF05923 [APC repeat],APC:ENST00000508376.6:synonymous_variant:LOW:exon17/17:c.4479G>A:p.Thr1493=:PF05923 [APC repeat]		611731_[GENE=APC_PHENOS=Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenoma, periampullary, somatic, 175100 (3); Hepatoblastoma, somatic, 114550 (3); Gastric cancer, somatic, 613659 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant]	42242 [benign DISEASE=Hepatocellular carcinoma,Gastric cancer,Carcinoma of colon,Colorectal cancer,Hereditary cancer-predisposing syndrome,Gastric adenocarcinoma and proximal polyposis of the stomach,Familial adenomatous polyposis 1,Familial colorectal cancer,Desmoid disease, hereditary,not specified,APC-Associated Polyposis Disorders,not provided];	CM2115758 [CLASS=R MUT=ALT PHEN="Adenomatous polyposis coli" GENE=APC];		rs41115	0.60157	0.53425,0.66901,0.81999,0.61262,0.73080	27950,	35424	60486	0.0920			2.72			COSV57321403,COSV57381675	0	25741868,20844743,23757202,23940558,14724163,27217144,16569251,19777185,20333795,20510605,21995949,24861525,27028212,27087319,27898031,26092435,28010732,27081525,28243320,25490678,33790997,27245242,33352971,35866738	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112840628	112840628	G	A	het		QUAL=236;DP=25;QD=9.44;AF=0.52;MQM=60;SAP=31;ABP=3;SAR=13;SAF=0	APC	synonymous	APC:ENST00000257430.9:synonymous_variant:LOW:exon16/16:c.5034G>A:p.Gly1678=:PF16634 [Unstructured region on APC between APC_crr and SAMP],APC:ENST00000508376.6:synonymous_variant:LOW:exon17/17:c.5034G>A:p.Gly1678=:PF16634 [Unstructured region on APC between APC_crr and SAMP]		611731_[GENE=APC_PHENOS=Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenoma, periampullary, somatic, 175100 (3); Hepatoblastoma, somatic, 114550 (3); Gastric cancer, somatic, 613659 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant]	42243 [benign DISEASE=Carcinoma of colon,Hereditary cancer-predisposing syndrome,Familial adenomatous polyposis 1,Familial colorectal cancer,not specified,APC-Associated Polyposis Disorders,not provided];			rs42427	0.60471	0.53580,0.67429,0.81994,0.61761,0.73044	28255,	35352	60050	0.4930			6.19			COSV57321627	0	25741868,20844743,25324626,23757202,23940558,14724163,18547414,27217144,23251617,24980784,16569251,20333795,20510605,15768050,17221838,26173102,30809121,28010732,27081525,24403877,16169467,33790997	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112840862	112840862	T	G	het		QUAL=3244;DP=259;QD=12.53;AF=0.49;MQM=60;SAP=3;ABP=3;SAR=66;SAF=61	APC	synonymous	APC:ENST00000257430.9:synonymous_variant:LOW:exon16/16:c.5268T>G:p.Ser1756=:PF16635 [Unstructured region on APC between SAMP and APC_crr],APC:ENST00000508376.6:synonymous_variant:LOW:exon17/17:c.5268T>G:p.Ser1756=:PF16635 [Unstructured region on APC between SAMP and APC_crr]		611731_[GENE=APC_PHENOS=Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenoma, periampullary, somatic, 175100 (3); Hepatoblastoma, somatic, 114550 (3); Gastric cancer, somatic, 613659 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant]	42245 [benign DISEASE=Carcinoma of colon,Hereditary cancer-predisposing syndrome,Familial adenomatous polyposis 1,Familial colorectal cancer,not specified,APC-Associated Polyposis Disorders,not provided];			rs866006	0.60282	0.53492,0.66916,0.81967,0.61469,0.73093	28119,	35354	60348	0.1690			0.45			COSV57321636,COSV57325918	0	25741868,20844743,23757202,23940558,11818965,27217144,16569251,20333795,21995949,27087319,14616385,15122587,21110124,27081525	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112841059	112841059	T	A	het		QUAL=4233;DP=367;QD=11.53;AF=0.45;MQM=60;SAP=8;ABP=10;SAR=73;SAF=93	APC	missense	APC:ENST00000257430.9:missense_variant:MODERATE:exon16/16:c.5465T>A:p.Val1822Asp:PF16635 [Unstructured region on APC between SAMP and APC_crr],APC:ENST00000508376.6:missense_variant:MODERATE:exon17/17:c.5465T>A:p.Val1822Asp:PF16635 [Unstructured region on APC between SAMP and APC_crr]		611731_[GENE=APC_PHENOS=Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenoma, periampullary, somatic, 175100 (3); Hepatoblastoma, somatic, 114550 (3); Gastric cancer, somatic, 613659 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant]	21030 [benign DISEASE=Hereditary cancer-predisposing syndrome,Familial multiple polyposis syndrome,Familial adenomatous polyposis 1,Familial colorectal cancer,not specified,APC-Associated Polyposis Disorders,not provided];			rs459552	0.81997	0.95649,0.81215,0.90223,0.76131,0.79345	51821,	21028	27372	2.3600	T(1.00),T(1.00)	B(0.00),B(0.00)	16.08	0.19		COSV57321643	0	25741868,26451011,20357209,20844743,24728327,23946381,21819567,30337837,23757202,25372392,18992263,23940558,14724163,22703879,29458332,20149637,24039736,27217144,29963112,19453261,19619005,28410400,24078348,18708403,31485167,24980784,31723073,16569251,20333795,20510605,21995949,27028212,27087319,17221838,14616385,11221825,17556698,18375958,20301519,23159591,23576677,25941542,26809274,23516639,29273807,30239722,22528324,28010732,27081525,26213617,25243319,18343606,25653542,33240400,33769591,32053874,32708070,31406247	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112841474	112841474	G	A	het		QUAL=9880;DP=805;QD=12.27;AF=0.48;MQM=60;SAP=3;ABP=5;SAR=191;SAF=198	APC	synonymous	APC:ENST00000257430.9:synonymous_variant:LOW:exon16/16:c.5880G>A:p.Pro1960=:PF05923 [APC repeat],APC:ENST00000508376.6:synonymous_variant:LOW:exon17/17:c.5880G>A:p.Pro1960=:PF05923 [APC repeat]		611731_[GENE=APC_PHENOS=Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenoma, periampullary, somatic, 175100 (3); Hepatoblastoma, somatic, 114550 (3); Gastric cancer, somatic, 613659 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant]	42247 [benign DISEASE=Carcinoma of colon,Hereditary cancer-predisposing syndrome,Familial adenomatous polyposis 1,Familial colorectal cancer,not specified,APC-Associated Polyposis Disorders,not provided];			rs465899	0.60277	0.53806,0.66947,0.82110,0.61287,0.73040	28071,	35400	60326	-0.1460			4.85			COSV57321652	0	25741868,20844743,25324626,23757202,27217144,16569251,20333795,27087319,15768050,17221838,14616385,25941542,30809121,28010732,27081525,24403877,33790997,25250560	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	132557287	132557287	G	A	hom	off-target	QUAL=1593;DP=65;QD=24.51;AF=1.00;MQM=60;SAP=144;ABP=0;SAR=0;SAF=65	RAD50	5'UTR	RAD50:ENST00000378823.8:5_prime_UTR_variant:MODIFIER:exon1/25:c.-38G>A::	regulatory_region_variant:promoter	604040_[GENE=RAD50_PHENOS=Nijmegen breakage syndrome-like disorder, 613078 (3), Autosomal recessive]				rs4526098	0.92981	0.76236,0.97194,0.99981,0.99666,0.98821	66576,	8345	10681	2.2570			14.68			COSV99528532	0.13	24743186,29879995,20805886,28541483,19917125	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD50 (inh=AR oe_syn=1.07 oe_mis=0.86 oe_lof=0.70)
chr5	132579521	132579521	G	A	het	off-target;low_conf_region	QUAL=1502;DP=144;QD=10.43;AF=0.47;MQM=60;SAP=69;ABP=5;SAR=56;SAF=11	RAD50	splice_region&intron	RAD50:ENST00000378823.8:splice_region_variant&intron_variant:LOW:intron4/24:c.551+19G>A::		604040_[GENE=RAD50_PHENOS=Nijmegen breakage syndrome-like disorder, 613078 (3), Autosomal recessive]	259870 [benign DISEASE=Nijmegen breakage syndrome-like disorder,Hereditary cancer-predisposing syndrome,not specified,not provided];	CS139954 [CLASS=DFP MUT=ALT PHEN="Acute lymphoblastic leukaemia decreased risk" GENE=RAD50];		rs17166050	0.18129	0.11571,0.14566,0.17578,0.21465,0.22494	2697,	22158	124428	-0.1920			1.50			COSV99528535	0	25741868,21356067,18614543,16724073,24079363,24093751,19917125,26014697,33969541,35126453	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD50 (inh=AR oe_syn=1.07 oe_mis=0.86 oe_lof=0.70)
chr5	132589791	132589791	G	C	het		QUAL=814;DP=67;QD=12.15;AF=0.49;MQM=60;SAP=3;ABP=3;SAR=16;SAF=17	RAD50	missense	RAD50:ENST00000378823.8:missense_variant:MODERATE:exon9/25:c.1406G>C:p.Gly469Ala:		604040_[GENE=RAD50_PHENOS=Nijmegen breakage syndrome-like disorder, 613078 (3), Autosomal recessive]	216618 [uncertain significance DISEASE=Hereditary cancer-predisposing syndrome];			rs55653181	0.00002	0.00000,0.00000,0.00000,0.00004,0.00000	0,	3	152131	6.4160	T(0.27)	B(0.20)	22.50	0.26			0	28202063	1	4	0 / 1					RAD50 (inh=AR oe_syn=1.07 oe_mis=0.86 oe_lof=0.70)
chr5	132595760	132595760	A	-	het	mosaic	QUAL=0;DP=927;QD=0.00;AF=0.03;MQM=60;SAP=3;ABP=0;SAR=16;SAF=16	RAD50	frameshift	RAD50:ENST00000378823.8:frameshift_variant:HIGH:exon13/25:c.2165del:p.Lys722ArgfsTer14:		604040_[GENE=RAD50_PHENOS=Nijmegen breakage syndrome-like disorder, 613078 (3), Autosomal recessive]	408407 [pathogenic DISEASE=Hereditary cancer-predisposing syndrome];	CD2036440 [CLASS=DM MUT=ALT PHEN="Breast cancer" GENE=RAD50];		rs397507178	0.00003	0.00005,0.00007,0.00000,0.00001,0.00000	0,	4	150308	-0.1260			22.30			COSV54758496	0	26689913,26824983,25452441,16385572,19409520,29566657,29739316,32832836,30755392,31742824,34070018,36140642,33378670	0	86	0 / 4					RAD50 (inh=AR oe_syn=1.07 oe_mis=0.86 oe_lof=0.70)
chr5	132604212	132604212	T	G	het	off-target	QUAL=291;DP=43;QD=6.77;AF=0.47;MQM=60;SAP=46;ABP=3;SAR=20;SAF=0	RAD50	intron	RAD50:ENST00000378823.8:intron_variant:MODIFIER:intron15/24:c.2524+166T>G::		604040_[GENE=RAD50_PHENOS=Nijmegen breakage syndrome-like disorder, 613078 (3), Autosomal recessive]	1224961 [benign DISEASE=not provided];			rs12187537	0.16166	0.06450,0.13934,0.17782,0.20761,0.21399	2314,	19961	127511	0.0490			6.13			COSV54749162	0	18614543,26622944	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD50 (inh=AR oe_syn=1.07 oe_mis=0.86 oe_lof=0.70)
chr5	132608437	132608437	G	A	het	off-target	QUAL=54;DP=4;QD=13.50;AF=0.75;MQM=60;SAP=10;ABP=5;SAR=0;SAF=3	RAD50	intron	RAD50:ENST00000378823.8:intron_variant:MODIFIER:intron16/24:c.2719-178G>A::		604040_[GENE=RAD50_PHENOS=Nijmegen breakage syndrome-like disorder, 613078 (3), Autosomal recessive]	1291971 [benign DISEASE=not provided];		MIR (SINE/MIR)	rs2522394	0.32634	0.62343,0.20447,0.17641,0.21453,0.23684	10670,	28227	102319	-0.0730			0.62				0	19840389,26622944	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD50 (inh=AR oe_syn=1.07 oe_mis=0.86 oe_lof=0.70)
chr5	132638371	132638371	T	A	het	off-target	QUAL=2451;DP=219;QD=11.19;AF=0.56;MQM=60;SAP=270;ABP=10;SAR=123;SAF=0	RAD50,TH2LCRR	intron,intron&non_coding_transcript	RAD50:ENST00000378823.8:intron_variant:MODIFIER:intron23/24:c.3618+148T>A::,TH2LCRR:ENST00000457489.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.29-106A>T::,TH2LCRR:ENST00000435042.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/3:n.283-106A>T::		604040_[GENE=RAD50_PHENOS=Nijmegen breakage syndrome-like disorder, 613078 (3), Autosomal recessive]	1269272 [benign DISEASE=not provided];			rs7737470	0.22208	0.25357,0.16741,0.17700,0.21569,0.23259	3878,	26005	118259	0.1150			3.89				0	20159242,18846228,18614543,23146381,25935106,23982189	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD50 (inh=AR oe_syn=1.07 oe_mis=0.86 oe_lof=0.70), TH2LCRR (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr5	176906125	176906125	C	T	het	off-target	QUAL=2842;DP=238;QD=11.94;AF=0.50;MQM=60;SAP=214;ABP=3;SAR=114;SAF=6	UIMC1	intron	UIMC1:ENST00000377227.8:intron_variant:MODIFIER:intron13/14:c.1913-78G>A::,UIMC1:ENST00000511320.6:intron_variant:MODIFIER:intron13/14:c.1913-78G>A::,UIMC1:ENST00000506128.5:intron_variant:MODIFIER:intron13/14:c.1415-78G>A::,UIMC1:ENST00000510698.2:intron_variant:MODIFIER:intron9/10:c.803-78G>A::						rs2292256	0.57699	0.81044,0.42450,0.49131,0.49672,0.50228	27012,	33652	64278	0.8360			11.01				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					UIMC1 (inh=n/a oe_syn=1.03 oe_mis=0.90 oe_lof=0.44)
chr5	176907194	176907194	C	T	het	off-target	QUAL=11594;DP=624;QD=18.58;AF=0.69;MQM=60;SAP=3;ABP=207;SAR=216;SAF=217	UIMC1	splice_region&intron	UIMC1:ENST00000377227.8:splice_region_variant&intron_variant:LOW:intron12/14:c.1849-17G>A::,UIMC1:ENST00000511320.6:splice_region_variant&intron_variant:LOW:intron12/14:c.1849-17G>A::,UIMC1:ENST00000506128.5:splice_region_variant&intron_variant:LOW:intron12/14:c.1351-17G>A::,UIMC1:ENST00000510698.2:splice_region_variant&intron_variant:LOW:intron8/10:c.739-17G>A::						rs2292255	0.58006	0.82165,0.42497,0.49014,0.49670,0.50166	27397,	33313	63787	-3.9000			0.00		12.99>12.00	COSV65894272	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					UIMC1 (inh=n/a oe_syn=1.03 oe_mis=0.90 oe_lof=0.44)
chr5	176911170	176911170	G	A	het	off-target;low_conf_region	QUAL=804;DP=45;QD=17.87;AF=0.87;MQM=60;SAP=88;ABP=56;SAR=0;SAF=39	UIMC1	intron	UIMC1:ENST00000377227.8:intron_variant:MODIFIER:intron11/14:c.1676+141C>T::,UIMC1:ENST00000511320.6:intron_variant:MODIFIER:intron11/14:c.1676+141C>T::,UIMC1:ENST00000506128.5:intron_variant:MODIFIER:intron11/14:c.1178+141C>T::,UIMC1:ENST00000510698.2:intron_variant:MODIFIER:intron7/10:c.566+141C>T::	regulatory_region_variant:enhancer				(AAGAA)n (Simple_repeat)	rs868843585						-0.0240			0.72				0		0	1	0 / 1					UIMC1 (inh=n/a oe_syn=1.03 oe_mis=0.90 oe_lof=0.44)
chr5	176911287	176911287	C	T	het	off-target	QUAL=3697;DP=317;QD=11.66;AF=0.49;MQM=60;SAP=111;ABP=3;SAR=122;SAF=34	UIMC1	intron	UIMC1:ENST00000377227.8:intron_variant:MODIFIER:intron11/14:c.1676+24G>A::,UIMC1:ENST00000511320.6:intron_variant:MODIFIER:intron11/14:c.1676+24G>A::,UIMC1:ENST00000506128.5:intron_variant:MODIFIER:intron11/14:c.1178+24G>A::,UIMC1:ENST00000510698.2:intron_variant:MODIFIER:intron7/10:c.566+24G>A::	regulatory_region_variant:enhancer					rs17078630	0.02353	0.00669,0.01699,0.00000,0.03732,0.00456	57,	3464	148470	-2.9070			0.02				0.02	26848770	28	1133	3 / 236					UIMC1 (inh=n/a oe_syn=1.03 oe_mis=0.90 oe_lof=0.44)
chr5	176968373	176968373	A	-	het	off-target	QUAL=13;DP=12;QD=1.08;AF=0.25;MQM=60;SAP=10;ABP=10;SAR=0;SAF=3	UIMC1	intron	UIMC1:ENST00000377227.8:intron_variant:MODIFIER:intron6/14:c.1200+182del::,UIMC1:ENST00000511320.6:intron_variant:MODIFIER:intron6/14:c.1200+182del::,UIMC1:ENST00000506128.5:intron_variant:MODIFIER:intron6/14:c.702+680del::,UIMC1:ENST00000510698.2:intron_variant:MODIFIER:intron2/10:c.90+1228del::					AluSg (SINE/Alu)	rs752467394	0.00259	0.00647,0.00095,0.00021,0.00080,0.00023	0,	355	136747	-0.0150			0.33				0.01		0	20	0 / 1					UIMC1 (inh=n/a oe_syn=1.03 oe_mis=0.90 oe_lof=0.44)
chr6	35452851	35452851	A	C	het	off-target	QUAL=67;DP=8;QD=8.38;AF=0.50;MQM=60;SAP=3;ABP=3;SAR=2;SAF=2	FANCE,MKRN6P	intron,downstream_gene	FANCE:ENST00000229769.3:intron_variant:MODIFIER:intron1/9:c.248+58A>C::,FANCE:ENST00000696264.1:intron_variant:MODIFIER:intron1/7:c.248+58A>C::,MKRN6P:ENST00000436521.2:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	613976_[GENE=FANCE_PHENOS=Fanconi anemia, complementation group E, 600901 (3), Autosomal recessive]	929571 [benign DISEASE=not provided];			rs9470029	0.61857	0.58065,0.66265,0.53395,0.63857,0.63934	29198,	35685	58013	-2.3380			2.41			COSV57691516	0.01	33863951	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MKRN6P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FANCE (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.56)
chr6	35455712	35455712	A	G	het	off-target	QUAL=7876;DP=618;QD=12.74;AF=0.49;MQM=60;SAP=3;ABP=4;SAR=151;SAF=151	FANCE	intron	FANCE:ENST00000229769.3:intron_variant:MODIFIER:intron1/9:c.249-35A>G::,FANCE:ENST00000696264.1:intron_variant:MODIFIER:intron1/7:c.249-35A>G::		613976_[GENE=FANCE_PHENOS=Fanconi anemia, complementation group E, 600901 (3), Autosomal recessive]	261434 [benign DISEASE=Fanconi anemia complementation group E,not specified,not provided];			rs7757405	0.74125	0.86538,0.76449,0.68443,0.67384,0.74398	42316,	27959	39303	1.6900			8.49			COSV57690099	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCE (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.56)
chr6	35455885	35455885	A	C	het		QUAL=875;DP=97;QD=9.02;AF=0.40;MQM=60;SAP=3;ABP=11;SAR=19;SAF=20	FANCE	synonymous	FANCE:ENST00000229769.3:synonymous_variant:LOW:exon2/10:c.387A>C:p.Pro129=:,FANCE:ENST00000696264.1:synonymous_variant:LOW:exon2/8:c.387A>C:p.Pro129=:		613976_[GENE=FANCE_PHENOS=Fanconi anemia, complementation group E, 600901 (3), Autosomal recessive]	261435 [benign DISEASE=Fanconi anemia complementation group E,not specified,not provided];			rs4713867	0.74286	0.87056,0.76650,0.68544,0.67365,0.74420	42567,	27786	39088	-1.1030			1.46			COSV57690669	0	25741868,14695169,32708070	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCE (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.56)
chr6	35456411	35456411	A	G	het	off-target	QUAL=1446;DP=104;QD=13.90;AF=0.54;MQM=60;SAP=7;ABP=4;SAR=23;SAF=33	FANCE	intron	FANCE:ENST00000229769.3:intron_variant:MODIFIER:intron2/9:c.855+58A>G::,FANCE:ENST00000696264.1:intron_variant:MODIFIER:intron2/7:c.855+58A>G::		613976_[GENE=FANCE_PHENOS=Fanconi anemia, complementation group E, 600901 (3), Autosomal recessive]	929575 [benign DISEASE=not provided];			rs3800377	0.71503	0.86382,0.73549,0.54934,0.64997,0.67496	39600,	29429	43293	-1.5070			0.07				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCE (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.56)
chr6	35456491	35456491	A	G	het	off-target	QUAL=542;DP=22;QD=24.64;AF=0.91;MQM=60;SAP=3;ABP=35;SAR=10;SAF=10	FANCE	intron	FANCE:ENST00000229769.3:intron_variant:MODIFIER:intron2/9:c.855+138A>G::,FANCE:ENST00000696264.1:intron_variant:MODIFIER:intron2/7:c.855+138A>G::		613976_[GENE=FANCE_PHENOS=Fanconi anemia, complementation group E, 600901 (3), Autosomal recessive]	1279735 [benign DISEASE=not provided];			rs4713868	0.74157	0.86517,0.76464,0.68544,0.67407,0.74262	42204,	27931	39149	-0.0720			1.75				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCE (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.56)
chr6	35456520	35456520	T	-	het	off-target	QUAL=20;DP=10;QD=2.00;AF=0.30;MQM=60;SAP=10;ABP=6;SAR=3;SAF=0	FANCE	intron	FANCE:ENST00000229769.3:intron_variant:MODIFIER:intron2/9:c.855+178del::,FANCE:ENST00000696264.1:intron_variant:MODIFIER:intron2/7:c.855+178del::		613976_[GENE=FANCE_PHENOS=Fanconi anemia, complementation group E, 600901 (3), Autosomal recessive]			AluSp (SINE/Alu)	rs373252078	0.00073	0.00043,0.00076,0.00040,0.00067,0.00000	0,	106	144686	-0.3510			0.18				0.02		0	34	0 / 1					FANCE (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.56)
chr6	35457639	35457639	A	G	het	off-target	QUAL=10862;DP=818;QD=13.28;AF=0.50;MQM=60;SAP=3;ABP=3;SAR=202;SAF=205	FANCE	intron	FANCE:ENST00000229769.3:intron_variant:MODIFIER:intron3/9:c.900+39A>G::,FANCE:ENST00000696264.1:intron_variant:MODIFIER:intron3/7:c.900+39A>G::		613976_[GENE=FANCE_PHENOS=Fanconi anemia, complementation group E, 600901 (3), Autosomal recessive]	261436 [benign DISEASE=Fanconi anemia complementation group E,not specified,not provided];			rs13214239	0.42525	0.13831,0.52060,0.35377,0.55907,0.42730	16449,	31714	87326	-0.6330			0.59			COSV57690016	0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCE (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.56)
chr6	130827597	130827597	G	A	het	off-target	QUAL=562;DP=41;QD=13.71;AF=0.66;MQM=60;SAP=62;ABP=12;SAR=0;SAF=27	SMLR1	missense	SMLR1:ENST00000541421.2:missense_variant:MODERATE:exon1/2:c.184G>A:p.Val62Met:	regulatory_region_variant:TF_binding_site					rs1044303	0.37129	0.43171,0.43559,0.64981,0.29228,0.48897	11119,	34068	95342	4.5270	D(0.03)	D(0.94)	25.60			COSV73407205	0	25025429	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMLR1 (inh=n/a oe_syn=1.20 oe_mis=0.93 oe_lof=0.36)
chr6	130827723	130827723	A	T	het		QUAL=4360;DP=361;QD=12.08;AF=0.52;MQM=60;SAP=223;ABP=4;SAR=25;SAF=163	SMLR1	intron	SMLR1:ENST00000541421.2:intron_variant:MODIFIER:intron1/1:c.238+72A>T::	regulatory_region_variant:TF_binding_site					rs9388856	0.37138	0.43187,0.43617,0.64725,0.29229,0.48918	11121,	34131	95419	0.2310			2.92				0	20189245,26045716	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMLR1 (inh=n/a oe_syn=1.20 oe_mis=0.93 oe_lof=0.36)
chr6	130827751	130827751	-	AT	het	off-target	QUAL=6593;DP=685;QD=9.62;AF=0.40;MQM=60;SAP=6;ABP=66;SAR=146;SAF=126	SMLR1	intron	SMLR1:ENST00000541421.2:intron_variant:MODIFIER:intron1/1:c.238+113_238+114dup::	regulatory_region_variant:TF_binding_site					rs113795427	0.39408	0.51935,0.43954,0.63311,0.29187,0.48595	12529,	34350	91342				3.79				0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMLR1 (inh=n/a oe_syn=1.20 oe_mis=0.93 oe_lof=0.36)
chr6	130827886	130827886	C	T	het	off-target	QUAL=2471;DP=329;QD=7.51;AF=0.50;MQM=60;SAP=363;ABP=3;SAR=166;SAF=0	SMLR1	intron	SMLR1:ENST00000541421.2:intron_variant:MODIFIER:intron1/1:c.238+235C>T::	regulatory_region_variant:TF_binding_site,TF_binding_site_variant					rs72998266	0.13380	0.19976,0.17150,0.08279,0.09741,0.12008	1655,	17029	131671	-0.4330			1.21				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMLR1 (inh=n/a oe_syn=1.20 oe_mis=0.93 oe_lof=0.36)
chr7	5987144	5987144	T	C	hom		QUAL=524;DP=21;QD=24.95;AF=1.00;MQM=60;SAP=49;ABP=0;SAR=21;SAF=0	PMS2	missense,intron	PMS2:ENST00000265849.12:missense_variant:MODERATE:exon11/15:c.1621A>G:p.Lys541Glu:,PMS2:ENST00000699811.1:missense_variant:MODERATE:exon11/15:c.1216A>G:p.Lys406Glu:,PMS2:ENST00000699752.1:missense_variant:MODERATE:exon10/14:c.1465A>G:p.Lys489Glu:,PMS2:ENST00000699818.1:missense_variant:MODERATE:exon11/15:c.1216A>G:p.Lys406Glu:,PMS2:ENST00000699754.1:missense_variant:MODERATE:exon9/13:c.1423A>G:p.Lys475Glu:,PMS2:ENST00000699760.1:missense_variant:MODERATE:exon9/13:c.1303A>G:p.Lys435Glu:,PMS2:ENST00000699761.1:missense_variant:MODERATE:exon11/15:c.1216A>G:p.Lys406Glu:,PMS2:ENST00000699762.1:missense_variant:MODERATE:exon10/14:c.1048A>G:p.Lys350Glu:,PMS2:ENST00000699821.1:missense_variant:MODERATE:exon11/15:c.1216A>G:p.Lys406Glu:,PMS2:ENST00000699766.1:missense_variant:MODERATE:exon11/15:c.1621A>G:p.Lys541Glu:,PMS2:ENST00000699768.1:missense_variant:MODERATE:exon11/14:c.1621A>G:p.Lys541Glu:,PMS2:ENST00000699839.1:missense_variant:MODERATE:exon12/16:c.1807A>G:p.Lys603Glu:,PMS2:ENST00000699823.1:missense_variant:MODERATE:exon10/14:c.1216A>G:p.Lys406Glu:,PMS2:ENST00000699837.1:missense_variant:MODERATE:exon10/14:c.1216A>G:p.Lys406Glu:,PMS2:ENST00000699825.1:missense_variant:MODERATE:exon10/14:c.1060A>G:p.Lys354Glu:,PMS2:ENST00000699827.1:missense_variant:MODERATE:exon10/14:c.1453A>G:p.Lys485Glu:,PMS2:ENST00000699952.1:intron_variant:MODIFIER:intron7/7:c.803+10182A>G::,PMS2:ENST00000642292.1:missense_variant:MODERATE:exon10/14:c.1216A>G:p.Lys406Glu:,PMS2:ENST00000642456.1:missense_variant:MODERATE:exon11/15:c.1216A>G:p.Lys406Glu:,PMS2:ENST00000382321.5:intron_variant:MODIFIER:intron7/10:c.804-4153A>G::		600259_[GENE=PMS2_PHENOS=Lynch syndrome 4, 614337 (3); Mismatch repair cancer syndrome 4, 619101 (3), Autosomal recessive]	135065 [benign DISEASE=Lynch syndrome 4,Mismatch repair cancer syndrome 4,Hereditary nonpolyposis colorectal neoplasms,not specified];			rs2228006	0.86539	0.92501,0.77189,0.91458,0.84541,0.89503	57124,	17289	20461	1.5020	T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00), ,T(1.00),T(1.00), 	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00), ,B(0.00),B(0.00), 	5.90	0.16		COSV56223170	0.1	25741868,24033266,24728327,26811195,22523087,22594646,16619239,21487324,26900293,22703879,29458332,29963112,27900359,18723338,24689082,15256438,8993976,16774946,29434720,16472587,24027009,14756672,20186689,24072394,28122645,28926134,31160353,33863951,33240400,32756484,32708070,34247610	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS2 (inh=AR+AD oe_syn=1.10 oe_mis=1.07 oe_lof=0.98)
chr7	5997349	5997349	G	C	hom		QUAL=731;DP=23;QD=31.78;AF=1.00;MQM=60;SAP=4;ABP=0;SAR=10;SAF=13	PMS2	synonymous,intron	PMS2:ENST00000265849.12:synonymous_variant:LOW:exon7/15:c.780C>G:p.Ser260=:,PMS2:ENST00000699811.1:synonymous_variant:LOW:exon7/15:c.375C>G:p.Ser125=:,PMS2:ENST00000699752.1:synonymous_variant:LOW:exon7/14:c.780C>G:p.Ser260=:,PMS2:ENST00000699818.1:synonymous_variant:LOW:exon7/15:c.375C>G:p.Ser125=:,PMS2:ENST00000699754.1:intron_variant:MODIFIER:intron6/12:c.705+1759C>G::,PMS2:ENST00000699760.1:synonymous_variant:LOW:exon5/13:c.462C>G:p.Ser154=:,PMS2:ENST00000699761.1:synonymous_variant:LOW:exon7/15:c.375C>G:p.Ser125=:,PMS2:ENST00000699762.1:synonymous_variant:LOW:exon6/14:c.207C>G:p.Ser69=:,PMS2:ENST00000699821.1:synonymous_variant:LOW:exon7/15:c.375C>G:p.Ser125=:,PMS2:ENST00000699766.1:synonymous_variant:LOW:exon7/15:c.780C>G:p.Ser260=:,PMS2:ENST00000699768.1:synonymous_variant:LOW:exon7/14:c.780C>G:p.Ser260=:,PMS2:ENST00000699839.1:synonymous_variant:LOW:exon8/16:c.966C>G:p.Ser322=:,PMS2:ENST00000699823.1:synonymous_variant:LOW:exon6/14:c.375C>G:p.Ser125=:,PMS2:ENST00000699837.1:synonymous_variant:LOW:exon6/14:c.375C>G:p.Ser125=:,PMS2:ENST00000699825.1:synonymous_variant:LOW:exon7/14:c.375C>G:p.Ser125=:,PMS2:ENST00000699827.1:synonymous_variant:LOW:exon6/14:c.612C>G:p.Ser204=:,PMS2:ENST00000699952.1:synonymous_variant:LOW:exon7/8:c.780C>G:p.Ser260=:,PMS2:ENST00000642292.1:synonymous_variant:LOW:exon6/14:c.375C>G:p.Ser125=:,PMS2:ENST00000642456.1:synonymous_variant:LOW:exon7/15:c.375C>G:p.Ser125=:,PMS2:ENST00000382321.5:synonymous_variant:LOW:exon7/11:c.780C>G:p.Ser260=:	regulatory_region_variant:TF_binding_site,regulatory_region_variant:CTCF_binding_site	600259_[GENE=PMS2_PHENOS=Lynch syndrome 4, 614337 (3); Mismatch repair cancer syndrome 4, 619101 (3), Autosomal recessive]	36693 [benign DISEASE=Endometrial carcinoma,Lynch syndrome,Lynch syndrome 4,Hereditary cancer-predisposing syndrome,Mismatch repair cancer syndrome 4,Hereditary nonpolyposis colorectal neoplasms,not specified,not provided];			rs1805319	0.81690	0.84318,0.73699,0.91480,0.81218,0.81234	50590,	22315	27681	-2.2610			0.03			COSV56223185	0.01	25741868,23757202,16619239,26900293,19692168,18268114,15256438,8993976,16472587,20205264,182681,19132747,34247610	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS2 (inh=AR+AD oe_syn=1.10 oe_mis=1.07 oe_lof=0.98)
chr7	5997426	5997426	-	A	het	low_conf_region	QUAL=206;DP=22;QD=9.36;AF=0.45;MQM=60;SAP=4;ABP=3;SAR=6;SAF=4	PMS2	splice_region&intron,intron	PMS2:ENST00000265849.12:splice_region_variant&intron_variant:LOW:intron6/14:c.706-4dup::,PMS2:ENST00000699811.1:splice_region_variant&intron_variant:LOW:intron6/14:c.301-4dup::,PMS2:ENST00000699752.1:splice_region_variant&intron_variant:LOW:intron6/13:c.706-4dup::,PMS2:ENST00000699818.1:splice_region_variant&intron_variant:LOW:intron6/14:c.301-4dup::,PMS2:ENST00000699754.1:intron_variant:MODIFIER:intron6/12:c.705+1681dup::,PMS2:ENST00000699760.1:splice_region_variant&intron_variant:LOW:intron4/12:c.388-4dup::,PMS2:ENST00000699761.1:splice_region_variant&intron_variant:LOW:intron6/14:c.301-4dup::,PMS2:ENST00000699762.1:splice_region_variant&intron_variant:LOW:intron5/13:c.133-4dup::,PMS2:ENST00000699821.1:splice_region_variant&intron_variant:LOW:intron6/14:c.301-4dup::,PMS2:ENST00000699766.1:splice_region_variant&intron_variant:LOW:intron6/14:c.706-4dup::,PMS2:ENST00000699768.1:splice_region_variant&intron_variant:LOW:intron6/13:c.706-4dup::,PMS2:ENST00000699839.1:splice_region_variant&intron_variant:LOW:intron7/15:c.892-4dup::,PMS2:ENST00000699823.1:splice_region_variant&intron_variant:LOW:intron5/13:c.301-4dup::,PMS2:ENST00000699837.1:splice_region_variant&intron_variant:LOW:intron5/13:c.301-4dup::,PMS2:ENST00000699825.1:splice_region_variant&intron_variant:LOW:intron6/13:c.301-4dup::,PMS2:ENST00000699827.1:splice_region_variant&intron_variant:LOW:intron5/13:c.538-4dup::,PMS2:ENST00000699952.1:splice_region_variant&intron_variant:LOW:intron6/7:c.706-4dup::,PMS2:ENST00000642292.1:splice_region_variant&intron_variant:LOW:intron5/13:c.301-4dup::,PMS2:ENST00000642456.1:splice_region_variant&intron_variant:LOW:intron6/14:c.301-4dup::,PMS2:ENST00000382321.5:splice_region_variant&intron_variant:LOW:intron6/10:c.706-4dup::	regulatory_region_variant:TF_binding_site,regulatory_region_variant:CTCF_binding_site	600259_[GENE=PMS2_PHENOS=Lynch syndrome 4, 614337 (3); Mismatch repair cancer syndrome 4, 619101 (3), Autosomal recessive]	198429 [benign(replaced by megSAP based on classifications:7x1,2x2,1x3) DISEASE=Lynch syndrome,Lynch syndrome 1,Lynch syndrome 4,Hereditary cancer-predisposing syndrome,Hereditary nonpolyposis colorectal neoplasms,not specified,not provided];			rs60794673	0.10139	0.10493,0.11468,0.02840,0.11059,0.03859	655,	12188	119628				3.73				0	25741868,24033266,33240400	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS2 (inh=AR+AD oe_syn=1.10 oe_mis=1.07 oe_lof=0.98)
chr7	5998990	5998990	A	-	het	off-target	QUAL=714;DP=42;QD=17.00;AF=0.60;MQM=60;SAP=57;ABP=6;SAR=0;SAF=25	PMS2	intron	PMS2:ENST00000265849.12:intron_variant:MODIFIER:intron6/14:c.705+118del::,PMS2:ENST00000699811.1:intron_variant:MODIFIER:intron6/14:c.300+118del::,PMS2:ENST00000699752.1:intron_variant:MODIFIER:intron6/13:c.705+118del::,PMS2:ENST00000699818.1:intron_variant:MODIFIER:intron6/14:c.300+118del::,PMS2:ENST00000699754.1:intron_variant:MODIFIER:intron6/12:c.705+118del::,PMS2:ENST00000699760.1:intron_variant:MODIFIER:intron4/12:c.387+118del::,PMS2:ENST00000699761.1:intron_variant:MODIFIER:intron6/14:c.300+118del::,PMS2:ENST00000699762.1:intron_variant:MODIFIER:intron5/13:c.133-1567del::,PMS2:ENST00000699821.1:intron_variant:MODIFIER:intron6/14:c.300+118del::,PMS2:ENST00000699766.1:intron_variant:MODIFIER:intron6/14:c.705+118del::,PMS2:ENST00000699768.1:intron_variant:MODIFIER:intron6/13:c.705+118del::,PMS2:ENST00000699839.1:intron_variant:MODIFIER:intron7/15:c.891+118del::,PMS2:ENST00000699823.1:intron_variant:MODIFIER:intron5/13:c.300+118del::,PMS2:ENST00000699837.1:intron_variant:MODIFIER:intron5/13:c.300+118del::,PMS2:ENST00000699825.1:intron_variant:MODIFIER:intron6/13:c.300+118del::,PMS2:ENST00000699827.1:intron_variant:MODIFIER:intron5/13:c.538-1567del::,PMS2:ENST00000699952.1:intron_variant:MODIFIER:intron6/7:c.705+118del::,PMS2:ENST00000642292.1:intron_variant:MODIFIER:intron5/13:c.300+118del::,PMS2:ENST00000642456.1:intron_variant:MODIFIER:intron6/14:c.300+118del::,PMS2:ENST00000382321.5:intron_variant:MODIFIER:intron6/10:c.705+118del::		600259_[GENE=PMS2_PHENOS=Lynch syndrome 4, 614337 (3); Mismatch repair cancer syndrome 4, 619101 (3), Autosomal recessive]			AluSx3 (SINE/Alu)	rs11289444	0.73556	0.74312,0.69578,0.81019,0.73687,0.71853	36440,	29023	36635	0.5950			0.67				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS2 (inh=AR+AD oe_syn=1.10 oe_mis=1.07 oe_lof=0.98)
chr7	5998990	5998991	AA	-	het	off-target	QUAL=714;DP=42;QD=17.00;AF=0.24;MQM=60;SAP=25;ABP=28;SAR=0;SAF=10	PMS2	intron	PMS2:ENST00000265849.12:intron_variant:MODIFIER:intron6/14:c.705+117_705+118del::,PMS2:ENST00000699811.1:intron_variant:MODIFIER:intron6/14:c.300+117_300+118del::,PMS2:ENST00000699752.1:intron_variant:MODIFIER:intron6/13:c.705+117_705+118del::,PMS2:ENST00000699818.1:intron_variant:MODIFIER:intron6/14:c.300+117_300+118del::,PMS2:ENST00000699754.1:intron_variant:MODIFIER:intron6/12:c.705+117_705+118del::,PMS2:ENST00000699760.1:intron_variant:MODIFIER:intron4/12:c.387+117_387+118del::,PMS2:ENST00000699761.1:intron_variant:MODIFIER:intron6/14:c.300+117_300+118del::,PMS2:ENST00000699762.1:intron_variant:MODIFIER:intron5/13:c.133-1568_133-1567del::,PMS2:ENST00000699821.1:intron_variant:MODIFIER:intron6/14:c.300+117_300+118del::,PMS2:ENST00000699766.1:intron_variant:MODIFIER:intron6/14:c.705+117_705+118del::,PMS2:ENST00000699768.1:intron_variant:MODIFIER:intron6/13:c.705+117_705+118del::,PMS2:ENST00000699839.1:intron_variant:MODIFIER:intron7/15:c.891+117_891+118del::,PMS2:ENST00000699823.1:intron_variant:MODIFIER:intron5/13:c.300+117_300+118del::,PMS2:ENST00000699837.1:intron_variant:MODIFIER:intron5/13:c.300+117_300+118del::,PMS2:ENST00000699825.1:intron_variant:MODIFIER:intron6/13:c.300+117_300+118del::,PMS2:ENST00000699827.1:intron_variant:MODIFIER:intron5/13:c.538-1568_538-1567del::,PMS2:ENST00000699952.1:intron_variant:MODIFIER:intron6/7:c.705+117_705+118del::,PMS2:ENST00000642292.1:intron_variant:MODIFIER:intron5/13:c.300+117_300+118del::,PMS2:ENST00000642456.1:intron_variant:MODIFIER:intron6/14:c.300+117_300+118del::,PMS2:ENST00000382321.5:intron_variant:MODIFIER:intron6/10:c.705+117_705+118del::		600259_[GENE=PMS2_PHENOS=Lynch syndrome 4, 614337 (3); Mismatch repair cancer syndrome 4, 619101 (3), Autosomal recessive]			AluSx3 (SINE/Alu)	rs11289444	0.00334	0.00519,0.00265,0.00105,0.00193,0.00046	0,	463	137995	0.5950			1.29				0		2	327	0 / 21					PMS2 (inh=AR+AD oe_syn=1.10 oe_mis=1.07 oe_lof=0.98)
chr7	6008925	6008925	G	A	het	off-target	QUAL=680;DP=48;QD=14.17;AF=0.56;MQM=60;SAP=3;ABP=5;SAR=14;SAF=13	PMS2,Y_RNA,AIMP2	intron,5'UTR,upstream_gene	PMS2:ENST00000265849.12:intron_variant:MODIFIER:intron1/14:c.23+72C>T::,PMS2:ENST00000699811.1:intron_variant:MODIFIER:intron1/14:c.-553+72C>T::,PMS2:ENST00000699752.1:intron_variant:MODIFIER:intron1/13:c.23+72C>T::,PMS2:ENST00000699818.1:5_prime_UTR_variant:MODIFIER:exon1/15:c.-501C>T::,PMS2:ENST00000699754.1:intron_variant:MODIFIER:intron1/12:c.23+72C>T::,PMS2:ENST00000699760.1:intron_variant:MODIFIER:intron1/12:c.-53+72C>T::,PMS2:ENST00000699761.1:intron_variant:MODIFIER:intron1/14:c.-325+72C>T::,PMS2:ENST00000699762.1:intron_variant:MODIFIER:intron1/13:c.-378+72C>T::,PMS2:ENST00000699766.1:intron_variant:MODIFIER:intron1/14:c.23+72C>T::,PMS2:ENST00000699768.1:intron_variant:MODIFIER:intron1/13:c.23+72C>T::,PMS2:ENST00000699839.1:intron_variant:MODIFIER:intron1/15:c.23+72C>T::,PMS2:ENST00000699823.1:intron_variant:MODIFIER:intron1/13:c.-190+72C>T::,PMS2:ENST00000699837.1:intron_variant:MODIFIER:intron1/13:c.-275+72C>T::,PMS2:ENST00000699825.1:intron_variant:MODIFIER:intron1/13:c.-378+72C>T::,PMS2:ENST00000699827.1:intron_variant:MODIFIER:intron1/13:c.23+72C>T::,PMS2:ENST00000699952.1:intron_variant:MODIFIER:intron1/7:c.23+72C>T::,PMS2:ENST00000642292.1:intron_variant:MODIFIER:intron1/13:c.-243+72C>T::,PMS2:ENST00000642456.1:intron_variant:MODIFIER:intron1/14:c.-378+72C>T::,PMS2:ENST00000382321.5:intron_variant:MODIFIER:intron1/10:c.23+72C>T::,PMS2:ENST00000699821.1:upstream_gene_variant:MODIFIER::::,Y_RNA:ENST00000365120.1:upstream_gene_variant:MODIFIER::::,AIMP2:ENST00000400479.6:upstream_gene_variant:MODIFIER::::,AIMP2:ENST00000223029.8:upstream_gene_variant:MODIFIER::::,AIMP2:ENST00000395236.2:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	600259_[GENE=PMS2_PHENOS=Lynch syndrome 4, 614337 (3); Mismatch repair cancer syndrome 4, 619101 (3), Autosomal recessive]&600859_[GENE=AIMP2_PHENOS=Leukodystrophy, hypomyelinating, 17, 618006 (3), Autosomal recessive]	1169336 [benign DISEASE=Hereditary nonpolyposis colorectal neoplasms,not provided];	CS1714329 [CLASS=R MUT=ALT PHEN="Lynch syndrome" GENE=PMS2];		rs3735295	0.22624	0.31711,0.15106,0.16060,0.18809,0.23292	4252,	25892	117640	1.0220			12.01				0	28499365,23424144	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS2 (inh=AR+AD oe_syn=1.10 oe_mis=1.07 oe_lof=0.98), AIMP2 (inh=AR oe_syn=1.21 oe_mis=1.17 oe_lof=0.46)
chr7	6009173	6009173	G	C	het	off-target	QUAL=58;DP=10;QD=5.80;AF=0.40;MQM=60;SAP=3;ABP=4;SAR=2;SAF=2	PMS2,Y_RNA,AIMP2	upstream_gene	PMS2:ENST00000265849.12:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699811.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699752.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699818.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699754.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699760.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699761.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699762.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699821.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699766.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699768.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699839.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699823.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699837.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699825.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699827.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699952.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000642292.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000642456.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000382321.5:upstream_gene_variant:MODIFIER::::,Y_RNA:ENST00000365120.1:upstream_gene_variant:MODIFIER::::,AIMP2:ENST00000400479.6:upstream_gene_variant:MODIFIER::::,AIMP2:ENST00000223029.8:upstream_gene_variant:MODIFIER::::,AIMP2:ENST00000395236.2:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	600259_[GENE=PMS2_PHENOS=Lynch syndrome 4, 614337 (3); Mismatch repair cancer syndrome 4, 619101 (3), Autosomal recessive]&600859_[GENE=AIMP2_PHENOS=Leukodystrophy, hypomyelinating, 17, 618006 (3), Autosomal recessive]	91280 [benign DISEASE=Lynch syndrome];			rs3735296	0.16232	0.22938,0.10762,0.06622,0.13795,0.14520	2212,	20247	127315	0.1400			8.88					24689082	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS2 (inh=AR+AD oe_syn=1.10 oe_mis=1.07 oe_lof=0.98), AIMP2 (inh=AR oe_syn=1.21 oe_mis=1.17 oe_lof=0.46)
chr7	129203328	129203328	C	T	hom	off-target	QUAL=315;DP=12;QD=26.25;AF=1.00;MQM=60;SAP=29;ABP=0;SAR=0;SAF=12	SMO	intron	SMO:ENST00000249373.8:intron_variant:MODIFIER:intron1/11:c.332-56C>T::		601500_[GENE=SMO_PHENOS=Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3)]	1244213 [benign DISEASE=not provided];			rs2566871	0.49186	0.47408,0.47230,0.40629,0.52349,0.43786	18493,	37778	77240	-1.2520			0.59			COSV50824292	0	31209431	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	129205177	129205177	C	T	hom	off-target	QUAL=6743;DP=204;QD=33.05;AF=1.00;MQM=60;SAP=26;ABP=0;SAR=79;SAF=125	SMO	intron	SMO:ENST00000249373.8:intron_variant:MODIFIER:intron2/11:c.538-26C>T::		601500_[GENE=SMO_PHENOS=Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3)]	1275728 [benign DISEASE=Hamartoma of hypothalamus,not provided];			rs2703091	0.78486	0.68691,0.74376,0.74314,0.84369,0.76485	47256,	24715	32681	0.0620			4.15			COSV99976307	0	28833756	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	129205436	129205436	G	C	hom	off-target	QUAL=1590;DP=55;QD=28.91;AF=1.00;MQM=60;SAP=83;ABP=0;SAR=5;SAF=50	SMO	intron	SMO:ENST00000249373.8:intron_variant:MODIFIER:intron3/11:c.747+24G>C::		601500_[GENE=SMO_PHENOS=Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3)]	1268093 [benign DISEASE=Hamartoma of hypothalamus,not provided];			rs2075777	0.78467	0.68677,0.74345,0.74342,0.84352,0.76328	47291,	24739	32745	-0.0750			1.81				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	129205484	129205484	G	A	hom	off-target	QUAL=1826;DP=62;QD=29.45;AF=1.00;MQM=60;SAP=30;ABP=0;SAR=17;SAF=45	SMO	intron	SMO:ENST00000249373.8:intron_variant:MODIFIER:intron3/11:c.747+72G>A::		601500_[GENE=SMO_PHENOS=Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3)]	1290719 [benign DISEASE=not provided];			rs2566872	0.78473	0.68651,0.74299,0.74218,0.84360,0.76582	47267,	24725	32715	-0.1160			0.88			COSV50827858	0.09		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	129205861	129205861	C	T	hom	off-target	QUAL=1233;DP=40;QD=30.83;AF=1.00;MQM=60;SAP=8;ABP=0;SAR=25;SAF=15	SMO	intron	SMO:ENST00000249373.8:intron_variant:MODIFIER:intron4/11:c.920+79C>T::		601500_[GENE=SMO_PHENOS=Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3)]	1221870 [benign DISEASE=not provided];			rs2075778	0.78586	0.69075,0.74375,0.74167,0.84365,0.76472	47389,	24676	32550	0.1800			2.65			COSV99976190	0.2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	129206066	129206066	T	C	hom	off-target	QUAL=113;DP=4;QD=28.25;AF=1.00;MQM=60;SAP=12;ABP=0;SAR=4;SAF=0	SMO	intron	SMO:ENST00000249373.8:intron_variant:MODIFIER:intron4/11:c.921-84T>C::		601500_[GENE=SMO_PHENOS=Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3)]	1259833 [benign DISEASE=not provided];			rs2075779	0.78591	0.69109,0.74385,0.74189,0.84361,0.76441	47409,	24678	32552	-0.2590			3.77			COSV50841276	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	129206487	129206487	G	C	hom		QUAL=28314;DP=899;QD=31.49;AF=1.00;MQM=60;SAP=4;ABP=0;SAR=440;SAF=459	SMO	synonymous	SMO:ENST00000249373.8:synonymous_variant:LOW:exon6/12:c.1164G>C:p.Gly388=:PF01534 [Frizzled/Smoothened family membrane region]		601500_[GENE=SMO_PHENOS=Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3)]	403462 [benign DISEASE=Hamartoma of hypothalamus,not specified,not provided];			rs2228617	0.78667	0.69119,0.74512,0.75464,0.84385,0.76628	47468,	24621	32421	1.1650			10.22			COSV50829466	0	24033266,27236920,30334169,23826113,25189937,28833756	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	129206628	129206628	A	G	hom	off-target	QUAL=27600;DP=850;QD=32.47;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=423;SAF=427	SMO	intron	SMO:ENST00000249373.8:intron_variant:MODIFIER:intron6/11:c.1264+41A>G::		601500_[GENE=SMO_PHENOS=Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3)]	1281387 [benign DISEASE=Hamartoma of hypothalamus,not provided];			rs2735842	0.78597	0.69125,0.74374,0.74199,0.84359,0.76494	47388,	24665	32525	0.2220			6.39			COSV50829472	0	27236920	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	129206716	129206716	-	AG	hom	off-target	QUAL=25299;DP=812;QD=31.16;AF=0.99;MQM=60;SAP=3;ABP=0;SAR=405;SAF=401	SMO	intron	SMO:ENST00000249373.8:intron_variant:MODIFIER:intron6/11:c.1264+130_1264+131dup::		601500_[GENE=SMO_PHENOS=Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3)]	1277300 [benign DISEASE=not provided];			rs10622446	0.78544	0.69002,0.74374,0.74167,0.84336,0.76419	47288,	24676	32576				8.20				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	129211961	129211961	G	A	het	off-target	QUAL=693;DP=56;QD=12.38;AF=0.59;MQM=60;SAP=58;ABP=7;SAR=2;SAF=31	SMO	intron	SMO:ENST00000249373.8:intron_variant:MODIFIER:intron11/11:c.1937-63G>A::		601500_[GENE=SMO_PHENOS=Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3)]				rs73230586	0.00018	0.00014,0.00000,0.00000,0.00029,0.00000	0,	28	152098	0.8380			4.78				0.05		0	12	0 / 4					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	142749281	142749281	A	C	hom	off-target	QUAL=1604;DP=76;QD=21.11;AF=1.00;MQM=59;SAP=168;ABP=0;SAR=0;SAF=76	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]	1169050 [benign DISEASE=Hereditary pancreatitis];			rs4726576	0.55515	0.55995,0.58763,0.22820,0.57834,0.31657	21898,	37062	64794	-3.0540			0.04					26820620,26784911,30832275,30467200,31506327	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749335	142749335	A	G	het	off-target	QUAL=559;DP=111;QD=5.04;AF=0.33;MQM=57;SAP=83;ABP=30;SAR=0;SAF=37	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1302270496	0.37120	0.43717,0.37699,0.12039,0.36330,0.19309	0,	41485	70275	-0.5770			0.68						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749336	142749336	G	A	het	off-target	QUAL=559;DP=111;QD=5.04;AF=0.33;MQM=57;SAP=83;ABP=30;SAR=0;SAF=37	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1466629343	0.37317	0.43913,0.37919,0.12379,0.36500,0.19737	0,	41797	70209	-0.2050			0.27						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749349	142749349	C	A	het	off-target	QUAL=580;DP=110;QD=5.27;AF=0.34;MQM=57;SAP=83;ABP=29;SAR=0;SAF=37	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1194150362	0.38814	0.45092,0.39302,0.14471,0.38063,0.22004	0,	46751	73699	-1.4380			0.34						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749351	142749351	C	A	het	off-target	QUAL=580;DP=110;QD=5.27;AF=0.34;MQM=57;SAP=83;ABP=29;SAR=0;SAF=37	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs796363879	0.38886	0.45167,0.39394,0.14629,0.38120,0.22030	0,	47061	73961	-0.0630			1.34						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749359	142749359	A	C	het	off-target	QUAL=560;DP=109;QD=5.14;AF=0.34;MQM=57;SAP=83;ABP=27;SAR=0;SAF=37	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs796221450	0.39152	0.45354,0.39643,0.15247,0.38426,0.22597	0,	48377	75185	0.2990			5.18						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749360	142749360	G	A	het	off-target	QUAL=560;DP=109;QD=5.14;AF=0.34;MQM=57;SAP=83;ABP=27;SAR=0;SAF=37	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs576859120	0.39202	0.45397,0.39685,0.15275,0.38470,0.22624	0,	48553	75301	0.6120			5.89						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749392	142749392	G	A	het	off-target	QUAL=1393;DP=255;QD=5.46;AF=0.29;MQM=51;SAP=3;ABP=101;SAR=37;SAF=37	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1329539668	0.39584	0.45361,0.40051,0.16434,0.39008,0.23555	0,	51467	78553	0.1980			4.22						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749413	142749413	T	A	het	off-target	QUAL=1285;DP=260;QD=4.94;AF=0.27;MQM=51;SAP=3;ABP=119;SAR=35;SAF=36	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs796163171	0.39877	0.45555,0.40314,0.16978,0.39299,0.24119	0,	52544	79222	-1.4940			0.92						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749434	142749434	G	C	het	off-target;low_conf_region	QUAL=185;DP=191;QD=0.97;AF=0.20;MQM=44;SAP=77;ABP=153;SAR=37;SAF=1	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs764706324	0.39485	0.45234,0.39893,0.16018,0.38935,0.23393	0,	50253	77019	-0.4660			1.58						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749435	142749435	T	A	het	off-target;low_conf_region	QUAL=185;DP=191;QD=0.97;AF=0.20;MQM=44;SAP=77;ABP=153;SAR=37;SAF=1	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs780768878	0.39420	0.45205,0.39879,0.15860,0.38871,0.23133	0,	49988	76822	-0.6810			0.90						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749439	142749439	G	C	het	off-target;low_conf_region	QUAL=185;DP=191;QD=0.97;AF=0.20;MQM=44;SAP=77;ABP=153;SAR=37;SAF=1	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs372312254	0.39306	0.45016,0.39795,0.15739,0.38797,0.23167	0,	49700	76744	0.0310			1.44						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749450	142749450	A	G	het	off-target;low_conf_region	QUAL=202;DP=190;QD=1.06;AF=0.20;MQM=44;SAP=77;ABP=152;SAR=37;SAF=1	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs972712999	0.38599	0.44368,0.39153,0.14854,0.38151,0.21973	0,	46757	74377	-0.3940			0.53						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749452	142749452	T	C	het	off-target;low_conf_region	QUAL=202;DP=190;QD=1.06;AF=0.20;MQM=44;SAP=77;ABP=152;SAR=37;SAF=1	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1387019363	0.38574	0.44462,0.39088,0.14691,0.38088,0.21888	0,	46387	73867	-0.6900			0.90						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749454	142749454	C	T	het	off-target;low_conf_region	QUAL=202;DP=190;QD=1.06;AF=0.20;MQM=44;SAP=77;ABP=152;SAR=37;SAF=1	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1431962420	0.38350	0.44205,0.38829,0.14470,0.37901,0.21481	0,	45903	73793	-0.1290			1.95						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749466	142749466	T	A	het	off-target;low_conf_region	QUAL=97;DP=206;QD=0.47;AF=0.18;MQM=44;SAP=75;ABP=187;SAR=36;SAF=1	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1170526371	0.37913	0.43811,0.38391,0.13671,0.37466,0.20845	0,	44301	72549	-2.0710			0.15						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749472	142749472	A	G	het	off-target;low_conf_region	QUAL=71;DP=211;QD=0.34;AF=0.18;MQM=44;SAP=75;ABP=196;SAR=36;SAF=1	PRSS1	5'UTR	PRSS1:ENST00000486171.5:5_prime_UTR_variant:MODIFIER:exon1/6:c.-13A>G::,PRSS1:ENST00000311737.12:5_prime_UTR_variant:MODIFIER:exon1/5:c.-13A>G::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs748424130	0.36810	0.42249,0.37463,0.12714,0.36630,0.19637	0,	41827	71803	1.0320			6.54						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749506	142749506	A	G	het	low_conf_region	QUAL=253;DP=183;QD=1.38;AF=0.21;MQM=44;SAP=77;ABP=139;SAR=37;SAF=1	PRSS1	missense	PRSS1:ENST00000486171.5:missense_variant:MODERATE:exon1/6:c.22A>G:p.Thr8Ala:,PRSS1:ENST00000311737.12:missense_variant:MODERATE:exon1/5:c.22A>G:p.Thr8Ala:	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]	1789246 [likely benign DISEASE=Hereditary pancreatitis];			rs749856663	0.32969	0.39219,0.33544,0.09155,0.32516,0.16186	0,	34677	70505	1.2940	T(1.00),T(1.00)	B(0.00),B(0.00)	0.03	0.24		COSV100298375	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749516	142749516	C	G	het	low_conf_region	QUAL=219;DP=189;QD=1.16;AF=0.20;MQM=44;SAP=77;ABP=150;SAR=37;SAF=1	PRSS1	missense	PRSS1:ENST00000486171.5:missense_variant:MODERATE:exon1/6:c.32C>G:p.Ala11Gly:,PRSS1:ENST00000311737.12:missense_variant:MODERATE:exon1/5:c.32C>G:p.Ala11Gly:	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]	1729944 [likely benign DISEASE=Hereditary pancreatitis];			rs748442280	0.33897	0.40174,0.34855,0.09916,0.33350,0.16178	0,	35790	69796	2.7440	T(1.00),T(1.00)	B(0.00),B(0.00)	7.26	0.26					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749524	142749524	C	G	het	low_conf_region	QUAL=235;DP=162;QD=1.45;AF=0.22;MQM=44;SAP=81;ABP=112;SAR=36;SAF=0	PRSS1	missense&splice_region	PRSS1:ENST00000486171.5:missense_variant&splice_region_variant:MODERATE:exon1/6:c.40C>G:p.Leu14Val:,PRSS1:ENST00000311737.12:missense_variant&splice_region_variant:MODERATE:exon1/5:c.40C>G:p.Leu14Val:	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]	939930 [likely benign(replaced by megSAP based on classifications:1x1,1x2,1x3) DISEASE=Hereditary pancreatitis];			rs747228052	0.34933	0.41287,0.35615,0.10637,0.34400,0.16903	0,	37367	69601	2.0030	T(1.00),T(1.00)	B(0.00),B(0.00)	6.17	0.22	8.41>10.10		0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749531	142749531	A	T	het	low_conf_region	QUAL=229;DP=163;QD=1.40;AF=0.23;MQM=44;SAP=83;ABP=109;SAR=37;SAF=0	PRSS1	splice_region&intron	PRSS1:ENST00000486171.5:splice_region_variant&intron_variant:LOW:intron1/5:c.40+7A>T::,PRSS1:ENST00000311737.12:splice_region_variant&intron_variant:LOW:intron1/4:c.40+7A>T::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs796173487	0.35426	0.41813,0.36031,0.11225,0.34887,0.17252	0,	38339	69885	-1.9840			0.04				0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142751804	142751804	C	T	het	mosaic;low_conf_region	QUAL=0;DP=1073;QD=0.00;AF=0.05;MQM=50;SAP=3;ABP=0;SAR=25;SAF=24	PRSS1	synonymous	PRSS1:ENST00000486171.5:synonymous_variant:LOW:exon4/6:c.273C>T:p.Asn91=:PF00089 [Trypsin],PRSS1:ENST00000311737.12:synonymous_variant:LOW:exon3/5:c.231C>T:p.Asn77=:PF00089 [Trypsin]		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]	1789545 [likely benign DISEASE=Hereditary pancreatitis];			rs555535168	0.00443	0.00554,0.00424,0.00152,0.00406,0.00269	0,	541	121591	5.9520			11.99			COSV105883384,COSV61196330	0.02		0	9702	0 / 1408					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142751878	142751878	A	T	het	mosaic	QUAL=0;DP=998;QD=0.00;AF=0.05;MQM=50;SAP=3;ABP=0;SAR=25;SAF=25	PRSS1	missense	PRSS1:ENST00000486171.5:missense_variant:MODERATE:exon4/6:c.347A>T:p.Lys116Met:PF00089 [Trypsin],PRSS1:ENST00000311737.12:missense_variant:MODERATE:exon3/5:c.305A>T:p.Lys102Met:PF00089 [Trypsin]		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs778568523	0.00859	0.01486,0.00719,0.00135,0.00643,0.00229	0,	898	103668	-1.2550	T(0.23),T(0.28)	B(0.16),B(0.16)	0.21	0.39			0.04		0	1267	0 / 565					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142751879	142751879	G	T	het	mosaic	QUAL=0;DP=998;QD=0.00;AF=0.05;MQM=50;SAP=3;ABP=0;SAR=25;SAF=25	PRSS1	missense	PRSS1:ENST00000486171.5:missense_variant:MODERATE:exon4/6:c.348G>T:p.Lys116Asn:PF00089 [Trypsin],PRSS1:ENST00000311737.12:missense_variant:MODERATE:exon3/5:c.306G>T:p.Lys102Asn:PF00089 [Trypsin]		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1373631104	0.00839	0.01459,0.00690,0.00112,0.00626,0.00229	0,	878	103718	0.1220	T(0.80),T(0.65)	B(0.00),B(0.00)	5.32	0.25			0.09		0	1260	0 / 565					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142751901	142751901	T	C	het	mosaic	QUAL=0;DP=1009;QD=0.00;AF=0.05;MQM=50;SAP=3;ABP=0;SAR=25;SAF=25	PRSS1	synonymous	PRSS1:ENST00000486171.5:synonymous_variant:LOW:exon4/6:c.370T>C:p.Leu124=:PF00089 [Trypsin],PRSS1:ENST00000311737.12:synonymous_variant:LOW:exon3/5:c.328T>C:p.Leu110=:PF00089 [Trypsin]		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs747546710	0.00233	0.00470,0.00173,0.00042,0.00124,0.00141	0,	284	121438	2.6340			7.74			COSV61190485	0.16		0	709	0 / 526					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142751903	142751903	A	G	het	mosaic	QUAL=0;DP=1009;QD=0.00;AF=0.05;MQM=50;SAP=3;ABP=0;SAR=25;SAF=25	PRSS1	synonymous	PRSS1:ENST00000486171.5:synonymous_variant:LOW:exon4/6:c.372A>G:p.Leu124=:PF00089 [Trypsin],PRSS1:ENST00000311737.12:synonymous_variant:LOW:exon3/5:c.330A>G:p.Leu110=:PF00089 [Trypsin]		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]	1730048 [likely benign DISEASE=Hereditary pancreatitis];			rs771259654	0.00168	0.00357,0.00120,0.00042,0.00083,0.00093	0,	210	124424	0.6840			5.07			COSV61190491	0.29		0	646	0 / 525					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752462	142752462	T	C	het		QUAL=4316;DP=187;QD=23.08;AF=0.87;MQM=60;SAP=12;ABP=221;SAR=68;SAF=94	PRSS1	synonymous	PRSS1:ENST00000486171.5:synonymous_variant:LOW:exon5/6:c.528T>C:p.Asp176=:PF00089 [Trypsin],PRSS1:ENST00000311737.12:synonymous_variant:LOW:exon4/5:c.486T>C:p.Asp162=:PF00089 [Trypsin]		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]	239391 [benign/likely benign DISEASE=Hereditary pancreatitis,not specified];			rs6666	0.42725	0.51720,0.42164,0.19748,0.40959,0.25928	1829,	59587	84783	-3.8310			0.17			COSV61190814	0	25741868,33202925,31506327	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752561	142752561	A	C	het		QUAL=86;DP=325;QD=0.26;AF=0.15;MQM=50;SAP=3;ABP=347;SAR=24;SAF=25	PRSS1	synonymous	PRSS1:ENST00000486171.5:synonymous_variant:LOW:exon5/6:c.627A>C:p.Ser209=:PF00089 [Trypsin],PRSS1:ENST00000311737.12:synonymous_variant:LOW:exon4/5:c.585A>C:p.Ser195=:PF00089 [Trypsin]		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]	826012 [benign DISEASE=Hereditary pancreatitis];			rs758274784	0.39848	0.44320,0.40928,0.17423,0.39767,0.24906	0,	52007	78505	0.0750			10.23			COSV61192546	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752564	142752564	T	C	het		QUAL=86;DP=325;QD=0.26;AF=0.15;MQM=50;SAP=3;ABP=347;SAR=24;SAF=25	PRSS1	synonymous	PRSS1:ENST00000486171.5:synonymous_variant:LOW:exon5/6:c.630T>C:p.Cys210=:PF00089 [Trypsin],PRSS1:ENST00000311737.12:synonymous_variant:LOW:exon4/5:c.588T>C:p.Cys196=:PF00089 [Trypsin]		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]	826034 [benign DISEASE=Hereditary pancreatitis];			rs751264273	0.39934	0.44676,0.40901,0.17324,0.39775,0.24871	0,	52113	78385	2.0850			12.49			COSV61192554	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752574	142752574	T	A	het		QUAL=85;DP=321;QD=0.26;AF=0.15;MQM=50;SAP=3;ABP=345;SAR=24;SAF=24	PRSS1	splice_region&intron	PRSS1:ENST00000486171.5:splice_region_variant&intron_variant:LOW:intron5/5:c.633+7T>A::,PRSS1:ENST00000311737.12:splice_region_variant&intron_variant:LOW:intron4/4:c.591+7T>A::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1437923103	0.40159	0.45521,0.40950,0.17055,0.39755,0.24668	0,	52489	78215	-2.2470			0.22				0.04		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752596	142752596	G	T	het	off-target	QUAL=806;DP=188;QD=4.29;AF=0.27;MQM=50;SAP=3;ABP=92;SAR=25;SAF=25	PRSS1	intron	PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.633+29G>T::,PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.591+29G>T::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1194632115	0.40297	0.46361,0.40915,0.16703,0.39581,0.24318	0,	52477	77749	-2.3330			0.58						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752598	142752598	C	T	het	off-target	QUAL=806;DP=188;QD=4.29;AF=0.27;MQM=50;SAP=3;ABP=92;SAR=25;SAF=25	PRSS1	intron	PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.633+31C>T::,PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.591+31C>T::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1287891250	0.40303	0.46438,0.40892,0.16565,0.39565,0.24156	0,	52455	77697	0.0720			0.27						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752612	142752612	T	C	het	off-target	QUAL=395;DP=45;QD=8.78;AF=0.56;MQM=40;SAP=57;ABP=4;SAR=25;SAF=0	PRSS1	intron	PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.633+45T>C::,PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.591+45T>C::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs751484562	0.40265	0.46630,0.40694,0.15939,0.39424,0.23866	0,	52112	77312	-1.0110			6.36			COSV61192569	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752616	142752616	C	A	het	off-target	QUAL=395;DP=45;QD=8.78;AF=0.56;MQM=40;SAP=57;ABP=4;SAR=25;SAF=0	PRSS1	intron	PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.633+49C>A::,PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.591+49C>A::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1277061180	0.40248	0.46671,0.40752,0.15832,0.39373,0.23593	0,	52040	77258	-0.6130			0.97			COSV100298220			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752631	142752631	G	A	het	off-target	QUAL=413;DP=51;QD=8.10;AF=0.49;MQM=40;SAP=57;ABP=3;SAR=25;SAF=0	PRSS1	intron	PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.633+64G>A::,PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.591+64G>A::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs796982044	0.40225	0.46737,0.40625,0.15717,0.39283,0.23615	0,	52152	77500	-0.0710			3.31			COSV61192304			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752643	142752643	A	C	het	off-target	QUAL=376;DP=50;QD=7.52;AF=0.48;MQM=40;SAP=55;ABP=3;SAR=24;SAF=0	PRSS1	intron	PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.633+76A>C::,PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.591+76A>C::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs564920652	0.40075	0.46733,0.40365,0.15095,0.39054,0.23380	0,	51278	76676	-0.1840			3.63			COSV61193671			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752644	142752644	A	C	het	off-target	QUAL=376;DP=50;QD=7.52;AF=0.48;MQM=40;SAP=55;ABP=3;SAR=24;SAF=0	PRSS1	intron	PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.633+77A>C::,PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.591+77A>C::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs879215460	0.40098	0.46777,0.40384,0.15075,0.39071,0.23255	0,	51272	76594	-0.0120			5.77			COSV61193677	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752652	142752652	T	-	het	off-target	QUAL=358;DP=48;QD=7.46;AF=0.48;MQM=40;SAP=53;ABP=3;SAR=23;SAF=0	PRSS1	intron	PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.633+85del::,PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.591+85del::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1316059404	0.40057	0.46761,0.40323,0.15247,0.39005,0.23327	0,	51651	77293	-1.9860			0.00			COSV61191754			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752718	142752718	T	C	het	off-target	QUAL=368;DP=78;QD=4.72;AF=0.38;MQM=60;SAP=68;ABP=12;SAR=0;SAF=30	PRSS1	intron	PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.634-150T>C::,PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.592-150T>C::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs377684105	0.41273	0.47388,0.41639,0.18714,0.40249,0.25667	0,	57765	82195	-0.6350			2.57			COSV61191941	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752752	142752752	A	G	het	off-target	QUAL=1377;DP=147;QD=9.37;AF=0.41;MQM=60;SAP=3;ABP=14;SAR=30;SAF=30	PRSS1	intron	PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.634-116A>G::,PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.592-116A>G::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs370565903	0.41647	0.47526,0.42142,0.19596,0.40633,0.26800	0,	60215	84369	-4.3710			0.06				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752760	142752760	G	A	het	off-target	QUAL=1346;DP=144;QD=9.35;AF=0.40;MQM=60;SAP=3;ABP=15;SAR=30;SAF=28	PRSS1	intron	PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.634-108G>A::,PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.592-108G>A::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1293060442	0.41703	0.47543,0.42181,0.19670,0.40714,0.26983	0,	60644	84776	1.3030			6.88				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752812	142752812	A	C	het	off-target	QUAL=1408;DP=145;QD=9.71;AF=0.41;MQM=60;SAP=3;ABP=12;SAR=30;SAF=30	PRSS1	intron	PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.634-56A>C::,PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.592-56A>C::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs571822942	0.41859	0.47587,0.42329,0.20309,0.40893,0.27521	0,	61870	85936	-1.0180			0.85				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752844	142752844	C	A	het	off-target;low_conf_region	QUAL=143;DP=407;QD=0.35;AF=0.15;MQM=60;SAP=3;ABP=442;SAR=30;SAF=30	PRSS1	intron	PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.634-24C>A::,PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.592-24C>A::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs192452846	0.41304	0.47337,0.41761,0.19284,0.40253,0.26298	0,	58804	83566	-0.8660			1.78			COSV104411417	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752861	142752861	C	A	het	low_conf_region	QUAL=99;DP=408;QD=0.24;AF=0.14;MQM=60;SAP=3;ABP=451;SAR=30;SAF=29	PRSS1	splice_region&intron	PRSS1:ENST00000486171.5:splice_region_variant&intron_variant:LOW:intron5/5:c.634-7C>A::,PRSS1:ENST00000311737.12:splice_region_variant&intron_variant:LOW:intron4/4:c.592-7C>A::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1443925968	0.40897	0.47194,0.41294,0.17942,0.39836,0.25165	0,	55266	79870	-1.6010			0.05		11.40>8.71				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752862	142752862	C	T	het	low_conf_region	QUAL=99;DP=408;QD=0.24;AF=0.14;MQM=60;SAP=3;ABP=451;SAR=30;SAF=29	PRSS1	splice_region&intron	PRSS1:ENST00000486171.5:splice_region_variant&intron_variant:LOW:intron5/5:c.634-6C>T::,PRSS1:ENST00000311737.12:splice_region_variant&intron_variant:LOW:intron4/4:c.592-6C>T::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1345716315	0.40836	0.47155,0.41222,0.17838,0.39786,0.25036	0,	54990	79670	-0.5380			1.24		11.40>9.68				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752863	142752863	C	G	het	low_conf_region	QUAL=99;DP=408;QD=0.24;AF=0.14;MQM=60;SAP=3;ABP=451;SAR=30;SAF=29	PRSS1	splice_region&intron	PRSS1:ENST00000486171.5:splice_region_variant&intron_variant:LOW:intron5/5:c.634-5C>G::,PRSS1:ENST00000311737.12:splice_region_variant&intron_variant:LOW:intron4/4:c.592-5C>G::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1220665540	0.40778	0.47133,0.41208,0.17845,0.39694,0.24905	0,	54665	79389	-0.8100			0.37		11.40>9.70				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142753014	142753014	T	C	hom		QUAL=10100;DP=349;QD=28.94;AF=1.00;MQM=60;SAP=395;ABP=0;SAR=300;SAF=49	PRSS1	synonymous	PRSS1:ENST00000486171.5:synonymous_variant:LOW:exon6/6:c.780T>C:p.Asn260=:,PRSS1:ENST00000311737.12:synonymous_variant:LOW:exon5/5:c.738T>C:p.Asn246=:		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]	258803 [benign/likely benign DISEASE=Hereditary pancreatitis,not specified];			rs6667	0.52711	0.46383,0.57487,0.22526,0.57682,0.30891	21011,	36332	70294	0.2440			2.45			COSV61193305	0	25741868,12011155,9633818,11842279,14526128,31506327	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr8	89943130	89943130	C	T	het	off-target	QUAL=1170;DP=111;QD=10.54;AF=0.45;MQM=60;SAP=3;ABP=5;SAR=25;SAF=25	NBN	intron	NBN:ENST00000697292.1:intron_variant:MODIFIER:intron14/16:c.2184+123G>A::,NBN:ENST00000697293.1:intron_variant:MODIFIER:intron14/16:c.2184+123G>A::,NBN:ENST00000517337.2:intron_variant:MODIFIER:intron15/16:c.1938+123G>A::,NBN:ENST00000697298.1:intron_variant:MODIFIER:intron16/17:c.1938+123G>A::,NBN:ENST00000697299.1:intron_variant:MODIFIER:intron13/14:c.1938+123G>A::,NBN:ENST00000697304.1:intron_variant:MODIFIER:intron12/13:c.1872+123G>A::,NBN:ENST00000697307.1:intron_variant:MODIFIER:intron12/13:c.1959+123G>A::,NBN:ENST00000697308.1:intron_variant:MODIFIER:intron13/14:c.2115+123G>A::,NBN:ENST00000265433.8:intron_variant:MODIFIER:intron14/15:c.2184+123G>A::,NBN:ENST00000523444.2:intron_variant:MODIFIER:intron15/16:c.1938+123G>A::,NBN:ENST00000409330.5:intron_variant:MODIFIER:intron14/15:c.1938+123G>A::,NBN:ENST00000697309.1:intron_variant:MODIFIER:intron14/14:c.2184+123G>A::,NBN:ENST00000697310.1:intron_variant:MODIFIER:intron14/16:c.2184+123G>A::		602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Aplastic anemia, 609135 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive]	1177037 [benign DISEASE=Microcephaly, normal intelligence and immunodeficiency,not provided];			rs7840099	0.33332	0.31531,0.35172,0.45244,0.32208,0.43661	8315,	33373	100013	0.1550			1.93			COSV55372468	0	20734064,21987080,20004634,26045716,24396275,26622944	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	89943396	89943396	T	A	het	off-target	QUAL=416;DP=29;QD=14.34;AF=0.59;MQM=60;SAP=18;ABP=5;SAR=14;SAF=3	NBN	intron	NBN:ENST00000697292.1:intron_variant:MODIFIER:intron13/16:c.2071-30A>T::,NBN:ENST00000697293.1:intron_variant:MODIFIER:intron13/16:c.2071-30A>T::,NBN:ENST00000517337.2:intron_variant:MODIFIER:intron14/16:c.1825-30A>T::,NBN:ENST00000697298.1:intron_variant:MODIFIER:intron15/17:c.1825-30A>T::,NBN:ENST00000697299.1:intron_variant:MODIFIER:intron12/14:c.1825-30A>T::,NBN:ENST00000697304.1:intron_variant:MODIFIER:intron11/13:c.1759-30A>T::,NBN:ENST00000697307.1:intron_variant:MODIFIER:intron11/13:c.1846-30A>T::,NBN:ENST00000697308.1:intron_variant:MODIFIER:intron12/14:c.2002-30A>T::,NBN:ENST00000265433.8:intron_variant:MODIFIER:intron13/15:c.2071-30A>T::,NBN:ENST00000523444.2:intron_variant:MODIFIER:intron14/16:c.1825-30A>T::,NBN:ENST00000409330.5:intron_variant:MODIFIER:intron13/15:c.1825-30A>T::,NBN:ENST00000697309.1:intron_variant:MODIFIER:intron13/14:c.2071-30A>T::,NBN:ENST00000697310.1:intron_variant:MODIFIER:intron13/16:c.2071-30A>T::		602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Aplastic anemia, 609135 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive]	258769 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Microcephaly, normal intelligence and immunodeficiency,not specified,not provided];			rs3736639	0.33369	0.31695,0.35228,0.45191,0.32211,0.43592	8507,	33648	101164	-0.7230			0.74			COSV55378350	0	25741868,20734064,20004634,19523210,19917125,24396275,27936167	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	89946194	89946194	T	C	het		QUAL=579;DP=46;QD=12.59;AF=0.54;MQM=60;SAP=10;ABP=4;SAR=17;SAF=8	NBN	synonymous,intron	NBN:ENST00000697292.1:synonymous_variant:LOW:exon13/17:c.2016A>G:p.Pro672=:,NBN:ENST00000697293.1:synonymous_variant:LOW:exon13/17:c.2016A>G:p.Pro672=:,NBN:ENST00000517337.2:synonymous_variant:LOW:exon14/17:c.1770A>G:p.Pro590=:,NBN:ENST00000697298.1:synonymous_variant:LOW:exon15/18:c.1770A>G:p.Pro590=:,NBN:ENST00000697299.1:synonymous_variant:LOW:exon12/15:c.1770A>G:p.Pro590=:,NBN:ENST00000697304.1:synonymous_variant:LOW:exon11/14:c.1704A>G:p.Pro568=:,NBN:ENST00000697307.1:intron_variant:MODIFIER:intron11/13:c.1846-2828A>G::,NBN:ENST00000697308.1:synonymous_variant:LOW:exon12/15:c.1947A>G:p.Pro649=:,NBN:ENST00000265433.8:synonymous_variant:LOW:exon13/16:c.2016A>G:p.Pro672=:,NBN:ENST00000523444.2:synonymous_variant:LOW:exon14/17:c.1770A>G:p.Pro590=:,NBN:ENST00000409330.5:synonymous_variant:LOW:exon13/16:c.1770A>G:p.Pro590=:,NBN:ENST00000697309.1:synonymous_variant:LOW:exon13/15:c.2016A>G:p.Pro672=:,NBN:ENST00000697310.1:synonymous_variant:LOW:exon13/17:c.2016A>G:p.Pro672=:		602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Aplastic anemia, 609135 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive]	183696 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Microcephaly, normal intelligence and immunodeficiency,Hereditary cancer-predisposing syndrome,not specified,not provided];			rs1061302	0.30820	0.23048,0.34123,0.45294,0.32156,0.43577	7452,	31884	105022	-2.5830			0.68			COSV55371426	0.04	25741868,24033266,20386703,20004634,30799775,19523210,20478923,20571895,29416357,19393077,24166361,26402912,30272267,28647780,28402931,19917125,24396275,28288557,22864661,21908578,27936167,33403820	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	89946302	89946302	T	C	het		QUAL=380;DP=35;QD=10.86;AF=0.46;MQM=60;SAP=12;ABP=4;SAR=12;SAF=4	NBN	splice_region&intron,intron	NBN:ENST00000697292.1:splice_region_variant&intron_variant:LOW:intron12/16:c.1915-7A>G::,NBN:ENST00000697293.1:splice_region_variant&intron_variant:LOW:intron12/16:c.1915-7A>G::,NBN:ENST00000517337.2:splice_region_variant&intron_variant:LOW:intron13/16:c.1669-7A>G::,NBN:ENST00000697298.1:splice_region_variant&intron_variant:LOW:intron14/17:c.1669-7A>G::,NBN:ENST00000697299.1:splice_region_variant&intron_variant:LOW:intron11/14:c.1669-7A>G::,NBN:ENST00000697304.1:splice_region_variant&intron_variant:LOW:intron10/13:c.1603-7A>G::,NBN:ENST00000697307.1:intron_variant:MODIFIER:intron11/13:c.1846-2936A>G::,NBN:ENST00000697308.1:splice_region_variant&intron_variant:LOW:intron11/14:c.1846-7A>G::,NBN:ENST00000265433.8:splice_region_variant&intron_variant:LOW:intron12/15:c.1915-7A>G::,NBN:ENST00000523444.2:splice_region_variant&intron_variant:LOW:intron13/16:c.1669-7A>G::,NBN:ENST00000409330.5:splice_region_variant&intron_variant:LOW:intron12/15:c.1669-7A>G::,NBN:ENST00000697309.1:splice_region_variant&intron_variant:LOW:intron12/14:c.1915-7A>G::,NBN:ENST00000697310.1:splice_region_variant&intron_variant:LOW:intron12/16:c.1915-7A>G::		602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Aplastic anemia, 609135 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive]	258768 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Microcephaly, normal intelligence and immunodeficiency,Hereditary cancer-predisposing syndrome,not specified,not provided];			rs2308962	0.33258	0.31396,0.35160,0.45311,0.32195,0.43631	8448,	33567	101267	-1.9330			0.03		3.91>3.28	COSV55371846	0.03	25741868,24033266,20004634,19523210,24396275	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	89955483	89955483	A	G	het		QUAL=338;DP=36;QD=9.39;AF=0.42;MQM=60;SAP=3;ABP=5;SAR=7;SAF=8	NBN	synonymous	NBN:ENST00000697292.1:synonymous_variant:LOW:exon10/17:c.1197T>C:p.Asp399=:,NBN:ENST00000697293.1:synonymous_variant:LOW:exon10/17:c.1197T>C:p.Asp399=:,NBN:ENST00000517337.2:synonymous_variant:LOW:exon11/17:c.951T>C:p.Asp317=:,NBN:ENST00000697298.1:synonymous_variant:LOW:exon12/18:c.951T>C:p.Asp317=:,NBN:ENST00000697299.1:synonymous_variant:LOW:exon9/15:c.951T>C:p.Asp317=:,NBN:ENST00000697304.1:synonymous_variant:LOW:exon8/14:c.885T>C:p.Asp295=:,NBN:ENST00000697307.1:synonymous_variant:LOW:exon10/14:c.1197T>C:p.Asp399=:,NBN:ENST00000697308.1:synonymous_variant:LOW:exon10/15:c.1197T>C:p.Asp399=:,NBN:ENST00000265433.8:synonymous_variant:LOW:exon10/16:c.1197T>C:p.Asp399=:,NBN:ENST00000523444.2:synonymous_variant:LOW:exon11/17:c.951T>C:p.Asp317=:,NBN:ENST00000409330.5:synonymous_variant:LOW:exon10/16:c.951T>C:p.Asp317=:,NBN:ENST00000697309.1:synonymous_variant:LOW:exon10/15:c.1197T>C:p.Asp399=:,NBN:ENST00000697310.1:synonymous_variant:LOW:exon10/17:c.1197T>C:p.Asp399=:		602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Aplastic anemia, 609135 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive]	183701 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Microcephaly, normal intelligence and immunodeficiency,Hereditary cancer-predisposing syndrome,not specified,not provided];			rs709816	0.50888	0.76781,0.52166,0.64985,0.36096,0.52179	21973,	33250	74502	-0.0610			1.13			COSV55371961	0.01	25741868,24033266,20003265,20386703,19276285,21987080,22933979,28610420,25542228,30799775,16091150,16620382,19523210,20478923,20571895,29416357,24166361,28356832,30272267,28647780,26101473,26045716,19917125,24396275,28288557,26064273,25755792,22864661,32461785,25176580,27936167,35164849,36139526	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	89955634	89955634	G	T	het	off-target	QUAL=747;DP=51;QD=14.65;AF=0.55;MQM=60;SAP=6;ABP=4;SAR=17;SAF=11	NBN	intron	NBN:ENST00000697292.1:intron_variant:MODIFIER:intron9/16:c.1125-79C>A::,NBN:ENST00000697293.1:intron_variant:MODIFIER:intron9/16:c.1125-79C>A::,NBN:ENST00000517337.2:intron_variant:MODIFIER:intron10/16:c.879-79C>A::,NBN:ENST00000697298.1:intron_variant:MODIFIER:intron11/17:c.879-79C>A::,NBN:ENST00000697299.1:intron_variant:MODIFIER:intron8/14:c.879-79C>A::,NBN:ENST00000697304.1:intron_variant:MODIFIER:intron7/13:c.813-79C>A::,NBN:ENST00000697307.1:intron_variant:MODIFIER:intron9/13:c.1125-79C>A::,NBN:ENST00000697308.1:intron_variant:MODIFIER:intron9/14:c.1125-79C>A::,NBN:ENST00000265433.8:intron_variant:MODIFIER:intron9/15:c.1125-79C>A::,NBN:ENST00000523444.2:intron_variant:MODIFIER:intron10/16:c.879-79C>A::,NBN:ENST00000409330.5:intron_variant:MODIFIER:intron9/15:c.879-79C>A::,NBN:ENST00000697309.1:intron_variant:MODIFIER:intron9/14:c.1125-79C>A::,NBN:ENST00000697310.1:intron_variant:MODIFIER:intron9/16:c.1125-79C>A::		602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Aplastic anemia, 609135 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive]	1239473 [benign DISEASE=not provided];			rs1805786	0.33080	0.30727,0.35026,0.45313,0.32206,0.43584	8364,	33471	101551	0.6450			3.55			COSV55376816	0	19276285,19523210	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	89958634	89958634	G	T	het	off-target	QUAL=163;DP=31;QD=5.26;AF=0.35;MQM=60;SAP=27;ABP=9;SAR=0;SAF=11	NBN	intron	NBN:ENST00000697292.1:intron_variant:MODIFIER:intron9/16:c.1124+91C>A::,NBN:ENST00000697293.1:intron_variant:MODIFIER:intron9/16:c.1124+91C>A::,NBN:ENST00000517337.2:intron_variant:MODIFIER:intron10/16:c.878+91C>A::,NBN:ENST00000697298.1:intron_variant:MODIFIER:intron11/17:c.878+91C>A::,NBN:ENST00000697299.1:intron_variant:MODIFIER:intron8/14:c.878+91C>A::,NBN:ENST00000697304.1:intron_variant:MODIFIER:intron7/13:c.812+91C>A::,NBN:ENST00000697307.1:intron_variant:MODIFIER:intron9/13:c.1124+91C>A::,NBN:ENST00000697308.1:intron_variant:MODIFIER:intron9/14:c.1124+91C>A::,NBN:ENST00000265433.8:intron_variant:MODIFIER:intron9/15:c.1124+91C>A::,NBN:ENST00000523444.2:intron_variant:MODIFIER:intron10/16:c.878+91C>A::,NBN:ENST00000409330.5:intron_variant:MODIFIER:intron9/15:c.878+91C>A::,NBN:ENST00000697309.1:intron_variant:MODIFIER:intron9/14:c.1124+91C>A::,NBN:ENST00000697310.1:intron_variant:MODIFIER:intron9/16:c.1124+91C>A::		602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Aplastic anemia, 609135 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive]	1177038 [benign DISEASE=Microcephaly, normal intelligence and immunodeficiency,not provided];			rs1805818	0.33054	0.30714,0.35018,0.45279,0.32200,0.43516	8366,	33469	101673	0.1280			2.00			COSV55373610	0	20004634,19523210,24396275	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	89958707	89958707	G	A	het	off-target	QUAL=463;DP=48;QD=9.65;AF=0.42;MQM=60;SAP=19;ABP=6;SAR=4;SAF=16	NBN	splice_region&intron	NBN:ENST00000697292.1:splice_region_variant&intron_variant:LOW:intron9/16:c.1124+18C>T::,NBN:ENST00000697293.1:splice_region_variant&intron_variant:LOW:intron9/16:c.1124+18C>T::,NBN:ENST00000517337.2:splice_region_variant&intron_variant:LOW:intron10/16:c.878+18C>T::,NBN:ENST00000697298.1:splice_region_variant&intron_variant:LOW:intron11/17:c.878+18C>T::,NBN:ENST00000697299.1:splice_region_variant&intron_variant:LOW:intron8/14:c.878+18C>T::,NBN:ENST00000697304.1:splice_region_variant&intron_variant:LOW:intron7/13:c.812+18C>T::,NBN:ENST00000697307.1:splice_region_variant&intron_variant:LOW:intron9/13:c.1124+18C>T::,NBN:ENST00000697308.1:splice_region_variant&intron_variant:LOW:intron9/14:c.1124+18C>T::,NBN:ENST00000265433.8:splice_region_variant&intron_variant:LOW:intron9/15:c.1124+18C>T::,NBN:ENST00000523444.2:splice_region_variant&intron_variant:LOW:intron10/16:c.878+18C>T::,NBN:ENST00000409330.5:splice_region_variant&intron_variant:LOW:intron9/15:c.878+18C>T::,NBN:ENST00000697309.1:splice_region_variant&intron_variant:LOW:intron9/14:c.1124+18C>T::,NBN:ENST00000697310.1:splice_region_variant&intron_variant:LOW:intron9/16:c.1124+18C>T::		602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Aplastic anemia, 609135 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive]	199080 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Microcephaly, normal intelligence and immunodeficiency,Hereditary cancer-predisposing syndrome,not specified,not provided];			rs2234744	0.30829	0.23059,0.34087,0.45260,0.32163,0.43569	7468,	31902	105090	-0.3950			0.75			COSV55373621	0	25741868,19276285,20004634,19523210,19917125,24396275,27936167	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	89978251	89978251	C	G	het		QUAL=10729;DP=820;QD=13.08;AF=0.50;MQM=60;SAP=3;ABP=3;SAR=210;SAF=203	NBN	missense	NBN:ENST00000697292.1:missense_variant:MODERATE:exon5/17:c.553G>C:p.Glu185Gln:,NBN:ENST00000697293.1:missense_variant:MODERATE:exon5/17:c.553G>C:p.Glu185Gln:,NBN:ENST00000517337.2:missense_variant:MODERATE:exon6/17:c.307G>C:p.Glu103Gln:,NBN:ENST00000697298.1:missense_variant:MODERATE:exon7/18:c.307G>C:p.Glu103Gln:,NBN:ENST00000697299.1:missense_variant:MODERATE:exon4/15:c.307G>C:p.Glu103Gln:,NBN:ENST00000697304.1:missense_variant:MODERATE:exon5/14:c.553G>C:p.Glu185Gln:,NBN:ENST00000697307.1:missense_variant:MODERATE:exon5/14:c.553G>C:p.Glu185Gln:,NBN:ENST00000697308.1:missense_variant:MODERATE:exon5/15:c.553G>C:p.Glu185Gln:,NBN:ENST00000265433.8:missense_variant:MODERATE:exon5/16:c.553G>C:p.Glu185Gln:,NBN:ENST00000523444.2:missense_variant:MODERATE:exon6/17:c.307G>C:p.Glu103Gln:,NBN:ENST00000409330.5:missense_variant:MODERATE:exon5/16:c.307G>C:p.Glu103Gln:,NBN:ENST00000697309.1:missense_variant:MODERATE:exon5/15:c.553G>C:p.Glu185Gln:,NBN:ENST00000697310.1:missense_variant:MODERATE:exon5/17:c.553G>C:p.Glu185Gln:	regulatory_region_variant:promoter	602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Aplastic anemia, 609135 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive]	134876 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Microcephaly, normal intelligence and immunodeficiency,Hereditary cancer-predisposing syndrome,not specified,not provided];	CM034886 [CLASS=DP MUT=ALT PHEN="Lung cancer association with" GENE=NBN];		rs1805794	0.31043	0.23748,0.34167,0.45309,0.32192,0.43535	7536,	32076	104730	2.2150	T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00)	 ,B(0.00), , , ,P(0.69),B(0.00),B(0.00), , , ,B(0.00), 	14.16	0.10		COSV55371261,COSV55372457,COSV55375647	0	25741868,24033266,20734064,24728327,28827732,23284679,18191955,26514363,16465622,16857995,18701435,19109789,19124499,20150366,21129811,21700777,23720673,31584889,20386703,18830263,29458332,19276285,29963112,18579371,22430443,24062231,25178586,23719583,18768505,31374908,22300735,29732392,32014908,21927616,20805886,19706757,18638378,19584272,21647442,22933979,28610420,20004634,25542228,19367277,30799775,19523210,20478923,20571895,29416357,19393077,24166361,24113799,26998278,12917199,21166880,21656575,22413803,23283743,23381647,23979977,25073514,26493193,27845421,28356832,28476809,29433451,24382701,24093751,28345844,28402931,22070649,26622786,24594932,26101473,19917125,30197789,24396275,26064273,20975951,18394656,22313875,17991492,22245109,15921821,19022265,32778093,22864661,32728337,33800431,21908578,32957448,34295994,21864546,22631660,26974709,26622944,32234891,25176580,21215087,27936167,34926254,35312585,35164849,35207542,36139526,35639187,34990726	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	89982791	89982791	C	T	het		QUAL=103;DP=18;QD=5.72;AF=0.39;MQM=60;SAP=18;ABP=5;SAR=7;SAF=0	NBN	synonymous,5'UTR,intron	NBN:ENST00000697292.1:synonymous_variant:LOW:exon2/17:c.102G>A:p.Leu34=:PF00498 [FHA domain],NBN:ENST00000697293.1:synonymous_variant:LOW:exon2/17:c.102G>A:p.Leu34=:PF00498 [FHA domain],NBN:ENST00000517337.2:5_prime_UTR_variant:MODIFIER:exon2/17:c.-195G>A::,NBN:ENST00000697298.1:5_prime_UTR_variant:MODIFIER:exon3/18:c.-195G>A::,NBN:ENST00000697299.1:intron_variant:MODIFIER:intron1/14:c.-75-1268G>A::,NBN:ENST00000697304.1:synonymous_variant:LOW:exon2/14:c.102G>A:p.Leu34=:PF00498 [FHA domain],NBN:ENST00000697307.1:synonymous_variant:LOW:exon2/14:c.102G>A:p.Leu34=:PF00498 [FHA domain],NBN:ENST00000697308.1:synonymous_variant:LOW:exon2/15:c.102G>A:p.Leu34=:PF00498 [FHA domain],NBN:ENST00000265433.8:synonymous_variant:LOW:exon2/16:c.102G>A:p.Leu34=:PF00498 [FHA domain],NBN:ENST00000523444.2:5_prime_UTR_variant:MODIFIER:exon2/17:c.-195G>A::,NBN:ENST00000409330.5:5_prime_UTR_variant:MODIFIER:exon2/16:c.-145G>A::,NBN:ENST00000697309.1:synonymous_variant:LOW:exon2/15:c.102G>A:p.Leu34=:PF00498 [FHA domain],NBN:ENST00000697310.1:synonymous_variant:LOW:exon2/17:c.102G>A:p.Leu34=:PF00498 [FHA domain]	regulatory_region_variant:promoter	602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Aplastic anemia, 609135 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive]	183697 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Microcephaly, normal intelligence and immunodeficiency,Hereditary cancer-predisposing syndrome,not specified,not provided];			rs1063045	0.33273	0.31391,0.35159,0.45255,0.32198,0.43582	8469,	33597	101345	-0.1370			5.51			COSV55371979	0	25741868,24033266,20386703,19276285,21987080,20004634,30799775,17496786,19523210,20478923,19393077,26402912,22841127,19917125,24396275,15921821,22864661,18612309,17001621,18023021,24645271,27936167	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	106223973	106223973	A	C	hom	off-target	QUAL=420;DP=14;QD=30.00;AF=1.00;MQM=60;SAP=5;ABP=0;SAR=5;SAF=9		intergenic	::intergenic_variant:MODIFIER::::					LTR33 (LTR/ERVL)	rs1393979	0.62266	0.33093,0.65326,0.84107,0.73289,0.84494	32098,	30418	57338	-0.9390			4.68						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr8	106224052	106224052	G	T	hom		QUAL=20492;DP=641;QD=31.97;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=325;SAF=316		intergenic	::intergenic_variant:MODIFIER::::					LTR33 (LTR/ERVL)	rs1393978	0.56208	0.27571,0.61584,0.83735,0.65937,0.82219	26584,	32176	66492	-0.5960			0.86						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr9	5919543	5919543	-	AC	het	off-target	QUAL=379;DP=66;QD=5.74;AF=0.27;MQM=60;SAP=7;ABP=33;SAR=6;SAF=12	KIAA2026	3'UTR	KIAA2026:ENST00000381461.6:3_prime_UTR_variant:MODIFIER:exon7/7:c.*139_*140dup::,KIAA2026:ENST00000399933.8:3_prime_UTR_variant:MODIFIER:exon8/8:c.*139_*140dup::						rs375745414	0.08651	0.06448,0.09103,0.01212,0.09674,0.07876	495,	10067	116761				5.51				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIAA2026 (inh=n/a oe_syn=1.46 oe_mis=1.38 oe_lof=0.22)
chr9	5921881	5921881	G	A	het		QUAL=15128;DP=1042;QD=14.52;AF=0.53;MQM=60;SAP=7;ABP=13;SAR=293;SAF=263	KIAA2026	missense	KIAA2026:ENST00000381461.6:missense_variant:MODERATE:exon7/7:c.4025C>T:p.Thr1342Ile:,KIAA2026:ENST00000399933.8:missense_variant:MODERATE:exon8/8:c.4115C>T:p.Thr1372Ile:						rs72697396	0.00003	0.00000,0.00000,0.00000,0.00006,0.00000	0,	4	152178	2.5130	D(0.02),D(0.02)	B(0.01),B(0.01)	14.15	0.03			0		0	17	0 / 3					KIAA2026 (inh=n/a oe_syn=1.46 oe_mis=1.38 oe_lof=0.22)
chr9	17235645	17235645	T	-	het	off-target	QUAL=521;DP=38;QD=13.71;AF=0.58;MQM=60;SAP=17;ABP=5;SAR=5;SAF=17	CNTLN	splice_region&intron	CNTLN:ENST00000380641.4:splice_region_variant&intron_variant:LOW:intron3/6:c.535-7del::,CNTLN:ENST00000380647.8:splice_region_variant&intron_variant:LOW:intron3/25:c.535-7del::						rs67017076	0.81722	0.95334,0.86086,0.99865,0.73343,0.93325	51837,	20506	27774	1.4780			7.52				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17273880	17273880	A	G	het		QUAL=1152;DP=63;QD=18.29;AF=0.71;MQM=60;SAP=3;ABP=28;SAR=21;SAF=24	CNTLN	splice_region&intron	CNTLN:ENST00000380641.4:splice_region_variant&intron_variant:LOW:intron6/6:c.983+14A>G::,CNTLN:ENST00000380647.8:splice_region_variant&intron_variant:LOW:intron6/25:c.983+14A>G::						rs12376938	0.23537	0.17336,0.23932,0.08375,0.26651,0.36373	4464,	26823	116139	-1.4110			0.27				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17273928	17273928	C	G	het	off-target	QUAL=192;DP=15;QD=12.80;AF=0.53;MQM=60;SAP=3;ABP=3;SAR=4;SAF=4	CNTLN	intron	CNTLN:ENST00000380641.4:intron_variant:MODIFIER:intron6/6:c.983+62C>G::,CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron6/25:c.983+62C>G::						rs12379655	0.29361	0.32127,0.27733,0.33250,0.27171,0.41611	6598,	31328	107122	-2.0210			0.13			COSV52090650,COSV52097738	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17298549	17298549	C	G	het	off-target	QUAL=78;DP=7;QD=11.14;AF=0.57;MQM=60;SAP=12;ABP=3;SAR=4;SAF=0	CNTLN	3'UTR,intron	CNTLN:ENST00000380641.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*167C>G::,CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron7/25:c.1146+197C>G::						rs3739490	0.25039	0.23089,0.24176,0.08330,0.26413,0.36248	4888,	28224	113766	-1.2110			0.12				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17308971	17308972	TG	-	hom	off-target	QUAL=8780;DP=350;QD=25.09;AF=0.98;MQM=60;SAP=750;ABP=0;SAR=0;SAF=344	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron7/25:c.1147-86_1147-85del::					L2d2 (LINE/L2)	rs66758062	0.79226	0.64548,0.81545,0.81410,0.86090,0.71622	48062,	23505	31369	0.2650			1.00				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17330560	17330560	T	A	het	off-target	QUAL=330;DP=21;QD=15.71;AF=0.62;MQM=60;SAP=3;ABP=6;SAR=7;SAF=6	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron8/25:c.1342-72T>A::						rs3765040	0.59350	0.56577,0.59832,0.72832,0.61226,0.34807	26998,	36047	61673	-0.0680			0.74				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17332487	17332487	T	-	het	off-target	QUAL=393;DP=25;QD=15.72;AF=0.52;MQM=60;SAP=31;ABP=3;SAR=0;SAF=13	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron9/25:c.1519-105del::	regulatory_region_variant:enhancer					rs3084508	0.23788	0.19744,0.23431,0.08598,0.25874,0.36996	4340,	26947	114145	0.7440			9.82			COSV52096250	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17332487	17332488	TT	-	het	off-target	QUAL=393;DP=25;QD=15.72;AF=0.28;MQM=60;SAP=18;ABP=14;SAR=0;SAF=7	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron9/25:c.1519-106_1519-105del::	regulatory_region_variant:enhancer					rs3084508	0.59139	0.56324,0.59818,0.72645,0.61092,0.34685	26277,	36047	61217	1.0530			10.59				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17342385	17342385	C	T	hom		QUAL=983;DP=30;QD=32.77;AF=1.00;MQM=60;SAP=13;ABP=0;SAR=21;SAF=9	CNTLN	synonymous	CNTLN:ENST00000380647.8:synonymous_variant:LOW:exon12/26:c.1827C>T:p.Asp609=:						rs1442527	0.95657	0.84870,0.98409,1.00000,0.99941,0.99834	69900,	5664	6604	2.1420			4.88				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17394538	17394538	C	T	hom		QUAL=1754;DP=55;QD=31.89;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=28;SAF=27	CNTLN	missense	CNTLN:ENST00000380647.8:missense_variant:MODERATE:exon15/26:c.2084C>T:p.Thr695Ile:	regulatory_region_variant:enhancer					rs7035276	0.81784	0.70475,0.82907,0.81822,0.87428,0.73846	51286,	21714	27682	0.3660	T(0.48)	B(0.00)	14.49	0.06		COSV52066811	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17394998	17394998	T	C	hom		QUAL=3131;DP=97;QD=32.28;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=48;SAF=49	CNTLN	synonymous	CNTLN:ENST00000380647.8:synonymous_variant:LOW:exon15/26:c.2544T>C:p.His848=:	regulatory_region_variant:enhancer					rs3739489	0.87050	0.78269,0.86492,0.82088,0.91645,0.86966	57902,	16554	19690	0.5350			6.62				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17395110	17395110	C	T	hom	off-target;low_conf_region	QUAL=6825;DP=215;QD=31.74;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=107;SAF=108	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron15/25:c.2615+41C>T::	regulatory_region_variant:enhancer					rs3739488	0.81808	0.70519,0.82955,0.81785,0.87433,0.74056	51336,	21677	27653	3.8150			16.14				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17409193	17409193	A	G	het	off-target	QUAL=73;DP=8;QD=9.13;AF=0.50;MQM=60;SAP=12;ABP=3;SAR=0;SAF=4	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron15/25:c.2616-100A>G::						rs62559023	0.00286	0.00065,0.00373,0.00019,0.00423,0.00435	1,	434	151774	0.0590			2.94				0		1	105	0 / 20					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17409368	17409368	G	A	hom		QUAL=12083;DP=378;QD=31.97;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=192;SAF=186	CNTLN	synonymous	CNTLN:ENST00000380647.8:synonymous_variant:LOW:exon16/26:c.2691G>A:p.Thr897=:						rs2780211	0.86785	0.78333,0.85948,0.82056,0.91448,0.84585	57514,	16871	20085	0.6420			5.75			COSV52096895	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17457515	17457515	A	-	hom	low_conf_region	QUAL=104;DP=4;QD=26.00;AF=1.00;MQM=60;SAP=12;ABP=0;SAR=4;SAF=0	CNTLN	splice_acceptor&inframe_deletion	CNTLN:ENST00000380647.8:splice_acceptor_variant&inframe_deletion:HIGH:intron18/25:c.3115-2del:p.?:					(TATATT)n (Simple_repeat)	rs35399020	0.79577	0.59033,0.79680,0.67262,0.90445,0.77292	49329,	21394	30810	0.1530			0.54			COSV52086669	0.1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17457856	17457856	A	G	hom	off-target	QUAL=5944;DP=231;QD=25.73;AF=1.00;MQM=60;SAP=505;ABP=0;SAR=231;SAF=0	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron19/25:c.3306+141A>G::						rs2197152	0.69283	0.56847,0.64791,0.92794,0.74630,0.69336	37174,	30730	46586	-0.7660			0.19				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17464404	17464404	G	C	hom	off-target	QUAL=8946;DP=306;QD=29.24;AF=1.00;MQM=60;SAP=4;ABP=0;SAR=146;SAF=160	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron20/25:c.3405-93G>C::						rs1442532	0.96684	0.90489,0.97732,0.92035,0.99923,0.95634	70663,	4532	5002	0.0040			0.91				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17494735	17494735	C	T	het	off-target	QUAL=714;DP=57;QD=12.53;AF=0.61;MQM=60;SAP=79;ABP=9;SAR=0;SAF=35	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron25/25:c.4119+7669C>T::					Tigger3b (DNA/TcMar-Tigger)	rs7861498	0.35963	0.30207,0.45548,0.52552,0.36320,0.31468	10119,	34362	97224	-0.6620			1.13			COSV52071433	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17494877	17494877	T	-	het	off-target;low_conf_region	QUAL=221;DP=18;QD=12.28;AF=0.28;MQM=60;SAP=14;ABP=11;SAR=0;SAF=5	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron25/25:c.4120-7653del::					Tigger3b (DNA/TcMar-Tigger), AluSx (SINE/Alu)	rs35224903	0.60097	0.59232,0.68404,0.71140,0.58194,0.68259	8271,	20939	24887	0.1770			0.52				0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17494877	17494879	TTT	-	het	off-target;low_conf_region	QUAL=221;DP=18;QD=12.28;AF=0.28;MQM=60;SAP=14;ABP=11;SAR=0;SAF=5	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron25/25:c.4120-7655_4120-7653del::					Tigger3b (DNA/TcMar-Tigger), AluSx (SINE/Alu)	rs35224903	0.00050	0.00027,0.00087,0.00000,0.00056,0.00000	0,	31	62267	0.1770			0.61				0.04		28	1129	0 / 136	2	"[2] auto-classification 15.09.2017  "			CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	21971138	21971138	T	G	het		QUAL=287;DP=51;QD=5.63;AF=0.47;MQM=60;SAP=55;ABP=3;SAR=0;SAF=24	CDKN2A,CDKN2A-DT	missense,synonymous,downstream_gene	CDKN2A:ENST00000304494.10:missense_variant:MODERATE:exon2/3:c.221A>C:p.Asp74Ala:,CDKN2A:ENST00000579755.2:synonymous_variant:LOW:exon2/3:c.264A>C:p.Arg88=:,CDKN2A:ENST00000579122.1:missense_variant:MODERATE:exon2/3:c.221A>C:p.Asp74Ala:,CDKN2A:ENST00000578845.2:missense_variant:MODERATE:exon1/2:c.68A>C:p.Asp23Ala:,CDKN2A:ENST00000530628.2:synonymous_variant:LOW:exon2/3:c.264A>C:p.Arg88=:,CDKN2A:ENST00000498124.1:missense_variant:MODERATE:exon2/4:c.221A>C:p.Asp74Ala:,CDKN2A:ENST00000498628.6:missense_variant:MODERATE:exon2/3:c.68A>C:p.Asp23Ala:,CDKN2A:ENST00000494262.5:missense_variant:MODERATE:exon3/4:c.68A>C:p.Asp23Ala:,CDKN2A:ENST00000479692.2:missense_variant:MODERATE:exon2/3:c.68A>C:p.Asp23Ala:,CDKN2A:ENST00000497750.1:missense_variant:MODERATE:exon2/2:c.68A>C:p.Asp23Ala:,CDKN2A-DT:ENST00000441769.3:downstream_gene_variant:MODIFIER::::		600160_[GENE=CDKN2A_PHENOS={Melanoma and neural system tumor syndrome}, 155755 (3), Autosomal dominant; {Melanoma, cutaneous malignant, 2}, 155601 (3), Autosomal dominant; {Melanoma-pancreatic cancer syndrome}, 606719 (3), Autosomal dominant]	802463 [uncertain significance DISEASE=Melanoma-pancreatic cancer syndrome];	CM165602 [CLASS=DM MUT=ALT PHEN="Breast cancer" GENE=CDKN2A];		rs200429615	0.00003	0.00000,0.00000,0.00039,0.00003,0.00000	0,	4	150578	7.4100	D(0.00), ,D(0.00),D(0.00), ,D(0.00),D(0.00),D(0.00),D(0.00),D(0.00), 	 , ,B(0.23), , , , , ,P(0.85),D(0.91), 	32.00	0.88		COSV104609655,COSV58684939,COSV58689077	0.01	25353071	10	282	10 / 281	1	"[1] old entry - no details available"			CDKN2A-DT (inh=n/a oe_syn=0.99 oe_mis=0.75 oe_lof=n/a), CDKN2A (inh=AD oe_syn=1.09 oe_mis=1.28 oe_lof=0.20)
chr9	21974672	21974672	A	C	het		QUAL=122;DP=19;QD=6.42;AF=0.74;MQM=60;SAP=33;ABP=12;SAR=14;SAF=0	CDKN2A	splice_region&intron,intron,upstream_gene	CDKN2A:ENST00000304494.10:splice_region_variant&intron_variant:LOW:intron1/2:c.150+6T>G::,CDKN2A:ENST00000579755.2:intron_variant:MODIFIER:intron1/2:c.194-3464T>G::,CDKN2A:ENST00000579122.1:splice_region_variant&intron_variant:LOW:intron1/2:c.150+6T>G::,CDKN2A:ENST00000530628.2:intron_variant:MODIFIER:intron1/2:c.194-3464T>G::,CDKN2A:ENST00000498124.1:splice_region_variant&intron_variant:LOW:intron1/3:c.150+6T>G::,CDKN2A:ENST00000498628.6:intron_variant:MODIFIER:intron1/2:c.-3-3464T>G::,CDKN2A:ENST00000494262.5:intron_variant:MODIFIER:intron2/3:c.-3-3464T>G::,CDKN2A:ENST00000578845.2:upstream_gene_variant:MODIFIER::::,CDKN2A:ENST00000479692.2:upstream_gene_variant:MODIFIER::::,CDKN2A:ENST00000497750.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	600160_[GENE=CDKN2A_PHENOS={Melanoma and neural system tumor syndrome}, 155755 (3), Autosomal dominant; {Melanoma, cutaneous malignant, 2}, 155601 (3), Autosomal dominant; {Melanoma-pancreatic cancer syndrome}, 606719 (3), Autosomal dominant]										0.6550			10.22		8.56>6.92	COSV105166956	0.11		31	350	31 / 350	2	"[2] auto-classification 15.09.2017  [3] ahsepai1 2016-07-13  "			CDKN2A (inh=AD oe_syn=1.09 oe_mis=1.28 oe_lof=0.20)
chr9	21974676	21974676	A	C	het		QUAL=122;DP=19;QD=6.42;AF=0.74;MQM=60;SAP=33;ABP=12;SAR=14;SAF=0	CDKN2A	splice_donor,intron,upstream_gene	CDKN2A:ENST00000304494.10:splice_donor_variant:HIGH:intron1/2:c.150+2T>G:p.?:,CDKN2A:ENST00000579755.2:intron_variant:MODIFIER:intron1/2:c.194-3468T>G::,CDKN2A:ENST00000579122.1:splice_donor_variant:HIGH:intron1/2:c.150+2T>G:p.?:,CDKN2A:ENST00000530628.2:intron_variant:MODIFIER:intron1/2:c.194-3468T>G::,CDKN2A:ENST00000498124.1:splice_donor_variant:HIGH:intron1/3:c.150+2T>G:p.?:,CDKN2A:ENST00000498628.6:intron_variant:MODIFIER:intron1/2:c.-3-3468T>G::,CDKN2A:ENST00000494262.5:intron_variant:MODIFIER:intron2/3:c.-3-3468T>G::,CDKN2A:ENST00000578845.2:upstream_gene_variant:MODIFIER::::,CDKN2A:ENST00000479692.2:upstream_gene_variant:MODIFIER::::,CDKN2A:ENST00000497750.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	600160_[GENE=CDKN2A_PHENOS={Melanoma and neural system tumor syndrome}, 155755 (3), Autosomal dominant; {Melanoma, cutaneous malignant, 2}, 155601 (3), Autosomal dominant; {Melanoma-pancreatic cancer syndrome}, 606719 (3), Autosomal dominant]	1773995 [likely pathogenic DISEASE=Hereditary cancer-predisposing syndrome];									5.5950			32.00		8.56>0.92	COSV58686447,COSV58697953	0.99		31	353	31 / 352	4	"[4] ahsepai1 2016-07-13 TEST TEST3124"		"testing"	CDKN2A (inh=AD oe_syn=1.09 oe_mis=1.28 oe_lof=0.20)
chr9	21975018	21975018	C	T	hom	off-target	QUAL=803;DP=31;QD=25.90;AF=1.00;MQM=60;SAP=70;ABP=0;SAR=31;SAF=0	CDKN2A	intron,upstream_gene	CDKN2A:ENST00000579755.2:intron_variant:MODIFIER:intron1/2:c.194-3810G>A::,CDKN2A:ENST00000530628.2:intron_variant:MODIFIER:intron1/2:c.194-3810G>A::,CDKN2A:ENST00000498628.6:intron_variant:MODIFIER:intron1/2:c.-3-3810G>A::,CDKN2A:ENST00000494262.5:intron_variant:MODIFIER:intron2/3:c.-3-3810G>A::,CDKN2A:ENST00000304494.10:upstream_gene_variant:MODIFIER::::,CDKN2A:ENST00000579122.1:upstream_gene_variant:MODIFIER::::,CDKN2A:ENST00000578845.2:upstream_gene_variant:MODIFIER::::,CDKN2A:ENST00000498124.1:upstream_gene_variant:MODIFIER::::,CDKN2A:ENST00000479692.2:upstream_gene_variant:MODIFIER::::,CDKN2A:ENST00000497750.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	600160_[GENE=CDKN2A_PHENOS={Melanoma and neural system tumor syndrome}, 155755 (3), Autosomal dominant; {Melanoma, cutaneous malignant, 2}, 155601 (3), Autosomal dominant; {Melanoma-pancreatic cancer syndrome}, 606719 (3), Autosomal dominant]	873184 [benign DISEASE=Squamous cell lung carcinoma,Melanoma, cutaneous malignant, susceptibility to, 2,not provided];			rs3814960	0.50353	0.23289,0.47557,0.64816,0.62591,0.61707	21594,	33334	75448	-0.1700			6.17			COSV58720858	0	27414035,27055116,21355081,18761660,20386740,25280564,20381282	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CDKN2A (inh=AD oe_syn=1.09 oe_mis=1.28 oe_lof=0.20)
chr9	35074920	35074920	T	C	hom		QUAL=3114;DP=98;QD=31.78;AF=1.00;MQM=60;SAP=6;ABP=0;SAR=55;SAF=43	FANCG,VCP	splice_region&intron,upstream_gene	FANCG:ENST00000378643.8:splice_region_variant&intron_variant:LOW:intron12/13:c.1636+7A>G::,FANCG:ENST00000448890.2:splice_region_variant&intron_variant:LOW:intron13/14:c.1636+7A>G::,FANCG:ENST00000696710.1:splice_region_variant&intron_variant:LOW:intron12/13:c.1630+7A>G::,FANCG:ENST00000696715.1:splice_region_variant&intron_variant:LOW:intron12/12:c.1636+7A>G::,VCP:ENST00000679902.1:upstream_gene_variant:MODIFIER::::,VCP:ENST00000678650.1:upstream_gene_variant:MODIFIER::::,VCP:ENST00000677257.1:upstream_gene_variant:MODIFIER::::,VCP:ENST00000358901.11:upstream_gene_variant:MODIFIER::::,VCP:ENST00000448530.6:upstream_gene_variant:MODIFIER::::,VCP:ENST00000679647.1:upstream_gene_variant:MODIFIER::::,VCP:ENST00000681335.1:upstream_gene_variant:MODIFIER::::,VCP:ENST00000417448.2:upstream_gene_variant:MODIFIER::::,VCP:ENST00000679862.1:upstream_gene_variant:MODIFIER::::		601023_[GENE=VCP_PHENOS=Frontotemporal dementia and/or amyotrophic lateral sclerosis 6, 613954 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 2Y, 616687 (3), Autosomal dominant; Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1, 167320 (3), Autosomal dominant]&602956_[GENE=FANCG_PHENOS=Fanconi anemia, complementation group G, 614082 (3), Autosomal recessive]	259477 [benign DISEASE=Fanconi anemia complementation group G,Fanconi anemia,not specified,Amyotrophic Lateral Sclerosis, Dominant,Inclusion Body Myopathy, Dominant,not provided];	CS2129783 [CLASS=DM? MUT=ALT PHEN="Fanconi anaemia" GENE=FANCG];		rs587118	0.35262	0.09116,0.45715,0.00520,0.49654,0.23571	12180,	29241	98409	0.4790			11.30			COSV62719986	0.07	25741868,17618707,32888493	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VCP (inh=AD oe_syn=1.12 oe_mis=0.28 oe_lof=0.03), FANCG (inh=AR oe_syn=1.00 oe_mis=0.96 oe_lof=0.78)
chr9	35077444	35077444	T	C	hom	off-target	QUAL=6853;DP=206;QD=33.27;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=103;SAF=103	FANCG,VCP	intron,upstream_gene	FANCG:ENST00000378643.8:intron_variant:MODIFIER:intron4/13:c.511-45A>G::,FANCG:ENST00000448890.2:intron_variant:MODIFIER:intron5/14:c.511-45A>G::,FANCG:ENST00000696710.1:intron_variant:MODIFIER:intron4/13:c.511-45A>G::,FANCG:ENST00000696715.1:intron_variant:MODIFIER:intron4/12:c.511-45A>G::,VCP:ENST00000679902.1:upstream_gene_variant:MODIFIER::::,VCP:ENST00000678650.1:upstream_gene_variant:MODIFIER::::,VCP:ENST00000677257.1:upstream_gene_variant:MODIFIER::::,VCP:ENST00000358901.11:upstream_gene_variant:MODIFIER::::,VCP:ENST00000448530.6:upstream_gene_variant:MODIFIER::::,VCP:ENST00000679647.1:upstream_gene_variant:MODIFIER::::,VCP:ENST00000681335.1:upstream_gene_variant:MODIFIER::::,VCP:ENST00000679862.1:upstream_gene_variant:MODIFIER::::		601023_[GENE=VCP_PHENOS=Frontotemporal dementia and/or amyotrophic lateral sclerosis 6, 613954 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 2Y, 616687 (3), Autosomal dominant; Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1, 167320 (3), Autosomal dominant]&602956_[GENE=FANCG_PHENOS=Fanconi anemia, complementation group G, 614082 (3), Autosomal recessive]	259478 [benign DISEASE=Fanconi anemia complementation group G,not specified,not provided];			rs554098	0.75271	0.74067,0.79440,0.46013,0.77968,0.70703	43310,	27607	37527	-1.4080			0.43			COSV62719498	0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VCP (inh=AD oe_syn=1.12 oe_mis=0.28 oe_lof=0.03), FANCG (inh=AR oe_syn=1.00 oe_mis=0.96 oe_lof=0.78)
chr9	35079364	35079364	G	T	hom	off-target	QUAL=5299;DP=168;QD=31.54;AF=1.00;MQM=60;SAP=20;ABP=0;SAR=66;SAF=102	FANCG	intron	FANCG:ENST00000378643.8:intron_variant:MODIFIER:intron1/13:c.84+77C>A::,FANCG:ENST00000448890.2:intron_variant:MODIFIER:intron2/14:c.84+77C>A::,FANCG:ENST00000696710.1:intron_variant:MODIFIER:intron1/13:c.84+77C>A::,FANCG:ENST00000696715.1:intron_variant:MODIFIER:intron1/12:c.84+77C>A::	regulatory_region_variant:promoter	602956_[GENE=FANCG_PHENOS=Fanconi anemia, complementation group G, 614082 (3), Autosomal recessive]	1177024 [benign DISEASE=Fanconi anemia complementation group G,not provided];			rs504082	0.54530	0.27385,0.65711,0.08327,0.70668,0.47620	25873,	31134	69110	-0.0480			6.76			COSV66213684	0.04	17618707,32888493,32888494	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCG (inh=AR oe_syn=1.00 oe_mis=0.96 oe_lof=0.78)
chr9	87447908	87447908	A	G	hom		QUAL=14878;DP=519;QD=28.67;AF=1.00;MQM=60;SAP=724;ABP=0;SAR=52;SAF=467		intergenic	::intergenic_variant:MODIFIER::::						rs12682834	0.59630	0.48420,0.64179,0.70530,0.62934,0.74606	27499,	35595	61333	-0.5610			0.49					19956101	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr9	95247331	95247331	-	A	het	off-target	QUAL=56;DP=50;QD=1.12;AF=0.16;MQM=60;SAP=3;ABP=53;SAR=4;SAF=4	FANCC	intron	FANCC:ENST00000289081.8:intron_variant:MODIFIER:intron3/14:c.250+100dup::,FANCC:ENST00000375305.6:intron_variant:MODIFIER:intron3/14:c.250+100dup::,FANCC:ENST00000490972.7:intron_variant:MODIFIER:intron3/13:c.250+100dup::,FANCC:ENST00000649872.1:intron_variant:MODIFIER:intron2/3:c.250+100dup::,FANCC:ENST00000696262.1:intron_variant:MODIFIER:intron3/3:c.250+100dup::		613899_[GENE=FANCC_PHENOS=Fanconi anemia, complementation group C, 227645 (3), Autosomal recessive]	1214388 [likely benign DISEASE=not provided];			rs529124256	0.00260	0.00084,0.00267,0.00100,0.00266,0.00044	1,	369	142563				0.69				0		0	91	0 / 7					FANCC (inh=AR oe_syn=1.09 oe_mis=1.03 oe_lof=0.74)
chr9	95447312	95447312	G	A	het		QUAL=1194;DP=67;QD=17.82;AF=0.69;MQM=60;SAP=4;ABP=23;SAR=21;SAF=25	PTCH1	missense	PTCH1:ENST00000331920.11:missense_variant:MODERATE:exon23/24:c.3944C>T:p.Pro1315Leu:,PTCH1:ENST00000437951.6:missense_variant:MODERATE:exon23/24:c.3941C>T:p.Pro1314Leu:,PTCH1:ENST00000430669.6:missense_variant:MODERATE:exon23/23:c.3746C>T:p.Pro1249Leu:,PTCH1:ENST00000692981.1:missense_variant:MODERATE:exon22/23:c.3491C>T:p.Pro1164Leu:,PTCH1:ENST00000429896.6:missense_variant:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu:	regulatory_region_variant:enhancer	601309_[GENE=PTCH1_PHENOS=Basal cell carcinoma, somatic, 605462 (3); Holoprosencephaly 7, 610828 (3), Autosomal dominant; Basal cell nevus syndrome, 109400 (3), Autosomal dominant]	41663 [benign DISEASE=Gorlin syndrome,Holoprosencephaly 7,Hereditary cancer-predisposing syndrome,not specified,not provided];			rs357564	0.33001	0.23243,0.38699,0.56362,0.33664,0.47219	8752,	32643	101807	9.5400	D(0.00),D(0.00),D(0.00),D(0.00),D(0.00)	P(0.71),P(0.85),P(0.85),P(0.71),P(0.71)	24.70	0.44		COSV59463357	0	25741868,24033266,24728327,23757202,19937600,22703879,26893459,21811255,20583170,30214282,22677152,24073265,20346027,22221699,27825128,30334169,31209431,31204176,24260604,27081528,23826113,18059179,27591082,31669095,33298892,34021172,29498494,35047024,34944636,35361970	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH1 (inh=AD oe_syn=1.25 oe_mis=0.84 oe_lof=0.02)
chr9	95468642	95468642	-	T	het	off-target	QUAL=84;DP=105;QD=0.80;AF=0.14;MQM=60;SAP=4;ABP=119;SAR=6;SAF=9	PTCH1	intron	PTCH1:ENST00000331920.11:intron_variant:MODIFIER:intron14/23:c.2250+108dup::,PTCH1:ENST00000437951.6:intron_variant:MODIFIER:intron14/23:c.2247+108dup::,PTCH1:ENST00000430669.6:intron_variant:MODIFIER:intron14/22:c.2052+108dup::,PTCH1:ENST00000692981.1:intron_variant:MODIFIER:intron13/22:c.1797+108dup::,PTCH1:ENST00000429896.6:intron_variant:MODIFIER:intron14/23:c.1797+108dup::		601309_[GENE=PTCH1_PHENOS=Basal cell carcinoma, somatic, 605462 (3); Holoprosencephaly 7, 610828 (3), Autosomal dominant; Basal cell nevus syndrome, 109400 (3), Autosomal dominant]				rs35352942	0.00505	0.00181,0.01016,0.00039,0.00578,0.00846	6,	745	149093				3.39				0		2	159	0 / 18					PTCH1 (inh=AD oe_syn=1.25 oe_mis=0.84 oe_lof=0.02)
chr9	95469942	95469942	A	-	het		QUAL=560;DP=57;QD=9.82;AF=0.53;MQM=60;SAP=68;ABP=3;SAR=30;SAF=0	PTCH1	splice_region&intron	PTCH1:ENST00000331920.11:splice_region_variant&intron_variant:LOW:intron12/23:c.1729-11del::,PTCH1:ENST00000437951.6:splice_region_variant&intron_variant:LOW:intron12/23:c.1726-11del::,PTCH1:ENST00000430669.6:splice_region_variant&intron_variant:LOW:intron12/22:c.1531-11del::,PTCH1:ENST00000692981.1:splice_region_variant&intron_variant:LOW:intron11/22:c.1276-11del::,PTCH1:ENST00000429896.6:splice_region_variant&intron_variant:LOW:intron12/23:c.1276-11del::		601309_[GENE=PTCH1_PHENOS=Basal cell carcinoma, somatic, 605462 (3); Holoprosencephaly 7, 610828 (3), Autosomal dominant; Basal cell nevus syndrome, 109400 (3), Autosomal dominant]	1290901 [benign/likely benign DISEASE=Gorlin syndrome,Hereditary cancer-predisposing syndrome,not provided];			rs779000277	0.00079	0.00017,0.00059,0.00000,0.00146,0.00000	0,	120	151876	0.9180			0.96			COSV59495096	0.01	27149842,30411536,27363716,21234763	0	61	0 / 15					PTCH1 (inh=AD oe_syn=1.25 oe_mis=0.84 oe_lof=0.02)
chr9	95476908	95476908	G	C	hom	off-target	QUAL=1285;DP=42;QD=30.60;AF=1.00;MQM=60;SAP=16;ABP=0;SAR=13;SAF=29	PTCH1	intron,downstream_gene	PTCH1:ENST00000331920.11:intron_variant:MODIFIER:intron10/23:c.1504-51C>G::,PTCH1:ENST00000437951.6:intron_variant:MODIFIER:intron10/23:c.1501-51C>G::,PTCH1:ENST00000430669.6:intron_variant:MODIFIER:intron10/22:c.1306-51C>G::,PTCH1:ENST00000692981.1:intron_variant:MODIFIER:intron9/22:c.1051-51C>G::,PTCH1:ENST00000429896.6:intron_variant:MODIFIER:intron10/23:c.1051-51C>G::,PTCH1:ENST00000468211.6:downstream_gene_variant:MODIFIER::::		601309_[GENE=PTCH1_PHENOS=Basal cell carcinoma, somatic, 605462 (3); Holoprosencephaly 7, 610828 (3), Autosomal dominant; Basal cell nevus syndrome, 109400 (3), Autosomal dominant]	1280181 [benign DISEASE=not provided];			rs574688	0.19572	0.05286,0.24391,0.08628,0.26417,0.28142	3674,	22414	122306	0.2170			3.49			COSV100107392	0.01	34021172,29498494	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH1 (inh=AD oe_syn=1.25 oe_mis=0.84 oe_lof=0.02)
chr10	43100333	43100333	G	T	hom	off-target	QUAL=309;DP=12;QD=25.75;AF=1.00;MQM=60;SAP=29;ABP=0;SAR=12;SAF=0	RET	intron	RET:ENST00000340058.6:intron_variant:MODIFIER:intron1/18:c.74-126G>T::,RET:ENST00000355710.8:intron_variant:MODIFIER:intron1/19:c.74-126G>T::,RET:ENST00000615310.5:intron_variant:MODIFIER:intron1/16:c.74-126G>T::		164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	677050 [benign DISEASE=Multiple endocrine neoplasia, type 2,not provided];	CS045982 [CLASS=DP MUT=ALT PHEN="Thyroid cancer association with" GENE=RET];		rs2565206	0.38122	0.58936,0.32091,0.11146,0.32992,0.19647	12369,	33039	93783	-0.0150			0.82				0	23820649,22312249,23059849,20860806,21995290,22584707,16816022,28930629,32411094,32228166,34950210	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43100389	43100389	T	-	het	off-target	QUAL=696;DP=63;QD=11.05;AF=0.51;MQM=60;SAP=25;ABP=3;SAR=7;SAF=25	RET	intron	RET:ENST00000340058.6:intron_variant:MODIFIER:intron1/18:c.74-57del::,RET:ENST00000355710.8:intron_variant:MODIFIER:intron1/19:c.74-57del::,RET:ENST00000615310.5:intron_variant:MODIFIER:intron1/16:c.74-57del::		164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	1258537 [benign DISEASE=not provided];			rs57003029	0.25163	0.25698,0.23959,0.11679,0.27481,0.11952	4408,	28219	110145	-0.5180			0.26				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43100520	43100520	A	G	hom		QUAL=16174;DP=519;QD=31.16;AF=1.00;MQM=60;SAP=4;ABP=0;SAR=268;SAF=251	RET	synonymous	RET:ENST00000340058.6:synonymous_variant:LOW:exon2/19:c.135A>G:p.Ala45=:PF17756 [RET Cadherin like domain 1],RET:ENST00000355710.8:synonymous_variant:LOW:exon2/20:c.135A>G:p.Ala45=:PF17756 [RET Cadherin like domain 1],RET:ENST00000615310.5:synonymous_variant:LOW:exon2/17:c.135A>G:p.Ala45=:PF17756 [RET Cadherin like domain 1]		164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	167589 [benign DISEASE=Pheochromocytoma,Multiple endocrine neoplasia, type 2b,Multiple endocrine neoplasia, type 2a,Multiple endocrine neoplasia, type 2,not specified,not provided];			rs1800858	0.78502	0.94912,0.75603,0.54785,0.74226,0.70735	47871,	23561	32671	-2.1930			0.35			COSV60686024	0	30409984,17267408,10090908,19138047,8001158,26102504,18091754,20532249,15759212,22312249,24897126,29131865,10521317,10528857,10922382,11950855,16091499,18284634,20123584,20454948,21349203,23059849,23084198,23527089,31644668,22648184,22584707,23840513,26191299,30072953,27174043,16443855,28930629,18436345,23441071,24651702,33827484,32411094,32364585,32708070,34950210,34981673,35078996	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43106301	43106301	T	C	hom	off-target	QUAL=1724;DP=55;QD=31.35;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=28;SAF=27	RET	intron	RET:ENST00000340058.6:intron_variant:MODIFIER:intron4/18:c.868-75T>C::,RET:ENST00000355710.8:intron_variant:MODIFIER:intron4/19:c.868-75T>C::,RET:ENST00000615310.5:intron_variant:MODIFIER:intron4/16:c.867+1108T>C::	regulatory_region_variant:CTCF_binding_site	164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	1222122 [benign DISEASE=not provided];			rs2742243	0.76351	0.87357,0.74951,0.54273,0.74213,0.70750	44937,	26188	35950	-1.7550			0.39			COSV60698036	0	24144365,32913965	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43108942	43108942	A	T	hom	off-target	QUAL=3910;DP=134;QD=29.18;AF=1.00;MQM=60;SAP=117;ABP=0;SAR=25;SAF=109	RET	intron	RET:ENST00000340058.6:intron_variant:MODIFIER:intron5/18:c.1064-89A>T::,RET:ENST00000355710.8:intron_variant:MODIFIER:intron5/19:c.1064-89A>T::,RET:ENST00000615310.5:intron_variant:MODIFIER:intron4/16:c.868-2265A>T::		164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	1277152 [benign DISEASE=not provided];			rs1864404	0.78432	0.94600,0.75828,0.54349,0.74228,0.70683	47800,	23657	32795	-0.0510			1.25				0.01	22584707	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43114918	43114918	G	A	hom	off-target	QUAL=1996;DP=77;QD=25.92;AF=1.00;MQM=60;SAP=170;ABP=0;SAR=77;SAF=0	RET	intron	RET:ENST00000340058.6:intron_variant:MODIFIER:intron11/18:c.2136+182G>A::,RET:ENST00000355710.8:intron_variant:MODIFIER:intron11/19:c.2136+182G>A::,RET:ENST00000615310.5:intron_variant:MODIFIER:intron9/16:c.1740+182G>A::		164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	1226080 [benign DISEASE=not provided];			rs1864400	0.82417	0.90794,0.80194,0.49708,0.81474,0.70756	52134,	20931	26711	-2.8890			0.05			COSV60687565	0	25310821,32851260	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43116417	43116417	T	C	hom	off-target	QUAL=791;DP=26;QD=30.42;AF=1.00;MQM=60;SAP=59;ABP=0;SAR=0;SAF=26	RET	intron	RET:ENST00000340058.6:intron_variant:MODIFIER:intron11/18:c.2137-167T>C::,RET:ENST00000355710.8:intron_variant:MODIFIER:intron11/19:c.2137-167T>C::,RET:ENST00000615310.5:intron_variant:MODIFIER:intron9/16:c.1741-167T>C::		164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	677053 [benign DISEASE=not provided];			rs2256550	0.55731	0.66350,0.49064,0.29310,0.55736,0.30935	24337,	36032	67284	-1.4090			7.43			COSV60688429	0	24144365	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43116778	43116778	C	T	het	off-target;low_conf_region	QUAL=2386;DP=306;QD=7.80;AF=0.45;MQM=60;SAP=200;ABP=9;SAR=125;SAF=13	RET	intron	RET:ENST00000340058.6:intron_variant:MODIFIER:intron12/18:c.2284+47C>T::,RET:ENST00000355710.8:intron_variant:MODIFIER:intron12/19:c.2284+47C>T::,RET:ENST00000615310.5:intron_variant:MODIFIER:intron10/16:c.1888+47C>T::		164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	261396 [benign DISEASE=not specified,not provided];			rs760466	0.19238	0.05756,0.20025,0.05556,0.28184,0.12943	3405,	21937	120683	-0.9730			0.51			COSV60689537	0	25741868,32411094,34981673	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43118395	43118395	G	T	hom		QUAL=37433;DP=1134;QD=33.01;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=571;SAF=563	RET	synonymous	RET:ENST00000340058.6:synonymous_variant:LOW:exon13/19:c.2307G>T:p.Leu769=:PF07714 [Protein tyrosine and serine/threonine kinase],RET:ENST00000355710.8:synonymous_variant:LOW:exon13/20:c.2307G>T:p.Leu769=:PF07714 [Protein tyrosine and serine/threonine kinase],RET:ENST00000615310.5:synonymous_variant:LOW:exon11/17:c.1911G>T:p.Leu637=:PF07714 [Protein tyrosine and serine/threonine kinase]		164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	167590 [benign DISEASE=Pheochromocytoma,Multiple endocrine neoplasia, type 2b,Multiple endocrine neoplasia, type 2a,Multiple endocrine neoplasia, type 2,not specified,not provided];			rs1800861	0.78463	0.88330,0.76583,0.49497,0.76707,0.62037	47391,	24515	32745	1.2810			7.08			COSV60687116	0.01	24033266,30089490,19379518,20565774,22024213,26829565,19138047,20532249,8084609,22312249,24897126,25330015,25736215,28946813,16091499,21349203,23059849,23084198,23527089,16118333,22648184,15531548,22584707,23840513,31263477,27174043,28930629,18976163,24651702,33342844,33827484,32411094,32228166,32913965,34769224,34950210,34981673,35454858	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43120057	43120057	G	A	het	off-target	QUAL=9207;DP=726;QD=12.68;AF=0.50;MQM=60;SAP=3;ABP=3;SAR=187;SAF=179	RET	intron	RET:ENST00000340058.6:intron_variant:MODIFIER:intron14/18:c.2608-24G>A::,RET:ENST00000355710.8:intron_variant:MODIFIER:intron14/19:c.2608-24G>A::,RET:ENST00000615310.5:intron_variant:MODIFIER:intron12/16:c.2212-24G>A::		164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	24956 [benign DISEASE=Multiple endocrine neoplasia, type 2,not specified,not provided];	CS116395 [CLASS=DP MUT=ALT PHEN="Hirschsprung disease association with" GENE=RET];		rs2472737	0.20243	0.14995,0.19271,0.23095,0.22745,0.15755	3272,	24236	121270	-0.3050			4.67			COSV60686346	0	25741868,23757202,22312249,24897126,18284634,12872262,11302967,16118333,24144365,34769224,34981673	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43126769	43126769	T	C	hom	off-target	QUAL=1163;DP=42;QD=27.69;AF=1.00;MQM=60;SAP=86;ABP=0;SAR=1;SAF=41	RET	3'UTR,intron	RET:ENST00000340058.6:3_prime_UTR_variant:MODIFIER:exon19/19:c.*15T>C::,RET:ENST00000355710.8:intron_variant:MODIFIER:intron19/19:c.3187+47T>C::,RET:ENST00000615310.5:3_prime_UTR_variant:MODIFIER:exon17/17:c.*15T>C::		164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	165056 [benign DISEASE=Pheochromocytoma,Multiple endocrine neoplasia, type 2b,Multiple endocrine neoplasia, type 2a,Multiple endocrine neoplasia, type 2,not specified];	CS032426 [CLASS=DP MUT=ALT PHEN="Hirschsprung disease association with" GENE=RET];		rs2075912	0.83072	0.91482,0.80518,0.49942,0.82300,0.71008	53013,	20295	25741	1.4280			13.49			COSV60689472	0.03	25741868,24033266,27798940,29131865,20454948,22648184,31247956,32411094,34981673	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43126920	43126920	T	A	hom	off-target	QUAL=1115;DP=43;QD=25.93;AF=1.00;MQM=60;SAP=96;ABP=0;SAR=43;SAF=0	RET	3'UTR,intron	RET:ENST00000340058.6:3_prime_UTR_variant:MODIFIER:exon19/19:c.*166T>A::,RET:ENST00000355710.8:intron_variant:MODIFIER:intron19/19:c.3187+198T>A::,RET:ENST00000615310.5:3_prime_UTR_variant:MODIFIER:exon17/17:c.*166T>A::		164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	1230253 [benign DISEASE=not provided];			rs2075913	0.75737	0.81565,0.75865,0.40335,0.76564,0.55031	44217,	26726	36892	3.1000			21.60			COSV60699882	0	32139661	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43128364	43128364	C	T	het	off-target	QUAL=7073;DP=491;QD=14.41;AF=0.54;MQM=60;SAP=9;ABP=10;SAR=146;SAF=119	RET	3'UTR,downstream_gene	RET:ENST00000355710.8:3_prime_UTR_variant:MODIFIER:exon20/20:c.*95C>T::,RET:ENST00000615310.5:3_prime_UTR_variant:MODIFIER:exon17/17:c.*1610C>T::,RET:ENST00000340058.6:downstream_gene_variant:MODIFIER::::		164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	299903 [benign DISEASE=Pheochromocytoma,Hirschsprung disease, susceptibility to, 1,Multiple endocrine neoplasia,Renal hypodysplasia/aplasia 1];			rs17028	0.16803	0.04147,0.17435,0.23139,0.21967,0.14437	2699,	20141	126453	0.3030			10.38			COSV60689480	0	22369086,20532249,21841314,32139661,29131865,34981673	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	86876022	86876022	C	A	het		QUAL=846;DP=68;QD=12.44;AF=0.56;MQM=53;SAP=3;ABP=5;SAR=20;SAF=18	BMPR1A	missense	BMPR1A:ENST00000372037.8:missense_variant:MODERATE:exon3/13:c.4C>A:p.Pro2Thr:		601299_[GENE=BMPR1A_PHENOS=Polyposis syndrome, hereditary mixed, 2, 610069 (3); Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant]	41782 [benign DISEASE=Generalized juvenile polyposis/juvenile polyposis coli,Hereditary cancer-predisposing syndrome,Juvenile polyposis syndrome,not specified,not provided];			rs11528010	0.40404	0.65971,0.34915,0.70286,0.25204,0.31460	14968,	31439	90529	3.2000	T(0.73)	B(0.00)	11.73	0.21		COSV64406247,COSV64409048	0.02	25741868,24728327,26293461,26900293,22703879,29458332,16436638,19502417,22886282,28473326,33032550	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BMPR1A (inh=AD oe_syn=0.97 oe_mis=0.69 oe_lof=0.17)
chr10	86890006	86890006	C	T	het	off-target;low_conf_region	QUAL=672;DP=53;QD=12.68;AF=0.49;MQM=60;SAP=15;ABP=3;SAR=7;SAF=19	BMPR1A,RNU1-19P	intron,downstream_gene	BMPR1A:ENST00000372037.8:intron_variant:MODIFIER:intron3/12:c.68-56C>T::,RNU1-19P:ENST00000363306.1:downstream_gene_variant:MODIFIER::::		601299_[GENE=BMPR1A_PHENOS=Polyposis syndrome, hereditary mixed, 2, 610069 (3); Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant]	1292350 [benign DISEASE=not provided];			rs7087358	0.44772	0.68373,0.37172,0.70851,0.30873,0.39280	17435,	33166	83924	-0.1980			2.09				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BMPR1A (inh=AD oe_syn=0.97 oe_mis=0.69 oe_lof=0.17), RNU1-19P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr10	86918991	86918991	A	T	hom	off-target	QUAL=159;DP=6;QD=26.50;AF=1.00;MQM=60;SAP=16;ABP=0;SAR=0;SAF=6	BMPR1A	intron	BMPR1A:ENST00000372037.8:intron_variant:MODIFIER:intron9/12:c.869-181A>T::		601299_[GENE=BMPR1A_PHENOS=Polyposis syndrome, hereditary mixed, 2, 610069 (3); Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant]	1292661 [benign DISEASE=not provided];			rs1240188	0.95796	0.97916,0.94969,0.96576,0.94608,0.97989	69863,	6085	6399	-0.4140			2.07				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BMPR1A (inh=AD oe_syn=0.97 oe_mis=0.69 oe_lof=0.17)
chr10	86923240	86923240	-	GAT	het	off-target	QUAL=5003;DP=556;QD=9.00;AF=0.46;MQM=60;SAP=559;ABP=11;SAR=0;SAF=256	BMPR1A	intron	BMPR1A:ENST00000372037.8:intron_variant:MODIFIER:intron11/12:c.1343-135_1343-134insATG::		601299_[GENE=BMPR1A_PHENOS=Polyposis syndrome, hereditary mixed, 2, 610069 (3); Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant]				rs544039657													0.03		219	2171	38 / 289					BMPR1A (inh=AD oe_syn=0.97 oe_mis=0.69 oe_lof=0.17)
chr10	86923242	86923242	-	ATATA	het	off-target	QUAL=5003;DP=556;QD=9.00;AF=0.46;MQM=60;SAP=559;ABP=11;SAR=0;SAF=256	BMPR1A	intron	BMPR1A:ENST00000372037.8:intron_variant:MODIFIER:intron11/12:c.1343-134_1343-133insATATA::		601299_[GENE=BMPR1A_PHENOS=Polyposis syndrome, hereditary mixed, 2, 610069 (3); Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant]				rs1554891541													0.07		215	2086	36 / 283					BMPR1A (inh=AD oe_syn=0.97 oe_mis=0.69 oe_lof=0.17)
chr10	86923365	86923365	T	C	het	off-target	QUAL=5544;DP=610;QD=9.09;AF=0.44;MQM=60;SAP=428;ABP=20;SAR=250;SAF=20	BMPR1A	splice_region&intron	BMPR1A:ENST00000372037.8:splice_region_variant&intron_variant:LOW:intron11/12:c.1343-11T>C::		601299_[GENE=BMPR1A_PHENOS=Polyposis syndrome, hereditary mixed, 2, 610069 (3); Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant]	259286 [benign DISEASE=Generalized juvenile polyposis/juvenile polyposis coli,Hereditary cancer-predisposing syndrome,Juvenile polyposis syndrome,not specified,not provided];			rs7074064	0.40199	0.66155,0.33419,0.69795,0.25092,0.31505	14879,	31288	90812	-0.2270			1.82		10.64>9.92		0	25741868,26293461,16385451,23555554,35037836	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BMPR1A (inh=AD oe_syn=0.97 oe_mis=0.69 oe_lof=0.17)
chr10	87893929	87893929	A	G	hom	off-target	QUAL=115;DP=4;QD=28.75;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=2;SAF=2	PTEN	intron	PTEN:ENST00000706954.1:intron_variant:MODIFIER:intron2/9:c.80-96A>G::,PTEN:ENST00000688308.1:intron_variant:MODIFIER:intron2/9:c.80-96A>G::,PTEN:ENST00000693560.1:intron_variant:MODIFIER:intron2/9:c.599-96A>G::,PTEN:ENST00000371953.8:intron_variant:MODIFIER:intron1/8:c.80-96A>G::,PTEN:ENST00000700021.1:intron_variant:MODIFIER:intron1/7:c.80-96A>G::,PTEN:ENST00000472832.3:intron_variant:MODIFIER:intron1/7:c.80-96A>G::	regulatory_region_variant:enhancer	601728_[GENE=PTEN_PHENOS={Glioma susceptibility 2}, 613028 (3); {Meningioma}, 607174 (3), Autosomal dominant; Cowden syndrome 1, 158350 (3), Autosomal dominant; Lhermitte-Duclos disease, 158350 (3), Autosomal dominant; Prostate cancer, somatic, 176807 (3); Macrocephaly/autism syndrome, 605309 (3), Autosomal dominant]	440219 [benign DISEASE=not provided];			rs1903858	0.38750	0.47179,0.44504,0.50753,0.32813,0.29883	11868,	33752	90870	-0.7510			0.54			COSV64292778	0	18805939,22562547,27187382,24959314,21633361,19625176,26082156,24132918,26220040,23930209,19421400,25881591,16574322,32547095,32537792,25419146,32583210,34594039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTEN (inh=AD oe_syn=1.02 oe_mis=0.33 oe_lof=0.24)
chr10	87931195	87931195	-	TTATC	het	off-target	QUAL=904;DP=54;QD=16.74;AF=0.63;MQM=60;SAP=7;ABP=11;SAR=21;SAF=13	PTEN	intron	PTEN:ENST00000706954.1:intron_variant:MODIFIER:intron5/9:c.253+109_253+110insTCTTA::,PTEN:ENST00000688308.1:intron_variant:MODIFIER:intron5/9:c.253+109_253+110insTCTTA::,PTEN:ENST00000693560.1:intron_variant:MODIFIER:intron5/9:c.772+109_772+110insTCTTA::,PTEN:ENST00000371953.8:intron_variant:MODIFIER:intron4/8:c.253+109_253+110insTCTTA::,PTEN:ENST00000700021.1:intron_variant:MODIFIER:intron3/7:c.208+109_208+110insTCTTA::,PTEN:ENST00000472832.3:intron_variant:MODIFIER:intron4/7:c.253+109_253+110insTCTTA::	regulatory_region_variant:enhancer	601728_[GENE=PTEN_PHENOS={Glioma susceptibility 2}, 613028 (3); {Meningioma}, 607174 (3), Autosomal dominant; Cowden syndrome 1, 158350 (3), Autosomal dominant; Lhermitte-Duclos disease, 158350 (3), Autosomal dominant; Prostate cancer, somatic, 176807 (3); Macrocephaly/autism syndrome, 605309 (3), Autosomal dominant]	1292390 [benign DISEASE=not provided];			rs1799734	0.39322	0.48311,0.44766,0.50427,0.33445,0.29900	12063,	35241	91609				10.40				0	31704287,17033968,26885116,24901890,26417029	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTEN (inh=AD oe_syn=1.02 oe_mis=0.33 oe_lof=0.24)
chr10	87961150	87961150	T	G	het	off-target	QUAL=251;DP=29;QD=8.66;AF=0.52;MQM=60;SAP=36;ABP=3;SAR=0;SAF=15	PTEN	intron,3'UTR	PTEN:ENST00000706954.1:intron_variant:MODIFIER:intron9/9:c.1026+32T>G::,PTEN:ENST00000688308.1:intron_variant:MODIFIER:intron9/9:c.1026+32T>G::,PTEN:ENST00000693560.1:intron_variant:MODIFIER:intron9/9:c.1545+32T>G::,PTEN:ENST00000371953.8:intron_variant:MODIFIER:intron8/8:c.1026+32T>G::,PTEN:ENST00000700021.1:intron_variant:MODIFIER:intron7/7:c.981+32T>G::,PTEN:ENST00000472832.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*23T>G::	regulatory_region_variant:enhancer	601728_[GENE=PTEN_PHENOS={Glioma susceptibility 2}, 613028 (3); {Meningioma}, 607174 (3), Autosomal dominant; Cowden syndrome 1, 158350 (3), Autosomal dominant; Lhermitte-Duclos disease, 158350 (3), Autosomal dominant; Prostate cancer, somatic, 176807 (3); Macrocephaly/autism syndrome, 605309 (3), Autosomal dominant]	92810 [benign DISEASE=Cowden syndrome 1,Macrocephaly-autism syndrome,Hereditary cancer-predisposing syndrome,PTEN hamartoma tumor syndrome,not specified,not provided];	CS1815672 [CLASS=R MUT=ALT PHEN="Cowden disease" GENE=PTEN];		rs555895	0.39943	0.50145,0.45145,0.50577,0.33574,0.30050	12632,	35397	91207	-0.8500			0.60			COSV64292683	0	25741868,23757202,18805939,17033968,23068025,26541596,25361012,26220040,19421400,21869887,16574322	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTEN (inh=AD oe_syn=1.02 oe_mis=0.33 oe_lof=0.24)
chr10	102504350	102504350	C	T	hom		QUAL=9794;DP=390;QD=25.11;AF=1.00;MQM=60;SAP=850;ABP=0;SAR=390;SAF=0	SUFU,ACTR1A	splice_region&intron,upstream_gene	SUFU:ENST00000369902.8:splice_region_variant&intron_variant:LOW:intron1/11:c.182+16C>T::,SUFU:ENST00000369899.6:splice_region_variant&intron_variant:LOW:intron1/10:c.182+16C>T::,SUFU:ENST00000423559.2:splice_region_variant&intron_variant:LOW:intron1/9:c.182+16C>T::,ACTR1A:ENST00000369905.9:upstream_gene_variant:MODIFIER::::,ACTR1A:ENST00000487599.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	607035_[GENE=SUFU_PHENOS={Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant; Joubert syndrome 32, 617757 (3), Autosomal recessive; Basal cell nevus syndrome, 109400 (3), Autosomal dominant; {Medulloblastoma}, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant]	260689 [benign DISEASE=Medulloblastoma,Gorlin syndrome,Joubert syndrome 32,not specified,not provided];			rs2274351	0.46132	0.31768,0.41188,0.32112,0.54696,0.48757	17115,	35786	81758	-0.1750			16.27			COSV64013811	0.03	25741868,26192919,22508808	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACTR1A (inh=n/a oe_syn=0.79 oe_mis=0.44 oe_lof=0.13), SUFU (inh=AR+AD oe_syn=0.92 oe_mis=0.68 oe_lof=0.00)
chr10	102509460	102509460	G	A	hom	off-target	QUAL=160;DP=6;QD=26.67;AF=1.00;MQM=60;SAP=16;ABP=0;SAR=6;SAF=0	SUFU	intron	SUFU:ENST00000369902.8:intron_variant:MODIFIER:intron2/11:c.317+157G>A::,SUFU:ENST00000369899.6:intron_variant:MODIFIER:intron2/10:c.317+157G>A::,SUFU:ENST00000423559.2:intron_variant:MODIFIER:intron2/9:c.317+157G>A::		607035_[GENE=SUFU_PHENOS={Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant; Joubert syndrome 32, 617757 (3), Autosomal recessive; Basal cell nevus syndrome, 109400 (3), Autosomal dominant; {Medulloblastoma}, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant]	677130 [benign DISEASE=not provided];			rs2281880	0.46198	0.31762,0.41169,0.32329,0.54763,0.48797	17171,	35773	81657	-0.3310			1.20			COSV64014869	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SUFU (inh=AR+AD oe_syn=0.92 oe_mis=0.68 oe_lof=0.00)
chr10	102597065	102597065	A	G	hom	off-target	QUAL=2276;DP=73;QD=31.18;AF=1.00;MQM=60;SAP=4;ABP=0;SAR=34;SAF=39	SUFU	intron	SUFU:ENST00000369902.8:intron_variant:MODIFIER:intron6/11:c.757-75A>G::,SUFU:ENST00000369899.6:intron_variant:MODIFIER:intron6/10:c.757-75A>G::,SUFU:ENST00000423559.2:intron_variant:MODIFIER:intron6/9:c.757-75A>G::	regulatory_region_variant:enhancer,regulatory_region_variant:CTCF_binding_site	607035_[GENE=SUFU_PHENOS={Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant; Joubert syndrome 32, 617757 (3), Autosomal recessive; Basal cell nevus syndrome, 109400 (3), Autosomal dominant; {Medulloblastoma}, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant]	1246567 [benign DISEASE=not provided];			rs10786690	0.99272	0.97561,0.99790,0.99922,0.99975,0.99958	74890,	1086	1106	-0.0720			4.54			COSV100882930	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SUFU (inh=AR+AD oe_syn=0.92 oe_mis=0.68 oe_lof=0.00)
chr10	102618932	102618935	GTGT	-	het	off-target;low_conf_region	QUAL=367;DP=34;QD=10.79;AF=0.32;MQM=60;SAP=3;ABP=12;SAR=5;SAF=6	SUFU	intron,downstream_gene	SUFU:ENST00000369902.8:intron_variant:MODIFIER:intron10/11:c.1296+1548_1296+1551del::,SUFU:ENST00000369899.6:intron_variant:MODIFIER:intron10/10:c.1297-90_1297-87del::,SUFU:ENST00000423559.2:downstream_gene_variant:MODIFIER::::		607035_[GENE=SUFU_PHENOS={Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant; Joubert syndrome 32, 617757 (3), Autosomal recessive; Basal cell nevus syndrome, 109400 (3), Autosomal dominant; {Medulloblastoma}, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant]			(GT)n (Simple_repeat)	rs59259635	0.12833	0.08521,0.10923,0.09828,0.14660,0.15929	974,	13656	105990	0.2690			0.66				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SUFU (inh=AR+AD oe_syn=0.92 oe_mis=0.68 oe_lof=0.00)
chr10	102618932	102618937	GTGTGT	-	het	off-target;low_conf_region	QUAL=367;DP=34;QD=10.79;AF=0.32;MQM=60;SAP=8;ABP=12;SAR=3;SAF=8	SUFU	intron,downstream_gene	SUFU:ENST00000369902.8:intron_variant:MODIFIER:intron10/11:c.1296+1546_1296+1551del::,SUFU:ENST00000369899.6:intron_variant:MODIFIER:intron10/10:c.1297-92_1297-87del::,SUFU:ENST00000423559.2:downstream_gene_variant:MODIFIER::::		607035_[GENE=SUFU_PHENOS={Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant; Joubert syndrome 32, 617757 (3), Autosomal recessive; Basal cell nevus syndrome, 109400 (3), Autosomal dominant; {Medulloblastoma}, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant]			(GT)n (Simple_repeat)	rs59259635	0.05563	0.07936,0.04052,0.06341,0.04848,0.02979	165,	6439	114907	0.2690			0.67				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SUFU (inh=AR+AD oe_syn=0.92 oe_mis=0.68 oe_lof=0.00)
chr10	102627262	102627262	T	C	het		QUAL=14782;DP=1165;QD=12.69;AF=0.49;MQM=60;SAP=3;ABP=4;SAR=290;SAF=282	SUFU	splice_region&intron	SUFU:ENST00000369902.8:splice_region_variant&intron_variant:LOW:intron11/11:c.1365+19T>C::		607035_[GENE=SUFU_PHENOS={Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant; Joubert syndrome 32, 617757 (3), Autosomal recessive; Basal cell nevus syndrome, 109400 (3), Autosomal dominant; {Medulloblastoma}, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant]	260688 [benign DISEASE=Medulloblastoma,Gorlin syndrome,Joubert syndrome 32,not specified,not provided];			rs12414407	0.68279	0.75238,0.63361,0.74769,0.65567,0.71145	35723,	32407	48249	0.4520			7.22			COSV64017850	0	25741868,26627480,23538333,24067507,27617143	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SUFU (inh=AR+AD oe_syn=0.92 oe_mis=0.68 oe_lof=0.00)
chr10	102630175	102630175	T	G	hom		QUAL=59197;DP=1850;QD=32.00;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=920;SAF=930	SUFU	3'UTR	SUFU:ENST00000369902.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*20T>G::		607035_[GENE=SUFU_PHENOS={Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant; Joubert syndrome 32, 617757 (3), Autosomal recessive; Basal cell nevus syndrome, 109400 (3), Autosomal dominant; {Medulloblastoma}, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant]	1175161 [benign DISEASE=Gorlin syndrome,Joubert syndrome 32,not specified];			rs4917980	0.99834	0.99435,0.99954,1.00000,0.99991,1.00000	75835,	251	253	1.4220			16.48			COSV100883278	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SUFU (inh=AR+AD oe_syn=0.92 oe_mis=0.68 oe_lof=0.00)
chr11	13081343	13081343	C	A	het	off-target	QUAL=22471;DP=1738;QD=12.93;AF=0.50;MQM=60;SAP=3;ABP=3;SAR=439;SAF=430		intergenic	::intergenic_variant:MODIFIER::::						rs2727397	0.58590	0.64427,0.64386,0.15097,0.59131,0.45445	26759,	35422	62860	0.0480			6.75						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr11	13081377	13081377	G	A	het		QUAL=297;DP=26;QD=11.42;AF=0.54;MQM=60;SAP=19;ABP=3;SAR=12;SAF=2		intergenic	::intergenic_variant:MODIFIER::::						rs2583136	0.58577	0.64407,0.64378,0.15075,0.59131,0.45398	26761,	35429	62903	-0.7750			0.63						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr11	22624479	22624479	G	A	hom	off-target	QUAL=925;DP=37;QD=25.00;AF=1.00;MQM=60;SAP=83;ABP=0;SAR=0;SAF=37	FANCF	3'UTR	FANCF:ENST00000327470.6:3_prime_UTR_variant:MODIFIER:exon1/1:c.*207C>T::	regulatory_region_variant:promoter	613897_[GENE=FANCF_PHENOS=Fanconi anemia, complementation group F, 603467 (3), Autosomal recessive]	304197 [benign DISEASE=Fanconi anemia complementation group F,not provided];			rs4447177	0.71290	0.41665,0.73143,0.89037,0.83476,0.82061	41376,	25602	43636	-0.3340			1.31				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCF (inh=AR oe_syn=1.43 oe_mis=1.38 oe_lof=0.00)
chr11	64804546	64804546	T	C	hom		QUAL=8075;DP=247;QD=32.69;AF=1.00;MQM=60;SAP=32;ABP=0;SAR=152;SAF=95	MEN1,MAP4K2	missense,upstream_gene	MEN1:ENST00000377316.6:missense_variant:MODERATE:exon8/8:c.1456A>G:p.Thr486Ala:,MEN1:ENST00000377313.6:missense_variant:MODERATE:exon9/9:c.1636A>G:p.Thr546Ala:,MEN1:ENST00000315422.9:missense_variant:MODERATE:exon10/10:c.1621A>G:p.Thr541Ala:,MEN1:ENST00000450708.7:missense_variant:MODERATE:exon10/10:c.1621A>G:p.Thr541Ala:,MEN1:ENST00000377321.5:missense_variant:MODERATE:exon10/10:c.1516A>G:p.Thr506Ala:,MEN1:ENST00000377326.7:missense_variant:MODERATE:exon9/9:c.1621A>G:p.Thr541Ala:,MEN1:ENST00000312049.11:missense_variant:MODERATE:exon10/10:c.1621A>G:p.Thr541Ala:,MEN1:ENST00000672304.1:missense_variant:MODERATE:exon11/11:c.1747A>G:p.Thr583Ala:,MEN1:ENST00000440873.6:missense_variant:MODERATE:exon10/10:c.1621A>G:p.Thr541Ala:,MAP4K2:ENST00000294066.7:upstream_gene_variant:MODIFIER::::,MAP4K2:ENST00000377350.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site	613733_[GENE=MEN1_PHENOS=Lipoma, somatic (3); Angiofibroma, somatic (3); Multiple endocrine neoplasia 1, 131100 (3), Autosomal dominant; Carcinoid tumor of lung (3); Adrenal adenoma, somatic (3); Parathyroid adenoma, somatic (3)]	134640 [benign DISEASE=Multiple endocrine neoplasia, type 1,not specified,not provided];			rs2959656	0.89752	0.71336,0.90327,0.70077,0.99597,0.98572	62559,	11399	15587	0.1390	T(1.00),T(0.98),T(1.00),T(1.00),T(0.99),T(1.00),T(1.00),T(0.96),T(1.00), , 	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00), , 	5.02	0.30		COSV53639974	0	25741868,24033266,24728327,23757202,22703879,26307114,564891,9215689,18775714,27185868,28969599,28899949,33240400,30214228,32708070,34750164	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP4K2 (inh=n/a oe_syn=1.12 oe_mis=0.79 oe_lof=0.50), MEN1 (inh=AD oe_syn=0.93 oe_mis=0.53 oe_lof=0.04)
chr11	64804931	64804931	C	G	het	off-target	QUAL=458;DP=42;QD=10.90;AF=0.48;MQM=60;SAP=3;ABP=3;SAR=10;SAF=10	MEN1,MAP4K2	intron,upstream_gene	MEN1:ENST00000377316.6:intron_variant:MODIFIER:intron7/7:c.1186-115G>C::,MEN1:ENST00000377313.6:intron_variant:MODIFIER:intron8/8:c.1365+103G>C::,MEN1:ENST00000315422.9:intron_variant:MODIFIER:intron9/9:c.1350+103G>C::,MEN1:ENST00000450708.7:intron_variant:MODIFIER:intron9/9:c.1350+103G>C::,MEN1:ENST00000377321.5:intron_variant:MODIFIER:intron9/9:c.1245+103G>C::,MEN1:ENST00000377326.7:intron_variant:MODIFIER:intron8/8:c.1350+103G>C::,MEN1:ENST00000312049.11:intron_variant:MODIFIER:intron9/9:c.1350+103G>C::,MEN1:ENST00000672304.1:intron_variant:MODIFIER:intron10/10:c.1476+103G>C::,MEN1:ENST00000440873.6:intron_variant:MODIFIER:intron9/9:c.1350+103G>C::,MAP4K2:ENST00000294066.7:upstream_gene_variant:MODIFIER::::,MAP4K2:ENST00000377350.7:upstream_gene_variant:MODIFIER::::		613733_[GENE=MEN1_PHENOS=Lipoma, somatic (3); Angiofibroma, somatic (3); Multiple endocrine neoplasia 1, 131100 (3), Autosomal dominant; Carcinoid tumor of lung (3); Adrenal adenoma, somatic (3); Parathyroid adenoma, somatic (3)]	1245707 [benign DISEASE=not provided];			rs654440	0.32018	0.08689,0.28096,0.00960,0.47241,0.25404	10216,	28261	103385	1.6130			8.90				0	27366707	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP4K2 (inh=n/a oe_syn=1.12 oe_mis=0.79 oe_lof=0.50), MEN1 (inh=AD oe_syn=0.93 oe_mis=0.53 oe_lof=0.04)
chr11	64805085	64805085	A	G	hom		QUAL=6504;DP=200;QD=32.52;AF=1.00;MQM=60;SAP=35;ABP=0;SAR=73;SAF=127	MEN1,MAP4K2	intron,synonymous,upstream_gene	MEN1:ENST00000377316.6:intron_variant:MODIFIER:intron7/7:c.1186-269T>C::,MEN1:ENST00000377313.6:synonymous_variant:LOW:exon8/9:c.1314T>C:p.His438=:PF05053 [Menin],MEN1:ENST00000315422.9:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433=:PF05053 [Menin],MEN1:ENST00000450708.7:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433=:PF05053 [Menin],MEN1:ENST00000377321.5:synonymous_variant:LOW:exon9/10:c.1194T>C:p.His398=:PF05053 [Menin],MEN1:ENST00000377326.7:synonymous_variant:LOW:exon8/9:c.1299T>C:p.His433=:PF05053 [Menin],MEN1:ENST00000312049.11:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433=:PF05053 [Menin],MEN1:ENST00000672304.1:synonymous_variant:LOW:exon10/11:c.1425T>C:p.His475=:PF05053 [Menin],MEN1:ENST00000440873.6:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433=:PF05053 [Menin],MAP4K2:ENST00000294066.7:upstream_gene_variant:MODIFIER::::,MAP4K2:ENST00000377350.7:upstream_gene_variant:MODIFIER::::		613733_[GENE=MEN1_PHENOS=Lipoma, somatic (3); Angiofibroma, somatic (3); Multiple endocrine neoplasia 1, 131100 (3), Autosomal dominant; Carcinoid tumor of lung (3); Adrenal adenoma, somatic (3); Parathyroid adenoma, somatic (3)]	167288 [benign DISEASE=Multiple endocrine neoplasia, type 1,not specified];			rs540012	0.97799	0.92299,0.99268,1.00000,0.99982,0.99979	72884,	3096	3350	-0.3010			1.30				0.07	26307114,28969599,28899949,32708070,34750164	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP4K2 (inh=n/a oe_syn=1.12 oe_mis=0.79 oe_lof=0.50), MEN1 (inh=AD oe_syn=0.93 oe_mis=0.53 oe_lof=0.04)
chr11	64810148	64810148	G	C	het	off-target	QUAL=189;DP=32;QD=5.91;AF=0.44;MQM=60;SAP=33;ABP=4;SAR=0;SAF=14	MEN1	5'UTR,splice_region&intron,upstream_gene	MEN1:ENST00000377316.6:5_prime_UTR_variant:MODIFIER:exon1/8:c.-39C>G::,MEN1:ENST00000315422.9:splice_region_variant&intron_variant:LOW:intron1/9:c.-23-16C>G::,MEN1:ENST00000450708.7:splice_region_variant&intron_variant:LOW:intron1/9:c.-23-16C>G::,MEN1:ENST00000377321.5:splice_region_variant&intron_variant:LOW:intron1/9:c.-23-16C>G::,MEN1:ENST00000377326.7:5_prime_UTR_variant:MODIFIER:exon1/9:c.-39C>G::,MEN1:ENST00000312049.11:splice_region_variant&intron_variant:LOW:intron1/9:c.-23-16C>G::,MEN1:ENST00000672304.1:splice_region_variant&intron_variant:LOW:intron1/10:c.-23-16C>G::,MEN1:ENST00000440873.6:splice_region_variant&intron_variant:LOW:intron1/9:c.-23-16C>G::,MEN1:ENST00000377313.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	613733_[GENE=MEN1_PHENOS=Lipoma, somatic (3); Angiofibroma, somatic (3); Multiple endocrine neoplasia 1, 131100 (3), Autosomal dominant; Carcinoid tumor of lung (3); Adrenal adenoma, somatic (3); Parathyroid adenoma, somatic (3)]	439889 [benign DISEASE=not provided];			rs509606	0.12728	0.10038,0.24202,0.27974,0.10163,0.19426	1531,	16233	132299	0.0940			5.60		11.39>10.32		0.01	35965945	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MEN1 (inh=AD oe_syn=0.93 oe_mis=0.53 oe_lof=0.04)
chr11	94479765	94479765	A	-	het	mosaic	QUAL=338;DP=507;QD=0.67;AF=0.12;MQM=60;SAP=3;ABP=937;SAR=10;SAF=10	MRE11	splice_region&intron	MRE11:ENST00000323929.8:splice_region_variant&intron_variant:LOW:intron4/19:c.315-4del::,MRE11:ENST00000407439.7:splice_region_variant&intron_variant:LOW:intron4/19:c.324-4del::,MRE11:ENST00000323977.7:splice_region_variant&intron_variant:LOW:intron4/18:c.315-4del::,MRE11:ENST00000393241.8:splice_region_variant&intron_variant:LOW:intron4/19:c.315-4del::,MRE11:ENST00000540013.5:splice_region_variant&intron_variant:LOW:intron4/7:c.315-4del::		600814_[GENE=MRE11_PHENOS=Ataxia-telangiectasia-like disorder 1, 604391 (3), Autosomal recessive]	140809 [benign/likely benign DISEASE=Ataxia-telangiectasia-like disorder,Hereditary cancer-predisposing syndrome,Ataxia-telangiectasia-like disorder 1,not provided];			rs35062043	0.00005	0.00002,0.00014,0.00000,0.00005,0.00000	0,	8	147024	0.6600			2.67				0.11	19383352,35853939	0	211	0 / 25	1	"[1] Ilnaz Sepahi 29-03-2016 batch import"			MRE11 (inh=AR oe_syn=1.11 oe_mis=0.98 oe_lof=0.60)
chr11	108229378	108229378	-	T	het	off-target;low_conf_region	QUAL=326;DP=36;QD=9.06;AF=0.44;MQM=60;SAP=17;ABP=4;SAR=3;SAF=13	ATM,Y_RNA	intron,3'UTR,downstream_gene	ATM:ENST00000675843.1:intron_variant:MODIFIER:intron4/62:c.331+69dup::,ATM:ENST00000530958.5:intron_variant:MODIFIER:intron3/3:c.331+69dup::,ATM:ENST00000452508.6:intron_variant:MODIFIER:intron5/63:c.331+69dup::,ATM:ENST00000682465.1:3_prime_UTR_variant:MODIFIER:exon4/4:c.*61dup::,ATM:ENST00000684029.1:intron_variant:MODIFIER:intron4/4:c.331+69dup::,ATM:ENST00000683468.1:downstream_gene_variant:MODIFIER::::,ATM:ENST00000683150.1:downstream_gene_variant:MODIFIER::::,ATM:ENST00000683914.1:downstream_gene_variant:MODIFIER::::,ATM:ENST00000639953.1:downstream_gene_variant:MODIFIER::::,ATM:ENST00000640388.1:downstream_gene_variant:MODIFIER::::,ATM:ENST00000639240.1:downstream_gene_variant:MODIFIER::::,ATM:ENST00000526567.5:downstream_gene_variant:MODIFIER::::,Y_RNA:ENST00000384240.1:downstream_gene_variant:MODIFIER::::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1225892 [benign DISEASE=not specified,not provided];			rs11390378	0.50080	0.37483,0.59369,0.44442,0.53005,0.63519	18361,	35604	72094				0.98				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108243935	108243935	T	-	het	off-target;low_conf_region	QUAL=63;DP=135;QD=0.47;AF=0.15;MQM=60;SAP=19;ABP=148;SAR=4;SAF=16	ATM	splice_region&intron	ATM:ENST00000675843.1:splice_region_variant&intron_variant:LOW:intron5/62:c.497-4del::,ATM:ENST00000452508.6:splice_region_variant&intron_variant:LOW:intron6/63:c.497-4del::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	183775 [benign/likely benign DISEASE=Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];			rs768748099	0.00208	0.00205,0.00154,0.00040,0.00172,0.00000	0,	300	143820	-0.2470			0.25				0.06		1	934	1 / 63					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108244634	108244634	T	-	hom	off-target	QUAL=6765;DP=306;QD=22.11;AF=0.92;MQM=60;SAP=615;ABP=0;SAR=0;SAF=282	ATM	intron	ATM:ENST00000675843.1:intron_variant:MODIFIER:intron6/62:c.663-144del::,ATM:ENST00000452508.6:intron_variant:MODIFIER:intron7/63:c.663-144del::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1257474 [benign DISEASE=not provided];			rs11298747	0.97916	0.99325,0.96349,0.99535,0.97176,0.98196	72252,	3048	3140	-0.8530			0.08				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108248889	108248889	A	-	het	off-target;low_conf_region	QUAL=11;DP=31;QD=0.35;AF=0.16;MQM=60;SAP=3;ABP=34;SAR=3;SAF=2	ATM	intron	ATM:ENST00000675843.1:intron_variant:MODIFIER:intron8/62:c.1066-31del::,ATM:ENST00000452508.6:intron_variant:MODIFIER:intron9/63:c.1066-31del::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1235015 [benign DISEASE=not specified,not provided];		AluSp (SINE/Alu)	rs35813860	0.00390	0.00393,0.00377,0.00139,0.00328,0.00060	2,	388	100016	1.8490			1.86				0.03		2	379	1 / 67					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108258930	108258930	A	G	het	off-target	QUAL=38;DP=16;QD=2.38;AF=0.25;MQM=60;SAP=3;ABP=12;SAR=2;SAF=2	ATM	intron	ATM:ENST00000675843.1:intron_variant:MODIFIER:intron15/62:c.2377-56A>G::,ATM:ENST00000452508.6:intron_variant:MODIFIER:intron16/63:c.2377-56A>G::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1177614 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Ataxia-telangiectasia syndrome,not specified,not provided];			rs672655	0.49452	0.27603,0.60701,0.42026,0.56726,0.60236	20105,	34927	76803	2.1810			17.13			COSV53757995	0	25010664,18433505	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108271229	108271230	TT	-	het	off-target;low_conf_region	QUAL=301;DP=148;QD=2.03;AF=0.17;MQM=60;SAP=4;ABP=144;SAR=11;SAF=14	ATM	splice_region&intron	ATM:ENST00000675843.1:splice_region_variant&intron_variant:LOW:intron19/62:c.2922-9_2922-8del::,ATM:ENST00000452508.6:splice_region_variant&intron_variant:LOW:intron20/63:c.2922-9_2922-8del::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1802800 [benign DISEASE=not specified,Breast and/or ovarian cancer];			rs373881770	0.00029	0.00008,0.00014,0.00000,0.00020,0.00000	0,	41	142199	0.1370			1.58				0.02		0	146	0 / 10					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108279481	108279481	T	-	het		QUAL=889;DP=98;QD=9.07;AF=0.39;MQM=60;SAP=3;ABP=14;SAR=19;SAF=19	ATM	splice_region&intron	ATM:ENST00000675843.1:splice_region_variant&intron_variant:LOW:intron22/62:c.3285-9del::,ATM:ENST00000452508.6:splice_region_variant&intron_variant:LOW:intron23/63:c.3285-9del::	regulatory_region_variant:enhancer	607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	181857 [benign/likely benign DISEASE=Hereditary breast ovarian cancer syndrome,Ataxia-telangiectasia syndrome,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];		(TTTG)n (Simple_repeat)	rs1799757	0.10637	0.02394,0.09176,0.00788,0.14453,0.07531	1202,	13768	135858	0.5080			3.27				0	25741868,24033266,30781715,18433505,19347964,33240400,36039053	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108280980	108280980	-	A	het	off-target;low_conf_region	QUAL=1037;DP=76;QD=13.64;AF=0.53;MQM=60;SAP=29;ABP=3;SAR=31;SAF=9	ATM	splice_region&intron	ATM:ENST00000675843.1:splice_region_variant&intron_variant:LOW:intron23/62:c.3403-13dup::,ATM:ENST00000452508.6:splice_region_variant&intron_variant:LOW:intron24/63:c.3403-13dup::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	181858 [benign/likely benign DISEASE=Ataxia-telangiectasia syndrome,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,Breast and/or ovarian cancer,not provided];			rs3218681	0.55149	0.46069,0.62740,0.39557,0.57459,0.64265	23475,	36676	68010				6.87				0.05	25741868,24033266,29879995,19222838,18433505	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108284670	108284670	G	A	het	off-target	QUAL=113;DP=15;QD=7.53;AF=0.40;MQM=60;SAP=16;ABP=4;SAR=6;SAF=0	ATM	intron	ATM:ENST00000675843.1:intron_variant:MODIFIER:intron26/62:c.3993+197G>A::,ATM:ENST00000452508.6:intron_variant:MODIFIER:intron27/63:c.3993+197G>A::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1226443 [benign DISEASE=not provided];			rs654005	0.53702	0.42258,0.61999,0.38616,0.56827,0.64872	22445,	36645	70293	-0.8670			0.86				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108299544	108299544	G	A	het	off-target	QUAL=199;DP=18;QD=11.06;AF=0.67;MQM=60;SAP=29;ABP=7;SAR=0;SAF=12	ATM	intron	ATM:ENST00000675843.1:intron_variant:MODIFIER:intron33/62:c.5006-170G>A::,ATM:ENST00000452508.6:intron_variant:MODIFIER:intron34/63:c.5006-170G>A::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1261675 [benign DISEASE=not provided];		AluSx (SINE/Alu)	rs1150203	0.50211	0.30878,0.60695,0.37118,0.56766,0.60250	20389,	35442	75580	-1.5540			0.39				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108304667	108304667	T	C	het		QUAL=161;DP=14;QD=11.50;AF=0.57;MQM=60;SAP=13;ABP=4;SAR=1;SAF=7	ATM,C11orf65	splice_region&intron,downstream_gene	ATM:ENST00000675843.1:splice_region_variant&intron_variant:LOW:intron36/62:c.5497-8T>C::,ATM:ENST00000452508.6:splice_region_variant&intron_variant:LOW:intron37/63:c.5497-8T>C::,C11orf65:ENST00000525729.5:downstream_gene_variant:MODIFIER::::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	132706 [benign/likely benign DISEASE=Hereditary breast ovarian cancer syndrome,Triple-negative breast carcinoma,Malignant tumor of breast,Ataxia-telangiectasia syndrome,Hereditary cancer-predisposing syndrome,not specified,not provided];			rs3092829	0.02150	0.00526,0.02323,0.00115,0.03290,0.00621	36,	3200	148922	1.2810			7.67		10.05>8.69	COSV53727999	0	25741868,30781715,22529920,18433505,18701470	47	1998	10 / 424	1	"[1] Ilnaz Sepahi 29-03-2016 batch import"			ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=AR+AD oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108304735	108304735	G	A	het		QUAL=388;DP=30;QD=12.93;AF=0.53;MQM=60;SAP=3;ABP=3;SAR=8;SAF=8	ATM,C11orf65	missense,downstream_gene	ATM:ENST00000675843.1:missense_variant:MODERATE:exon37/63:c.5557G>A:p.Asp1853Asn:,ATM:ENST00000452508.6:missense_variant:MODERATE:exon38/64:c.5557G>A:p.Asp1853Asn:,C11orf65:ENST00000525729.5:downstream_gene_variant:MODIFIER::::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	128458 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Ataxia-telangiectasia syndrome,Hereditary cancer-predisposing syndrome,not specified,not provided];	CM077896 [CLASS=DP MUT=ALT PHEN="Breast cancer bilateral association with" GENE=ATM];		rs1801516	0.10639	0.02402,0.09071,0.00789,0.14466,0.07492	1205,	13764	135846	5.9270	D(0.01),D(0.01), 	B(0.06),B(0.06), 	22.90	0.12		COSV53728020	0.12	25741868,24033266,24728327,21504893,28499365,30089490,30781715,29178884,26648445,19536092,24756757,18559551,24531918,23238918,26870349,16465622,31584889,22792358,27608007,25077817,28844157,29458332,28206966,28324443,31095341,24218030,24642353,19276285,29963112,18579371,24062231,25591549,32039725,23697595,18768505,21877955,27258253,19094228,31914346,22927776,24980573,29433565,24599715,23313170,19286843,17132159,22276117,30194396,22537351,17582598,23154078,29691986,21983787,18433505,17623063,18701470,19348699,21332318,15756685,16496408,18264724,20799949,21327466,24105688,25849217,26627042,27057881,30384829,31756226,25837821,26857527,29753029,29788924,9711876,10425038,25530832,22438227,19347964,29888979,24392023,27993549,28212542,27443449,30231410,27527855,25380778,22842228,23642098,29657992,25879635,29507678,29890168,27764772,25355167,22952040,26384276,20531418,25861265,23537197,24177593,24324286,24790730,17331670,18374504,17889263,20170971,19162519,19022265,32341527,17351744,10397742,24416720,12473594,31658756	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=AR+AD oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108312687	108312688	CT	-	het	off-target	QUAL=150;DP=23;QD=6.52;AF=0.43;MQM=60;SAP=25;ABP=4;SAR=10;SAF=0	ATM,C11orf65	intron	ATM:ENST00000675843.1:intron_variant:MODIFIER:intron40/62:c.6006+191_6006+192del::,ATM:ENST00000452508.6:intron_variant:MODIFIER:intron41/63:c.6006+191_6006+192del::,C11orf65:ENST00000525729.5:intron_variant:MODIFIER:intron6/6:c.641-3617_641-3616del::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1253719 [benign DISEASE=not provided];		MIRb (SINE/MIR)	rs10588462	0.52306	0.36865,0.61642,0.43435,0.56784,0.64851	21620,	36105	72349	0.0960			1.39				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=AR+AD oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108325250	108325250	T	-	het	off-target;low_conf_region	QUAL=108;DP=8;QD=13.50;AF=0.75;MQM=60;SAP=4;ABP=7;SAR=2;SAF=4	ATM,C11orf65	intron	ATM:ENST00000675843.1:intron_variant:MODIFIER:intron45/62:c.6573-42del::,ATM:ENST00000452508.6:intron_variant:MODIFIER:intron46/63:c.6573-42del::,C11orf65:ENST00000525729.5:intron_variant:MODIFIER:intron6/6:c.641-16179del::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1252304 [benign DISEASE=not specified,not provided];		(T)n (Simple_repeat)	rs11366542	0.64918	0.46557,0.76861,0.78674,0.69710,0.81058	20268,	30666	38478	1.3490			2.34				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=AR+AD oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108325986	108325988	ATT	-	het	off-target;low_conf_region	QUAL=203;DP=21;QD=9.67;AF=0.48;MQM=60;SAP=11;ABP=3;SAR=2;SAF=8	ATM,C11orf65	intron	ATM:ENST00000675843.1:intron_variant:MODIFIER:intron46/62:c.6808-60_6808-58del::,ATM:ENST00000452508.6:intron_variant:MODIFIER:intron47/63:c.6808-60_6808-58del::,C11orf65:ENST00000525729.5:intron_variant:MODIFIER:intron6/6:c.641-16917_641-16915del::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	633055 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Ataxia-telangiectasia syndrome,not specified,not provided];			rs3212322	0.50092	0.30037,0.60848,0.41373,0.56713,0.60162	20272,	35339	75603	3.0460			6.09				0	18433505	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2022-06-22 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2021-03-02 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2021-03-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=AR+AD oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108347469	108347469	T	C	het	off-target	QUAL=103;DP=8;QD=12.88;AF=0.75;MQM=60;SAP=16;ABP=7;SAR=6;SAF=0	ATM,C11orf65	intron	ATM:ENST00000675843.1:intron_variant:MODIFIER:intron59/62:c.8671+104T>C::,ATM:ENST00000452508.6:intron_variant:MODIFIER:intron60/63:c.8671+104T>C::,C11orf65:ENST00000525729.5:intron_variant:MODIFIER:intron6/6:c.641-38398A>G::,C11orf65:ENST00000615746.4:intron_variant:MODIFIER:intron11/12:c.*1196+7446A>G::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1177615 [benign DISEASE=Ataxia-telangiectasia syndrome,not provided];			rs227075	0.62071	0.68523,0.66208,0.44757,0.57754,0.65211	29548,	35157	57593	0.0580			3.45				0	32408300	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=AR+AD oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108353970	108353970	G	A	hom	off-target	QUAL=82;DP=3;QD=27.33;AF=1.00;MQM=60;SAP=10;ABP=0;SAR=3;SAF=0	ATM,C11orf65	intron	ATM:ENST00000675843.1:intron_variant:MODIFIER:intron60/62:c.8786+90G>A::,ATM:ENST00000452508.6:intron_variant:MODIFIER:intron61/63:c.8786+90G>A::,C11orf65:ENST00000525729.5:intron_variant:MODIFIER:intron6/6:c.640+31950C>T::,C11orf65:ENST00000615746.4:intron_variant:MODIFIER:intron11/12:c.*1196+945C>T::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1192463 [benign DISEASE=Ataxia-telangiectasia syndrome,not provided];		FLAM_A (SINE/Alu)	rs179108	0.99978	0.99959,0.99993,1.00000,1.00000,1.00000	75890,	33	33	-0.4880			1.02				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=AR+AD oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108354070	108354070	A	C	het	off-target	QUAL=35;DP=6;QD=5.83;AF=0.50;MQM=60;SAP=10;ABP=3;SAR=3;SAF=0	ATM,C11orf65	intron	ATM:ENST00000675843.1:intron_variant:MODIFIER:intron60/62:c.8786+190A>C::,ATM:ENST00000452508.6:intron_variant:MODIFIER:intron61/63:c.8786+190A>C::,C11orf65:ENST00000525729.5:intron_variant:MODIFIER:intron6/6:c.640+31850T>G::,C11orf65:ENST00000615746.4:intron_variant:MODIFIER:intron11/12:c.*1196+845T>G::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]			(AC)n (Simple_repeat)	rs678526	0.11220	0.06049,0.13931,0.07918,0.13644,0.16818	840,	11257	102365	-2.4860			1.07			COSV53731754	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=AR+AD oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108354756	108354756	C	T	het	off-target	QUAL=1979;DP=158;QD=12.53;AF=0.47;MQM=60;SAP=5;ABP=4;SAR=42;SAF=33	ATM,C11orf65	intron	ATM:ENST00000675843.1:intron_variant:MODIFIER:intron60/62:c.8787-55C>T::,ATM:ENST00000452508.6:intron_variant:MODIFIER:intron61/63:c.8787-55C>T::,C11orf65:ENST00000525729.5:intron_variant:MODIFIER:intron6/6:c.640+31164G>A::,C11orf65:ENST00000615746.4:intron_variant:MODIFIER:intron11/12:c.*1196+159G>A::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1177616 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Ataxia-telangiectasia syndrome,not specified,not provided];			rs664982	0.53748	0.41607,0.62381,0.43548,0.56867,0.64868	22528,	36600	70268	-1.7010			0.07			COSV53733871	0	31548641,12466288,19193393,25010664,19584272,20004998,16622469,28756982,28825373,34522244,21058196	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=AR+AD oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108354934	108354934	A	G	het	off-target	QUAL=4407;DP=272;QD=16.20;AF=0.58;MQM=60;SAP=3;ABP=20;SAR=80;SAF=79	ATM,C11orf65	intron,3'UTR	ATM:ENST00000675843.1:intron_variant:MODIFIER:intron61/62:c.8850+60A>G::,ATM:ENST00000452508.6:intron_variant:MODIFIER:intron62/63:c.8850+60A>G::,C11orf65:ENST00000525729.5:intron_variant:MODIFIER:intron6/6:c.640+30986T>C::,C11orf65:ENST00000615746.4:3_prime_UTR_variant:MODIFIER:exon11/13:c.*1177T>C::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1169174 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Ataxia-telangiectasia syndrome,not specified,not provided];			rs664143	0.61801	0.67649,0.66166,0.44547,0.57737,0.65160	29289,	35333	58047	-0.6960			0.44			COSV53746535	0.05	22665904,19536092,19115993,24218030,12466288,29879995,23318652,19193393,19584272,17151932,17132159,25196645,29246212,17431766,28756982,22203481,26094126,30514381,22767148,27905519,28642860,24177593,20171797,17222938,32329754,34540891,32408300,33918597,21058196,33507988,34650388	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=AR+AD oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	117226142	117226142	T	-	het	off-target	QUAL=329;DP=49;QD=6.71;AF=0.35;MQM=60;SAP=3;ABP=13;SAR=8;SAF=9	PCSK7	intron	PCSK7:ENST00000320934.8:intron_variant:MODIFIER:intron5/16:c.770-121del::,PCSK7:ENST00000524507.6:intron_variant:MODIFIER:intron5/16:c.770-121del::,PCSK7:ENST00000676339.1:intron_variant:MODIFIER:intron4/15:c.770-121del::					AluSz (SINE/Alu)	rs11419279	0.00439	0.00803,0.00266,0.00122,0.00265,0.00044	2,	620	141586	0.0730			1.16				0.02		1	312	0 / 8					PCSK7 (inh=n/a oe_syn=0.96 oe_mis=0.81 oe_lof=0.31)
chr11	125627571	125627571	G	T	het	off-target;low_conf_region	QUAL=1071;DP=108;QD=9.92;AF=0.49;MQM=60;SAP=118;ABP=3;SAR=0;SAF=53	CHEK1,STT3A	intron,downstream_gene	CHEK1:ENST00000438015.7:intron_variant:MODIFIER:intron2/12:c.66-36G>T::,CHEK1:ENST00000427383.6:intron_variant:MODIFIER:intron2/11:c.337+738G>T::,CHEK1:ENST00000428830.6:intron_variant:MODIFIER:intron2/13:c.66-36G>T::,CHEK1:ENST00000278916.8:intron_variant:MODIFIER:intron2/11:c.66-36G>T::,CHEK1:ENST00000544373.5:intron_variant:MODIFIER:intron2/11:c.7+738G>T::,CHEK1:ENST00000532449.6:intron_variant:MODIFIER:intron2/12:c.66-36G>T::,CHEK1:ENST00000534070.5:intron_variant:MODIFIER:intron2/12:c.66-36G>T::,STT3A:ENST00000392708.9:downstream_gene_variant:MODIFIER::::,STT3A:ENST00000649491.1:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	601134_[GENE=STT3A_PHENOS=Congenital disorder of glycosylation, type Iw, autosomal dominant, 619714 (3), Autosomal dominant; Congenital disorder of glycosylation, type Iw, autosomal recessive, 615596 (3), Autosomal recessive]				rs491528	0.31509	0.37160,0.24174,0.42194,0.29450,0.34907	7802,	32258	104040	-0.6450			2.27			COSV54022242	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STT3A (inh=AR oe_syn=0.85 oe_mis=0.50 oe_lof=0.31), CHEK1 (inh=n/a oe_syn=1.07 oe_mis=0.68 oe_lof=0.61)
chr11	125644678	125644678	G	A	het	off-target	QUAL=839;DP=103;QD=8.15;AF=0.42;MQM=60;SAP=52;ABP=9;SAR=37;SAF=6	CHEK1	intron	CHEK1:ENST00000438015.7:intron_variant:MODIFIER:intron11/12:c.1233+35G>A::,CHEK1:ENST00000427383.6:intron_variant:MODIFIER:intron10/11:c.1281+35G>A::,CHEK1:ENST00000428830.6:intron_variant:MODIFIER:intron11/13:c.1233+35G>A::,CHEK1:ENST00000278916.8:intron_variant:MODIFIER:intron11/11:c.1233+35G>A::,CHEK1:ENST00000544373.5:intron_variant:MODIFIER:intron10/11:c.951+35G>A::,CHEK1:ENST00000532449.6:intron_variant:MODIFIER:intron11/12:c.1233+35G>A::,CHEK1:ENST00000534070.5:intron_variant:MODIFIER:intron11/12:c.1233+35G>A::						rs521102	0.45440	0.28235,0.56695,0.40108,0.52216,0.54762	16574,	35842	82838	0.6180			8.77				0	22665904,29928473,27905519	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHEK1 (inh=n/a oe_syn=1.07 oe_mis=0.68 oe_lof=0.61)
chr11	125655300	125655300	A	G	hom		QUAL=1971;DP=59;QD=33.41;AF=1.00;MQM=60;SAP=11;ABP=0;SAR=22;SAF=37	CHEK1	missense	CHEK1:ENST00000438015.7:missense_variant:MODERATE:exon13/13:c.1411A>G:p.Ile471Val:,CHEK1:ENST00000427383.6:missense_variant:MODERATE:exon12/12:c.1459A>G:p.Ile487Val:,CHEK1:ENST00000428830.6:missense_variant:MODERATE:exon13/14:c.1411A>G:p.Ile471Val:,CHEK1:ENST00000278916.8:missense_variant:MODERATE:exon12/12:c.1309A>G:p.Ile437Val:,CHEK1:ENST00000544373.5:missense_variant:MODERATE:exon12/12:c.1129A>G:p.Ile377Val:,CHEK1:ENST00000532449.6:missense_variant:MODERATE:exon13/13:c.1411A>G:p.Ile471Val:,CHEK1:ENST00000534070.5:missense_variant:MODERATE:exon13/13:c.1411A>G:p.Ile471Val:			496139 [benign DISEASE=not provided];			rs506504	0.97470	0.99308,0.97395,0.99981,0.96404,0.97786	72309,	3726	3850	1.2110	T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	14.31	0.05			0	18805967,29458332	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHEK1 (inh=n/a oe_syn=1.07 oe_mis=0.68 oe_lof=0.61)
chr12	57748709	57748709	T	-	het	off-target;low_conf_region	QUAL=43;DP=79;QD=0.54;AF=0.15;MQM=60;SAP=6;ABP=86;SAR=8;SAF=4	TSPAN31,CDK4,MIR6759	3'UTR,intron,downstream_gene,upstream_gene	TSPAN31:ENST00000547992.5:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1433del::,TSPAN31:ENST00000257910.8:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1433del::,CDK4:ENST00000257904.11:intron_variant:MODIFIER:intron7/7:c.820-92del::,CDK4:ENST00000312990.10:intron_variant:MODIFIER:intron6/6:c.*132-92del::,CDK4:ENST00000549606.5:intron_variant:MODIFIER:intron3/3:c.31-92del::,TSPAN31:ENST00000547472.5:downstream_gene_variant:MODIFIER::::,MIR6759:ENST00000638110.1:upstream_gene_variant:MODIFIER::::		123829_[GENE=CDK4_PHENOS={Melanoma, cutaneous malignant, 3}, 609048 (3), Autosomal dominant]			AluSx (SINE/Alu)	rs545773931	0.00228	0.00215,0.00268,0.00020,0.00174,0.00110	0,	323	141203	-2.6220			0.13				0		0	465	0 / 16					TSPAN31 (inh=AR oe_syn=0.93 oe_mis=0.85 oe_lof=0.26), CDK4 (inh=AD oe_syn=1.26 oe_mis=0.68 oe_lof=0.31), MIR6759 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr12	57749071	57749071	C	A	het	off-target	QUAL=1468;DP=105;QD=13.98;AF=0.52;MQM=60;SAP=3;ABP=4;SAR=26;SAF=29	TSPAN31,CDK4,MIR6759	3'UTR,intron,downstream_gene,upstream_gene	TSPAN31:ENST00000547992.5:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1781C>A::,TSPAN31:ENST00000257910.8:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1781C>A::,CDK4:ENST00000257904.11:intron_variant:MODIFIER:intron7/7:c.819+111G>T::,CDK4:ENST00000312990.10:intron_variant:MODIFIER:intron6/6:c.*131+111G>T::,CDK4:ENST00000549606.5:intron_variant:MODIFIER:intron3/3:c.30+111G>T::,TSPAN31:ENST00000547472.5:downstream_gene_variant:MODIFIER::::,MIR6759:ENST00000638110.1:upstream_gene_variant:MODIFIER::::		123829_[GENE=CDK4_PHENOS={Melanoma, cutaneous malignant, 3}, 609048 (3), Autosomal dominant]	1182049 [benign DISEASE=not provided];			rs2069506	0.26496	0.08201,0.25589,0.65551,0.31445,0.49067	6734,	26823	111775	0.2050			5.63				0	18174243,19258477,18281541	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSPAN31 (inh=AR oe_syn=0.93 oe_mis=0.85 oe_lof=0.26), CDK4 (inh=AD oe_syn=1.26 oe_mis=0.68 oe_lof=0.31), MIR6759 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr12	57750882	57750882	C	T	het	off-target	QUAL=1932;DP=159;QD=12.15;AF=0.48;MQM=60;SAP=12;ABP=4;SAR=29;SAF=47	CDK4,TSPAN31,MIR6759,MARCHF9	intron,downstream_gene,upstream_gene	CDK4:ENST00000257904.11:intron_variant:MODIFIER:intron4/7:c.522+41G>A::,CDK4:ENST00000312990.10:intron_variant:MODIFIER:intron3/6:c.265-211G>A::,CDK4:ENST00000549606.5:intron_variant:MODIFIER:intron1/3:c.-158+1293G>A::,TSPAN31:ENST00000547992.5:downstream_gene_variant:MODIFIER::::,TSPAN31:ENST00000257910.8:downstream_gene_variant:MODIFIER::::,TSPAN31:ENST00000547472.5:downstream_gene_variant:MODIFIER::::,MIR6759:ENST00000638110.1:upstream_gene_variant:MODIFIER::::,MARCHF9:ENST00000266643.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	123829_[GENE=CDK4_PHENOS={Melanoma, cutaneous malignant, 3}, 609048 (3), Autosomal dominant]	1292556 [benign DISEASE=not provided];			rs2069502	0.26586	0.08229,0.25543,0.65201,0.31570,0.49357	6780,	26863	111621	0.5710			9.49			COSV56983640	0	19258477,23761422,24743186,28806841,23160276,23406874,23150009,23567489,34641739	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSPAN31 (inh=AR oe_syn=0.93 oe_mis=0.85 oe_lof=0.26), CDK4 (inh=AD oe_syn=1.26 oe_mis=0.68 oe_lof=0.31), MIR6759 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MARCHF9 (inh=n/a oe_syn=0.68 oe_mis=0.69 oe_lof=0.15)
chr12	57751373	57751373	C	T	het	off-target	QUAL=5444;DP=399;QD=13.64;AF=0.57;MQM=60;SAP=199;ABP=19;SAR=185;SAF=42	CDK4,TSPAN31,MIR6759,MARCHF9	intron,downstream_gene,upstream_gene	CDK4:ENST00000257904.11:intron_variant:MODIFIER:intron2/7:c.219-31G>A::,CDK4:ENST00000312990.10:intron_variant:MODIFIER:intron2/6:c.219-31G>A::,CDK4:ENST00000549606.5:intron_variant:MODIFIER:intron1/3:c.-158+802G>A::,TSPAN31:ENST00000547992.5:downstream_gene_variant:MODIFIER::::,TSPAN31:ENST00000257910.8:downstream_gene_variant:MODIFIER::::,TSPAN31:ENST00000547472.5:downstream_gene_variant:MODIFIER::::,MIR6759:ENST00000638110.1:upstream_gene_variant:MODIFIER::::,MARCHF9:ENST00000266643.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	123829_[GENE=CDK4_PHENOS={Melanoma, cutaneous malignant, 3}, 609048 (3), Autosomal dominant]	1249096 [benign DISEASE=not provided];			rs2270777	0.33339	0.16834,0.33440,0.15691,0.43879,0.23818	9617,	31408	101260	-1.0380			6.46			COSV56985436	0.07	18174243,19258477,18507837,23567489,35835914	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSPAN31 (inh=AR oe_syn=0.93 oe_mis=0.85 oe_lof=0.26), CDK4 (inh=AD oe_syn=1.26 oe_mis=0.68 oe_lof=0.31), MIR6759 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MARCHF9 (inh=n/a oe_syn=0.68 oe_mis=0.69 oe_lof=0.15)
chr13	32316435	32316435	G	A	het	off-target	QUAL=1359;DP=118;QD=11.52;AF=0.45;MQM=60;SAP=6;ABP=6;SAR=22;SAF=31	BRCA2,ZAR1L	5'UTR,upstream_gene	BRCA2:ENST00000544455.6:5_prime_UTR_variant:MODIFIER:exon2/27:c.-26G>A::,BRCA2:ENST00000380152.8:5_prime_UTR_variant:MODIFIER:exon2/27:c.-26G>A::,ZAR1L:ENST00000533490.7:upstream_gene_variant:MODIFIER::::,ZAR1L:ENST00000345108.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant]	125965 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D1,Breast-ovarian cancer, familial, susceptibility to, 2,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];	CR068211 [CLASS=DFP MUT=ALT PHEN="Breast cancer sporadic protection against" GENE=BRCA2];		rs1799943	0.21352	0.10580,0.18953,0.38741,0.26629,0.28139	3894,	24674	119570	0.5460			9.46			COSV61525225	0.04	25741868,19276285,21161372,23663450,12466288,19644020,22513257,26979245,16760289,24337145,21702907,21356067,18724707,21939546,23767878,18694767,28944232,17945002,19012493,23755158,29460995,32284662,28076423,33643918,34287479,22809218,33499154,34295994,24938600	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZAR1L (inh=AD oe_syn=0.79 oe_mis=0.65 oe_lof=0.30), BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32326796	32326796	T	A	het	off-target	QUAL=52;DP=4;QD=13.00;AF=0.75;MQM=60;SAP=10;ABP=5;SAR=3;SAF=0	BRCA2	intron	BRCA2:ENST00000544455.6:intron_variant:MODIFIER:intron7/26:c.631+183T>A::,BRCA2:ENST00000380152.8:intron_variant:MODIFIER:intron7/26:c.631+183T>A::		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant]	209652 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 2,not specified,not provided];			rs3752451	0.33401	0.28402,0.32489,0.49981,0.34956,0.41072	8620,	33398	100968	0.0330			2.64				0	25741868,19276285	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32329548	32329548	C	T	het	off-target	QUAL=608;DP=43;QD=14.14;AF=0.56;MQM=60;SAP=6;ABP=4;SAR=15;SAF=9	BRCA2	intron	BRCA2:ENST00000544455.6:intron_variant:MODIFIER:intron8/26:c.681+56C>T::,BRCA2:ENST00000380152.8:intron_variant:MODIFIER:intron8/26:c.681+56C>T::		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant]	126192 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Breast-ovarian cancer, familial, susceptibility to, 2,Hereditary cancer-predisposing syndrome,not specified];			rs2126042	0.20508	0.24931,0.20419,0.08243,0.18836,0.12619	3378,	24367	120637	-0.2650			7.64			COSV66457755	0	25741868,19276285,21161372,17428325,19644020,10923033,21356067,18694767,28944232,30323354,28076423,33643918	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32331082	32331082	-	T	het	off-target	QUAL=107;DP=102;QD=1.05;AF=0.17;MQM=60;SAP=3;ABP=101;SAR=9;SAF=8	BRCA2	intron	BRCA2:ENST00000544455.6:intron_variant:MODIFIER:intron9/26:c.793+64dup::,BRCA2:ENST00000380152.8:intron_variant:MODIFIER:intron9/26:c.793+64dup::		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant]			AluSx (SINE/Alu)	rs751977993	0.00350	0.01023,0.00110,0.00040,0.00094,0.00108	3,	504	145386				0.19				0		0	26	0 / 1					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32331128	32331128	G	A	hom	off-target	QUAL=4125;DP=125;QD=33.00;AF=1.00;MQM=60;SAP=18;ABP=0;SAR=77;SAF=48	BRCA2	intron	BRCA2:ENST00000544455.6:intron_variant:MODIFIER:intron9/26:c.793+98G>A::,BRCA2:ENST00000380152.8:intron_variant:MODIFIER:intron9/26:c.793+98G>A::		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant]	209936 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 2,not provided];		AluSx (SINE/Alu)	rs206073	0.97869	0.92595,0.99245,0.99981,0.99969,0.99958	72563,	2993	3225	-0.1220			0.34				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32336191	32336191	T	C	het	off-target	QUAL=804;DP=79;QD=10.18;AF=0.44;MQM=60;SAP=13;ABP=5;SAR=11;SAF=24	BRCA2	intron	BRCA2:ENST00000544455.6:intron_variant:MODIFIER:intron10/26:c.1910-74T>C::,BRCA2:ENST00000380152.8:intron_variant:MODIFIER:intron10/26:c.1910-74T>C::		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant]	209687 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 2,Hereditary cancer-predisposing syndrome,not specified,not provided];			rs2320236	0.19429	0.21269,0.19849,0.08253,0.18827,0.12547	3023,	23498	122514	1.7040			14.19				0	21161372	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32337751	32337751	A	G	het		QUAL=823;DP=72;QD=11.43;AF=0.49;MQM=60;SAP=6;ABP=3;SAR=21;SAF=14	BRCA2	synonymous	BRCA2:ENST00000544455.6:synonymous_variant:LOW:exon11/27:c.3396A>G:p.Lys1132=:,BRCA2:ENST00000380152.8:synonymous_variant:LOW:exon11/27:c.3396A>G:p.Lys1132=:		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant]	126010 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D1,Breast-ovarian cancer, familial, susceptibility to, 2,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];	CM2110542 [CLASS=DM? MUT=ALT PHEN="Breast cancer" GENE=BRCA2];		rs1801406	0.28441	0.23048,0.22425,0.39872,0.31646,0.29536	6331,	30542	108704	0.2330			6.39			COSV66448451	0	25741868,16857995,18830263,19692168,19902366,28415781,19276285,21161372,19644020,27478808,20807450,12474142,18431501,21346221,21987080,23767878,28944232,26840129,29884136,27273131,25304112,32284662,28076423,33643918,33814932,34295994,33462484,35686104	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32338918	32338918	A	G	hom		QUAL=31793;DP=975;QD=32.61;AF=1.00;MQM=60;SAP=9;ABP=0;SAR=512;SAF=462	BRCA2	synonymous	BRCA2:ENST00000544455.6:synonymous_variant:LOW:exon11/27:c.4563A>G:p.Leu1521=:,BRCA2:ENST00000380152.8:synonymous_variant:LOW:exon11/27:c.4563A>G:p.Leu1521=:		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant]	132779 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Malignant tumor of breast,Fanconi anemia complementation group D1,Breast-ovarian cancer, familial, susceptibility to, 2,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];			rs206075	0.97868	0.92597,0.99247,0.99981,0.99969,0.99959	72964,	3007	3245	0.0760			4.48			COSV101203861	0	25741868,24033266,18414213,27478808,1517275,1684755,9971877,12552570,15744044,16847550,19941162,20104584,22034289,28944232,29997359,28076423,33643918,32327675,32708070,31962039,35300046,35686104	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32340868	32340868	G	C	hom		QUAL=857;DP=26;QD=32.96;AF=1.00;MQM=60;SAP=15;ABP=0;SAR=7;SAF=19	BRCA2	synonymous	BRCA2:ENST00000544455.6:synonymous_variant:LOW:exon11/27:c.6513G>C:p.Val2171=:,BRCA2:ENST00000380152.8:synonymous_variant:LOW:exon11/27:c.6513G>C:p.Val2171=:		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant]	132780 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Malignant tumor of breast,Fanconi anemia complementation group D1,Breast-ovarian cancer, familial, susceptibility to, 2,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];			rs206076	0.97855	0.92552,0.99248,0.99981,0.99969,0.99959	72963,	3025	3265	-0.8640			0.07			COSV66458663	0	25741868,18414213,27478808,9971877,15744044,16847550,20127978,21156238,28439188,29997359,32284662,30254663,28076423,33643918,32327675,31962039,35300046,35686104	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32346707	32346707	T	C	hom	off-target	QUAL=122;DP=4;QD=30.50;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=2;SAF=2	BRCA2	intron	BRCA2:ENST00000544455.6:intron_variant:MODIFIER:intron12/26:c.6938-120T>C::,BRCA2:ENST00000380152.8:intron_variant:MODIFIER:intron12/26:c.6938-120T>C::		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant]	209939 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 2,not specified,not provided];			rs206080	0.97858	0.92579,0.99241,0.99981,0.99969,0.99834	72868,	3016	3256	-2.1790			0.12				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32355095	32355095	A	G	het		QUAL=445;DP=35;QD=12.71;AF=0.54;MQM=60;SAP=4;ABP=4;SAR=8;SAF=11	BRCA2	synonymous	BRCA2:ENST00000544455.6:synonymous_variant:LOW:exon14/27:c.7242A>G:p.Ser2414=:,BRCA2:ENST00000380152.8:synonymous_variant:LOW:exon14/27:c.7242A>G:p.Ser2414=:		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant]	126133 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D1,Breast-ovarian cancer, familial, susceptibility to, 2,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];			rs1799955	0.22148	0.21599,0.18283,0.39629,0.21910,0.22098	3840,	25989	118353	0.0960			6.91			COSV66447569	0	25741868,16857995,18830263,21161372,17428325,19644020,22430443,27478808,22034289,20807450,18431501,19471317,12955716,17018160,17686308,21042765,22713736,21356067,21987080,23767878,28944232,29884136,28334899,25304112,28076423,33643918,33004033,34295994	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32355250	32355250	T	C	hom		QUAL=19223;DP=585;QD=32.86;AF=1.00;MQM=60;SAP=4;ABP=0;SAR=300;SAF=285	BRCA2	missense	BRCA2:ENST00000544455.6:missense_variant:MODERATE:exon14/27:c.7397T>C:p.Val2466Ala:,BRCA2:ENST00000380152.8:missense_variant:MODERATE:exon14/27:c.7397T>C:p.Val2466Ala:		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant]	133738 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Breast-ovarian cancer, familial, susceptibility to, 2,Ductal breast carcinoma,not specified,not provided];			rs169547	0.98061	0.93275,0.99300,0.99981,0.99975,0.99959	73240,	2761	2951	2.4910	T(1.00),T(1.00)	B(0.00),B(0.00)	8.75	0.09		COSV66451785	0	25741868,24033266,24728327,29458332,23961350,27478808,8665505,27698805,27900359,31203256,25802882,26092435,28944232,26358132,29997359,25923920,28076423,33643918,34203389,33240400,32327675,32708070,31962039,35300046,35686104	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32362509	32362509	T	C	hom	off-target	QUAL=2086;DP=62;QD=33.65;AF=1.00;MQM=60;SAP=8;ABP=0;SAR=37;SAF=25	BRCA2	splice_region&intron	BRCA2:ENST00000544455.6:splice_region_variant&intron_variant:LOW:intron16/26:c.7806-14T>C::,BRCA2:ENST00000380152.8:splice_region_variant&intron_variant:LOW:intron16/26:c.7806-14T>C::	regulatory_region_variant:enhancer	600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant]	126158 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D1,Breast-ovarian cancer, familial, susceptibility to, 2,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,Breast and/or ovarian cancer,not provided];	CS147979 [CLASS=FP MUT=ALT PHEN="Alternative splicing" GENE=BRCA2];		rs9534262	0.53702	0.56668,0.53573,0.57181,0.52104,0.48052	22016,	37515	70303	-1.4060			6.79		8.33>7.94	COSV66447577	0.02	25741868,24033266,21161372,19644020,22382497,21702907,24123850,18694767,29884136,26852130,28076423,33643918,35300046,35686104	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32376521	32376521	-	A	het	off-target	QUAL=139;DP=32;QD=4.34;AF=0.28;MQM=60;SAP=23;ABP=16;SAR=0;SAF=9	BRCA2	intron	BRCA2:ENST00000544455.6:intron_variant:MODIFIER:intron20/26:c.8633-135dup::,BRCA2:ENST00000380152.8:intron_variant:MODIFIER:intron20/26:c.8633-135dup::	regulatory_region_variant:enhancer	600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant]	1273323 [benign DISEASE=not provided];		AluSz (SINE/Alu)	rs200156944	0.25130	0.23589,0.22055,0.42111,0.25112,0.25686	3358,	24329	92495				1.28				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32379251	32379251	T	C	hom	off-target	QUAL=7073;DP=245;QD=28.87;AF=1.00;MQM=60;SAP=306;ABP=0;SAR=30;SAF=215	BRCA2	intron	BRCA2:ENST00000544455.6:intron_variant:MODIFIER:intron21/26:c.8755-66T>C::,BRCA2:ENST00000380152.8:intron_variant:MODIFIER:intron21/26:c.8755-66T>C::		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant]	126190 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Breast-ovarian cancer, familial, susceptibility to, 2,Hereditary cancer-predisposing syndrome,not specified];			rs4942486	0.51735	0.50034,0.52929,0.57107,0.51951,0.47902	20418,	37752	73316	-1.1820			1.32			COSV66457232	0	25741868,24097068,21161372,22382497,26637267,18694767,28250428,30926973,29507422,28334899,32284662,28076423,33643918,32040442,34290314,33462484	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	79192053	79192053	A	G	het		QUAL=10928;DP=816;QD=13.39;AF=0.52;MQM=60;SAP=4;ABP=5;SAR=206;SAF=216		intergenic	::intergenic_variant:MODIFIER::::						rs2988039	0.40587	0.70015,0.38629,0.67499,0.25263,0.35839	15626,	30380	90218	-0.9400			5.13						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr14	45137184	45137184	A	G	het		QUAL=596;DP=52;QD=11.46;AF=0.48;MQM=60;SAP=5;ABP=3;SAR=15;SAF=10	FANCM,FKBP3	missense,3'UTR,upstream_gene	FANCM:ENST00000267430.10:missense_variant:MODERATE:exon2/23:c.624A>G:p.Ile208Met:PF04851 [Type III restriction enzyme res subunit],FANCM:ENST00000556250.6:missense_variant:MODERATE:exon2/22:c.624A>G:p.Ile208Met:PF04851 [Type III restriction enzyme res subunit],FANCM:ENST00000556036.6:missense_variant:MODERATE:exon2/11:c.624A>G:p.Ile208Met:PF04851 [Type III restriction enzyme res subunit],FANCM:ENST00000542564.6:missense_variant:MODERATE:exon2/22:c.624A>G:p.Ile208Met:PF00270 [DEAD/DEAH box helicase],FANCM:ENST00000696676.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*38A>G::,FANCM:ENST00000554030.2:missense_variant:MODERATE:exon2/2:c.624A>G:p.Ile208Met:PF00270 [DEAD/DEAH box helicase],FANCM:ENST00000696662.1:missense_variant:MODERATE:exon2/10:c.624A>G:p.Ile208Met:PF00270 [DEAD/DEAH box helicase],FANCM:ENST00000696649.1:missense_variant:MODERATE:exon2/22:c.624A>G:p.Ile208Met:PF04851 [Type III restriction enzyme res subunit],FANCM:ENST00000696643.1:missense_variant:MODERATE:exon2/9:c.624A>G:p.Ile208Met:PF04851 [Type III restriction enzyme res subunit],FANCM:ENST00000696682.1:missense_variant:MODERATE:exon2/10:c.624A>G:p.Ile208Met:PF04851 [Type III restriction enzyme res subunit],FKBP3:ENST00000396062.4:upstream_gene_variant:MODIFIER::::,FKBP3:ENST00000216330.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	609644_[GENE=FANCM_PHENOS=?Premature ovarian failure 15, 618096 (3), Autosomal recessive; Spermatogenic failure 28, 618086 (3), Autosomal recessive]	241326 [benign/likely benign DISEASE=Fanconi anemia,not specified,not provided];	CM2212569 [CLASS=DM? MUT=ALT PHEN="Azoospermia non-obstructive" GENE=FANCM];		rs45547534	0.01052	0.00297,0.01341,0.00000,0.01648,0.00848	11,	1579	150581	0.0190	D(0.00),D(0.00),D(0.00),D(0.00), ,D(0.00),D(0.00),D(0.00),D(0.00),D(0.00), , 	D(0.95),B(0.28),P(0.79),D(0.97), ,P(0.61),P(0.85),P(0.85),P(0.71),P(0.79), , 	24.10	0.12		COSV53531926	0.13	29351780	9	717	2 / 111	2	"[2] Ilnaz Sepahi 12-10-2016 batch import"			FKBP3 (inh=n/a oe_syn=1.05 oe_mis=1.00 oe_lof=0.54), FANCM (inh=AR oe_syn=1.00 oe_mis=1.01 oe_lof=0.46)
chr14	67823655	67823655	T	G	het	off-target	QUAL=6787;DP=519;QD=13.08;AF=0.50;MQM=60;SAP=4;ABP=3;SAR=124;SAF=135	RAD51B	intron	RAD51B:ENST00000471583.6:intron_variant:MODIFIER:intron2/10:c.84+28T>G::,RAD51B:ENST00000487861.5:intron_variant:MODIFIER:intron2/10:c.84+28T>G::,RAD51B:ENST00000487270.5:intron_variant:MODIFIER:intron2/10:c.84+28T>G::,RAD51B:ENST00000390683.7:intron_variant:MODIFIER:intron2/6:c.84+28T>G::,RAD51B:ENST00000488612.5:intron_variant:MODIFIER:intron2/11:c.84+28T>G::			1264893 [benign DISEASE=Hereditary breast ovarian cancer syndrome,not provided];			rs17783124	0.32358	0.34293,0.25305,0.07442,0.35398,0.23861	8298,	32572	102782	0.1820			5.16				0.01	29879995,27149063	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	67823709	67823709	T	C	het	off-target	QUAL=126;DP=26;QD=4.85;AF=0.35;MQM=60;SAP=23;ABP=8;SAR=0;SAF=9	RAD51B	intron	RAD51B:ENST00000471583.6:intron_variant:MODIFIER:intron2/10:c.84+82T>C::,RAD51B:ENST00000487861.5:intron_variant:MODIFIER:intron2/10:c.84+82T>C::,RAD51B:ENST00000487270.5:intron_variant:MODIFIER:intron2/10:c.84+82T>C::,RAD51B:ENST00000390683.7:intron_variant:MODIFIER:intron2/6:c.84+82T>C::,RAD51B:ENST00000488612.5:intron_variant:MODIFIER:intron2/11:c.84+82T>C::			1270487 [benign DISEASE=not provided];			rs28604984	0.32368	0.34297,0.25318,0.07437,0.35404,0.23840	8305,	32579	102781	0.2040			3.11				0	29879995,27149063	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	67823747	67823747	G	A	het	off-target	QUAL=216;DP=34;QD=6.35;AF=0.35;MQM=60;SAP=10;ABP=9;SAR=9;SAF=3	RAD51B	intron	RAD51B:ENST00000471583.6:intron_variant:MODIFIER:intron2/10:c.84+120G>A::,RAD51B:ENST00000487861.5:intron_variant:MODIFIER:intron2/10:c.84+120G>A::,RAD51B:ENST00000487270.5:intron_variant:MODIFIER:intron2/10:c.84+120G>A::,RAD51B:ENST00000390683.7:intron_variant:MODIFIER:intron2/6:c.84+120G>A::,RAD51B:ENST00000488612.5:intron_variant:MODIFIER:intron2/11:c.84+120G>A::			1271766 [benign DISEASE=not provided];			rs28623567	0.32394	0.34337,0.25331,0.07501,0.35417,0.23871	8317,	32582	102714	0.9070			16.54				0	29879995,27149063	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	67823803	67823803	T	G	het	off-target	QUAL=146;DP=22;QD=6.64;AF=0.36;MQM=60;SAP=20;ABP=7;SAR=8;SAF=0	RAD51B	intron	RAD51B:ENST00000471583.6:intron_variant:MODIFIER:intron2/10:c.84+176T>G::,RAD51B:ENST00000487861.5:intron_variant:MODIFIER:intron2/10:c.84+176T>G::,RAD51B:ENST00000487270.5:intron_variant:MODIFIER:intron2/10:c.84+176T>G::,RAD51B:ENST00000390683.7:intron_variant:MODIFIER:intron2/6:c.84+176T>G::,RAD51B:ENST00000488612.5:intron_variant:MODIFIER:intron2/11:c.84+176T>G::			1259949 [benign DISEASE=not provided];			rs8006089	0.36330	0.46627,0.27393,0.14825,0.35560,0.24389	10629,	33955	96765	0.0840			7.01				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	67835050	67835050	-	A	het	off-target	QUAL=2981;DP=247;QD=12.07;AF=0.49;MQM=60;SAP=3;ABP=3;SAR=61;SAF=61	RAD51B	intron	RAD51B:ENST00000471583.6:intron_variant:MODIFIER:intron3/10:c.199-22dup::,RAD51B:ENST00000487861.5:intron_variant:MODIFIER:intron3/10:c.199-22dup::,RAD51B:ENST00000487270.5:intron_variant:MODIFIER:intron3/10:c.199-22dup::,RAD51B:ENST00000390683.7:intron_variant:MODIFIER:intron3/6:c.199-22dup::,RAD51B:ENST00000488612.5:intron_variant:MODIFIER:intron3/11:c.199-22dup::			1270868 [benign DISEASE=not provided];			rs34564590	0.37252	0.49614,0.27881,0.14739,0.35642,0.24325	11256,	33961	95123				7.56				0.01	29879995,27149063	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	67864958	67864958	A	T	hom	off-target;low_conf_region	QUAL=13281;DP=494;QD=26.88;AF=0.98;MQM=60;SAP=926;ABP=0;SAR=15;SAF=468	RAD51B	intron	RAD51B:ENST00000471583.6:intron_variant:MODIFIER:intron4/10:c.316-45A>T::,RAD51B:ENST00000487861.5:intron_variant:MODIFIER:intron4/10:c.316-45A>T::,RAD51B:ENST00000487270.5:intron_variant:MODIFIER:intron4/10:c.316-45A>T::,RAD51B:ENST00000390683.7:intron_variant:MODIFIER:intron4/6:c.316-45A>T::,RAD51B:ENST00000488612.5:intron_variant:MODIFIER:intron4/11:c.316-45A>T::			1264510 [benign DISEASE=Hereditary breast ovarian cancer syndrome,not provided];			rs1474939	0.95035	0.93584,0.96368,0.95208,0.95356,0.94700	45517,	5012	5018	-0.7160			0.54				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	67865242	67865242	T	-	het	off-target	QUAL=197;DP=42;QD=4.69;AF=0.29;MQM=60;SAP=4;ABP=20;SAR=5;SAF=7	RAD51B	intron	RAD51B:ENST00000471583.6:intron_variant:MODIFIER:intron5/10:c.452+116del::,RAD51B:ENST00000487861.5:intron_variant:MODIFIER:intron5/10:c.452+116del::,RAD51B:ENST00000487270.5:intron_variant:MODIFIER:intron5/10:c.452+116del::,RAD51B:ENST00000390683.7:intron_variant:MODIFIER:intron5/6:c.452+116del::,RAD51B:ENST00000488612.5:intron_variant:MODIFIER:intron5/11:c.452+116del::					AluSz (SINE/Alu)	rs1269999800	0.00105	0.00131,0.00087,0.00000,0.00068,0.00069	0,	145	138323	0.7530			2.04				0		0	69	0 / 6					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	68477457	68477457	C	T	het	off-target	QUAL=173;DP=19;QD=9.11;AF=0.53;MQM=60;SAP=25;ABP=3;SAR=0;SAF=10	RAD51B	intron	RAD51B:ENST00000471583.6:intron_variant:MODIFIER:intron10/10:c.1037-191C>T::,RAD51B:ENST00000487861.5:intron_variant:MODIFIER:intron10/10:c.1036+9207C>T::,RAD51B:ENST00000487270.5:intron_variant:MODIFIER:intron10/10:c.1036+9207C>T::,RAD51B:ENST00000488612.5:intron_variant:MODIFIER:intron10/11:c.1036+9207C>T::						rs36094690	0.00809	0.00280,0.00609,0.00019,0.01345,0.00664	7,	1216	150876	-0.4100			0.72				0		3	222	0 / 41					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	68477627	68477627	T	-	het	off-target;low_conf_region	QUAL=740;DP=357;QD=2.07;AF=0.18;MQM=60;SAP=106;ABP=311;SAR=5;SAF=61	RAD51B	splice_region&intron,intron	RAD51B:ENST00000471583.6:splice_region_variant&intron_variant:LOW:intron10/10:c.1037-8del::,RAD51B:ENST00000487861.5:intron_variant:MODIFIER:intron10/10:c.1036+9390del::,RAD51B:ENST00000487270.5:intron_variant:MODIFIER:intron10/10:c.1036+9390del::,RAD51B:ENST00000488612.5:intron_variant:MODIFIER:intron10/11:c.1036+9390del::					(T)n (Simple_repeat)	rs528099287	0.01068	0.03162,0.00332,0.00123,0.00221,0.00182	19,	1452	138076	-0.6900			0.04				0.04		1	1095	0 / 89					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	103699416	103699416	G	A	het		QUAL=12771;DP=948;QD=13.47;AF=0.51;MQM=60;SAP=3;ABP=5;SAR=242;SAF=245	KLC1,XRCC3	intron,missense	KLC1:ENST00000348520.10:intron_variant:MODIFIER:intron13/14:c.1651-1239G>A::,KLC1:ENST00000334553.11:intron_variant:MODIFIER:intron15/16:c.1849-1239G>A::,KLC1:ENST00000555836.5:intron_variant:MODIFIER:intron15/16:c.1822-1239G>A::,KLC1:ENST00000557450.5:intron_variant:MODIFIER:intron13/14:c.1624-1239G>A::,KLC1:ENST00000452929.6:intron_variant:MODIFIER:intron14/15:c.1782-1239G>A::,KLC1:ENST00000554280.5:intron_variant:MODIFIER:intron14/15:c.1755-1239G>A::,XRCC3:ENST00000554913.5:missense_variant:MODERATE:exon8/10:c.722C>T:p.Thr241Met:PF08423 [Rad51],XRCC3:ENST00000555055.6:missense_variant:MODERATE:exon8/10:c.722C>T:p.Thr241Met:PF08423 [Rad51],XRCC3:ENST00000352127.11:missense_variant:MODERATE:exon7/9:c.722C>T:p.Thr241Met:PF08423 [Rad51],XRCC3:ENST00000553264.5:missense_variant:MODERATE:exon6/8:c.722C>T:p.Thr241Met:PF08423 [Rad51],XRCC3:ENST00000554974.5:missense_variant:MODERATE:exon2/4:c.107C>T:p.Thr36Met:PF08423 [Rad51]	regulatory_region_variant:enhancer	600675_[GENE=XRCC3_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Melanoma, cutaneous malignant, 6}, 613972 (3)]	8944 [risk factor DISEASE=Melanoma, cutaneous malignant, susceptibility to, 6];	CM003625 [CLASS=DFP MUT=ALT PHEN="Melanoma association with" GENE=XRCC3];		rs861539	0.29780	0.20914,0.25927,0.06526,0.37551,0.23324	7375,	30461	106605	0.7970	 , , , , , ,T(0.26),T(0.26),T(0.26),T(0.26),T(0.28)	 , , , , , ,B(0.19),B(0.19),B(0.19),B(0.19),B(0.19)	7.75	0.03		COSV57974380	0.01	30409984,26451011,21708280,21514219,25928231,28827732,31516756,30781715,29178884,21658613,26029010,18191955,22655231,16465622,16857995,18701435,19109789,19124499,20150366,21700777,23720673,24500421,25231222,27415837,31584889,23565320,26263974,21487324,24701578,18830263,21347786,27608007,31395900,24315498,28717179,20226869,19902366,28415781,29458332,21195504,23443124,26159902,28206966,28324443,23663450,18990748,21561390,26843108,28520216,30588297,18086758,18579371,22430443,25178586,25452763,28342452,23697595,19127255,21974800,18768505,21877955,27258253,31374908,18194558,27053949,29732392,25589620,30235774,24756092,31629678,19815090,21183201,25529925,27460091,27571987,28749454,29035403,29139108,31446980,31914346,30584056,31175773,24325908,19706757,28983784,21047201,24939416,23313170,22525558,27754415,21104022,21647442,21725594,21749698,22272830,22933979,26339569,28965273,30033552,30712190,31905201,20004634,19367277,30022792,31186630,22868256,28453695,21332318,26627042,28356832,18708406,17557904,21617942,1841058	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KLC1 (inh=n/a oe_syn=1.01 oe_mis=0.52 oe_lof=0.23), XRCC3 (inh=AD oe_syn=1.06 oe_mis=0.92 oe_lof=1.13)
chr14	104773454	104773454	C	A	het	mosaic	QUAL=0;DP=303;QD=0.00;AF=0.06;MQM=60;SAP=3;ABP=0;SAR=10;SAF=8	AKT1	splice_donor	AKT1:ENST00000554581.5:splice_donor_variant:HIGH:intron8/12:c.828+1G>T:p.?:,AKT1:ENST00000407796.7:splice_donor_variant:HIGH:intron9/13:c.828+1G>T:p.?:,AKT1:ENST00000649815.2:splice_donor_variant:HIGH:intron10/14:c.828+1G>T:p.?:,AKT1:ENST00000349310.7:splice_donor_variant:HIGH:intron10/14:c.828+1G>T:p.?:,AKT1:ENST00000402615.6:splice_donor_variant:HIGH:intron9/13:c.828+1G>T:p.?:,AKT1:ENST00000555528.5:splice_donor_variant:HIGH:intron9/13:c.828+1G>T:p.?:,AKT1:ENST00000683722.1:splice_donor_variant:HIGH:intron9/13:c.828+1G>T:p.?:,AKT1:ENST00000553797.2:splice_donor_variant:HIGH:intron10/14:c.903+1G>T:p.?:,AKT1:ENST00000554848.5:splice_donor_variant:HIGH:intron9/13:c.828+1G>T:p.?:	regulatory_region_variant:CTCF_binding_site	164730_[GENE=AKT1_PHENOS=Breast cancer, somatic, 114480 (3); Cowden syndrome 6, 615109 (3); Colorectal cancer, somatic, 114500 (3); Proteus syndrome, somatic, 176920 (3); Ovarian cancer, somatic, 167000 (3)]										5.7320			34.00		9.05>0.54		0.99		0	1	0 / 1					AKT1 (inh=AD oe_syn=1.05 oe_mis=0.46 oe_lof=0.14)
chr14	104776629	104776629	T	C	het	off-target	QUAL=1969;DP=129;QD=15.26;AF=0.61;MQM=60;SAP=13;ABP=17;SAR=49;SAF=30	AKT1	intron	AKT1:ENST00000554581.5:intron_variant:MODIFIER:intron3/12:c.287+30A>G::,AKT1:ENST00000407796.7:intron_variant:MODIFIER:intron4/13:c.287+30A>G::,AKT1:ENST00000649815.2:intron_variant:MODIFIER:intron5/14:c.287+30A>G::,AKT1:ENST00000349310.7:intron_variant:MODIFIER:intron5/14:c.287+30A>G::,AKT1:ENST00000402615.6:intron_variant:MODIFIER:intron4/13:c.287+30A>G::,AKT1:ENST00000555528.5:intron_variant:MODIFIER:intron4/13:c.287+30A>G::,AKT1:ENST00000683722.1:intron_variant:MODIFIER:intron4/13:c.287+30A>G::,AKT1:ENST00000553797.2:intron_variant:MODIFIER:intron5/14:c.287+30A>G::,AKT1:ENST00000554848.5:intron_variant:MODIFIER:intron4/13:c.287+30A>G::		164730_[GENE=AKT1_PHENOS=Breast cancer, somatic, 114480 (3); Cowden syndrome 6, 615109 (3); Colorectal cancer, somatic, 114500 (3); Proteus syndrome, somatic, 176920 (3); Ovarian cancer, somatic, 167000 (3)]	1272355 [benign DISEASE=not provided];			rs2494735	0.48857	0.70563,0.51963,0.64682,0.35482,0.57796	20042,	34216	77776	-3.6570			0.14			COSV62573175	0	28050343,28822116,19461960	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AKT1 (inh=AD oe_syn=1.05 oe_mis=0.46 oe_lof=0.14)
chr14	104792555	104792555	C	T	hom	off-target	QUAL=3623;DP=110;QD=32.94;AF=1.00;MQM=60;SAP=14;ABP=0;SAR=67;SAF=43	AKT1	intron	AKT1:ENST00000554581.5:intron_variant:MODIFIER:intron1/12:c.46+43G>A::,AKT1:ENST00000407796.7:intron_variant:MODIFIER:intron2/13:c.46+43G>A::,AKT1:ENST00000649815.2:intron_variant:MODIFIER:intron3/14:c.46+43G>A::,AKT1:ENST00000349310.7:intron_variant:MODIFIER:intron3/14:c.46+43G>A::,AKT1:ENST00000402615.6:intron_variant:MODIFIER:intron2/13:c.46+43G>A::,AKT1:ENST00000555528.5:intron_variant:MODIFIER:intron2/13:c.46+43G>A::,AKT1:ENST00000683722.1:intron_variant:MODIFIER:intron2/13:c.46+43G>A::,AKT1:ENST00000553797.2:intron_variant:MODIFIER:intron3/14:c.46+43G>A::,AKT1:ENST00000554848.5:intron_variant:MODIFIER:intron2/13:c.46+43G>A::	regulatory_region_variant:promoter	164730_[GENE=AKT1_PHENOS=Breast cancer, somatic, 114480 (3); Cowden syndrome 6, 615109 (3); Colorectal cancer, somatic, 114500 (3); Proteus syndrome, somatic, 176920 (3); Ovarian cancer, somatic, 167000 (3)]	1182199 [benign DISEASE=not provided];			rs2494748	0.48171	0.25865,0.50334,0.21183,0.60928,0.39872	19603,	34004	78768	-0.8470			1.14			COSV62573228	0	22929028,30275531,30595370,32203549,32888494,34594039,35213538	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AKT1 (inh=AD oe_syn=1.05 oe_mis=0.46 oe_lof=0.14)
chr14	104792556	104792556	A	G	hom	off-target	QUAL=3623;DP=110;QD=32.94;AF=1.00;MQM=60;SAP=14;ABP=0;SAR=67;SAF=43	AKT1	intron	AKT1:ENST00000554581.5:intron_variant:MODIFIER:intron1/12:c.46+42T>C::,AKT1:ENST00000407796.7:intron_variant:MODIFIER:intron2/13:c.46+42T>C::,AKT1:ENST00000649815.2:intron_variant:MODIFIER:intron3/14:c.46+42T>C::,AKT1:ENST00000349310.7:intron_variant:MODIFIER:intron3/14:c.46+42T>C::,AKT1:ENST00000402615.6:intron_variant:MODIFIER:intron2/13:c.46+42T>C::,AKT1:ENST00000555528.5:intron_variant:MODIFIER:intron2/13:c.46+42T>C::,AKT1:ENST00000683722.1:intron_variant:MODIFIER:intron2/13:c.46+42T>C::,AKT1:ENST00000553797.2:intron_variant:MODIFIER:intron3/14:c.46+42T>C::,AKT1:ENST00000554848.5:intron_variant:MODIFIER:intron2/13:c.46+42T>C::	regulatory_region_variant:promoter	164730_[GENE=AKT1_PHENOS=Breast cancer, somatic, 114480 (3); Cowden syndrome 6, 615109 (3); Colorectal cancer, somatic, 114500 (3); Proteus syndrome, somatic, 176920 (3); Ovarian cancer, somatic, 167000 (3)]	1238585 [benign DISEASE=not provided];			rs2494749	0.87155	0.88837,0.79446,0.34105,0.92408,0.65463	58789,	14884	19522	-1.6150			0.28			COSV62573234	0	29023587	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AKT1 (inh=AD oe_syn=1.05 oe_mis=0.46 oe_lof=0.14)
chr15	40701377	40701377	T	-	het	off-target;low_conf_region	QUAL=55;DP=14;QD=3.93;AF=0.29;MQM=60;SAP=12;ABP=9;SAR=4;SAF=0	RAD51	intron	RAD51:ENST00000423169.6:intron_variant:MODIFIER:intron3/8:c.225+190del::,RAD51:ENST00000557850.5:intron_variant:MODIFIER:intron3/7:c.225+190del::,RAD51:ENST00000382643.7:intron_variant:MODIFIER:intron3/9:c.225+190del::,RAD51:ENST00000267868.8:intron_variant:MODIFIER:intron3/9:c.225+190del::,RAD51:ENST00000645673.2:intron_variant:MODIFIER:intron3/9:c.225+190del::,RAD51:ENST00000532743.6:intron_variant:MODIFIER:intron3/9:c.225+190del::		179617_[GENE=RAD51_PHENOS=Mirror movements 2, 614508 (3), Autosomal dominant; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; Fanconi anemia, complementation group R, 617244 (3), Autosomal dominant]	1227276 [benign DISEASE=not provided];		AluSx (SINE/Alu)	rs57054958	0.50820	0.50118,0.57099,0.74164,0.47252,0.63412	10732,	34124	53794	0.1210			0.17				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51 (inh=AD oe_syn=1.10 oe_mis=0.45 oe_lof=0.33)
chr15	40706144	40706144	T	G	het	off-target	QUAL=1322;DP=99;QD=13.35;AF=0.56;MQM=60;SAP=28;ABP=6;SAR=40;SAF=15	RAD51	intron	RAD51:ENST00000423169.6:intron_variant:MODIFIER:intron3/8:c.226-33T>G::,RAD51:ENST00000557850.5:intron_variant:MODIFIER:intron3/7:c.225+4943T>G::,RAD51:ENST00000382643.7:intron_variant:MODIFIER:intron4/9:c.347-2881T>G::,RAD51:ENST00000267868.8:intron_variant:MODIFIER:intron3/9:c.226-33T>G::,RAD51:ENST00000645673.2:intron_variant:MODIFIER:intron4/9:c.347-2881T>G::,RAD51:ENST00000532743.6:intron_variant:MODIFIER:intron3/9:c.226-33T>G::	regulatory_region_variant:open_chromatin_region	179617_[GENE=RAD51_PHENOS=Mirror movements 2, 614508 (3), Autosomal dominant; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; Fanconi anemia, complementation group R, 617244 (3), Autosomal dominant]	1255257 [benign DISEASE=not provided];			rs45457497	0.22303	0.24118,0.35017,0.67027,0.15489,0.31020	4765,	24377	118125	1.4560			10.92			COSV51111815	0.11	25918678	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51 (inh=AD oe_syn=1.10 oe_mis=0.45 oe_lof=0.33)
chr15	40719057	40719057	-	T	het	off-target	QUAL=31;DP=119;QD=0.26;AF=0.17;MQM=60;SAP=46;ABP=117;SAR=20;SAF=0	RAD51	intron	RAD51:ENST00000423169.6:intron_variant:MODIFIER:intron6/8:c.530+172dup::,RAD51:ENST00000557850.5:intron_variant:MODIFIER:intron4/7:c.239+172dup::,RAD51:ENST00000382643.7:intron_variant:MODIFIER:intron6/9:c.533+172dup::,RAD51:ENST00000267868.8:intron_variant:MODIFIER:intron6/9:c.530+172dup::,RAD51:ENST00000645673.2:intron_variant:MODIFIER:intron6/9:c.533+172dup::,RAD51:ENST00000532743.6:intron_variant:MODIFIER:intron6/9:c.530+172dup::		179617_[GENE=RAD51_PHENOS=Mirror movements 2, 614508 (3), Autosomal dominant; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; Fanconi anemia, complementation group R, 617244 (3), Autosomal dominant]	1202166 [likely benign DISEASE=not provided];		AluSx (SINE/Alu)	rs938761449	0.00229	0.00154,0.00258,0.00139,0.00176,0.00066	0,	332	144340				3.13				0.01		0	74	0 / 1					RAD51 (inh=AD oe_syn=1.10 oe_mis=0.45 oe_lof=0.33)
chr15	40729373	40729373	A	-	het	off-target;low_conf_region	QUAL=378;DP=43;QD=8.79;AF=0.19;MQM=60;SAP=20;ABP=40;SAR=0;SAF=8	RAD51	intron	RAD51:ENST00000423169.6:intron_variant:MODIFIER:intron7/8:c.645-108del::,RAD51:ENST00000557850.5:intron_variant:MODIFIER:intron5/7:c.354-108del::,RAD51:ENST00000382643.7:intron_variant:MODIFIER:intron7/9:c.648-108del::,RAD51:ENST00000267868.8:intron_variant:MODIFIER:intron7/9:c.645-108del::,RAD51:ENST00000645673.2:intron_variant:MODIFIER:intron7/9:c.648-108del::,RAD51:ENST00000532743.6:intron_variant:MODIFIER:intron7/9:c.645-108del::		179617_[GENE=RAD51_PHENOS=Mirror movements 2, 614508 (3), Autosomal dominant; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; Fanconi anemia, complementation group R, 617244 (3), Autosomal dominant]			AluYm1 (SINE/Alu)	rs60375696	0.24753	0.16544,0.22989,0.17464,0.28690,0.32043	460,	15019	48453	0.9390			0.90				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51 (inh=AD oe_syn=1.10 oe_mis=0.45 oe_lof=0.33)
chr15	40729373	40729374	AA	-	het	off-target;low_conf_region	QUAL=378;DP=43;QD=8.79;AF=0.19;MQM=60;SAP=25;ABP=30;SAR=0;SAF=10	RAD51	intron	RAD51:ENST00000423169.6:intron_variant:MODIFIER:intron7/8:c.645-109_645-108del::,RAD51:ENST00000557850.5:intron_variant:MODIFIER:intron5/7:c.354-109_354-108del::,RAD51:ENST00000382643.7:intron_variant:MODIFIER:intron7/9:c.648-109_648-108del::,RAD51:ENST00000267868.8:intron_variant:MODIFIER:intron7/9:c.645-109_645-108del::,RAD51:ENST00000645673.2:intron_variant:MODIFIER:intron7/9:c.648-109_648-108del::,RAD51:ENST00000532743.6:intron_variant:MODIFIER:intron7/9:c.645-109_645-108del::		179617_[GENE=RAD51_PHENOS=Mirror movements 2, 614508 (3), Autosomal dominant; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; Fanconi anemia, complementation group R, 617244 (3), Autosomal dominant]			AluYm1 (SINE/Alu)	rs60375696	0.21275	0.23178,0.30233,0.45848,0.17369,0.25095	513,	12436	49814	0.9390			0.89				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51 (inh=AD oe_syn=1.10 oe_mis=0.45 oe_lof=0.33)
chr15	43408229	43408229	G	A	het	off-target	QUAL=2349;DP=365;QD=6.44;AF=0.48;MQM=60;SAP=383;ABP=4;SAR=175;SAF=0	TUBGCP4,TP53BP1	3'UTR,intron,downstream_gene	TUBGCP4:ENST00000564079.6:3_prime_UTR_variant:MODIFIER:exon18/18:c.*3015G>A::,TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron26/27:c.5601-141C>T::,TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron26/27:c.5586-141C>T::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron25/26:c.5451-141C>T::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron26/27:c.5595-141C>T::,TUBGCP4:ENST00000260383.11:downstream_gene_variant:MODIFIER::::		609610_[GENE=TUBGCP4_PHENOS=Microcephaly and chorioretinopathy, autosomal recessive, 3, 616335 (3), Autosomal recessive]			AluJb (SINE/Alu)	rs45585139	0.17512	0.33366,0.17769,0.27082,0.09338,0.17523	3239,	20151	125433	1.4850			6.09				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TUBGCP4 (inh=AR oe_syn=0.95 oe_mis=0.62 oe_lof=0.50), TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43409749	43409749	A	-	het		QUAL=561;DP=58;QD=9.67;AF=0.43;MQM=60;SAP=5;ABP=5;SAR=15;SAF=10	TUBGCP4,TP53BP1	3'UTR,splice_region&intron,downstream_gene	TUBGCP4:ENST00000564079.6:3_prime_UTR_variant:MODIFIER:exon18/18:c.*4545del::,TP53BP1:ENST00000382044.9:splice_region_variant&intron_variant:LOW:intron24/27:c.5306-8del::,TP53BP1:ENST00000263801.7:splice_region_variant&intron_variant:LOW:intron24/27:c.5291-8del::,TP53BP1:ENST00000382039.7:splice_region_variant&intron_variant:LOW:intron23/26:c.5156-8del::,TP53BP1:ENST00000450115.6:splice_region_variant&intron_variant:LOW:intron24/27:c.5300-8del::,TUBGCP4:ENST00000260383.11:downstream_gene_variant:MODIFIER::::		609610_[GENE=TUBGCP4_PHENOS=Microcephaly and chorioretinopathy, autosomal recessive, 3, 616335 (3), Autosomal recessive]				rs56813954	0.22856	0.11713,0.28474,0.34516,0.26575,0.26469	4177,	25533	114375	0.7380			0.86				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TUBGCP4 (inh=AR oe_syn=0.95 oe_mis=0.62 oe_lof=0.50), TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43413472	43413472	C	T	het	off-target	QUAL=716;DP=63;QD=11.37;AF=0.48;MQM=60;SAP=6;ABP=3;SAR=18;SAF=12	TP53BP1,TUBGCP4	intron,downstream_gene	TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron23/27:c.5090-138G>A::,TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron23/27:c.5075-138G>A::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron22/26:c.4940-138G>A::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron23/27:c.5090-144G>A::,TUBGCP4:ENST00000564079.6:downstream_gene_variant:MODIFIER::::		609610_[GENE=TUBGCP4_PHENOS=Microcephaly and chorioretinopathy, autosomal recessive, 3, 616335 (3), Autosomal recessive]				rs12908460	0.16842	0.17161,0.14373,0.00135,0.18797,0.18931	2340,	20929	126443	0.7620			14.34				0.12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TUBGCP4 (inh=AR oe_syn=0.95 oe_mis=0.62 oe_lof=0.50), TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43415610	43415610	A	T	het		QUAL=1613;DP=130;QD=12.41;AF=0.47;MQM=60;SAP=13;ABP=4;SAR=22;SAF=39	TP53BP1	synonymous	TP53BP1:ENST00000382044.9:synonymous_variant:LOW:exon23/28:c.5073T>A:p.Ser1691=:,TP53BP1:ENST00000263801.7:synonymous_variant:LOW:exon23/28:c.5058T>A:p.Ser1686=:,TP53BP1:ENST00000382039.7:synonymous_variant:LOW:exon22/27:c.4923T>A:p.Ser1641=:,TP53BP1:ENST00000450115.6:synonymous_variant:LOW:exon23/28:c.5073T>A:p.Ser1691=:						rs2230451	0.16844	0.17148,0.14455,0.00134,0.18802,0.18779	2343,	20931	126467	0.1790			9.38			COSV55501344	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43420139	43420139	A	G	het	off-target	QUAL=1750;DP=208;QD=8.41;AF=0.45;MQM=60;SAP=205;ABP=8;SAR=0;SAF=93	TP53BP1	intron	TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron21/27:c.4681+166T>C::,TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron21/27:c.4666+166T>C::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron20/26:c.4531+166T>C::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron21/27:c.4681+166T>C::						rs62021180	0.16871	0.17229,0.14475,0.00135,0.18806,0.18841	2342,	20969	126403	0.2160			6.80				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43427958	43427958	A	-	het	off-target;low_conf_region	QUAL=1013;DP=270;QD=3.75;AF=0.19;MQM=60;SAP=3;ABP=230;SAR=24;SAF=27	TP53BP1	intron	TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron18/27:c.3828+58del::,TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron18/27:c.3813+58del::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron18/26:c.3828+58del::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron18/27:c.3828+58del::					AluJb (SINE/Alu)	rs35437737	0.00343	0.00107,0.00481,0.00118,0.00290,0.00029	0,	354	102964	0.3850			1.04				0		18	10658	1 / 2617					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43427999	43427999	C	T	het	off-target	QUAL=3848;DP=300;QD=12.83;AF=0.52;MQM=60;SAP=58;ABP=4;SAR=110;SAF=47	TP53BP1	splice_region&intron	TP53BP1:ENST00000382044.9:splice_region_variant&intron_variant:LOW:intron18/27:c.3828+17G>A::,TP53BP1:ENST00000263801.7:splice_region_variant&intron_variant:LOW:intron18/27:c.3813+17G>A::,TP53BP1:ENST00000382039.7:splice_region_variant&intron_variant:LOW:intron18/26:c.3828+17G>A::,TP53BP1:ENST00000450115.6:splice_region_variant&intron_variant:LOW:intron18/27:c.3828+17G>A::						rs550239	0.28119	0.64972,0.21565,0.39787,0.10678,0.22898	10161,	22239	108801	0.2330			13.83			COSV55496522	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43428335	43428335	G	C	hom	off-target	QUAL=1552;DP=56;QD=27.71;AF=1.00;MQM=60;SAP=125;ABP=0;SAR=56;SAF=0	TP53BP1	intron	TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron17/27:c.3676-167C>G::,TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron17/27:c.3661-167C>G::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron17/26:c.3676-167C>G::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron17/27:c.3676-167C>G::						rs2249952	0.46025	0.85408,0.36276,0.39868,0.29509,0.43483	20870,	28152	81966	-0.6650			0.93			COSV55506772	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43432448	43432448	T	G	hom		QUAL=19908;DP=625;QD=31.85;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=309;SAF=315	TP53BP1	missense	TP53BP1:ENST00000382044.9:missense_variant:MODERATE:exon17/28:c.3421A>C:p.Lys1141Gln:,TP53BP1:ENST00000263801.7:missense_variant:MODERATE:exon17/28:c.3406A>C:p.Lys1136Gln:,TP53BP1:ENST00000382039.7:missense_variant:MODERATE:exon17/27:c.3421A>C:p.Lys1141Gln:,TP53BP1:ENST00000450115.6:missense_variant:MODERATE:exon17/28:c.3421A>C:p.Lys1141Gln:				CM067476 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=TP53BP1];		rs2602141	0.45961	0.85121,0.36234,0.39900,0.29511,0.44063	20795,	28252	82116	3.6770	T(1.00),T(1.00),T(1.00),T(1.00)		17.49	0.08		COSV55496532	0.06	21807602,20106900,21212151,26130668,16741161,23349013,21303977,15987456,20686496,24603722,28487205,26693075,24761925,24316395	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43438288	43438288	A	G	het	off-target	QUAL=11429;DP=888;QD=12.87;AF=0.49;MQM=60;SAP=4;ABP=3;SAR=213;SAF=225	TP53BP1	intron	TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron16/27:c.3191+36T>C::,TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron16/27:c.3176+36T>C::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron16/26:c.3191+36T>C::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron16/27:c.3191+36T>C::						rs16957730	0.17489	0.19430,0.14619,0.00135,0.18804,0.18750	2510,	21557	125385	1.4740			6.59				0	27462919	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43455721	43455721	A	-	het	off-target	QUAL=164;DP=99;QD=1.66;AF=0.17;MQM=60;SAP=40;ABP=96;SAR=0;SAF=17	TP53BP1	intron	TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron12/27:c.2716+171del::,TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron12/27:c.2701+171del::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron12/26:c.2716+171del::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron12/27:c.2716+171del::					AluSz (SINE/Alu)	rs774205426	0.00209	0.00084,0.00160,0.00112,0.00195,0.00049	0,	267	127449	-0.3170			0.15				0		0	155	0 / 14					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43456106	43456106	A	G	hom		QUAL=30121;DP=950;QD=31.71;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=468;SAF=482	TP53BP1	synonymous	TP53BP1:ENST00000382044.9:synonymous_variant:LOW:exon12/28:c.2502T>C:p.Asp834=:,TP53BP1:ENST00000263801.7:synonymous_variant:LOW:exon12/28:c.2487T>C:p.Asp829=:,TP53BP1:ENST00000382039.7:synonymous_variant:LOW:exon12/27:c.2502T>C:p.Asp834=:,TP53BP1:ENST00000450115.6:synonymous_variant:LOW:exon12/28:c.2502T>C:p.Asp834=:						rs690367	0.46349	0.86651,0.36443,0.39938,0.29511,0.42387	21348,	27781	81581	1.4440			5.25			COSV55496541,COSV55506600	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43469723	43469723	A	C	het	off-target	QUAL=421;DP=32;QD=13.16;AF=0.56;MQM=60;SAP=7;ABP=4;SAR=6;SAF=12	TP53BP1	intron	TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron11/27:c.1389+135T>G::,TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron11/27:c.1374+135T>G::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron11/26:c.1389+135T>G::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron11/27:c.1389+135T>G::					L1MB7 (LINE/L1)	rs7181783	0.17486	0.19417,0.14584,0.00135,0.18836,0.18742	2508,	21588	125538	1.4250			8.66				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43469998	43469998	C	T	het		QUAL=3289;DP=203;QD=16.20;AF=0.59;MQM=60;SAP=7;ABP=16;SAR=67;SAF=52	TP53BP1	missense	TP53BP1:ENST00000382044.9:missense_variant:MODERATE:exon11/28:c.1249G>A:p.Gly417Ser:,TP53BP1:ENST00000263801.7:missense_variant:MODERATE:exon11/28:c.1234G>A:p.Gly412Ser:,TP53BP1:ENST00000382039.7:missense_variant:MODERATE:exon11/27:c.1249G>A:p.Gly417Ser:,TP53BP1:ENST00000450115.6:missense_variant:MODERATE:exon11/28:c.1249G>A:p.Gly417Ser:	regulatory_region_variant:TF_binding_site,TF_binding_site_variant			CM107902 [CLASS=DP MUT=ALT PHEN="Basal cell carcinoma reduced risk association with" GENE=TP53BP1];		rs689647	0.28162	0.64983,0.21497,0.39703,0.10673,0.23590	10211,	22347	109099	1.3850	D(0.04),D(0.04),D(0.04),D(0.04)		10.29	0.07		COSV55496549,COSV55506613	0	21368091,21303977,20805886,15987456,20686496,24603722,24316395	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43475576	43475576	G	C	hom		QUAL=3605;DP=116;QD=31.08;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=58;SAF=58	TP53BP1	missense	TP53BP1:ENST00000382044.9:missense_variant:MODERATE:exon9/28:c.1074C>G:p.Asp358Glu:,TP53BP1:ENST00000263801.7:missense_variant:MODERATE:exon9/28:c.1059C>G:p.Asp353Glu:,TP53BP1:ENST00000382039.7:missense_variant:MODERATE:exon9/27:c.1074C>G:p.Asp358Glu:,TP53BP1:ENST00000450115.6:missense_variant:MODERATE:exon9/28:c.1074C>G:p.Asp358Glu:				CM067475 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=TP53BP1];		rs560191	0.46311	0.86638,0.36429,0.39826,0.29488,0.42434	21315,	27764	81610	0.1670	T(1.00),T(1.00),T(1.00),T(1.00)		10.29	0.24		COSV55496034	0.01	29551738,21807602,20106900,20385987,24820515,21212151,26130668,16741161,23349013,21303977,20805886,15987456,20646866,20686496,25532599,24603722,26693075,25937777,26076430,26823859,24316395,33906323	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43480838	43480838	A	C	het	off-target	QUAL=10477;DP=859;QD=12.20;AF=0.48;MQM=60;SAP=3;ABP=6;SAR=207;SAF=206	TP53BP1	intron	TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron5/27:c.499+57T>G::,TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron5/27:c.484+57T>G::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron5/26:c.499+57T>G::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron5/27:c.499+57T>G::						rs7173383	0.17481	0.19403,0.14572,0.00135,0.18822,0.18716	2501,	21593	125543	-0.0460			1.75				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43491802	43491802	C	T	hom	off-target	QUAL=26548;DP=834;QD=31.83;AF=1.00;MQM=60;SAP=4;ABP=0;SAR=424;SAF=407	TP53BP1	intron	TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron3/27:c.287-49G>A::,TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron3/27:c.272-49G>A::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron3/26:c.287-49G>A::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron3/27:c.287-49G>A::	regulatory_region_variant:promoter					rs555252	0.96492	0.88000,0.99123,0.99942,0.99938,0.96941	71066,	4734	5340	0.0420			6.87				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43492901	43492901	T	C	het	off-target	QUAL=8;DP=8;QD=1.00;AF=0.38;MQM=50;SAP=10;ABP=4;SAR=0;SAF=3	TP53BP1	intron	TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron1/27:c.7+136A>G::,TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron1/27:c.-8-433A>G::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron1/26:c.7+136A>G::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron1/27:c.7+136A>G::	regulatory_region_variant:promoter,TF_binding_site_variant					rs1231205428	0.03326	0.05493,0.03972,0.01558,0.02371,0.02457	0,	1944	56498	1.9050			19.98			COSV55502878	0		0	341	0 / 9					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43492904	43492904	T	C	het	off-target	QUAL=8;DP=8;QD=1.00;AF=0.38;MQM=50;SAP=10;ABP=4;SAR=0;SAF=3	TP53BP1	intron	TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron1/27:c.7+133A>G::,TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron1/27:c.-8-436A>G::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron1/26:c.7+133A>G::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron1/27:c.7+133A>G::	regulatory_region_variant:promoter,TF_binding_site_variant					rs1272262482	0.00203	0.00453,0.00255,0.00092,0.00088,0.00114	0,	192	94600	0.0990			17.12				0		0	51	0 / 4					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	75351274	75351274	-	T	het	off-target;low_conf_region	QUAL=563;DP=91;QD=6.19;AF=0.12;MQM=60;SAP=55;ABP=47;SAR=0;SAF=24	NEIL1,MIR631,MAN2C1	intron,downstream_gene	NEIL1:ENST00000355059.9:intron_variant:MODIFIER:intron2/9:c.435-818dup::,NEIL1:ENST00000564784.5:intron_variant:MODIFIER:intron3/10:c.435-818dup::,NEIL1:ENST00000569035.5:intron_variant:MODIFIER:intron2/9:c.435-818dup::,MIR631:ENST00000384904.1:downstream_gene_variant:MODIFIER::::,MAN2C1:ENST00000569482.5:downstream_gene_variant:MODIFIER::::,MAN2C1:ENST00000565683.5:downstream_gene_variant:MODIFIER::::,MAN2C1:ENST00000563622.5:downstream_gene_variant:MODIFIER::::,MAN2C1:ENST00000267978.10:downstream_gene_variant:MODIFIER::::		154580_[GENE=MAN2C1_PHENOS=Congenital disorder of deglycosylation 2, 619775 (3), Autosomal recessive]				rs11422837	0.39718	0.24113,0.41473,0.49052,0.46842,0.54153	10964,	26158	72984				0.87						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NEIL1 (inh=n/a oe_syn=1.20 oe_mis=1.05 oe_lof=0.64), MIR631 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MAN2C1 (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.85)
chr15	75351275	75351275	T	-	het	off-target;low_conf_region	QUAL=563;DP=91;QD=6.19;AF=0.26;MQM=60;SAP=27;ABP=117;SAR=0;SAF=11	NEIL1,MIR631,MAN2C1	intron,downstream_gene	NEIL1:ENST00000355059.9:intron_variant:MODIFIER:intron2/9:c.435-818del::,NEIL1:ENST00000564784.5:intron_variant:MODIFIER:intron3/10:c.435-818del::,NEIL1:ENST00000569035.5:intron_variant:MODIFIER:intron2/9:c.435-818del::,MIR631:ENST00000384904.1:downstream_gene_variant:MODIFIER::::,MAN2C1:ENST00000569482.5:downstream_gene_variant:MODIFIER::::,MAN2C1:ENST00000565683.5:downstream_gene_variant:MODIFIER::::,MAN2C1:ENST00000563622.5:downstream_gene_variant:MODIFIER::::,MAN2C1:ENST00000267978.10:downstream_gene_variant:MODIFIER::::		154580_[GENE=MAN2C1_PHENOS=Congenital disorder of deglycosylation 2, 619775 (3), Autosomal recessive]			AluJr (SINE/Alu)	rs11422837	0.01555	0.00926,0.01582,0.00102,0.01961,0.02962	8,	1867	119229	-0.0650			0.66				0.01		40	7758	6 / 1650					NEIL1 (inh=n/a oe_syn=1.20 oe_mis=1.05 oe_lof=0.64), MIR631 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MAN2C1 (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.85)
chr15	75351842	75351842	G	A	het	off-target	QUAL=90;DP=8;QD=11.25;AF=0.63;MQM=60;SAP=14;ABP=4;SAR=0;SAF=5	NEIL1,MIR631,MAN2C1	intron,downstream_gene	NEIL1:ENST00000355059.9:intron_variant:MODIFIER:intron2/9:c.435-269G>A::,NEIL1:ENST00000564784.5:intron_variant:MODIFIER:intron3/10:c.435-269G>A::,NEIL1:ENST00000569035.5:intron_variant:MODIFIER:intron2/9:c.435-269G>A::,MIR631:ENST00000384904.1:downstream_gene_variant:MODIFIER::::,MAN2C1:ENST00000569482.5:downstream_gene_variant:MODIFIER::::,MAN2C1:ENST00000565683.5:downstream_gene_variant:MODIFIER::::,MAN2C1:ENST00000563622.5:downstream_gene_variant:MODIFIER::::,MAN2C1:ENST00000267978.10:downstream_gene_variant:MODIFIER::::		154580_[GENE=MAN2C1_PHENOS=Congenital disorder of deglycosylation 2, 619775 (3), Autosomal recessive]			AluSx1 (SINE/Alu)	rs5745916	0.01780	0.00432,0.01617,0.00019,0.02503,0.00704	34,	2639	149343	-0.8210			1.10				0	31415677	10	530	2 / 73					NEIL1 (inh=n/a oe_syn=1.20 oe_mis=1.05 oe_lof=0.64), MIR631 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MAN2C1 (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.85)
chr15	90803400	90803400	-	A	hom	off-target	QUAL=623;DP=24;QD=25.96;AF=1.00;MQM=60;SAP=55;ABP=0;SAR=0;SAF=24	BLM	intron	BLM:ENST00000355112.8:intron_variant:MODIFIER:intron17/21:c.3359-121_3359-120insA::,BLM:ENST00000681142.1:intron_variant:MODIFIER:intron17/21:c.3359-121_3359-120insA::,BLM:ENST00000648453.1:intron_variant:MODIFIER:intron17/22:c.3359-121_3359-120insA::,BLM:ENST00000560509.5:intron_variant:MODIFIER:intron17/19:c.3358+5063_3358+5064insA::,BLM:ENST00000680772.1:intron_variant:MODIFIER:intron17/21:c.3359-121_3359-120insA::		604610_[GENE=BLM_PHENOS=Bloom syndrome, 210900 (3), Autosomal recessive]	210529 [benign/likely benign DISEASE=not specified,not provided];			rs11377009	0.67234	0.65192,0.74567,0.84324,0.65974,0.66736	34638,	32759	49725				0.59				0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BLM (inh=AR oe_syn=0.91 oe_mis=0.91 oe_lof=0.56)
chr15	90804072	90804072	G	A	hom	off-target	QUAL=7385;DP=267;QD=27.66;AF=1.00;MQM=60;SAP=583;ABP=0;SAR=0;SAF=267	BLM	intron	BLM:ENST00000355112.8:intron_variant:MODIFIER:intron18/21:c.3559-95G>A::,BLM:ENST00000681142.1:intron_variant:MODIFIER:intron18/21:c.3559-95G>A::,BLM:ENST00000648453.1:intron_variant:MODIFIER:intron18/22:c.3559-95G>A::,BLM:ENST00000560509.5:intron_variant:MODIFIER:intron17/19:c.3359-5065G>A::,BLM:ENST00000680772.1:intron_variant:MODIFIER:intron18/21:c.3559-95G>A::		604610_[GENE=BLM_PHENOS=Bloom syndrome, 210900 (3), Autosomal recessive]	1239684 [benign DISEASE=not provided];			rs2301602	0.63125	0.58231,0.72233,0.81419,0.63126,0.63906	30632,	34603	56001	-0.4040			0.69				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BLM (inh=AR oe_syn=0.91 oe_mis=0.91 oe_lof=0.56)
chr15	90804525	90804525	A	G	hom	off-target	QUAL=7944;DP=312;QD=25.46;AF=1.00;MQM=60;SAP=681;ABP=0;SAR=312;SAF=0	BLM	intron	BLM:ENST00000355112.8:intron_variant:MODIFIER:intron19/21:c.3751+166A>G::,BLM:ENST00000681142.1:intron_variant:MODIFIER:intron19/21:c.3751+166A>G::,BLM:ENST00000648453.1:intron_variant:MODIFIER:intron19/22:c.3751+166A>G::,BLM:ENST00000560509.5:intron_variant:MODIFIER:intron17/19:c.3359-4612A>G::,BLM:ENST00000680772.1:intron_variant:MODIFIER:intron19/21:c.3751+166A>G::		604610_[GENE=BLM_PHENOS=Bloom syndrome, 210900 (3), Autosomal recessive]	1252270 [benign DISEASE=not provided];		AluJb (SINE/Alu)	rs454060	0.66419	0.64008,0.74230,0.81687,0.65813,0.64722	33806,	33259	50999	-2.2290			1.50				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BLM (inh=AR oe_syn=0.91 oe_mis=0.91 oe_lof=0.56)
chr15	90804554	90804554	C	T	hom	off-target	QUAL=4031;DP=202;QD=19.96;AF=1.00;MQM=60;SAP=442;ABP=0;SAR=202;SAF=0	BLM	intron	BLM:ENST00000355112.8:intron_variant:MODIFIER:intron19/21:c.3751+195C>T::,BLM:ENST00000681142.1:intron_variant:MODIFIER:intron19/21:c.3751+195C>T::,BLM:ENST00000648453.1:intron_variant:MODIFIER:intron19/22:c.3751+195C>T::,BLM:ENST00000560509.5:intron_variant:MODIFIER:intron17/19:c.3359-4583C>T::,BLM:ENST00000680772.1:intron_variant:MODIFIER:intron19/21:c.3751+195C>T::		604610_[GENE=BLM_PHENOS=Bloom syndrome, 210900 (3), Autosomal recessive]	1178809 [benign DISEASE=not provided];		AluJb (SINE/Alu)	rs405610	0.38407	0.19526,0.53392,0.55394,0.43649,0.48465	12381,	33571	93547	0.3440			6.08				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BLM (inh=AR oe_syn=0.91 oe_mis=0.91 oe_lof=0.56)
chr16	3589138	3589138	A	G	het		QUAL=1356;DP=100;QD=13.56;AF=0.53;MQM=60;SAP=5;ABP=4;SAR=30;SAF=23	SLX4	synonymous	SLX4:ENST00000294008.4:synonymous_variant:LOW:exon12/15:c.4500T>C:p.Asn1500=:		613278_[GENE=SLX4_PHENOS=Fanconi anemia, complementation group P, 613951 (3), Autosomal recessive]	262053 [benign DISEASE=Fanconi anemia complementation group P,Fanconi anemia,not specified,not provided];			rs3810812	0.63826	0.87463,0.61892,0.71550,0.51206,0.77412	32978,	31010	54956	0.7530			2.17			COSV53564459	0	25741868,22401137,22911665,32708070	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLX4 (inh=AR oe_syn=1.24 oe_mis=1.16 oe_lof=0.68)
chr16	3589229	3589229	G	A	het		QUAL=1412;DP=109;QD=12.95;AF=0.49;MQM=60;SAP=3;ABP=3;SAR=25;SAF=28	SLX4	missense	SLX4:ENST00000294008.4:missense_variant:MODERATE:exon12/15:c.4409C>T:p.Pro1470Leu:		613278_[GENE=SLX4_PHENOS=Fanconi anemia, complementation group P, 613951 (3), Autosomal recessive]	885261 [uncertain significance DISEASE=Fanconi anemia complementation group P,Fanconi anemia];	CM136925 [CLASS=DM MUT=ALT PHEN="Breast and/or ovarian cancer" GENE=SLX4];		rs72778139	0.00009	0.00005,0.00007,0.00000,0.00015,0.00000	0,	14	152156	0.6280	T(0.08)	B(0.06)	16.19	0.11		COSV53560456	0	22401137,23211700,23840564	0	13	0 / 5					SLX4 (inh=AR oe_syn=1.24 oe_mis=1.16 oe_lof=0.68)
chr16	23603722	23603722	A	-	het	off-target;low_conf_region	QUAL=275;DP=182;QD=1.51;AF=0.17;MQM=60;SAP=23;ABP=175;SAR=24;SAF=7	PALB2	intron	PALB2:ENST00000261584.9:intron_variant:MODIFIER:intron12/12:c.3351-53del::,PALB2:ENST00000568219.5:intron_variant:MODIFIER:intron12/12:c.2466-53del::,PALB2:ENST00000697374.1:intron_variant:MODIFIER:intron12/12:c.2466-53del::,PALB2:ENST00000697376.1:intron_variant:MODIFIER:intron12/12:c.2317-53del::,PALB2:ENST00000697377.1:intron_variant:MODIFIER:intron12/12:c.2304-53del::,PALB2:ENST00000561514.2:intron_variant:MODIFIER:intron12/12:c.2466-53del::,PALB2:ENST00000697379.1:intron_variant:MODIFIER:intron13/13:c.2466-53del::,PALB2:ENST00000697383.1:intron_variant:MODIFIER:intron8/8:c.885-53del::		610355_[GENE=PALB2_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer, susceptibility to, 3}, 613348 (3); Fanconi anemia, complementation group N, 610832 (3)]	1231515 [benign DISEASE=not provided];		(A)n (Simple_repeat)	rs35294437	0.09724	0.14029,0.07638,0.18838,0.07037,0.09257	589,	11379	116575	-1.7020			0.18			COSV55163224	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2022-06-22 Batch import from command line. GCHBOC VUS-Task-Force classification "			PALB2 (inh=AR+AD oe_syn=1.06 oe_mis=0.97 oe_lof=0.76)
chr16	23621158	23621158	C	T	het	off-target	QUAL=294;DP=33;QD=8.91;AF=0.52;MQM=60;SAP=40;ABP=3;SAR=0;SAF=17	PALB2	intron	PALB2:ENST00000261584.9:intron_variant:MODIFIER:intron10/12:c.3113+204G>A::,PALB2:ENST00000568219.5:intron_variant:MODIFIER:intron10/12:c.2228+204G>A::,PALB2:ENST00000697374.1:intron_variant:MODIFIER:intron10/12:c.2228+204G>A::,PALB2:ENST00000697376.1:intron_variant:MODIFIER:intron11/12:c.2228+204G>A::,PALB2:ENST00000697377.1:intron_variant:MODIFIER:intron10/12:c.2066+204G>A::,PALB2:ENST00000561514.2:intron_variant:MODIFIER:intron10/12:c.2228+204G>A::,PALB2:ENST00000697379.1:intron_variant:MODIFIER:intron11/13:c.2228+204G>A::,PALB2:ENST00000697383.1:intron_variant:MODIFIER:intron6/8:c.647+204G>A::		610355_[GENE=PALB2_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer, susceptibility to, 3}, 613348 (3); Fanconi anemia, complementation group N, 610832 (3)]	1181215 [benign DISEASE=not provided];		AluSz (SINE/Alu)	rs8060124	0.18208	0.22338,0.19259,0.19250,0.14935,0.20818	2633,	22396	124264	-0.6370			0.68			COSV55167095	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PALB2 (inh=AR+AD oe_syn=1.06 oe_mis=0.97 oe_lof=0.76)
chr16	23623201	23623202	TT	-	het	off-target;low_conf_region	QUAL=52;DP=18;QD=2.89;AF=0.22;MQM=60;SAP=12;ABP=15;SAR=0;SAF=4	PALB2	intron	PALB2:ENST00000261584.9:intron_variant:MODIFIER:intron8/12:c.2835-72_2835-71del::,PALB2:ENST00000568219.5:intron_variant:MODIFIER:intron8/12:c.1950-72_1950-71del::,PALB2:ENST00000697374.1:intron_variant:MODIFIER:intron8/12:c.1950-72_1950-71del::,PALB2:ENST00000697376.1:intron_variant:MODIFIER:intron9/12:c.1950-72_1950-71del::,PALB2:ENST00000697377.1:intron_variant:MODIFIER:intron8/12:c.1788-72_1788-71del::,PALB2:ENST00000561514.2:intron_variant:MODIFIER:intron8/12:c.1950-72_1950-71del::,PALB2:ENST00000697379.1:intron_variant:MODIFIER:intron9/13:c.1950-72_1950-71del::,PALB2:ENST00000697383.1:intron_variant:MODIFIER:intron4/8:c.369-72_369-71del::		610355_[GENE=PALB2_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer, susceptibility to, 3}, 613348 (3); Fanconi anemia, complementation group N, 610832 (3)]	1229808 [benign DISEASE=not provided];		AluSx3 (SINE/Alu)	rs754470879	0.15210	0.17776,0.15650,0.17164,0.13578,0.17795	783,	17356	105486	0.8200			4.82				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PALB2 (inh=AR+AD oe_syn=1.06 oe_mis=0.97 oe_lof=0.76)
chr16	23629146	23629146	G	A	het	off-target	QUAL=255;DP=23;QD=11.09;AF=0.48;MQM=60;SAP=13;ABP=3;SAR=2;SAF=9	PALB2	intron	PALB2:ENST00000261584.9:intron_variant:MODIFIER:intron6/12:c.2586+58C>T::,PALB2:ENST00000568219.5:intron_variant:MODIFIER:intron6/12:c.1701+58C>T::,PALB2:ENST00000697374.1:intron_variant:MODIFIER:intron6/12:c.1701+58C>T::,PALB2:ENST00000697376.1:intron_variant:MODIFIER:intron7/12:c.1701+58C>T::,PALB2:ENST00000697377.1:intron_variant:MODIFIER:intron7/12:c.1701+58C>T::,PALB2:ENST00000561514.2:intron_variant:MODIFIER:intron6/12:c.1701+58C>T::,PALB2:ENST00000697379.1:intron_variant:MODIFIER:intron7/13:c.1701+58C>T::,PALB2:ENST00000697383.1:intron_variant:MODIFIER:intron2/8:c.120+58C>T::		610355_[GENE=PALB2_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer, susceptibility to, 3}, 613348 (3); Fanconi anemia, complementation group N, 610832 (3)]	126663 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Familial cancer of breast,not specified,not provided];			rs249954	0.31024	0.43644,0.29103,0.36534,0.23757,0.31159	7832,	31443	104733	0.3290			2.34			COSV55164558	0	21356067,29879995,23318652,28419251,30799775,22332084,20122277,18446436,19635604,22052327,23935836,18794107,26981788,30362319,19921424,23453885,30309218,32894086,35008387	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2022-06-22 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2021-03-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			PALB2 (inh=AR+AD oe_syn=1.06 oe_mis=0.97 oe_lof=0.76)
chr16	68737438	68737440	TCT	-	het		QUAL=577;DP=134;QD=4.31;AF=0.33;MQM=60;SAP=99;ABP=37;SAR=44;SAF=0	CDH1	inframe_deletion	CDH1:ENST00000261769.10:inframe_deletion:MODERATE:exon1/16:c.23_25del:p.Leu8_Ser9delinsPro:,CDH1:ENST00000422392.6:inframe_deletion:MODERATE:exon1/15:c.23_25del:p.Leu8_Ser9delinsPro:	regulatory_region_variant:promoter	192090_[GENE=CDH1_PHENOS=Ovarian cancer, somatic, 167000 (3); Blepharocheilodontic syndrome 1, 119580 (3), Autosomal dominant; Diffuse gastric and lobular breast cancer syndrome with or without cleft lip and/or palate, 137215 (3), Autosomal dominant; Endometrial carcinoma, somatic, 608089 (3); Breast cancer, lobular, somatic, 114480 (3); {Prostate cancer, susceptibility to}, 176807 (3), Somatic mutation, Autosomal dominant]										0.2190							0		0	45	0 / 45					CDH1 (inh=AD oe_syn=0.99 oe_mis=0.91 oe_lof=0.25)
chr16	68737469	68737469	C	T	hom		QUAL=3993;DP=125;QD=31.94;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=62;SAF=63	CDH1	splice_region&intron	CDH1:ENST00000261769.10:splice_region_variant&intron_variant:LOW:intron1/15:c.48+6C>T::,CDH1:ENST00000422392.6:splice_region_variant&intron_variant:LOW:intron1/14:c.48+6C>T::	regulatory_region_variant:promoter	192090_[GENE=CDH1_PHENOS=Ovarian cancer, somatic, 167000 (3); Blepharocheilodontic syndrome 1, 119580 (3), Autosomal dominant; Diffuse gastric and lobular breast cancer syndrome with or without cleft lip and/or palate, 137215 (3), Autosomal dominant; Endometrial carcinoma, somatic, 608089 (3); Breast cancer, lobular, somatic, 114480 (3); {Prostate cancer, susceptibility to}, 176807 (3), Somatic mutation, Autosomal dominant]	136692 [benign DISEASE=Malignant tumor of prostate,Hereditary diffuse gastric adenocarcinoma,Hereditary cancer-predisposing syndrome,Familial cancer of breast,Blepharocheilodontic syndrome 1,not specified,not provided];			rs3743674	0.80498	0.66322,0.79937,0.77299,0.88439,0.78364	50031,	22339	29653	-0.1320			6.86		8.63>8.16	COSV55733220	0	25741868,24033266,21686129,21356067,22875147,23431106,27192129,20632448,29295527,30641862,31600923,30895400,24684952,30642281,33240400,33465060,35686104	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CDH1 (inh=AD oe_syn=0.99 oe_mis=0.91 oe_lof=0.25)
chr16	68737515	68737515	-	GCCCCAGCCCCGT	hom	off-target	QUAL=2378;DP=85;QD=27.98;AF=0.99;MQM=60;SAP=3;ABP=0;SAR=43;SAF=41	CDH1,RNA5SP429	intron,upstream_gene	CDH1:ENST00000261769.10:intron_variant:MODIFIER:intron1/15:c.48+62_48+63insCGTGCCCCAGCCC::,CDH1:ENST00000422392.6:intron_variant:MODIFIER:intron1/14:c.48+62_48+63insCGTGCCCCAGCCC::,RNA5SP429:ENST00000363688.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	192090_[GENE=CDH1_PHENOS=Ovarian cancer, somatic, 167000 (3); Blepharocheilodontic syndrome 1, 119580 (3), Autosomal dominant; Diffuse gastric and lobular breast cancer syndrome with or without cleft lip and/or palate, 137215 (3), Autosomal dominant; Endometrial carcinoma, somatic, 608089 (3); Breast cancer, lobular, somatic, 114480 (3); {Prostate cancer, susceptibility to}, 176807 (3), Somatic mutation, Autosomal dominant]	1243608 [benign DISEASE=not provided];			rs45625236	0.80732	0.68710,0.79232,0.77027,0.87351,0.78171	47776,	23735	28469				8.71			COSV55741627	0	21686129,35686104	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CDH1 (inh=AD oe_syn=0.99 oe_mis=0.91 oe_lof=0.25), RNA5SP429 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr16	68823238	68823238	A	-	het	off-target	QUAL=94;DP=38;QD=2.47;AF=0.18;MQM=60;SAP=18;ABP=36;SAR=0;SAF=7	CDH1,FTLP14	intron,downstream_gene	CDH1:ENST00000261769.10:intron_variant:MODIFIER:intron12/15:c.1937-144del::,CDH1:ENST00000422392.6:intron_variant:MODIFIER:intron11/14:c.1754-144del::,FTLP14:ENST00000562087.2:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	192090_[GENE=CDH1_PHENOS=Ovarian cancer, somatic, 167000 (3); Blepharocheilodontic syndrome 1, 119580 (3), Autosomal dominant; Diffuse gastric and lobular breast cancer syndrome with or without cleft lip and/or palate, 137215 (3), Autosomal dominant; Endometrial carcinoma, somatic, 608089 (3); Breast cancer, lobular, somatic, 114480 (3); {Prostate cancer, susceptibility to}, 176807 (3), Somatic mutation, Autosomal dominant]	1249384 [benign DISEASE=not provided];		(A)n (Simple_repeat)	rs146046879	0.13902	0.09019,0.10606,0.09879,0.17264,0.07249	718,	12881	88671	0.0360			0.32				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CDH1 (inh=AD oe_syn=0.99 oe_mis=0.91 oe_lof=0.25), FTLP14 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr16	68823538	68823538	T	C	het		QUAL=14754;DP=1127;QD=13.09;AF=0.52;MQM=60;SAP=4;ABP=8;SAR=286;SAF=304	CDH1,FTLP14	synonymous,downstream_gene	CDH1:ENST00000261769.10:synonymous_variant:LOW:exon13/16:c.2076T>C:p.Ala692=:,CDH1:ENST00000422392.6:synonymous_variant:LOW:exon12/15:c.1893T>C:p.Ala631=:,FTLP14:ENST00000562087.2:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer,TF_binding_site_variant	192090_[GENE=CDH1_PHENOS=Ovarian cancer, somatic, 167000 (3); Blepharocheilodontic syndrome 1, 119580 (3), Autosomal dominant; Diffuse gastric and lobular breast cancer syndrome with or without cleft lip and/or palate, 137215 (3), Autosomal dominant; Endometrial carcinoma, somatic, 608089 (3); Breast cancer, lobular, somatic, 114480 (3); {Prostate cancer, susceptibility to}, 176807 (3), Somatic mutation, Autosomal dominant]	142770 [benign DISEASE=Malignant tumor of prostate,Hereditary diffuse gastric adenocarcinoma,Hereditary cancer-predisposing syndrome,Familial cancer of breast,Blepharocheilodontic syndrome 1,not specified,not provided];	CM1414917 [CLASS=DP MUT=ALT PHEN="Gastric cancer early-onset diffuse association with" GENE=CDH1];		rs1801552	0.69833	0.88401,0.65330,0.63573,0.62821,0.65564	38020,	30015	45815	0.0880			8.26			COSV55728161	0.05	25741868,24033266,20844743,21356067,28419251,26285011,22535324,19965908,23431106,23555086,21459793,27192129,24838934,28151848,29295527,30641862,31600923,30895400,24684952,31638990,18059179,30642281,19269290,33888005,33195260,33465060,34503274,32708070,25150394,35267574,35686104	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CDH1 (inh=AD oe_syn=0.99 oe_mis=0.91 oe_lof=0.25), FTLP14 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr16	81782975	81782975	C	G	hom	off-target	QUAL=142;DP=6;QD=23.67;AF=1.00;MQM=60;SAP=16;ABP=0;SAR=0;SAF=6	PLCG2	intron	PLCG2:ENST00000563193.2:intron_variant:MODIFIER:intron1/13:c.-47-2968C>G::,PLCG2:ENST00000564138.6:intron_variant:MODIFIER:intron1/32:c.-47-2968C>G::,PLCG2:ENST00000697564.1:intron_variant:MODIFIER:intron1/30:c.-47-2968C>G::		600220_[GENE=PLCG2_PHENOS=Autoinflammation, antibody deficiency, and immune dysregulation syndrome, 614878 (3), Autosomal dominant; Familial cold autoinflammatory syndrome 3, 614468 (3), Autosomal dominant]				rs6564919	0.76727	0.69928,0.79810,0.79184,0.78524,0.88288	45009,	26602	35374	-0.4630			1.64				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLCG2 (inh=AD oe_syn=1.36 oe_mis=0.92 oe_lof=0.18)
chr16	81783128	81783128	C	T	het		QUAL=4977;DP=419;QD=11.88;AF=0.50;MQM=60;SAP=276;ABP=3;SAR=24;SAF=187	PLCG2	intron	PLCG2:ENST00000563193.2:intron_variant:MODIFIER:intron1/13:c.-47-2815C>T::,PLCG2:ENST00000564138.6:intron_variant:MODIFIER:intron1/32:c.-47-2815C>T::,PLCG2:ENST00000697564.1:intron_variant:MODIFIER:intron1/30:c.-47-2815C>T::		600220_[GENE=PLCG2_PHENOS=Autoinflammation, antibody deficiency, and immune dysregulation syndrome, 614878 (3), Autosomal dominant; Familial cold autoinflammatory syndrome 3, 614468 (3), Autosomal dominant]				rs8045964	0.42064	0.41191,0.36563,0.28353,0.43245,0.63259	13632,	36527	87861	-0.4400			1.02			COSV63869127	0	19956101	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLCG2 (inh=AD oe_syn=1.36 oe_mis=0.92 oe_lof=0.18)
chr16	81783182	81783182	T	A	hom	off-target	QUAL=23894;DP=732;QD=32.64;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=368;SAF=364	PLCG2	intron	PLCG2:ENST00000563193.2:intron_variant:MODIFIER:intron1/13:c.-47-2761T>A::,PLCG2:ENST00000564138.6:intron_variant:MODIFIER:intron1/32:c.-47-2761T>A::,PLCG2:ENST00000697564.1:intron_variant:MODIFIER:intron1/30:c.-47-2761T>A::		600220_[GENE=PLCG2_PHENOS=Autoinflammation, antibody deficiency, and immune dysregulation syndrome, 614878 (3), Autosomal dominant; Familial cold autoinflammatory syndrome 3, 614468 (3), Autosomal dominant]				rs4476171	0.99940	0.99802,1.00000,1.00000,1.00000,0.99834	76019,	91	91	-1.8100			0.13				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLCG2 (inh=AD oe_syn=1.36 oe_mis=0.92 oe_lof=0.18)
chr16	81783213	81783213	C	T	het	off-target	QUAL=9074;DP=714;QD=12.71;AF=0.48;MQM=60;SAP=4;ABP=5;SAR=178;SAF=167	PLCG2	intron	PLCG2:ENST00000563193.2:intron_variant:MODIFIER:intron1/13:c.-47-2730C>T::,PLCG2:ENST00000564138.6:intron_variant:MODIFIER:intron1/32:c.-47-2730C>T::,PLCG2:ENST00000697564.1:intron_variant:MODIFIER:intron1/30:c.-47-2730C>T::		600220_[GENE=PLCG2_PHENOS=Autoinflammation, antibody deficiency, and immune dysregulation syndrome, 614878 (3), Autosomal dominant; Familial cold autoinflammatory syndrome 3, 614468 (3), Autosomal dominant]				rs72834729	0.34235	0.27422,0.43113,0.50790,0.35204,0.24907	9230,	33553	99917	-1.2660			0.30				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLCG2 (inh=AD oe_syn=1.36 oe_mis=0.92 oe_lof=0.18)
chr16	89738447	89738447	C	T	het	off-target	QUAL=653;DP=54;QD=12.09;AF=0.65;MQM=60;SAP=79;ABP=13;SAR=0;SAF=35	ZNF276,FANCA	3'UTR,downstream_gene	ZNF276:ENST00000289816.9:3_prime_UTR_variant:MODIFIER:exon11/11:c.*201C>T::,ZNF276:ENST00000568064.5:3_prime_UTR_variant:MODIFIER:exon10/10:c.*538C>T::,ZNF276:ENST00000443381.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*201C>T::,FANCA:ENST00000389301.8:3_prime_UTR_variant:MODIFIER:exon43/43:c.*154G>A::,FANCA:ENST00000568369.6:3_prime_UTR_variant:MODIFIER:exon43/43:c.*251G>A::,FANCA:ENST00000564475.6:downstream_gene_variant:MODIFIER::::,FANCA:ENST00000696287.1:downstream_gene_variant:MODIFIER::::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	321323 [benign DISEASE=Fanconi anemia complementation group A,not provided];			rs1230	0.53571	0.74249,0.54770,0.97999,0.39297,0.62133	24272,	32901	70587	-0.4200			3.15			COSV57073486	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZNF276 (inh=AR oe_syn=1.48 oe_mis=1.27 oe_lof=0.47), FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89738853	89738853	A	G	hom	off-target	QUAL=17951;DP=570;QD=31.49;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=288;SAF=280	ZNF276,FANCA	3'UTR,intron,synonymous,downstream_gene	ZNF276:ENST00000289816.9:3_prime_UTR_variant:MODIFIER:exon11/11:c.*607A>G::,ZNF276:ENST00000443381.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*607A>G::,FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron42/42:c.4260+29T>C::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron42/42:c.4264+29T>C::,FANCA:ENST00000564475.6:synonymous_variant:LOW:exon42/42:c.4293T>C:p.His1431=:,FANCA:ENST00000696287.1:synonymous_variant:LOW:exon41/41:c.4164T>C:p.His1388=:,ZNF276:ENST00000568064.5:downstream_gene_variant:MODIFIER::::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255266 [benign DISEASE=Fanconi anemia complementation group A,not specified,not provided];			rs1800359	0.72281	0.92829,0.70347,0.98595,0.59573,0.82320	41663,	26645	42173	-6.7440			0.04			COSV57066846	0.13	25741868,23637625,19578364,23021409,26540268	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZNF276 (inh=AR oe_syn=1.48 oe_mis=1.27 oe_lof=0.47), FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89739569	89739569	G	A	het	off-target	QUAL=2219;DP=179;QD=12.40;AF=0.49;MQM=60;SAP=10;ABP=3;SAR=35;SAF=52	ZNF276,FANCA	3'UTR,splice_region&intron,downstream_gene	ZNF276:ENST00000289816.9:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1323G>A::,ZNF276:ENST00000443381.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1323G>A::,FANCA:ENST00000389301.8:splice_region_variant&intron_variant:LOW:intron39/42:c.3935-16C>T::,FANCA:ENST00000568369.6:splice_region_variant&intron_variant:LOW:intron39/42:c.3935-16C>T::,FANCA:ENST00000564475.6:splice_region_variant&intron_variant:LOW:intron39/41:c.3935-16C>T::,FANCA:ENST00000696287.1:splice_region_variant&intron_variant:LOW:intron38/40:c.3806-16C>T::,ZNF276:ENST00000568064.5:downstream_gene_variant:MODIFIER::::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255264 [benign DISEASE=Fanconi anemia complementation group A,Fanconi anemia,not specified,not provided];			rs1061646	0.41016	0.53867,0.48428,0.74370,0.29973,0.49212	14112,	34096	89620	0.3980			4.77		8.17>8.42	COSV57068489	0.05	25741868,18701435,18056155,23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZNF276 (inh=AR oe_syn=1.48 oe_mis=1.27 oe_lof=0.47), FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89739939	89739939	A	T	het	off-target	QUAL=879;DP=48;QD=18.31;AF=0.71;MQM=60;SAP=3;ABP=21;SAR=17;SAF=17	ZNF276,FANCA	3'UTR,intron,downstream_gene	ZNF276:ENST00000289816.9:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1693A>T::,ZNF276:ENST00000443381.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1693A>T::,FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron39/42:c.3934+55T>A::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron39/42:c.3934+55T>A::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron39/41:c.3934+55T>A::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron38/40:c.3805+55T>A::,ZNF276:ENST00000568064.5:downstream_gene_variant:MODIFIER::::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	135541 [benign DISEASE=Fanconi anemia complementation group A,not specified,not provided];			rs7195906	0.54211	0.76231,0.55050,0.98054,0.39438,0.62308	24964,	32487	69611	-0.7080			2.22	0.08		COSV57065786	0.01	24728327	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZNF276 (inh=AR oe_syn=1.48 oe_mis=1.27 oe_lof=0.47), FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89744788	89744788	T	C	het	off-target	QUAL=588;DP=53;QD=11.09;AF=0.58;MQM=60;SAP=70;ABP=6;SAR=0;SAF=31	FANCA,ZNF276	intron,downstream_gene	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron36/42:c.3626+171A>G::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron36/42:c.3626+171A>G::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron36/41:c.3626+171A>G::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron35/40:c.3497+171A>G::,ZNF276:ENST00000289816.9:downstream_gene_variant:MODIFIER::::,ZNF276:ENST00000443381.7:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1243121 [benign DISEASE=not provided];		AluSg4 (SINE/Alu)	rs9923733	0.54432	0.76408,0.55841,0.98173,0.39589,0.62095	25018,	32407	69017	-0.6340			3.84				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZNF276 (inh=AR oe_syn=1.48 oe_mis=1.27 oe_lof=0.47), FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89748809	89748809	C	T	het	off-target	QUAL=1916;DP=156;QD=12.28;AF=0.51;MQM=60;SAP=3;ABP=3;SAR=41;SAF=38	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron32/42:c.3240-42G>A::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron32/42:c.3240-42G>A::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron32/41:c.3240-42G>A::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron31/40:c.3111-42G>A::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255254 [benign DISEASE=Fanconi anemia complementation group A,Fanconi anemia,not specified,not provided];	CS137887 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA];		rs1800345	0.41354	0.54264,0.48885,0.75863,0.30090,0.49709	14350,	34090	89046	-0.7150			0.63				0.02	25741868,23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89752083	89752083	T	C	het	off-target	QUAL=9339;DP=743;QD=12.57;AF=0.49;MQM=60;SAP=3;ABP=4;SAR=180;SAF=183	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron31/42:c.3066+55A>G::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron31/42:c.3066+55A>G::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron31/41:c.3066+55A>G::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron30/40:c.2937+55A>G::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1235276 [benign DISEASE=not provided];			rs3743860	0.47303	0.55610,0.51410,0.76579,0.39143,0.60428	17820,	36201	80033	-0.1620			4.09			COSV59795426	0	31209889,29785010,30054594,32352494,29617998	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89765102	89765102	C	A	het	off-target	QUAL=11980;DP=961;QD=12.47;AF=0.48;MQM=60;SAP=3;ABP=5;SAR=227;SAF=237	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron27/42:c.2602-36G>T::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron27/42:c.2602-36G>T::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron27/41:c.2602-36G>T::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron27/40:c.2602-36G>T::	regulatory_region_variant:promoter,TF_binding_site_variant	607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255248 [benign DISEASE=Fanconi anemia complementation group A,not specified];			rs2159116	0.12241	0.03821,0.12137,0.00443,0.17270,0.17143	1477,	15667	133505	-2.7020			0.46			COSV59796461	0.01	25741868,20585627,20981448	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89767366	89767366	C	G	het	off-target	QUAL=130;DP=29;QD=4.48;AF=0.31;MQM=60;SAP=23;ABP=12;SAR=9;SAF=0	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron26/42:c.2505-129G>C::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron26/42:c.2505-129G>C::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron26/41:c.2505-129G>C::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron26/40:c.2505-129G>C::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1251422 [benign DISEASE=not provided];			rs7203907	0.51751	0.67710,0.53874,0.98150,0.39529,0.62712	22291,	34076	73336	-0.4910			0.81				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89769915	89769915	C	T	het		QUAL=831;DP=92;QD=9.03;AF=0.40;MQM=60;SAP=13;ABP=11;SAR=25;SAF=12	FANCA	missense	FANCA:ENST00000389301.8:missense_variant:MODERATE:exon26/43:c.2426G>A:p.Gly809Asp:,FANCA:ENST00000568369.6:missense_variant:MODERATE:exon26/43:c.2426G>A:p.Gly809Asp:,FANCA:ENST00000564475.6:missense_variant:MODERATE:exon26/42:c.2426G>A:p.Gly809Asp:,FANCA:ENST00000696287.1:missense_variant:MODERATE:exon26/41:c.2426G>A:p.Gly809Asp:		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	134254 [benign/likely benign DISEASE=Fanconi anemia complementation group A,Fanconi anemia,Inborn genetic diseases,not specified,not provided];	CM137288 [CLASS=R MUT=ALT PHEN="Fanconi anaemia A" GENE=FANCA];		rs7195066	0.47223	0.66233,0.52360,0.98125,0.32130,0.62313	19532,	32666	80166	0.0770	T(0.18),T(0.18),T(0.22),T(0.22)	B(0.00),B(0.00),B(0.00),B(0.00)	12.81	0.20		COSV59796193	0.41	25741868,24728327,20585627,20546537,18483556,23826176,19012493,23021409,24188633	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89770099	89770099	T	C	hom	off-target	QUAL=4520;DP=134;QD=33.73;AF=1.00;MQM=60;SAP=5;ABP=0;SAR=73;SAF=61	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron25/42:c.2316+67A>G::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron25/42:c.2316+67A>G::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron25/41:c.2316+67A>G::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron25/40:c.2316+67A>G::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1180460 [benign DISEASE=Fanconi anemia complementation group A,not provided];			rs7200990	0.97142	0.99255,0.97814,0.99981,0.95650,0.98262	71826,	4219	4351	-0.2620			2.36				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89770373	89770373	G	A	het	off-target	QUAL=326;DP=40;QD=8.15;AF=0.45;MQM=60;SAP=42;ABP=4;SAR=18;SAF=0	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron24/42:c.2223-114C>T::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron24/42:c.2223-114C>T::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron24/41:c.2223-114C>T::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron24/40:c.2223-114C>T::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1180461 [benign DISEASE=Fanconi anemia complementation group A,Fanconi anemia,not provided];			rs886952	0.52336	0.69696,0.54338,0.98128,0.39473,0.62438	22921,	33707	72447	-1.2700			0.28				0.02	23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89771670	89771670	A	G	het		QUAL=12873;DP=1039;QD=12.39;AF=0.49;MQM=60;SAP=3;ABP=5;SAR=254;SAF=251	FANCA	splice_region&intron	FANCA:ENST00000389301.8:splice_region_variant&intron_variant:LOW:intron23/42:c.2151+8T>C::,FANCA:ENST00000568369.6:splice_region_variant&intron_variant:LOW:intron23/42:c.2151+8T>C::,FANCA:ENST00000564475.6:splice_region_variant&intron_variant:LOW:intron23/41:c.2151+8T>C::,FANCA:ENST00000696287.1:splice_region_variant&intron_variant:LOW:intron23/40:c.2151+8T>C::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255245 [benign DISEASE=Fanconi anemia complementation group A,Fanconi anemia,not specified];			rs1800340	0.41431	0.51402,0.48674,0.75445,0.31074,0.59854	14233,	34402	88872	-1.3870			0.04			COSV66881670	0	25741868,23021409,32572023	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89775621	89775621	C	G	het	off-target	QUAL=69;DP=13;QD=5.31;AF=0.38;MQM=60;SAP=14;ABP=5;SAR=0;SAF=5	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron21/42:c.1900+121G>C::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron21/42:c.1900+121G>C::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron21/41:c.1900+121G>C::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron21/40:c.1900+121G>C::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1225017 [benign DISEASE=not provided];			rs3785275	0.41640	0.55314,0.48328,0.75338,0.30165,0.50807	14624,	34052	88718	-0.4590			0.63			COSV66881241	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89778702	89778702	A	T	het	off-target	QUAL=6407;DP=609;QD=10.52;AF=0.53;MQM=60;SAP=700;ABP=7;SAR=321;SAF=0	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron20/42:c.1826+99T>A::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron20/42:c.1826+99T>A::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron20/41:c.1826+99T>A::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron20/40:c.1826+99T>A::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1180464 [benign DISEASE=Fanconi anemia complementation group A,not provided];			rs7187436	0.50836	0.65726,0.53079,0.98102,0.39345,0.62663	21145,	33399	73201	-1.3470			0.48				0.07		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89778786	89778786	A	G	het	off-target	QUAL=6230;DP=605;QD=10.30;AF=0.53;MQM=60;SAP=681;ABP=7;SAR=318;SAF=2	FANCA	splice_region&intron	FANCA:ENST00000389301.8:splice_region_variant&intron_variant:LOW:intron20/42:c.1826+15T>C::,FANCA:ENST00000568369.6:splice_region_variant&intron_variant:LOW:intron20/42:c.1826+15T>C::,FANCA:ENST00000564475.6:splice_region_variant&intron_variant:LOW:intron20/41:c.1826+15T>C::,FANCA:ENST00000696287.1:splice_region_variant&intron_variant:LOW:intron20/40:c.1826+15T>C::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255241 [benign DISEASE=Fanconi anemia complementation group A,Fanconi anemia,not specified,not provided];			rs1800337	0.51773	0.67914,0.53889,0.98091,0.39443,0.62739	22344,	33885	73191	-1.3620			0.76				0.06	25741868,23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89783072	89783072	C	T	hom		QUAL=6693;DP=199;QD=33.63;AF=1.00;MQM=60;SAP=86;ABP=0;SAR=143;SAF=56	FANCA	missense	FANCA:ENST00000389301.8:missense_variant:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000568369.6:missense_variant:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000564475.6:missense_variant:MODERATE:exon16/42:c.1501G>A:p.Gly501Ser:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000696287.1:missense_variant:MODERATE:exon16/41:c.1501G>A:p.Gly501Ser:PF15865 [Fanconi anaemia group A protein N terminus]		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	134244 [benign DISEASE=Fanconi anemia complementation group A,Fanconi anemia,not specified,not provided];	CM137880 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA];		rs2239359	0.51337	0.68440,0.52534,0.84592,0.38841,0.51102	21654,	34586	73838	-0.9650	T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00)	0.34	0.26		COSV66881058	0.01	25741868,23554684,24728327,17267408,26139146,24045675,23826176,19012493,23021409,23424144,31535215,18059179,28500464,25653542,33202820	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89783175	89783175	C	T	het	off-target	QUAL=937;DP=80;QD=11.71;AF=0.48;MQM=60;SAP=3;ABP=3;SAR=19;SAF=19	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron15/42:c.1471-73G>A::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron15/42:c.1471-73G>A::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron15/41:c.1471-73G>A::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron15/40:c.1471-73G>A::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1180470 [benign DISEASE=Fanconi anemia complementation group A,not provided];			rs2239360	0.46325	0.68350,0.50446,0.76157,0.31156,0.59863	18703,	32962	81532	-1.8400			0.17			COSV66881248	0.04	20837404,23350966	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89783221	89783221	T	A	het	off-target	QUAL=920;DP=78;QD=11.79;AF=0.49;MQM=60;SAP=3;ABP=3;SAR=19;SAF=19	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron15/42:c.1471-119A>T::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron15/42:c.1471-119A>T::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron15/41:c.1471-119A>T::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron15/40:c.1471-119A>T::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1180471 [benign DISEASE=Fanconi anemia complementation group A,not provided];			rs12448860	0.51245	0.66006,0.53889,0.98090,0.39512,0.62490	21762,	34284	74028	0.0000			2.11			COSV66882732	0.06	23350966	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89791292	89791292	A	G	het	off-target	QUAL=891;DP=68;QD=13.10;AF=0.53;MQM=60;SAP=3;ABP=4;SAR=18;SAF=18	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron14/42:c.1359+111T>C::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron14/42:c.1359+111T>C::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron14/41:c.1359+111T>C::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron14/40:c.1359+111T>C::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1230103 [benign DISEASE=not provided];			rs8049660	0.47427	0.71890,0.51110,0.76569,0.31251,0.59784	19874,	32247	79807	-1.5800			0.90				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89791556	89791556	T	C	het	off-target	QUAL=14506;DP=1032;QD=14.06;AF=0.53;MQM=60;SAP=4;ABP=11;SAR=265;SAF=281	FANCA	splice_region&intron	FANCA:ENST00000389301.8:splice_region_variant&intron_variant:LOW:intron13/42:c.1226-20A>G::,FANCA:ENST00000568369.6:splice_region_variant&intron_variant:LOW:intron13/42:c.1226-20A>G::,FANCA:ENST00000564475.6:splice_region_variant&intron_variant:LOW:intron13/41:c.1226-20A>G::,FANCA:ENST00000696287.1:splice_region_variant&intron_variant:LOW:intron13/40:c.1226-20A>G::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255232 [benign DISEASE=Fanconi anemia complementation group A,Fanconi anemia,not specified];			rs1800330	0.42531	0.55114,0.48892,0.76526,0.31166,0.59772	15190,	34242	87318	-5.4410			0.01		4.71>4.86	COSV66881251	0.01	25741868,21850187,23021409,33863951	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89791616	89791616	A	G	het	off-target	QUAL=6259;DP=534;QD=11.72;AF=0.53;MQM=60;SAP=481;ABP=8;SAR=267;SAF=17	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron13/42:c.1226-80T>C::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron13/42:c.1226-80T>C::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron13/41:c.1226-80T>C::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron13/40:c.1226-80T>C::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1180472 [benign DISEASE=Fanconi anemia complementation group A,not provided];			rs6500450	0.53836	0.75168,0.54545,0.98102,0.39559,0.62407	24611,	32575	70141	-0.7840			0.32			COSV66881253	0.05	23021409,33863951	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89791776	89791776	A	G	hom	off-target	QUAL=1851;DP=59;QD=31.37;AF=0.98;MQM=60;SAP=3;ABP=0;SAR=29;SAF=29	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron13/42:c.1225+151T>C::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron13/42:c.1225+151T>C::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron13/41:c.1225+151T>C::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron13/40:c.1225+151T>C::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1180473 [benign DISEASE=Fanconi anemia complementation group A,not provided];			rs6500451	0.97157	0.99257,0.97831,0.99981,0.95676,0.98407	71802,	4195	4325	-0.7740			1.34				0.08	23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89792097	89792097	T	C	het	off-target	QUAL=4326;DP=300;QD=14.42;AF=0.51;MQM=60;SAP=3;ABP=3;SAR=78;SAF=75	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron12/42:c.1084-29A>G::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron12/42:c.1084-29A>G::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron12/41:c.1084-29A>G::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron12/40:c.1084-29A>G::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255229 [benign DISEASE=Fanconi anemia complementation group A,not specified,not provided];			rs6500452	0.40303	0.50583,0.47851,0.75983,0.30234,0.50166	13540,	34157	90705	-2.0850			0.09			COSV66880734	0.02	25741868,23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89792117	89792117	C	G	het	off-target	QUAL=4329;DP=302;QD=14.33;AF=0.51;MQM=60;SAP=3;ABP=3;SAR=79;SAF=74	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron12/42:c.1084-49G>C::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron12/42:c.1084-49G>C::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron12/41:c.1084-49G>C::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron12/40:c.1084-49G>C::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255230 [benign DISEASE=Fanconi anemia complementation group A,not specified,not provided];			rs1800287	0.53831	0.75109,0.54573,0.98095,0.39560,0.62391	24598,	32605	70157	-0.1090			1.07			COSV66881254	0.01	25741868,23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89792249	89792249	C	G	het	off-target	QUAL=316;DP=26;QD=12.15;AF=0.58;MQM=60;SAP=21;ABP=4;SAR=2;SAF=13	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron12/42:c.1084-181G>C::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron12/42:c.1084-181G>C::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron12/41:c.1084-181G>C::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron12/40:c.1084-181G>C::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1264276 [benign DISEASE=not provided];			rs6500453	0.53832	0.75068,0.54597,0.98142,0.39571,0.62624	24569,	32587	70089	0.9310			4.21				0.02	23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89792351	89792351	C	T	het	off-target	QUAL=456;DP=49;QD=9.31;AF=0.41;MQM=60;SAP=31;ABP=7;SAR=2;SAF=18	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron12/42:c.1083+120G>A::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron12/42:c.1083+120G>A::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron12/41:c.1083+120G>A::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron12/40:c.1083+120G>A::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1180474 [benign DISEASE=Fanconi anemia complementation group A,not provided];			rs17226159	0.12113	0.03812,0.11986,0.00443,0.17070,0.16998	1445,	15540	133718	-1.1480			0.77				0.24	23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89792600	89792600	G	A	het	off-target	QUAL=948;DP=102;QD=9.29;AF=0.41;MQM=60;SAP=24;ABP=10;SAR=11;SAF=31	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron11/42:c.1007-53C>T::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron11/42:c.1007-53C>T::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron11/41:c.1007-53C>T::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron11/40:c.1007-53C>T::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1242487 [benign DISEASE=not provided];			rs3856	0.40454	0.50601,0.47866,0.80173,0.30324,0.51125	13293,	34081	89299	-0.0020			2.88				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89792608	89792608	T	-	het	off-target	QUAL=876;DP=104;QD=8.42;AF=0.39;MQM=60;SAP=22;ABP=13;SAR=11;SAF=30	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron11/42:c.1007-61del::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron11/42:c.1007-61del::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron11/41:c.1007-61del::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron11/40:c.1007-61del::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1289093 [benign DISEASE=not provided];			rs35617323	0.48465	0.56812,0.52439,0.98072,0.39414,0.62292	19147,	35104	78048	0.0480			0.75				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89798903	89798903	T	C	het	off-target	QUAL=375;DP=32;QD=11.72;AF=0.50;MQM=60;SAP=38;ABP=3;SAR=0;SAF=16	FANCA	intron,3'UTR,downstream_gene	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron10/42:c.893+263A>G::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron10/42:c.893+263A>G::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron10/41:c.893+263A>G::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron10/40:c.893+263A>G::,FANCA:ENST00000389302.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*176A>G::,FANCA:ENST00000563673.5:3_prime_UTR_variant:MODIFIER:exon10/10:c.*205A>G::,FANCA:ENST00000534992.5:downstream_gene_variant:MODIFIER::::,FANCA:ENST00000543736.5:downstream_gene_variant:MODIFIER::::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1218370 [likely benign DISEASE=not provided];			rs17226026	0.01232	0.00290,0.01166,0.00019,0.01546,0.05879	29,	1814	150104	-1.9270			0.09				0.03		13	462	4 / 53					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89799635	89799635	T	C	het		QUAL=9356;DP=724;QD=12.92;AF=0.50;MQM=60;SAP=3;ABP=3;SAR=178;SAF=182	FANCA	missense	FANCA:ENST00000389301.8:missense_variant:MODERATE:exon9/43:c.796A>G:p.Thr266Ala:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000568369.6:missense_variant:MODERATE:exon9/43:c.796A>G:p.Thr266Ala:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000564475.6:missense_variant:MODERATE:exon9/42:c.796A>G:p.Thr266Ala:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000696287.1:missense_variant:MODERATE:exon9/41:c.796A>G:p.Thr266Ala:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000389302.7:missense_variant:MODERATE:exon9/11:c.796A>G:p.Thr266Ala:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000563673.5:missense_variant:MODERATE:exon9/10:c.796A>G:p.Thr266Ala:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000534992.5:missense_variant:MODERATE:exon9/11:c.796A>G:p.Thr266Ala:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000543736.5:missense_variant:MODERATE:exon8/10:c.700A>G:p.Thr234Ala:PF15865 [Fanconi anaemia group A protein N terminus]		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	134294 [benign DISEASE=Malignant tumor of breast,Fanconi anemia complementation group A,Fanconi anemia,Inborn genetic diseases,not specified,not provided];	CM137879 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA];		rs7190823	0.53093	0.71720,0.54423,0.98136,0.39900,0.62837	23636,	33447	71315	0.6710	T(0.84),T(0.83),T(0.82),T(0.85),T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	2.79	0.08			0.25	25741868,24728327,20386703,26139146,23826176,19012493,23021409,24320210,30072632,29098742,25653542	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89799752	89799752	A	G	het	off-target	QUAL=1464;DP=98;QD=14.94;AF=0.61;MQM=60;SAP=4;ABP=14;SAR=32;SAF=28	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron8/42:c.793-114T>C::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron8/42:c.793-114T>C::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron8/41:c.793-114T>C::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron8/40:c.793-114T>C::,FANCA:ENST00000389302.7:intron_variant:MODIFIER:intron8/10:c.793-114T>C::,FANCA:ENST00000563673.5:intron_variant:MODIFIER:intron8/9:c.793-114T>C::,FANCA:ENST00000534992.5:intron_variant:MODIFIER:intron8/10:c.793-114T>C::,FANCA:ENST00000543736.5:intron_variant:MODIFIER:intron7/9:c.697-114T>C::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1253922 [benign DISEASE=not provided];		AluYk4 (SINE/Alu)	rs7186192	0.65533	0.77443,0.65102,0.98556,0.56819,0.73768	33734,	32161	52399	-1.6560			0.56			COSV66881257	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89799769	89799769	G	A	het	off-target	QUAL=41;DP=7;QD=5.86;AF=0.43;MQM=60;SAP=10;ABP=3;SAR=3;SAF=0	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron8/42:c.793-131C>T::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron8/42:c.793-131C>T::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron8/41:c.793-131C>T::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron8/40:c.793-131C>T::,FANCA:ENST00000389302.7:intron_variant:MODIFIER:intron8/10:c.793-131C>T::,FANCA:ENST00000563673.5:intron_variant:MODIFIER:intron8/9:c.793-131C>T::,FANCA:ENST00000534992.5:intron_variant:MODIFIER:intron8/10:c.793-131C>T::,FANCA:ENST00000543736.5:intron_variant:MODIFIER:intron7/9:c.697-131C>T::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1194031 [likely benign DISEASE=not provided];		AluYk4 (SINE/Alu)	rs34427386	0.00745	0.00183,0.00282,0.00000,0.01204,0.00248	9,	1115	151035	-2.7840			0.12				0		2	236	2 / 31					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89803156	89803156	G	A	het	off-target	QUAL=12893;DP=1028;QD=12.54;AF=0.49;MQM=60;SAP=3;ABP=4;SAR=257;SAF=248	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron8/42:c.792+103C>T::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron8/42:c.792+103C>T::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron8/41:c.792+103C>T::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron8/40:c.792+103C>T::,FANCA:ENST00000389302.7:intron_variant:MODIFIER:intron8/10:c.792+103C>T::,FANCA:ENST00000563673.5:intron_variant:MODIFIER:intron8/9:c.792+103C>T::,FANCA:ENST00000534992.5:intron_variant:MODIFIER:intron8/10:c.792+103C>T::,FANCA:ENST00000543736.5:intron_variant:MODIFIER:intron7/9:c.696+103C>T::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1197847 [likely benign DISEASE=not provided];		L1MA5A (LINE/L1)	rs35506335	0.02428	0.00575,0.03094,0.00019,0.02941,0.07857	78,	3537	148379	-2.8750			0.13				0		12	272	0 / 32					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89803353	89803353	T	C	hom	off-target	QUAL=3848;DP=114;QD=33.75;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=58;SAF=56	FANCA	splice_region&intron	FANCA:ENST00000389301.8:splice_region_variant&intron_variant:LOW:intron7/42:c.710-12A>G::,FANCA:ENST00000568369.6:splice_region_variant&intron_variant:LOW:intron7/42:c.710-12A>G::,FANCA:ENST00000564475.6:splice_region_variant&intron_variant:LOW:intron7/41:c.710-12A>G::,FANCA:ENST00000696287.1:splice_region_variant&intron_variant:LOW:intron7/40:c.710-12A>G::,FANCA:ENST00000389302.7:splice_region_variant&intron_variant:LOW:intron7/10:c.710-12A>G::,FANCA:ENST00000563673.5:splice_region_variant&intron_variant:LOW:intron7/9:c.710-12A>G::,FANCA:ENST00000534992.5:splice_region_variant&intron_variant:LOW:intron7/10:c.710-12A>G::,FANCA:ENST00000543736.5:splice_region_variant&intron_variant:LOW:intron6/9:c.614-12A>G::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255269 [benign DISEASE=Fanconi anemia complementation group A,Fanconi anemia,not specified,not provided];			rs1800286	0.71720	0.91655,0.69487,0.98652,0.59507,0.81514	40949,	27114	42984	-1.9470			1.75		9.13>9.77		0.08	25741868,23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89808151	89808151	A	C	het	off-target	QUAL=1869;DP=132;QD=14.16;AF=0.60;MQM=60;SAP=105;ABP=14;SAR=9;SAF=70	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron6/42:c.596+143T>G::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron6/42:c.596+143T>G::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron6/41:c.596+143T>G::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron6/40:c.596+143T>G::,FANCA:ENST00000389302.7:intron_variant:MODIFIER:intron6/10:c.596+143T>G::,FANCA:ENST00000563673.5:intron_variant:MODIFIER:intron6/9:c.596+143T>G::,FANCA:ENST00000534992.5:intron_variant:MODIFIER:intron6/10:c.596+143T>G::,FANCA:ENST00000543736.5:intron_variant:MODIFIER:intron5/9:c.500+143T>G::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1180476 [benign DISEASE=Fanconi anemia complementation group A,not provided];			rs11076627	0.46060	0.50831,0.51533,0.97729,0.38840,0.52008	17323,	35314	81930	0.4050			7.35				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89808220	89808220	C	T	het	off-target	QUAL=1661;DP=117;QD=14.20;AF=0.61;MQM=60;SAP=89;ABP=15;SAR=9;SAF=62	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron6/42:c.596+74G>A::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron6/42:c.596+74G>A::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron6/41:c.596+74G>A::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron6/40:c.596+74G>A::,FANCA:ENST00000389302.7:intron_variant:MODIFIER:intron6/10:c.596+74G>A::,FANCA:ENST00000563673.5:intron_variant:MODIFIER:intron6/9:c.596+74G>A::,FANCA:ENST00000534992.5:intron_variant:MODIFIER:intron6/10:c.596+74G>A::,FANCA:ENST00000543736.5:intron_variant:MODIFIER:intron5/9:c.500+74G>A::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1180477 [benign DISEASE=Fanconi anemia complementation group A,not provided];			rs1800285	0.53057	0.72171,0.54089,0.98150,0.39789,0.61634	23652,	33270	71288	-0.2360			2.77				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr17	7673145	7673145	G	A	hom	off-target	QUAL=281;DP=15;QD=18.73;AF=0.93;MQM=60;SAP=33;ABP=0;SAR=0;SAF=14	TP53	intron	TP53:ENST00000413465.6:intron_variant:MODIFIER:intron6/6:c.782+1036C>T::,TP53:ENST00000359597.8:intron_variant:MODIFIER:intron8/8:c.993+390C>T::,TP53:ENST00000504290.5:intron_variant:MODIFIER:intron6/7:c.*12+62C>T::,TP53:ENST00000504937.5:intron_variant:MODIFIER:intron5/6:c.597+390C>T::,TP53:ENST00000510385.5:intron_variant:MODIFIER:intron6/7:c.*100+62C>T::,TP53:ENST00000610623.4:intron_variant:MODIFIER:intron6/7:c.*12+62C>T::,TP53:ENST00000618944.4:intron_variant:MODIFIER:intron6/7:c.*100+62C>T::,TP53:ENST00000619186.4:intron_variant:MODIFIER:intron5/6:c.516+390C>T::,TP53:ENST00000610292.4:intron_variant:MODIFIER:intron8/9:c.876+390C>T::,TP53:ENST00000620739.4:intron_variant:MODIFIER:intron9/10:c.876+390C>T::,TP53:ENST00000420246.6:intron_variant:MODIFIER:intron10/11:c.*100+62C>T::,TP53:ENST00000455263.6:intron_variant:MODIFIER:intron10/11:c.*12+62C>T::,TP53:ENST00000610538.4:intron_variant:MODIFIER:intron10/11:c.*12+62C>T::,TP53:ENST00000622645.4:intron_variant:MODIFIER:intron10/11:c.*100+62C>T::,TP53:ENST00000445888.6:intron_variant:MODIFIER:intron9/10:c.993+390C>T::,TP53:ENST00000619485.4:intron_variant:MODIFIER:intron9/10:c.876+390C>T::,TP53:ENST00000269305.9:intron_variant:MODIFIER:intron9/10:c.993+390C>T::		191170_[GENE=TP53_PHENOS={Basal cell carcinoma 7}, 614740 (3), Autosomal dominant; {Adrenocortical carcinoma, pediatric}, 202300 (3), Autosomal dominant; Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Li-Fraumeni syndrome, 151623 (3), Autosomal dominant; Pancreatic cancer, somatic, 260350 (3); Nasopharyngeal carcinoma, somatic, 607107 (3); {Osteosarcoma}, 259500 (3), Somatic mutation; {Choroid plexus papilloma}, 260500 (3), Autosomal dominant; {Colorectal cancer}, 114500 (3), Somatic mutation, Autosomal dominant; {Glioma susceptibility 1}, 137800 (3), Somatic mutation, Autosomal dominant; Bone marrow failure syndrome 5, 618165 (3), Autosomal dominant]			Tigger5b (DNA/TcMar-Tigger)	rs1375871549	0.00037	0.00016,0.00048,0.00085,0.00023,0.00038	0,	32	85334	-1.3800			0.45				0		4	0	4 / 0					TP53 (inh=AD oe_syn=1.07 oe_mis=0.82 oe_lof=0.20)
chr17	7674797	7674797	T	C	het	off-target	QUAL=66;DP=12;QD=5.50;AF=0.42;MQM=60;SAP=14;ABP=4;SAR=0;SAF=5	TP53	intron	TP53:ENST00000413465.6:intron_variant:MODIFIER:intron5/6:c.672+62A>G::,TP53:ENST00000359597.8:intron_variant:MODIFIER:intron5/8:c.672+62A>G::,TP53:ENST00000504290.5:intron_variant:MODIFIER:intron2/7:c.276+62A>G::,TP53:ENST00000504937.5:intron_variant:MODIFIER:intron2/6:c.276+62A>G::,TP53:ENST00000510385.5:intron_variant:MODIFIER:intron2/7:c.276+62A>G::,TP53:ENST00000610623.4:intron_variant:MODIFIER:intron2/7:c.195+62A>G::,TP53:ENST00000618944.4:intron_variant:MODIFIER:intron2/7:c.195+62A>G::,TP53:ENST00000619186.4:intron_variant:MODIFIER:intron2/6:c.195+62A>G::,TP53:ENST00000610292.4:intron_variant:MODIFIER:intron5/9:c.555+62A>G::,TP53:ENST00000620739.4:intron_variant:MODIFIER:intron6/10:c.555+62A>G::,TP53:ENST00000420246.6:intron_variant:MODIFIER:intron6/11:c.672+62A>G::,TP53:ENST00000455263.6:intron_variant:MODIFIER:intron6/11:c.672+62A>G::,TP53:ENST00000610538.4:intron_variant:MODIFIER:intron6/11:c.555+62A>G::,TP53:ENST00000622645.4:intron_variant:MODIFIER:intron6/11:c.555+62A>G::,TP53:ENST00000445888.6:intron_variant:MODIFIER:intron6/10:c.672+62A>G::,TP53:ENST00000619485.4:intron_variant:MODIFIER:intron6/10:c.555+62A>G::,TP53:ENST00000269305.9:intron_variant:MODIFIER:intron6/10:c.672+62A>G::		191170_[GENE=TP53_PHENOS={Basal cell carcinoma 7}, 614740 (3), Autosomal dominant; {Adrenocortical carcinoma, pediatric}, 202300 (3), Autosomal dominant; Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Li-Fraumeni syndrome, 151623 (3), Autosomal dominant; Pancreatic cancer, somatic, 260350 (3); Nasopharyngeal carcinoma, somatic, 607107 (3); {Osteosarcoma}, 259500 (3), Somatic mutation; {Choroid plexus papilloma}, 260500 (3), Autosomal dominant; {Colorectal cancer}, 114500 (3), Somatic mutation, Autosomal dominant; {Glioma susceptibility 1}, 137800 (3), Somatic mutation, Autosomal dominant; Bone marrow failure syndrome 5, 618165 (3), Autosomal dominant]	256603 [benign DISEASE=Li-Fraumeni syndrome 1,Hereditary cancer-predisposing syndrome,not specified,not provided];			rs1625895	0.83055	0.71312,0.88436,0.96668,0.87256,0.79888	52884,	20492	25760	0.2300			3.31				0.01	25741868,27917368,18854777,16465622,18640487,19826048,19426493,19276375,28415781,24818791,21402718,25340731,19276285,12466288,17428325,28678827,30867801,25233467,18798306,17151932,17301252,17449902,17624591,19193430,19423538,19505915,21810023,21838531,23029260,23360829,29167767,30796655,31205533,31788124,17908995,25430047,30048458,31624379,31686737,25925845,30801535,29892419,22829776,27503997,23412385,21342648,30944658,20445773,16039051,18314326,21869887,19386249,33942220,33544795,32423484,34190520,25842861,34295994,31143958,32214837,32552660,33462484,32445942,33985476,32888145,34953598,34848757,35571038,35865244,36039053	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2022-06-22 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2021-03-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			TP53 (inh=AD oe_syn=1.07 oe_mis=0.82 oe_lof=0.20)
chr17	7675327	7675327	C	T	het	off-target	QUAL=16271;DP=1265;QD=12.86;AF=0.51;MQM=60;SAP=4;ABP=4;SAR=329;SAF=315	TP53	intron,5'UTR	TP53:ENST00000413465.6:intron_variant:MODIFIER:intron3/6:c.376-91G>A::,TP53:ENST00000359597.8:intron_variant:MODIFIER:intron3/8:c.376-91G>A::,TP53:ENST00000504290.5:5_prime_UTR_variant:MODIFIER:exon1/8:c.-112G>A::,TP53:ENST00000504937.5:5_prime_UTR_variant:MODIFIER:exon1/7:c.-112G>A::,TP53:ENST00000510385.5:5_prime_UTR_variant:MODIFIER:exon1/8:c.-112G>A::,TP53:ENST00000610623.4:5_prime_UTR_variant:MODIFIER:exon1/8:c.-193G>A::,TP53:ENST00000618944.4:5_prime_UTR_variant:MODIFIER:exon1/8:c.-193G>A::,TP53:ENST00000619186.4:5_prime_UTR_variant:MODIFIER:exon1/7:c.-193G>A::,TP53:ENST00000610292.4:intron_variant:MODIFIER:intron3/9:c.259-91G>A::,TP53:ENST00000620739.4:intron_variant:MODIFIER:intron4/10:c.259-91G>A::,TP53:ENST00000420246.6:intron_variant:MODIFIER:intron4/11:c.376-91G>A::,TP53:ENST00000455263.6:intron_variant:MODIFIER:intron4/11:c.376-91G>A::,TP53:ENST00000610538.4:intron_variant:MODIFIER:intron4/11:c.259-91G>A::,TP53:ENST00000622645.4:intron_variant:MODIFIER:intron4/11:c.259-91G>A::,TP53:ENST00000445888.6:intron_variant:MODIFIER:intron4/10:c.376-91G>A::,TP53:ENST00000619485.4:intron_variant:MODIFIER:intron4/10:c.259-91G>A::,TP53:ENST00000269305.9:intron_variant:MODIFIER:intron4/10:c.376-91G>A::		191170_[GENE=TP53_PHENOS={Basal cell carcinoma 7}, 614740 (3), Autosomal dominant; {Adrenocortical carcinoma, pediatric}, 202300 (3), Autosomal dominant; Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Li-Fraumeni syndrome, 151623 (3), Autosomal dominant; Pancreatic cancer, somatic, 260350 (3); Nasopharyngeal carcinoma, somatic, 607107 (3); {Osteosarcoma}, 259500 (3), Somatic mutation; {Choroid plexus papilloma}, 260500 (3), Autosomal dominant; {Colorectal cancer}, 114500 (3), Somatic mutation, Autosomal dominant; {Glioma susceptibility 1}, 137800 (3), Somatic mutation, Autosomal dominant; Bone marrow failure syndrome 5, 618165 (3), Autosomal dominant]	440348 [benign DISEASE=Li-Fraumeni syndrome 1,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];			rs2909430	0.83740	0.73666,0.88711,0.96694,0.87256,0.79988	53502,	19882	24638	0.3200			2.35			COSV52668782	0.01	27917368,23761422,27246533,19276375,18678618,24818791,21402718,24218030,19276285,28976792,29963112,25233467,15450681,17301252,17449902,19423538,22962577,28364582,28373458,31205533,31788124,25925845,28542283,26503811,20352120,21342648,24177593,32882831,33942220,32899294,35923699,36164436	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53 (inh=AD oe_syn=1.07 oe_mis=0.82 oe_lof=0.20)
chr17	7675394	7675395	TT	-	het	off-target	QUAL=101;DP=16;QD=6.31;AF=0.25;MQM=60;SAP=12;ABP=12;SAR=4;SAF=0	TP53	intron,5'UTR	TP53:ENST00000413465.6:intron_variant:MODIFIER:intron3/6:c.376-159_376-158del::,TP53:ENST00000359597.8:intron_variant:MODIFIER:intron3/8:c.376-159_376-158del::,TP53:ENST00000504290.5:5_prime_UTR_variant:MODIFIER:exon1/8:c.-180_-179del::,TP53:ENST00000504937.5:5_prime_UTR_variant:MODIFIER:exon1/7:c.-180_-179del::,TP53:ENST00000510385.5:5_prime_UTR_variant:MODIFIER:exon1/8:c.-180_-179del::,TP53:ENST00000610623.4:5_prime_UTR_variant:MODIFIER:exon1/8:c.-261_-260del::,TP53:ENST00000618944.4:5_prime_UTR_variant:MODIFIER:exon1/8:c.-261_-260del::,TP53:ENST00000619186.4:5_prime_UTR_variant:MODIFIER:exon1/7:c.-261_-260del::,TP53:ENST00000610292.4:intron_variant:MODIFIER:intron3/9:c.259-159_259-158del::,TP53:ENST00000620739.4:intron_variant:MODIFIER:intron4/10:c.259-159_259-158del::,TP53:ENST00000420246.6:intron_variant:MODIFIER:intron4/11:c.376-159_376-158del::,TP53:ENST00000455263.6:intron_variant:MODIFIER:intron4/11:c.376-159_376-158del::,TP53:ENST00000610538.4:intron_variant:MODIFIER:intron4/11:c.259-159_259-158del::,TP53:ENST00000622645.4:intron_variant:MODIFIER:intron4/11:c.259-159_259-158del::,TP53:ENST00000445888.6:intron_variant:MODIFIER:intron4/10:c.376-159_376-158del::,TP53:ENST00000619485.4:intron_variant:MODIFIER:intron4/10:c.259-159_259-158del::,TP53:ENST00000269305.9:intron_variant:MODIFIER:intron4/10:c.376-159_376-158del::		191170_[GENE=TP53_PHENOS={Basal cell carcinoma 7}, 614740 (3), Autosomal dominant; {Adrenocortical carcinoma, pediatric}, 202300 (3), Autosomal dominant; Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Li-Fraumeni syndrome, 151623 (3), Autosomal dominant; Pancreatic cancer, somatic, 260350 (3); Nasopharyngeal carcinoma, somatic, 607107 (3); {Osteosarcoma}, 259500 (3), Somatic mutation; {Choroid plexus papilloma}, 260500 (3), Autosomal dominant; {Colorectal cancer}, 114500 (3), Somatic mutation, Autosomal dominant; {Glioma susceptibility 1}, 137800 (3), Somatic mutation, Autosomal dominant; Bone marrow failure syndrome 5, 618165 (3), Autosomal dominant]	1213246 [likely benign DISEASE=not provided];		AluJb (SINE/Alu)	rs5819162	0.00823	0.00923,0.00650,0.00128,0.00849,0.00915	6,	1123	136817	0.2640			1.04				0		3	201	0 / 19					TP53 (inh=AD oe_syn=1.07 oe_mis=0.82 oe_lof=0.20)
chr17	7675394	7675396	TTT	-	het	off-target	QUAL=101;DP=16;QD=6.31;AF=0.31;MQM=60;SAP=14;ABP=8;SAR=5;SAF=0	TP53	intron,5'UTR	TP53:ENST00000413465.6:intron_variant:MODIFIER:intron3/6:c.376-160_376-158del::,TP53:ENST00000359597.8:intron_variant:MODIFIER:intron3/8:c.376-160_376-158del::,TP53:ENST00000504290.5:5_prime_UTR_variant:MODIFIER:exon1/8:c.-181_-179del::,TP53:ENST00000504937.5:5_prime_UTR_variant:MODIFIER:exon1/7:c.-181_-179del::,TP53:ENST00000510385.5:5_prime_UTR_variant:MODIFIER:exon1/8:c.-181_-179del::,TP53:ENST00000610623.4:5_prime_UTR_variant:MODIFIER:exon1/8:c.-262_-260del::,TP53:ENST00000618944.4:5_prime_UTR_variant:MODIFIER:exon1/8:c.-262_-260del::,TP53:ENST00000619186.4:5_prime_UTR_variant:MODIFIER:exon1/7:c.-262_-260del::,TP53:ENST00000610292.4:intron_variant:MODIFIER:intron3/9:c.259-160_259-158del::,TP53:ENST00000620739.4:intron_variant:MODIFIER:intron4/10:c.259-160_259-158del::,TP53:ENST00000420246.6:intron_variant:MODIFIER:intron4/11:c.376-160_376-158del::,TP53:ENST00000455263.6:intron_variant:MODIFIER:intron4/11:c.376-160_376-158del::,TP53:ENST00000610538.4:intron_variant:MODIFIER:intron4/11:c.259-160_259-158del::,TP53:ENST00000622645.4:intron_variant:MODIFIER:intron4/11:c.259-160_259-158del::,TP53:ENST00000445888.6:intron_variant:MODIFIER:intron4/10:c.376-160_376-158del::,TP53:ENST00000619485.4:intron_variant:MODIFIER:intron4/10:c.259-160_259-158del::,TP53:ENST00000269305.9:intron_variant:MODIFIER:intron4/10:c.376-160_376-158del::		191170_[GENE=TP53_PHENOS={Basal cell carcinoma 7}, 614740 (3), Autosomal dominant; {Adrenocortical carcinoma, pediatric}, 202300 (3), Autosomal dominant; Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Li-Fraumeni syndrome, 151623 (3), Autosomal dominant; Pancreatic cancer, somatic, 260350 (3); Nasopharyngeal carcinoma, somatic, 607107 (3); {Osteosarcoma}, 259500 (3), Somatic mutation; {Choroid plexus papilloma}, 260500 (3), Autosomal dominant; {Colorectal cancer}, 114500 (3), Somatic mutation, Autosomal dominant; {Glioma susceptibility 1}, 137800 (3), Somatic mutation, Autosomal dominant; Bone marrow failure syndrome 5, 618165 (3), Autosomal dominant]	803309 [benign/likely benign DISEASE=Li-Fraumeni syndrome 1,Squamous cell carcinoma of the head and neck,Hereditary cancer-predisposing syndrome,not provided];		AluJb (SINE/Alu)	rs5819162	0.80866	0.70640,0.81918,0.95874,0.85226,0.77974	45249,	21036	26390	0.2640			1.02				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53 (inh=AD oe_syn=1.07 oe_mis=0.82 oe_lof=0.20)
chr17	7676154	7676154	G	C	het		QUAL=7587;DP=557;QD=13.62;AF=0.54;MQM=60;SAP=3;ABP=10;SAR=147;SAF=153	TP53	missense,upstream_gene	TP53:ENST00000413465.6:missense_variant:MODERATE:exon3/7:c.215C>G:p.Pro72Arg:,TP53:ENST00000359597.8:missense_variant:MODERATE:exon3/9:c.215C>G:p.Pro72Arg:,TP53:ENST00000610292.4:missense_variant:MODERATE:exon3/10:c.98C>G:p.Pro33Arg:,TP53:ENST00000620739.4:missense_variant:MODERATE:exon4/11:c.98C>G:p.Pro33Arg:,TP53:ENST00000420246.6:missense_variant:MODERATE:exon4/12:c.215C>G:p.Pro72Arg:,TP53:ENST00000455263.6:missense_variant:MODERATE:exon4/12:c.215C>G:p.Pro72Arg:,TP53:ENST00000610538.4:missense_variant:MODERATE:exon4/12:c.98C>G:p.Pro33Arg:,TP53:ENST00000622645.4:missense_variant:MODERATE:exon4/12:c.98C>G:p.Pro33Arg:,TP53:ENST00000445888.6:missense_variant:MODERATE:exon4/11:c.215C>G:p.Pro72Arg:,TP53:ENST00000619485.4:missense_variant:MODERATE:exon4/11:c.98C>G:p.Pro33Arg:,TP53:ENST00000269305.9:missense_variant:MODERATE:exon4/11:c.215C>G:p.Pro72Arg:,TP53:ENST00000504290.5:upstream_gene_variant:MODIFIER::::,TP53:ENST00000504937.5:upstream_gene_variant:MODIFIER::::,TP53:ENST00000510385.5:upstream_gene_variant:MODIFIER::::,TP53:ENST00000610623.4:upstream_gene_variant:MODIFIER::::,TP53:ENST00000618944.4:upstream_gene_variant:MODIFIER::::,TP53:ENST00000619186.4:upstream_gene_variant:MODIFIER::::		191170_[GENE=TP53_PHENOS={Basal cell carcinoma 7}, 614740 (3), Autosomal dominant; {Adrenocortical carcinoma, pediatric}, 202300 (3), Autosomal dominant; Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Li-Fraumeni syndrome, 151623 (3), Autosomal dominant; Pancreatic cancer, somatic, 260350 (3); Nasopharyngeal carcinoma, somatic, 607107 (3); {Osteosarcoma}, 259500 (3), Somatic mutation; {Choroid plexus papilloma}, 260500 (3), Autosomal dominant; {Colorectal cancer}, 114500 (3), Somatic mutation, Autosomal dominant; {Glioma susceptibility 1}, 137800 (3), Somatic mutation, Autosomal dominant; Bone marrow failure syndrome 5, 618165 (3), Autosomal dominant]	12351 [benign DISEASE=CODON 72 POLYMORPHISM,Li-Fraumeni syndrome 1,Hepatocellular carcinoma,Acute myeloid leukemia,Choroid plexus papilloma,Bone osteosarcoma,Hereditary breast ovarian cancer syndrome,Carcinoma of pancreas,Colorectal cancer,Adrenocortical carcinoma, hereditary,Basal cell carcinoma, susceptibility to, 7,Hereditary cancer-predisposing syndrome,Nasopharyngeal carcinoma,Familial cancer of breast,Li-Fraumeni syndrome,Lip and oral cavity carcinoma,Glioma susceptibility 1,Bone marrow failure syndrome 5,not specified,not provided];			rs1042522	0.62732	0.38751,0.69938,0.57654,0.74502,0.52117	31786,	31721	56611	1.4380	T(0.06),T(0.11),D(0.03),D(0.03),T(0.09),T(0.10),T(0.08),T(0.08),T(0.14),D(0.03),T(0.14), , , , , , 	B(0.38),B(0.23), , , , , , , , , , , , , , , 	5.09	0.37		COSV52666208,COSV53098660	0.05	25741868,30409984,23267696,26451011,24033266,24728327,24944790,21708280,21514219,23946381,28652652,30551681,22879966,22992668,23820649,27277665,27716216,25214541,25719551,20599859,28827732,30337837,30793520,30988702,26690118,20003265,26873362,23757202,30781715,29193749,18805939,18854777,30937706,18191955,23168575,18298806,22215955,22655231,24084248,27871254,26870349,16465622,16857995,19822020,27415837,27588484,29484706,19911060,20855462,25479941,18640487,19470478,21779510,24654968,26382048,26867771,30956778,21589938,23906684,18978339,30139066,30807515,28881764,18547414,18715757,18830263,19826048,23072573,20638924,20847277,21897271,27618021,28348449,19426493,19657586,20452958,21841506,24820515,27246533,21533266,24534481,22194650,26900293,31821471,19276375,22703879,18678618,28415781,29458332,24818791,27376129,25203442,21402718,28324443,24218030,25412941,18990748,19442035,22742565,26130668,17428325,27698805,27900359,29860059,25591549,26683024,31528229,28351583,23697595,21877955,30867801,22300735,28210099,2287514	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2022-06-22 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2021-03-02 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahpohla1 15.04.2019"			TP53 (inh=AD oe_syn=1.07 oe_mis=0.82 oe_lof=0.20)
chr17	7676326	7676341	CCCCAGCCCTCCAGGT	-	het	off-target;low_conf_region	QUAL=131;DP=19;QD=6.89;AF=0.47;MQM=60;SAP=15;ABP=3;SAR=8;SAF=1	TP53	intron,upstream_gene	TP53:ENST00000413465.6:intron_variant:MODIFIER:intron2/6:c.96+41_97-54del::,TP53:ENST00000359597.8:intron_variant:MODIFIER:intron2/8:c.96+41_97-54del::,TP53:ENST00000610292.4:intron_variant:MODIFIER:intron2/9:c.-22+41_-21-54del::,TP53:ENST00000620739.4:intron_variant:MODIFIER:intron3/10:c.-22+41_-21-54del::,TP53:ENST00000420246.6:intron_variant:MODIFIER:intron3/11:c.96+41_97-54del::,TP53:ENST00000455263.6:intron_variant:MODIFIER:intron3/11:c.96+41_97-54del::,TP53:ENST00000610538.4:intron_variant:MODIFIER:intron3/11:c.-22+41_-21-54del::,TP53:ENST00000622645.4:intron_variant:MODIFIER:intron3/11:c.-22+41_-21-54del::,TP53:ENST00000445888.6:intron_variant:MODIFIER:intron3/10:c.96+41_97-54del::,TP53:ENST00000619485.4:intron_variant:MODIFIER:intron3/10:c.-22+41_-21-54del::,TP53:ENST00000269305.9:intron_variant:MODIFIER:intron3/10:c.96+41_97-54del::,TP53:ENST00000504290.5:upstream_gene_variant:MODIFIER::::,TP53:ENST00000504937.5:upstream_gene_variant:MODIFIER::::,TP53:ENST00000510385.5:upstream_gene_variant:MODIFIER::::,TP53:ENST00000610623.4:upstream_gene_variant:MODIFIER::::,TP53:ENST00000618944.4:upstream_gene_variant:MODIFIER::::,TP53:ENST00000619186.4:upstream_gene_variant:MODIFIER::::		191170_[GENE=TP53_PHENOS={Basal cell carcinoma 7}, 614740 (3), Autosomal dominant; {Adrenocortical carcinoma, pediatric}, 202300 (3), Autosomal dominant; Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Li-Fraumeni syndrome, 151623 (3), Autosomal dominant; Pancreatic cancer, somatic, 260350 (3); Nasopharyngeal carcinoma, somatic, 607107 (3); {Osteosarcoma}, 259500 (3), Somatic mutation; {Choroid plexus papilloma}, 260500 (3), Autosomal dominant; {Colorectal cancer}, 114500 (3), Somatic mutation, Autosomal dominant; {Glioma susceptibility 1}, 137800 (3), Somatic mutation, Autosomal dominant; Bone marrow failure syndrome 5, 618165 (3), Autosomal dominant]	440349 [benign DISEASE=Li-Fraumeni syndrome 1,Hereditary cancer-predisposing syndrome,not specified,Breast and/or ovarian cancer,not provided];			rs59758982	0.82696	0.73321,0.87551,0.96349,0.85639,0.79109	51911,	20932	26104	1.0620			2.80				0	19471604,31772679,31316092,32000721,30816478,32888145,36123588	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53 (inh=AD oe_syn=1.07 oe_mis=0.82 oe_lof=0.20)
chr17	31201318	31201318	A	T	het	off-target	QUAL=264;DP=24;QD=11.00;AF=0.75;MQM=60;SAP=42;ABP=16;SAR=18;SAF=0	NF1	intron	NF1:ENST00000487476.5:intron_variant:MODIFIER:intron10/13:c.1186-93A>T::,NF1:ENST00000356175.7:intron_variant:MODIFIER:intron10/56:c.1186-93A>T::,NF1:ENST00000696138.1:intron_variant:MODIFIER:intron10/58:c.1186-93A>T::,NF1:ENST00000431387.8:intron_variant:MODIFIER:intron10/14:c.1186-93A>T::,NF1:ENST00000358273.9:intron_variant:MODIFIER:intron10/57:c.1186-93A>T::,NF1:ENST00000691014.1:intron_variant:MODIFIER:intron10/58:c.1186-93A>T::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Somatic mutation, Autosomal dominant; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]										0.5050			1.99				0		0	2	0 / 1					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31226318	31226318	-	ACAC	het	off-target	QUAL=372;DP=24;QD=15.50;AF=0.25;MQM=60;SAP=16;ABP=16;SAR=0;SAF=6	NF1	intron,downstream_gene	NF1:ENST00000356175.7:intron_variant:MODIFIER:intron17/56:c.2002-79_2002-76dup::,NF1:ENST00000696138.1:intron_variant:MODIFIER:intron18/58:c.2047-79_2047-76dup::,NF1:ENST00000358273.9:intron_variant:MODIFIER:intron17/57:c.2002-79_2002-76dup::,NF1:ENST00000691014.1:intron_variant:MODIFIER:intron18/58:c.2032-79_2032-76dup::,NF1:ENST00000431387.8:downstream_gene_variant:MODIFIER::::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Somatic mutation, Autosomal dominant; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]	1257651 [benign DISEASE=not provided];			rs59547221	0.10524	0.08823,0.11006,0.06127,0.11595,0.07044	826,	12898	123708				0.99				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31226318	31226318	-	ACACAC	het	off-target	QUAL=372;DP=24;QD=15.50;AF=0.25;MQM=60;SAP=31;ABP=3;SAR=0;SAF=13	NF1	intron,downstream_gene	NF1:ENST00000356175.7:intron_variant:MODIFIER:intron17/56:c.2002-81_2002-76dup::,NF1:ENST00000696138.1:intron_variant:MODIFIER:intron18/58:c.2047-81_2047-76dup::,NF1:ENST00000358273.9:intron_variant:MODIFIER:intron17/57:c.2002-81_2002-76dup::,NF1:ENST00000691014.1:intron_variant:MODIFIER:intron18/58:c.2032-81_2032-76dup::,NF1:ENST00000431387.8:downstream_gene_variant:MODIFIER::::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Somatic mutation, Autosomal dominant; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]	1220711 [benign DISEASE=not provided];			rs59547221	0.10640	0.07430,0.14812,0.05158,0.12344,0.07279	906,	12898	123548				0.95				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31226467	31226467	G	A	hom		QUAL=2514;DP=83;QD=30.29;AF=1.00;MQM=60;SAP=25;ABP=0;SAR=27;SAF=56	NF1	synonymous,downstream_gene	NF1:ENST00000356175.7:synonymous_variant:LOW:exon18/57:c.2034G>A:p.Pro678=:,NF1:ENST00000696138.1:synonymous_variant:LOW:exon19/59:c.2079G>A:p.Pro693=:,NF1:ENST00000358273.9:synonymous_variant:LOW:exon18/58:c.2034G>A:p.Pro678=:,NF1:ENST00000691014.1:synonymous_variant:LOW:exon19/59:c.2064G>A:p.Pro688=:,NF1:ENST00000431387.8:downstream_gene_variant:MODIFIER::::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Somatic mutation, Autosomal dominant; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]	183826 [benign DISEASE=Neurofibromatosis, familial spinal,Cafe-au-lait macules with pulmonary stenosis,Neurofibromatosis-Noonan syndrome,Hereditary cancer-predisposing syndrome,Neurofibromatosis, type 1,not specified,Cardiovascular phenotype,not provided];			rs2285892	0.42520	0.67404,0.43291,0.52415,0.29533,0.38200	15853,	32808	87212	-1.2810			1.98			COSV62191601	0.02	25741868,24033266,17668375,21354044,30283335,34449562	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31231064	31231064	T	C	hom	off-target	QUAL=426;DP=17;QD=25.06;AF=1.00;MQM=60;SAP=40;ABP=0;SAR=17;SAF=0	NF1	intron	NF1:ENST00000356175.7:intron_variant:MODIFIER:intron24/56:c.3197+139T>C::,NF1:ENST00000696138.1:intron_variant:MODIFIER:intron25/58:c.3242+139T>C::,NF1:ENST00000358273.9:intron_variant:MODIFIER:intron24/57:c.3197+139T>C::,NF1:ENST00000691014.1:intron_variant:MODIFIER:intron25/58:c.3227+139T>C::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Somatic mutation, Autosomal dominant; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]	561469 [benign DISEASE=not provided];			rs2071009	0.46511	0.80772,0.44777,0.53512,0.29712,0.38350	20227,	30206	81262	-0.0860			1.06				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31232043	31232043	-	T	het	off-target;low_conf_region	QUAL=512;DP=87;QD=5.89;AF=0.30;MQM=60;SAP=15;ABP=34;SAR=19;SAF=7	NF1	splice_region&intron	NF1:ENST00000356175.7:splice_region_variant&intron_variant:LOW:intron24/56:c.3198-4dup::,NF1:ENST00000696138.1:splice_region_variant&intron_variant:LOW:intron25/58:c.3243-4dup::,NF1:ENST00000358273.9:splice_region_variant&intron_variant:LOW:intron24/57:c.3198-4dup::,NF1:ENST00000691014.1:splice_region_variant&intron_variant:LOW:intron25/58:c.3228-4dup::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Somatic mutation, Autosomal dominant; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]	803349 [benign DISEASE=Neurofibromatosis, type 1,not specified,not provided];			rs371047262	0.21949	0.22000,0.20680,0.30315,0.22976,0.23009	4358,	11221	70897				3.43						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31232570	31232570	G	C	hom	off-target	QUAL=8058;DP=401;QD=20.09;AF=1.00;MQM=60;SAP=874;ABP=0;SAR=0;SAF=401	NF1	intron	NF1:ENST00000356175.7:intron_variant:MODIFIER:intron25/56:c.3315-130G>C::,NF1:ENST00000696138.1:intron_variant:MODIFIER:intron26/58:c.3360-130G>C::,NF1:ENST00000358273.9:intron_variant:MODIFIER:intron25/57:c.3315-130G>C::,NF1:ENST00000691014.1:intron_variant:MODIFIER:intron26/58:c.3345-130G>C::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Somatic mutation, Autosomal dominant; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]	561471 [benign DISEASE=not provided];			rs2072131	0.46282	0.81343,0.44749,0.43863,0.29654,0.37459	20122,	30052	81592	-0.0560			1.26			COSV62206709	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31232914	31232914	C	A	hom	off-target	QUAL=1030;DP=35;QD=29.43;AF=1.00;MQM=60;SAP=71;ABP=0;SAR=34;SAF=1	NF1	intron	NF1:ENST00000356175.7:intron_variant:MODIFIER:intron26/56:c.3496+33C>A::,NF1:ENST00000696138.1:intron_variant:MODIFIER:intron27/58:c.3541+33C>A::,NF1:ENST00000358273.9:intron_variant:MODIFIER:intron26/57:c.3496+33C>A::,NF1:ENST00000691014.1:intron_variant:MODIFIER:intron27/58:c.3526+33C>A::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Somatic mutation, Autosomal dominant; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]	257285 [benign DISEASE=Neurofibromatosis, type 1,not specified,not provided];			rs2066736	0.40357	0.61123,0.42581,0.43786,0.29439,0.37250	13847,	33577	90551	0.2040			1.36			COSV62196981	0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31236055	31236055	-	TG	hom	off-target;low_conf_region	QUAL=9225;DP=397;QD=23.24;AF=0.90;MQM=60;SAP=508;ABP=0;SAR=35;SAF=324	NF1	intron	NF1:ENST00000356175.7:intron_variant:MODIFIER:intron29/56:c.3974+36_3974+37dup::,NF1:ENST00000696138.1:intron_variant:MODIFIER:intron30/58:c.4019+36_4019+37dup::,NF1:ENST00000358273.9:intron_variant:MODIFIER:intron29/57:c.3974+36_3974+37dup::,NF1:ENST00000691014.1:intron_variant:MODIFIER:intron30/58:c.4004+36_4004+37dup::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Somatic mutation, Autosomal dominant; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]			(T)n (Simple_repeat)	rs1555615581	0.00116	0.00853,0.00063,0.00062,0.00059,0.00208	0,	63	54165				1.26				0		1037	13631	259 / 2435					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31236067	31236067	T	G	hom	off-target;low_conf_region	QUAL=10229;DP=371;QD=27.57;AF=0.99;MQM=60;SAP=508;ABP=0;SAR=38;SAF=331	NF1	intron	NF1:ENST00000356175.7:intron_variant:MODIFIER:intron29/56:c.3974+46T>G::,NF1:ENST00000696138.1:intron_variant:MODIFIER:intron30/58:c.4019+46T>G::,NF1:ENST00000358273.9:intron_variant:MODIFIER:intron29/57:c.3974+46T>G::,NF1:ENST00000691014.1:intron_variant:MODIFIER:intron30/58:c.4004+46T>G::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Somatic mutation, Autosomal dominant; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]			(T)n (Simple_repeat)	rs72813695	0.00236	0.00092,0.00178,0.00312,0.00265,0.00291	1,	355	150937	-1.2570			0.72			COSV62193060	0.01		1018	13827	287 / 2435					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31336154	31336154	A	C	hom	off-target	QUAL=690;DP=24;QD=28.75;AF=1.00;MQM=60;SAP=55;ABP=0;SAR=0;SAF=24	NF1	intron	NF1:ENST00000356175.7:intron_variant:MODIFIER:intron39/56:c.5944-179A>C::,NF1:ENST00000696138.1:intron_variant:MODIFIER:intron40/58:c.5989-179A>C::,NF1:ENST00000358273.9:intron_variant:MODIFIER:intron40/57:c.6007-179A>C::,NF1:ENST00000691014.1:intron_variant:MODIFIER:intron41/58:c.6037-179A>C::,NF1:ENST00000687027.1:intron_variant:MODIFIER:intron4/21:c.163-179A>C::,NF1:ENST00000693617.1:intron_variant:MODIFIER:intron6/23:c.571-179A>C::,NF1:ENST00000684826.1:intron_variant:MODIFIER:intron5/23:c.571-179A>C::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Somatic mutation, Autosomal dominant; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]	561473 [benign DISEASE=not provided];			rs10853138	0.89315	0.83274,0.88041,0.89073,0.91864,0.95197	60778,	14177	16239	-0.4210			0.98				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31336607	31336607	-	A	het	off-target;low_conf_region	QUAL=815;DP=37;QD=22.03;AF=0.78;MQM=60;SAP=43;ABP=29;SAR=26;SAF=3	NF1	splice_region&intron	NF1:ENST00000356175.7:splice_region_variant&intron_variant:LOW:intron40/56:c.6085-17dup::,NF1:ENST00000696138.1:splice_region_variant&intron_variant:LOW:intron41/58:c.6130-17dup::,NF1:ENST00000358273.9:splice_region_variant&intron_variant:LOW:intron41/57:c.6148-17dup::,NF1:ENST00000691014.1:splice_region_variant&intron_variant:LOW:intron42/58:c.6178-17dup::,NF1:ENST00000687027.1:splice_region_variant&intron_variant:LOW:intron5/21:c.304-17dup::,NF1:ENST00000693617.1:splice_region_variant&intron_variant:LOW:intron7/23:c.712-17dup::,NF1:ENST00000684826.1:splice_region_variant&intron_variant:LOW:intron6/23:c.712-17dup::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Somatic mutation, Autosomal dominant; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]	495785 [benign DISEASE=Hereditary cancer-predisposing syndrome,Cardiovascular phenotype,not provided];			rs33925668	0.34199	0.45752,0.39669,0.41520,0.27736,0.24779	9270,	32489	98185				0.15				0.01	20186797,10678181,23460398,27069254	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31343172	31343172	C	G	hom	off-target	QUAL=5223;DP=163;QD=32.04;AF=1.00;MQM=60;SAP=3;ABP=0;SAR=79;SAF=84	NF1,AK4P1	intron,upstream_gene	NF1:ENST00000356175.7:intron_variant:MODIFIER:intron47/56:c.7126+37C>G::,NF1:ENST00000696138.1:intron_variant:MODIFIER:intron48/58:c.7171+37C>G::,NF1:ENST00000358273.9:intron_variant:MODIFIER:intron48/57:c.7189+37C>G::,NF1:ENST00000691014.1:intron_variant:MODIFIER:intron49/58:c.7219+37C>G::,NF1:ENST00000687027.1:intron_variant:MODIFIER:intron12/21:c.1345+37C>G::,NF1:ENST00000693617.1:intron_variant:MODIFIER:intron14/23:c.1753+37C>G::,NF1:ENST00000684826.1:intron_variant:MODIFIER:intron13/23:c.1753+37C>G::,AK4P1:ENST00000581275.2:upstream_gene_variant:MODIFIER::::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Somatic mutation, Autosomal dominant; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]	257300 [benign DISEASE=Neurofibromatosis, type 1,not specified,not provided];			rs7405740	0.88388	0.80045,0.87750,0.89099,0.91839,0.95201	59658,	15149	17665	-1.4250			1.00				0	25741868,19417008	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22), AK4P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr17	35101468	35101468	A	G	het	off-target	QUAL=1248;DP=83;QD=15.04;AF=0.57;MQM=60;SAP=7;ABP=6;SAR=28;SAF=19	RAD51D,Vault	intron,upstream_gene	RAD51D:ENST00000345365.11:intron_variant:MODIFIER:intron8/9:c.739-103T>C::,RAD51D:ENST00000394589.8:intron_variant:MODIFIER:intron9/10:c.739-103T>C::,RAD51D:ENST00000335858.11:intron_variant:MODIFIER:intron5/6:c.403-103T>C::,RAD51D:ENST00000590016.5:intron_variant:MODIFIER:intron8/9:c.799-103T>C::,RAD51D:ENST00000460118.6:intron_variant:MODIFIER:intron7/8:c.208-103T>C::,Vault:ENST00000516519.1:upstream_gene_variant:MODIFIER::::		602954_[GENE=RAD51D_PHENOS={Breast-ovarian cancer, familial, susceptibility to, 4}, 614291 (3)]	1269566 [benign DISEASE=not provided];		MIR3 (SINE/MIR)	rs28363289	0.07858	0.03492,0.06722,0.04836,0.09336,0.14665	579,	10797	140181	0.3060			8.27				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51D (inh=AD oe_syn=1.01 oe_mis=1.02 oe_lof=0.80)
chr17	35106468	35106468	C	T	hom		QUAL=2514;DP=84;QD=29.93;AF=1.00;MQM=60;SAP=49;ABP=0;SAR=63;SAF=21	RAD51D	missense,5'UTR	RAD51D:ENST00000345365.11:missense_variant:MODERATE:exon6/10:c.494G>A:p.Arg165Gln:PF08423 [Rad51],RAD51D:ENST00000394589.8:missense_variant:MODERATE:exon7/11:c.494G>A:p.Arg165Gln:PF08423 [Rad51],RAD51D:ENST00000335858.11:missense_variant:MODERATE:exon3/7:c.158G>A:p.Arg53Gln:PF08423 [Rad51],RAD51D:ENST00000590016.5:missense_variant:MODERATE:exon6/10:c.554G>A:p.Arg185Gln:PF08423 [Rad51],RAD51D:ENST00000460118.6:5_prime_UTR_variant:MODIFIER:exon5/9:c.-38G>A::		602954_[GENE=RAD51D_PHENOS={Breast-ovarian cancer, familial, susceptibility to, 4}, 614291 (3)]	142159 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 4,Hereditary cancer-predisposing syndrome,not specified,not provided];	CM172631 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=RAD51D];		rs4796033	0.12112	0.03354,0.21713,0.04580,0.14407,0.14434	1452,	15517	133671	1.1790	T(1.00),T(1.00),T(1.00),T(1.00), 	B(0.00),B(0.00),B(0.00),B(0.01), 	14.87	0.13		COSV104653496	0.04	25741868,29458332,21822267,22986143,22652533,23372765,22415235,30591675	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahstaea1 08.05.2018: AF 15% in gnomAD und ExAC"			RAD51D (inh=AD oe_syn=1.01 oe_mis=1.02 oe_lof=0.80)
chr17	35106801	35106801	A	G	hom	off-target	QUAL=8879;DP=347;QD=25.59;AF=1.00;MQM=60;SAP=757;ABP=0;SAR=0;SAF=347	RAD51D	intron	RAD51D:ENST00000345365.11:intron_variant:MODIFIER:intron5/9:c.480+187T>C::,RAD51D:ENST00000394589.8:intron_variant:MODIFIER:intron6/10:c.480+187T>C::,RAD51D:ENST00000335858.11:intron_variant:MODIFIER:intron2/6:c.145-320T>C::,RAD51D:ENST00000590016.5:intron_variant:MODIFIER:intron5/9:c.540+187T>C::,RAD51D:ENST00000460118.6:intron_variant:MODIFIER:intron4/8:c.-52+187T>C::		602954_[GENE=RAD51D_PHENOS={Breast-ovarian cancer, familial, susceptibility to, 4}, 614291 (3)]	679676 [benign DISEASE=not provided];			rs936656	0.51041	0.53056,0.59973,0.57079,0.48279,0.62065	20012,	37501	74363	-3.7110			0.01				0.01	22652533	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51D (inh=AD oe_syn=1.01 oe_mis=1.02 oe_lof=0.80)
chr17	35118530	35118530	G	A	het		QUAL=1535;DP=116;QD=13.23;AF=0.52;MQM=60;SAP=17;ABP=3;SAR=20;SAF=40	RAD51D,FNDC8	synonymous,intron,upstream_gene	RAD51D:ENST00000345365.11:synonymous_variant:LOW:exon3/10:c.234C>T:p.Ser78=:PF08423 [Rad51],RAD51D:ENST00000394589.8:synonymous_variant:LOW:exon4/11:c.234C>T:p.Ser78=:PF08423 [Rad51],RAD51D:ENST00000335858.11:intron_variant:MODIFIER:intron2/6:c.144+581C>T::,RAD51D:ENST00000590016.5:intron_variant:MODIFIER:intron2/9:c.144+581C>T::,RAD51D:ENST00000460118.6:intron_variant:MODIFIER:intron2/8:c.-208+581C>T::,FNDC8:ENST00000158009.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site	602954_[GENE=RAD51D_PHENOS={Breast-ovarian cancer, familial, susceptibility to, 4}, 614291 (3)]	183785 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 4,Hereditary cancer-predisposing syndrome,not specified,not provided];			rs9901455	0.15578	0.29987,0.12559,0.22669,0.08274,0.08638	2577,	18529	128347	1.6750			17.75			COSV99338663	0.01	25741868,21822267,22986143,22652533,23372765,22415235	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51D (inh=AD oe_syn=1.01 oe_mis=1.02 oe_lof=0.80), FNDC8 (inh=n/a oe_syn=0.99 oe_mis=0.91 oe_lof=0.69)
chr17	43051308	43051308	T	A	het	off-target	QUAL=696;DP=60;QD=11.60;AF=0.48;MQM=60;SAP=66;ABP=3;SAR=29;SAF=0	BRCA1	intron	BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron19/22:c.5278-191A>T::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron18/21:c.1852-191A>T::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron20/23:c.5341-191A>T::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron19/21:c.1966-191A>T::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron17/20:c.1840-191A>T::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron4/7:c.208-191A>T::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron7/10:c.751-191A>T::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-98-1118A>T::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron18/21:c.5137-191A>T::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron19/22:c.1966-191A>T::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	209259 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 1,not provided];			rs8176297	0.31051	0.23232,0.27201,0.36961,0.33185,0.49419	7708,	31784	104810	-1.1500			0.37			COSV58783637	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43067543	43067543	C	T	het	off-target	QUAL=439;DP=32;QD=13.72;AF=0.56;MQM=60;SAP=3;ABP=4;SAR=9;SAF=9	BRCA1	intron,downstream_gene	BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron16/22:c.5074+65G>A::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron15/21:c.1648+65G>A::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron17/23:c.5137+65G>A::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron16/21:c.1762+65G>A::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron14/20:c.1636+65G>A::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-3592G>A::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron4/10:c.547+65G>A::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-98-17353G>A::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron15/21:c.4933+65G>A::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron16/22:c.1762+65G>A::,BRCA1:ENST00000700182.1:downstream_gene_variant:MODIFIER::::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	127126 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 1,Familial cancer of breast,not specified,not provided];		AluSc (SINE/Alu)	rs8176235	0.24720	0.16937,0.26764,0.37199,0.25479,0.46085	5009,	27531	114347	0.1670			3.77			COSV58786515	0	25741868,21989022,26926928	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43067763	43067763	T	C	het	off-target	QUAL=386;DP=33;QD=11.70;AF=0.67;MQM=60;SAP=42;ABP=11;SAR=21;SAF=1	BRCA1	intron,downstream_gene	BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron15/22:c.4987-68A>G::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron14/21:c.1561-68A>G::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron16/23:c.5050-68A>G::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron15/21:c.1675-68A>G::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron13/20:c.1549-68A>G::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-3812A>G::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron3/10:c.460-68A>G::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-98-17573A>G::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron14/21:c.4846-68A>G::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron15/22:c.1675-68A>G::,BRCA1:ENST00000700182.1:downstream_gene_variant:MODIFIER::::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	125746 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Breast-ovarian cancer, familial, susceptibility to, 1,Hereditary cancer-predisposing syndrome,not specified,not provided];			rs8176234	0.31558	0.23374,0.32637,0.36905,0.33127,0.48937	7826,	32001	103347	-2.2540			0.13			COSV58794203	0.01	25741868,17916242,28076423	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43071077	43071077	T	C	het		QUAL=4318;DP=415;QD=10.40;AF=0.47;MQM=60;SAP=253;ABP=7;SAR=171;SAF=22	BRCA1	missense,intron	BRCA1:ENST00000357654.9:missense_variant:MODERATE:exon15/23:c.4837A>G:p.Ser1613Gly:,BRCA1:ENST00000352993.7:missense_variant:MODERATE:exon14/22:c.1411A>G:p.Ser471Gly:,BRCA1:ENST00000471181.7:missense_variant:MODERATE:exon16/24:c.4900A>G:p.Ser1634Gly:,BRCA1:ENST00000468300.5:missense_variant:MODERATE:exon15/22:c.1525A>G:p.Ser509Gly:,BRCA1:ENST00000484087.6:missense_variant:MODERATE:exon13/21:c.1399A>G:p.Ser467Gly:,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-7126A>G::,BRCA1:ENST00000591534.5:missense_variant:MODERATE:exon3/11:c.310A>G:p.Ser104Gly:,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-98-20887A>G::,BRCA1:ENST00000493795.5:missense_variant:MODERATE:exon14/22:c.4696A>G:p.Ser1566Gly:,BRCA1:ENST00000491747.6:missense_variant:MODERATE:exon15/23:c.1525A>G:p.Ser509Gly:,BRCA1:ENST00000700182.1:missense_variant:MODERATE:exon14/14:c.1444A>G:p.Ser482Gly:		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	41827 [benign DISEASE=Breast carcinoma,Hereditary breast ovarian cancer syndrome,Malignant tumor of breast,Breast-ovarian cancer, familial, susceptibility to, 1,Pancreatic cancer, susceptibility to, 4,Hereditary cancer-predisposing syndrome,Familial cancer of breast,Fanconi anemia, complementation group S,not specified,not provided];	CM1210129 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=BRCA1];		rs1799966	0.31785	0.23698,0.32922,0.37071,0.33220,0.49274	8001,	32288	103636	-0.1940	T(0.08),T(0.05),T(0.09),T(0.08),T(0.09), ,T(0.35), ,T(0.09),T(0.30),D(0.04)	B(0.04),B(0.30),B(0.04),B(0.16),B(0.24), ,B(0.04), ,B(0.04),B(0.24),B(0.24)	8.64	0.25		COSV58783381	0	25741868,24033266,24728327,21204206,18559551,26901225,30693270,18830263,22703879,29458332,21161372,21597964,22430443,23961350,24062231,27478808,28415599,27698805,31203256,20104584,20807450,25896959,32039725,10728701,12955716,17341484,21702907,21990134,21356067,15617999,23767878,17308087,18694767,28439188,26183948,22921312,21989022,28771511,17916242,24986639,15235020,21890493,29492227,32100578,19482343,24933103,30832521,17585057,22136207,15726418,9333265,9523200,10951344,15689452,25735359,21447777,17719744,23674270,15350310,21765009,18992264,15004537,27008870,26092435,28944232,31131559,22503699,26414677,29657992,31205572,29997359,28672935,25602962,18558292,21504591,33547301,23749302,31706072,32284662,21712546,25923920,28076423,9326340,30765603,25653542,27251275,23186163,25159151,26052455,28781887,32324802,31123752,30541318,27899611,33004033,33499154,34094541,32203205,32606146,34242281,34319543,32424803,33507988,32606887,31962039,35300046,35693198	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43074584	43074584	G	C	het	off-target	QUAL=75;DP=12;QD=6.25;AF=0.42;MQM=60;SAP=14;ABP=4;SAR=5;SAF=0	BRCA1,RPL21P4	intron,upstream_gene	BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron13/22:c.4485-63C>G::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron12/21:c.1059-63C>G::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron14/23:c.4548-63C>G::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron13/21:c.1173-63C>G::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron11/20:c.1047-63C>G::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-10633C>G::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-63C>G::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-98-24394C>G::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron12/21:c.4344-63C>G::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron13/22:c.1173-63C>G::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron12/13:c.1092-63C>G::,RPL21P4:ENST00000497954.1:upstream_gene_variant:MODIFIER::::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	209374 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 1,not specified,not provided];			rs273900734	0.31653	0.23458,0.32938,0.36974,0.33110,0.49296	7936,	32228	103860	0.0020			3.09			COSV58794229	0	25741868,21356067,28944232,28076423	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73), RPL21P4 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr17	43074658	43074658	A	T	het	off-target	QUAL=367;DP=34;QD=10.79;AF=0.59;MQM=60;SAP=46;ABP=5;SAR=20;SAF=0	BRCA1,RPL21P4	intron,upstream_gene	BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron13/22:c.4485-137T>A::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron12/21:c.1059-137T>A::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron14/23:c.4548-137T>A::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron13/21:c.1173-137T>A::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron11/20:c.1047-137T>A::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-10707T>A::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-137T>A::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-98-24468T>A::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron12/21:c.4344-137T>A::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron13/22:c.1173-137T>A::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron12/13:c.1092-137T>A::,RPL21P4:ENST00000497954.1:upstream_gene_variant:MODIFIER::::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	209375 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 1,not specified,not provided];			rs2236762	0.45139	0.68782,0.37618,0.37051,0.34047,0.52219	17260,	34033	83317	-0.5760			0.58			COSV58801011	0	19276285	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73), RPL21P4 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr17	43074720	43074724	GGGTT	-	het	off-target	QUAL=256;DP=31;QD=8.26;AF=0.52;MQM=60;SAP=38;ABP=3;SAR=16;SAF=0	BRCA1,RPL21P4	intron,upstream_gene	BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron13/22:c.4485-203_4485-199del::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron12/21:c.1059-203_1059-199del::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron14/23:c.4548-203_4548-199del::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron13/21:c.1173-203_1173-199del::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron11/20:c.1047-203_1047-199del::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-10773_5-10769del::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-203_-43-199del::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-98-24534_-98-24530del::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron12/21:c.4344-203_4344-199del::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron13/22:c.1173-203_1173-199del::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron12/13:c.1092-203_1092-199del::,RPL21P4:ENST00000497954.1:upstream_gene_variant:MODIFIER::::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	209376 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 1,not provided];			rs34250703	0.29917	0.17934,0.31918,0.36678,0.33005,0.49149	7304,	30757	106271	0.9620			4.91				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73), RPL21P4 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr17	43079499	43079499	C	T	het	off-target	QUAL=1760;DP=109;QD=16.15;AF=0.59;MQM=60;SAP=3;ABP=10;SAR=32;SAF=32	BRCA1,RPL21P4	intron,non_coding_transcript_exon	BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron12/22:c.4358-2885G>A::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron11/21:c.932-2885G>A::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron12/23:c.4358-100G>A::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron12/21:c.1049-2888G>A::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron10/20:c.923-2888G>A::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-15548G>A::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-4978G>A::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-98-29309G>A::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron11/21:c.4217-2885G>A::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron12/22:c.1049-2888G>A::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron11/13:c.968-2888G>A::,RPL21P4:ENST00000497954.1:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.198C>T::	regulatory_region_variant:enhancer	113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	209399 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Breast-ovarian cancer, familial, susceptibility to, 1,not provided];			rs8176193	0.31648	0.23424,0.32900,0.37022,0.33078,0.49316	7928,	32211	103813	0.5280			7.21			COSV58789905	0	26012346,33126731	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73), RPL21P4 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr17	43082453	43082453	A	G	het		QUAL=321;DP=32;QD=10.03;AF=0.47;MQM=60;SAP=27;ABP=3;SAR=1;SAF=14	BRCA1,RPL21P4	synonymous,intron,downstream_gene	BRCA1:ENST00000357654.9:synonymous_variant:LOW:exon12/23:c.4308T>C:p.Ser1436=:,BRCA1:ENST00000352993.7:synonymous_variant:LOW:exon11/22:c.882T>C:p.Ser294=:,BRCA1:ENST00000471181.7:synonymous_variant:LOW:exon12/24:c.4308T>C:p.Ser1436=:,BRCA1:ENST00000468300.5:synonymous_variant:LOW:exon12/22:c.999T>C:p.Ser333=:,BRCA1:ENST00000484087.6:synonymous_variant:LOW:exon10/21:c.873T>C:p.Ser291=:,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-18502T>C::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-7932T>C::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-98-32263T>C::,BRCA1:ENST00000493795.5:synonymous_variant:LOW:exon11/22:c.4167T>C:p.Ser1389=:,BRCA1:ENST00000491747.6:synonymous_variant:LOW:exon12/23:c.999T>C:p.Ser333=:,BRCA1:ENST00000700182.1:synonymous_variant:LOW:exon11/14:c.918T>C:p.Ser306=:,RPL21P4:ENST00000497954.1:downstream_gene_variant:MODIFIER::::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	125703 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Breast-ovarian cancer, familial, susceptibility to, 1,Pancreatic cancer, susceptibility to, 4,Hereditary cancer-predisposing syndrome,Familial cancer of breast,Fanconi anemia, complementation group S,not specified,not provided];	CM1719086 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=BRCA1];		rs1060915	0.30082	0.18076,0.31979,0.36912,0.33168,0.49233	7437,	30849	106273	0.1030			3.88	0.06		COSV58783806	0	25741868,24033266,21161372,21597964,19644020,27478808,20807450,19471317,21702907,21356067,23767878,21191178,17916242,24986639,22136207,26092435,28944232,22503699,29997359,31934565,28076423,31658756,33004033,31962039,35300046,35693198	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahstaea1 10.08.2018: AF"			BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73), RPL21P4 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr17	43091173	43091173	T	G	het	off-target	QUAL=110;DP=16;QD=6.88;AF=0.44;MQM=60;SAP=18;ABP=4;SAR=7;SAF=0	BRCA1	intron,3'UTR	BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron10/22:c.4097-141A>C::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron9/21:c.671-141A>C::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron10/23:c.4097-141A>C::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron10/21:c.788-141A>C::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron8/20:c.665-141A>C::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-27222A>C::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-16652A>C::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+34098A>C::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron9/21:c.3956-141A>C::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron10/22:c.788-141A>C::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron9/13:c.707-141A>C::,BRCA1:ENST00000354071.7:3_prime_UTR_variant:MODIFIER:exon10/10:c.*158A>C::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	125674 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 1,Familial cancer of breast,not specified,not provided];			rs799916	0.45112	0.68595,0.37561,0.37003,0.34120,0.52345	17223,	34091	83389	-2.5950			0.01			COSV58794250	0	30594178,12466288,17916242,33507988,35087763	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43091983	43091983	T	C	het		QUAL=4691;DP=347;QD=13.52;AF=0.49;MQM=60;SAP=4;ABP=3;SAR=90;SAF=81	BRCA1	missense,intron	BRCA1:ENST00000357654.9:missense_variant:MODERATE:exon10/23:c.3548A>G:p.Lys1183Arg:,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron9/21:c.671-951A>G::,BRCA1:ENST00000471181.7:missense_variant:MODERATE:exon10/24:c.3548A>G:p.Lys1183Arg:,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron10/21:c.788-951A>G::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron8/20:c.665-951A>G::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-28032A>G::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-17462A>G::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+33288A>G::,BRCA1:ENST00000493795.5:missense_variant:MODERATE:exon9/22:c.3407A>G:p.Lys1136Arg:,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron10/22:c.788-951A>G::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron9/13:c.707-951A>G::,BRCA1:ENST00000354071.7:missense_variant:MODERATE:exon10/10:c.3548A>G:p.Lys1183Arg:		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	41818 [benign DISEASE=Breast carcinoma,Hereditary breast ovarian cancer syndrome,Breast-ovarian cancer, familial, susceptibility to, 1,Pancreatic cancer, susceptibility to, 4,Hereditary cancer-predisposing syndrome,Familial cancer of breast,Fanconi anemia, complementation group S,not specified,not provided];	CM058359 [CLASS=DP MUT=ALT PHEN="Breast cancer protection against association with" GENE=BRCA1];		rs16942	0.31546	0.23247,0.32778,0.36978,0.33013,0.49378	7887,	32152	103998	-0.3190	T(1.00), ,T(1.00), , , , , ,T(1.00), , ,T(1.00)	B(0.00), ,B(0.00), , , , , ,B(0.00), , , 	1.10	0.07		COSV58784397	0	25741868,24728327,21204206,18830263,26012346,22703879,29458332,30594178,26559640,21161372,21597964,19644020,22430443,23961350,25178586,27478808,28415599,27698805,31203256,20104584,20807450,32039725,21702907,21990134,12872265,18694767,28439188,21766209,21708019,21890493,16026807,20233625,23313170,19482343,22136207,23674270,15923272,25802882,30075112,24052750,28944232,31131559,22503699,26052370,26414677,29997359,28672935,25602962,27273131,21504591,25923920,29785135,28076423,25653542,26052455,24244370,32324802,31123752,33004033,33126731,33499154,33875706,34094541,25771414,33240400,32606146,33462484,32459809,33407290,31962039,34608183,35300046,35693198	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43092418	43092418	T	C	het		QUAL=10733;DP=958;QD=11.20;AF=0.48;MQM=60;SAP=5;ABP=5;SAR=221;SAF=242	BRCA1	missense,intron	BRCA1:ENST00000357654.9:missense_variant:MODERATE:exon10/23:c.3113A>G:p.Glu1038Gly:,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron9/21:c.671-1386A>G::,BRCA1:ENST00000471181.7:missense_variant:MODERATE:exon10/24:c.3113A>G:p.Glu1038Gly:,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron10/21:c.788-1386A>G::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron8/20:c.665-1386A>G::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-28467A>G::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-17897A>G::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+32853A>G::,BRCA1:ENST00000493795.5:missense_variant:MODERATE:exon9/22:c.2972A>G:p.Glu991Gly:,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron10/22:c.788-1386A>G::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron9/13:c.707-1386A>G::,BRCA1:ENST00000354071.7:missense_variant:MODERATE:exon10/10:c.3113A>G:p.Glu1038Gly:		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	41815 [benign DISEASE=Breast carcinoma,Hereditary breast ovarian cancer syndrome,Malignant tumor of breast,Breast-ovarian cancer, familial, susceptibility to, 1,Pancreatic cancer, susceptibility to, 4,Hereditary cancer-predisposing syndrome,Familial cancer of breast,Fanconi anemia, complementation group S,not specified,not provided];	CM032861 [CLASS=DP MUT=ALT PHEN="Endometriosis association with" GENE=BRCA1];		rs16941	0.30030	0.18034,0.31894,0.36922,0.33127,0.49272	7401,	30781	106209	-0.1490	T(0.09), ,T(0.08), , , , , ,T(0.08), , ,T(0.08)	P(0.62), ,B(0.03), , , , , ,P(0.62), , , 	14.07	0.23		COSV58786412	0	25741868,24033266,24728327,18974781,18559551,18830263,22703879,29458332,21161372,19644020,22430443,23961350,27478808,28415599,27698805,31203256,20104584,20807450,24504028,32039725,12955716,21702907,21990134,23633455,12872265,23767878,22875147,18694767,24986639,9063749,12188064,15235020,20352487,21708019,21890493,24599715,29492227,32100578,23313170,19482343,23619945,22136207,17719744,23674270,15923272,30075112,24052750,28944232,31131559,29099791,22503699,19012493,29921024,26414677,29997359,28672935,25602962,27273131,18558292,32284662,29233532,25923920,30266954,29785135,28076423,25653542,26052455,21720365,27908594,30541318,33004033,33499154,33875706,34094541,33240400,34295994,32606146,32351891,33946592,32606887,31962039,35300046,35693198	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43092919	43092919	G	A	het		QUAL=2116;DP=128;QD=16.53;AF=0.59;MQM=60;SAP=8;ABP=11;SAR=44;SAF=31	BRCA1	missense,intron	BRCA1:ENST00000357654.9:missense_variant:MODERATE:exon10/23:c.2612C>T:p.Pro871Leu:,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron9/21:c.671-1887C>T::,BRCA1:ENST00000471181.7:missense_variant:MODERATE:exon10/24:c.2612C>T:p.Pro871Leu:,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron10/21:c.787+1825C>T::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron8/20:c.664+1825C>T::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-28968C>T::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-18398C>T::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+32352C>T::,BRCA1:ENST00000493795.5:missense_variant:MODERATE:exon9/22:c.2471C>T:p.Pro824Leu:,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron10/22:c.787+1825C>T::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron9/13:c.706+1825C>T::,BRCA1:ENST00000354071.7:missense_variant:MODERATE:exon10/10:c.2612C>T:p.Pro871Leu:	regulatory_region_variant:open_chromatin_region	113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	41812 [benign DISEASE=Breast carcinoma,Hereditary breast ovarian cancer syndrome,Breast-ovarian cancer, familial, susceptibility to, 1,Pancreatic cancer, susceptibility to, 4,Hereditary cancer-predisposing syndrome,Familial cancer of breast,Fanconi anemia, complementation group S,not specified,not provided];	CM096315 [CLASS=DFP MUT=ALT PHEN="Cervical cancer decreased risk association with" GENE=BRCA1];		rs799917	0.48708	0.81036,0.39014,0.37066,0.34073,0.52381	21221,	31573	77941	4.2470	T(1.00), ,T(1.00), , , , , ,T(1.00), , ,T(1.00)	B(0.00), ,B(0.00), , , , , ,B(0.00), , , 	17.66	0.14		COSV58784386	0.01	25741868,23554684,23614619,28698656,24728327,25114582,20332227,20003265,18937358,21204206,18559551,23973201,26263974,18830263,22703879,22778704,29458332,27859935,19276285,21161372,21597964,29963112,19644020,22430443,23961350,24062231,25178586,27478808,28415599,29209986,27698805,31203256,20104584,20807450,19471317,10923033,25896959,32039725,21702907,21990134,28678827,16111488,18694767,24756092,20843204,27073502,17916242,24986639,21708019,21890493,29492227,15743496,19482343,19484476,23293655,23619945,23749772,24933103,25266802,28744749,30820179,30832521,22136207,23996866,17719744,23674270,29582646,25652403,15923272,26092435,30075112,24052750,25759599,28944232,23964347,31131559,29099791,22503699,30322005,30531820,22035854,29921024,26414677,16381944,31938277,14681474,29997359,28672935,26180747,23555923,25602962,27273131,30536617,27572852,31706072,27983536,25923920,29785135,28076423,25653542,26052455,24244370,31658756,30541318,32284927,33499154,21286719,27221928,34008499,34094541,33240400,34295994,32606146,2685001	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43093220	43093220	A	G	het		QUAL=1541;DP=126;QD=12.23;AF=0.46;MQM=60;SAP=3;ABP=5;SAR=28;SAF=30	BRCA1	synonymous,intron	BRCA1:ENST00000357654.9:synonymous_variant:LOW:exon10/23:c.2311T>C:p.Leu771=:,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron9/21:c.671-2188T>C::,BRCA1:ENST00000471181.7:synonymous_variant:LOW:exon10/24:c.2311T>C:p.Leu771=:,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron10/21:c.787+1524T>C::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron8/20:c.664+1524T>C::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-29269T>C::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-18699T>C::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+32051T>C::,BRCA1:ENST00000493795.5:synonymous_variant:LOW:exon9/22:c.2170T>C:p.Leu724=:,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron10/22:c.787+1524T>C::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron9/13:c.706+1524T>C::,BRCA1:ENST00000354071.7:synonymous_variant:LOW:exon10/10:c.2311T>C:p.Leu771=:	regulatory_region_variant:open_chromatin_region	113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	125554 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Breast-ovarian cancer, familial, susceptibility to, 1,Pancreatic cancer, susceptibility to, 4,Hereditary cancer-predisposing syndrome,Familial cancer of breast,Fanconi anemia, complementation group S,not specified,not provided];	CM1719261 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=BRCA1];		rs16940	0.29951	0.18014,0.31916,0.36858,0.32954,0.49294	7352,	30778	106374	-0.4420			3.67			COSV58786443	0	25741868,17697348,18830263,19276285,21161372,21597964,19644020,22430443,25178586,27478808,20104584,20807450,21702907,23767878,21989022,24986639,15923272,26092435,30075112,28944232,31131559,29997359,27273131,32284662,28076423,33004033,34295994,33534415,31962039,35300046,35693198	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahstaea1 10.08.2018: AF"			BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43093449	43093449	G	A	het		QUAL=467;DP=61;QD=7.66;AF=0.44;MQM=60;SAP=62;ABP=5;SAR=0;SAF=27	BRCA1	synonymous,intron	BRCA1:ENST00000357654.9:synonymous_variant:LOW:exon10/23:c.2082C>T:p.Ser694=:,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron9/21:c.670+2397C>T::,BRCA1:ENST00000471181.7:synonymous_variant:LOW:exon10/24:c.2082C>T:p.Ser694=:,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron10/21:c.787+1295C>T::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron8/20:c.664+1295C>T::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-29498C>T::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-18928C>T::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+31822C>T::,BRCA1:ENST00000493795.5:synonymous_variant:LOW:exon9/22:c.1941C>T:p.Ser647=:,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron10/22:c.787+1295C>T::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron9/13:c.706+1295C>T::,BRCA1:ENST00000354071.7:synonymous_variant:LOW:exon10/10:c.2082C>T:p.Ser694=:		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	125536 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Breast-ovarian cancer, familial, susceptibility to, 1,Pancreatic cancer, susceptibility to, 4,Hereditary cancer-predisposing syndrome,Familial cancer of breast,Fanconi anemia, complementation group S,not specified,not provided];	CM1719085 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=BRCA1];		rs1799949	0.31569	0.23309,0.32811,0.36994,0.33021,0.49378	7893,	32165	103943	-0.0010			2.62			COSV58784419	0	25741868,24033266,19276285,21161372,19644020,27478808,20104584,20807450,12955716,21702907,22713736,28439188,21989022,24986639,16760288,15923272,25633036,30075112,24052750,28944232,29773799,26414677,29997359,27273131,28076423,34203389,33004033,33499154,33462484,32557794,31962039,29848177,35300046	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahstaea1 10.08.2018: AF"			BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43097077	43097077	A	G	het	off-target	QUAL=459;DP=43;QD=10.67;AF=0.56;MQM=60;SAP=55;ABP=4;SAR=0;SAF=24	BRCA1	intron	BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron8/22:c.593+167T>C::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron8/21:c.593+167T>C::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron8/23:c.593+167T>C::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron8/21:c.593+167T>C::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron7/20:c.548-2217T>C::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.4+28105T>C::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-22556T>C::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+28194T>C::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron7/21:c.452+167T>C::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron8/22:c.593+167T>C::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron7/13:c.512+167T>C::,BRCA1:ENST00000354071.7:intron_variant:MODIFIER:intron8/9:c.593+167T>C::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	209451 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 1,not provided];		L1PREC2 (LINE/L1)	rs8176145	0.31541	0.23241,0.32802,0.36926,0.33010,0.49337	7886,	32140	103990	-0.7490			1.10				0	17916242	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43097347	43097347	A	-	het	off-target	QUAL=537;DP=69;QD=7.78;AF=0.38;MQM=60;SAP=11;ABP=12;SAR=18;SAF=8	BRCA1	intron	BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron7/22:c.548-58del::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron7/21:c.548-58del::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron7/23:c.548-58del::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron7/21:c.548-58del::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron7/20:c.547+2428del::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.4+27835del::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-22826del::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+27924del::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron6/21:c.407-58del::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron7/22:c.548-58del::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron6/13:c.467-58del::,BRCA1:ENST00000354071.7:intron_variant:MODIFIER:intron7/9:c.548-58del::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	125889 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Breast-ovarian cancer, familial, susceptibility to, 1,Hereditary cancer-predisposing syndrome,not specified,not provided];	CD1727436 [CLASS=DM? MUT=ALT PHEN="Breast and/or ovarian cancer" GENE=BRCA1];		rs8176144	0.29981	0.18044,0.31914,0.36907,0.32972,0.49234	7387,	30764	106350	0.8980			12.13				0	25741868,21989022	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43099629	43099629	T	A	het	off-target	QUAL=2604;DP=242;QD=10.76;AF=0.54;MQM=60;SAP=285;ABP=6;SAR=0;SAF=130	BRCA1	intron	BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron7/22:c.547+146A>T::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron7/21:c.547+146A>T::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron7/23:c.547+146A>T::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron7/21:c.547+146A>T::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron7/20:c.547+146A>T::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.4+25553A>T::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-25108A>T::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+25642A>T::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron6/21:c.406+146A>T::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron7/22:c.547+146A>T::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron6/13:c.466+146A>T::,BRCA1:ENST00000354071.7:intron_variant:MODIFIER:intron7/9:c.547+146A>T::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	125879 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 1,Hereditary cancer-predisposing syndrome,not provided];		L2d (LINE/L2)	rs8176140	0.31548	0.23245,0.32815,0.37057,0.33013,0.49336	7889,	32127	103943	1.2360			16.67				0	28076423	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43104073	43104086	AAAAAAAAGAAAAG	-	het	off-target;low_conf_region	QUAL=12;DP=10;QD=1.20;AF=0.30;MQM=60;SAP=10;ABP=6;SAR=0;SAF=3	BRCA1	intron	BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron6/22:c.441+36_441+49del::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron6/21:c.441+36_441+49del::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron6/23:c.441+36_441+49del::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron6/21:c.441+36_441+49del::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron6/20:c.441+36_441+49del::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.4+21096_4+21109del::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-44+21185_-44+21198del::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+21185_-99+21198del::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron5/21:c.300+36_300+49del::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron6/22:c.441+36_441+49del::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron5/13:c.363+36_363+49del::,BRCA1:ENST00000354071.7:intron_variant:MODIFIER:intron6/9:c.441+36_441+49del::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	225705 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 1,Pancreatic cancer, susceptibility to, 4,Familial cancer of breast,Fanconi anemia, complementation group S,not specified,not provided];		Alu (SINE/Alu), (AAG)n (Simple_repeat)	rs373413425	0.30710	0.22195,0.32109,0.36202,0.32612,0.48626	7273,	30890	102514	1.8490			1.40				0	25741868,28439188	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2022-06-22 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2021-03-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43124230	43124230	A	G	het	off-target	QUAL=388;DP=43;QD=9.02;AF=0.49;MQM=60;SAP=49;ABP=3;SAR=21;SAF=0	BRCA1,NBR2	intron,upstream_gene	BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron1/22:c.-19-115T>C::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron1/21:c.-19-115T>C::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron1/23:c.-19-115T>C::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron1/21:c.-19-115T>C::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron1/20:c.-19-115T>C::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.4+952T>C::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-44+1041T>C::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+1041T>C::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron1/21:c.-106-115T>C::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron1/22:c.-19-115T>C::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron1/13:c.-19-115T>C::,BRCA1:ENST00000354071.7:intron_variant:MODIFIER:intron1/9:c.-19-115T>C::,NBR2:ENST00000657841.1:upstream_gene_variant:MODIFIER::::,NBR2:ENST00000467245.5:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	125468 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 1,not specified,not provided];			rs3765640	0.31651	0.23296,0.33030,0.36975,0.33176,0.49296	7943,	32212	103864	-0.1120			4.51			COSV58789216	0.01	28439188,21766209,29997359,34287479,31962039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73), NBR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr17	58692526	58692526	G	A	het	off-target	QUAL=228;DP=23;QD=9.91;AF=0.52;MQM=60;SAP=29;ABP=3;SAR=0;SAF=12	TEX14,IGBP1C,RAD51C	upstream_gene	TEX14:ENST00000349033.10:upstream_gene_variant:MODIFIER::::,TEX14:ENST00000389934.7:upstream_gene_variant:MODIFIER::::,TEX14:ENST00000240361.12:upstream_gene_variant:MODIFIER::::,IGBP1C:ENST00000583666.3:upstream_gene_variant:MODIFIER::::,RAD51C:ENST00000583539.5:upstream_gene_variant:MODIFIER::::,RAD51C:ENST00000461271.6:upstream_gene_variant:MODIFIER::::,RAD51C:ENST00000697686.1:upstream_gene_variant:MODIFIER::::,RAD51C:ENST00000697690.1:upstream_gene_variant:MODIFIER::::,RAD51C:ENST00000337432.9:upstream_gene_variant:MODIFIER::::,RAD51C:ENST00000421782.3:upstream_gene_variant:MODIFIER::::,RAD51C:ENST00000697694.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	605792_[GENE=TEX14_PHENOS=Spermatogenic failure 23, 617707 (3), Autosomal recessive]&602774_[GENE=RAD51C_PHENOS={Breast-ovarian cancer, familial, susceptibility to, 3}, 613399 (3); Fanconi anemia, complementation group O, 613390 (3), Autosomal recessive]	1250767 [benign DISEASE=not provided];			rs16943176	0.18467	0.13674,0.17650,0.17602,0.21153,0.13851	2772,	22548	124026	0.8640			8.86					25343521,31905201,21980511,26406419,29659014,22843497	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TEX14 (inh=AR oe_syn=0.96 oe_mis=1.04 oe_lof=0.78), IGBP1C (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), RAD51C (inh=AR+AD oe_syn=0.97 oe_mis=0.98 oe_lof=1.03)
chr17	58692618	58692618	C	T	het	off-target	QUAL=11293;DP=971;QD=11.63;AF=0.47;MQM=60;SAP=5;ABP=11;SAR=217;SAF=238	RAD51C,TEX14,IGBP1C	5'UTR,upstream_gene	RAD51C:ENST00000583539.5:5_prime_UTR_variant:MODIFIER:exon1/8:c.-26C>T::,RAD51C:ENST00000461271.6:5_prime_UTR_variant:MODIFIER:exon1/8:c.-274C>T::,RAD51C:ENST00000697686.1:5_prime_UTR_variant:MODIFIER:exon1/10:c.-221C>T::,RAD51C:ENST00000697690.1:5_prime_UTR_variant:MODIFIER:exon1/7:c.-26C>T::,RAD51C:ENST00000337432.9:5_prime_UTR_variant:MODIFIER:exon1/9:c.-26C>T::,TEX14:ENST00000349033.10:upstream_gene_variant:MODIFIER::::,TEX14:ENST00000389934.7:upstream_gene_variant:MODIFIER::::,TEX14:ENST00000240361.12:upstream_gene_variant:MODIFIER::::,IGBP1C:ENST00000583666.3:upstream_gene_variant:MODIFIER::::,RAD51C:ENST00000421782.3:upstream_gene_variant:MODIFIER::::,RAD51C:ENST00000697694.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	605792_[GENE=TEX14_PHENOS=Spermatogenic failure 23, 617707 (3), Autosomal recessive]&602774_[GENE=RAD51C_PHENOS={Breast-ovarian cancer, familial, susceptibility to, 3}, 613399 (3); Fanconi anemia, complementation group O, 613390 (3), Autosomal recessive]	324173 [benign/likely benign DISEASE=Fanconi anemia,not specified,Breast and Ovarian Cancer Susceptibility,not provided];			rs12946397	0.18462	0.13679,0.17633,0.17626,0.21154,0.13845	2765,	22550	124018	-3.2430			1.61			COSV53625930	0.03	29879995,25343521,31905201,21980511,26406419,22843497	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TEX14 (inh=AR oe_syn=0.96 oe_mis=1.04 oe_lof=0.78), IGBP1C (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), RAD51C (inh=AR+AD oe_syn=0.97 oe_mis=0.98 oe_lof=1.03)
chr17	58720846	58720846	T	C	het	off-target	QUAL=203;DP=27;QD=7.52;AF=0.44;MQM=60;SAP=29;ABP=4;SAR=12;SAF=0	RAD51C	intron	RAD51C:ENST00000583539.5:intron_variant:MODIFIER:intron6/7:c.904+34T>C::,RAD51C:ENST00000461271.6:intron_variant:MODIFIER:intron6/7:c.553+34T>C::,RAD51C:ENST00000697686.1:intron_variant:MODIFIER:intron6/9:c.553+34T>C::,RAD51C:ENST00000697690.1:intron_variant:MODIFIER:intron6/6:c.904+34T>C::,RAD51C:ENST00000337432.9:intron_variant:MODIFIER:intron6/8:c.904+34T>C::,RAD51C:ENST00000697694.1:intron_variant:MODIFIER:intron6/8:c.553+34T>C::		602774_[GENE=RAD51C_PHENOS={Breast-ovarian cancer, familial, susceptibility to, 3}, 613399 (3); Fanconi anemia, complementation group O, 613390 (3), Autosomal recessive]	1275824 [benign DISEASE=Fanconi anemia complementation group O,not specified,not provided];			rs28363318	0.29732	0.27049,0.26130,0.00231,0.34509,0.17964	7194,	30813	106825	0.2890			5.35				0	29879995,26406419,21392410	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51C (inh=AR+AD oe_syn=0.97 oe_mis=0.98 oe_lof=1.03)
chr17	60656452	60656452	-	A	het	off-target	QUAL=10;DP=209;QD=0.05;AF=0.11;MQM=60;SAP=55;ABP=272;SAR=0;SAF=24	PPM1D	intron	PPM1D:ENST00000305921.8:intron_variant:MODIFIER:intron4/5:c.1018-134dup::,PPM1D:ENST00000629650.3:intron_variant:MODIFIER:intron4/4:c.1018-134dup::	regulatory_region_variant:CTCF_binding_site	605100_[GENE=PPM1D_PHENOS=Breast cancer, somatic, 114480 (3); Jansen de Vries syndrome, 617450 (3), Autosomal dominant]	1179594 [benign DISEASE=not provided];		AluYh3 (SINE/Alu)	rs375982628	0.04242	0.06784,0.03672,0.00422,0.02929,0.08253	46,	3304	76652				0.78				0		0	86	0 / 4					PPM1D (inh=AD oe_syn=0.86 oe_mis=0.59 oe_lof=0.75)
chr17	61683138	61683138	A	G	hom	off-target	QUAL=250;DP=10;QD=25.00;AF=1.00;MQM=60;SAP=25;ABP=0;SAR=0;SAF=10	BRIP1	3'UTR,downstream_gene	BRIP1:ENST00000682755.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*158T>C::,BRIP1:ENST00000259008.7:3_prime_UTR_variant:MODIFIER:exon20/20:c.*158T>C::,BRIP1:ENST00000683039.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*158T>C::,BRIP1:ENST00000682453.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*158T>C::,BRIP1:ENST00000682989.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*999T>C::,BRIP1:ENST00000577598.5:downstream_gene_variant:MODIFIER::::		605882_[GENE=BRIP1_PHENOS=Fanconi anemia, complementation group J, 609054 (3); {Breast cancer, early-onset, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	324344 [benign DISEASE=Fanconi anemia complementation group J,not provided];		AluSg (SINE/Alu)	rs1978111	0.60622	0.65577,0.73424,0.72032,0.58298,0.45854	28511,	34993	59771	0.4260			0.73				0	19935797	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	61683635	61683635	A	G	hom		QUAL=7615;DP=306;QD=24.89;AF=1.00;MQM=60;SAP=667;ABP=0;SAR=0;SAF=306	BRIP1	synonymous,3'UTR,downstream_gene	BRIP1:ENST00000682755.1:synonymous_variant:LOW:exon18/18:c.3189T>C:p.Tyr1063=:,BRIP1:ENST00000259008.7:synonymous_variant:LOW:exon20/20:c.3411T>C:p.Tyr1137=:,BRIP1:ENST00000683039.1:synonymous_variant:LOW:exon21/21:c.3411T>C:p.Tyr1137=:,BRIP1:ENST00000682453.1:synonymous_variant:LOW:exon21/21:c.3411T>C:p.Tyr1137=:,BRIP1:ENST00000682989.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*502T>C::,BRIP1:ENST00000577598.5:downstream_gene_variant:MODIFIER::::		605882_[GENE=BRIP1_PHENOS=Fanconi anemia, complementation group J, 609054 (3); {Breast cancer, early-onset, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	183702 [benign DISEASE=Neoplasm of ovary,Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group J,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];			rs4986763	0.60484	0.65154,0.73388,0.72049,0.58289,0.45776	28379,	35117	60025	3.2750			8.10			COSV51995377	0	25741868,24033266,27415837,28415781,19276285,21356067,19935797,23473757,23644138,20693321,28968953,26790966,29138235,31214711,24301948,27542272	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	61685753	61685753	A	T	het	off-target	QUAL=391;DP=22;QD=17.77;AF=0.73;MQM=60;SAP=3;ABP=13;SAR=8;SAF=8	BRIP1	intron,3'UTR	BRIP1:ENST00000682755.1:intron_variant:MODIFIER:intron17/17:c.2683+83T>A::,BRIP1:ENST00000259008.7:intron_variant:MODIFIER:intron19/19:c.2905+83T>A::,BRIP1:ENST00000683039.1:intron_variant:MODIFIER:intron20/20:c.2905+83T>A::,BRIP1:ENST00000682453.1:intron_variant:MODIFIER:intron20/20:c.2905+83T>A::,BRIP1:ENST00000682989.1:intron_variant:MODIFIER:intron18/18:c.2610-1613T>A::,BRIP1:ENST00000577598.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*3T>A::		605882_[GENE=BRIP1_PHENOS=Fanconi anemia, complementation group J, 609054 (3); {Breast cancer, early-onset, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	1275841 [benign DISEASE=Hereditary breast ovarian cancer syndrome,not specified,not provided];			rs4988357	0.33869	0.35273,0.29936,0.48940,0.34811,0.26265	8931,	33612	100508	3.8370			18.52			COSV51997887	0	19935797	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	61685986	61685986	A	G	hom		QUAL=373;DP=12;QD=31.08;AF=1.00;MQM=60;SAP=6;ABP=0;SAR=8;SAF=4	BRIP1	missense,intron	BRIP1:ENST00000682755.1:missense_variant:MODERATE:exon17/18:c.2533T>C:p.Ser845Pro:,BRIP1:ENST00000259008.7:missense_variant:MODERATE:exon19/20:c.2755T>C:p.Ser919Pro:,BRIP1:ENST00000683039.1:missense_variant:MODERATE:exon20/21:c.2755T>C:p.Ser919Pro:,BRIP1:ENST00000682453.1:missense_variant:MODERATE:exon20/21:c.2755T>C:p.Ser919Pro:,BRIP1:ENST00000682989.1:intron_variant:MODIFIER:intron18/18:c.2610-1846T>C::,BRIP1:ENST00000577598.5:missense_variant:MODERATE:exon18/18:c.2755T>C:p.Ser919Pro:		605882_[GENE=BRIP1_PHENOS=Fanconi anemia, complementation group J, 609054 (3); {Breast cancer, early-onset, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	133756 [benign DISEASE=Neoplasm of ovary,Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group J,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];			rs4986764	0.61175	0.67190,0.73865,0.72033,0.58359,0.45837	29042,	34774	58932	0.2010	T(0.57),T(0.53),T(0.53),T(0.53), ,T(0.56)	B(0.00),B(0.00),B(0.00),B(0.00), ,B(0.00)	3.59	0.09		COSV51995396,COSV99369284	0.01	25741868,24033266,24728327,20150366,26901225,28415781,29458332,19276285,15113441,19138047,21356067,23318652,19935797,23473757,23644138,29466248,28968953,19127258,26921362,26790966,19012493,29138235,17504528,24137204,31214711,25653542,29221171,24301948,32894086,33240400,33928715,34050209	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	61686104	61686104	T	C	hom		QUAL=3654;DP=113;QD=32.34;AF=1.00;MQM=60;SAP=111;ABP=0;SAR=19;SAF=94	BRIP1	synonymous,intron	BRIP1:ENST00000682755.1:synonymous_variant:LOW:exon17/18:c.2415A>G:p.Glu805=:,BRIP1:ENST00000259008.7:synonymous_variant:LOW:exon19/20:c.2637A>G:p.Glu879=:,BRIP1:ENST00000683039.1:synonymous_variant:LOW:exon20/21:c.2637A>G:p.Glu879=:,BRIP1:ENST00000682453.1:synonymous_variant:LOW:exon20/21:c.2637A>G:p.Glu879=:,BRIP1:ENST00000682989.1:intron_variant:MODIFIER:intron18/18:c.2610-1964A>G::,BRIP1:ENST00000577598.5:synonymous_variant:LOW:exon18/18:c.2637A>G:p.Glu879=:		605882_[GENE=BRIP1_PHENOS=Fanconi anemia, complementation group J, 609054 (3); {Breast cancer, early-onset, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	183703 [benign DISEASE=Neoplasm of ovary,Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group J,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,not provided];			rs4986765	0.74213	0.90365,0.83054,0.89287,0.65648,0.71835	43144,	26462	39178	-0.1910			6.68				0	25741868,24033266,19276285,21356067,17342202,19935797,28968953,26790966,29138235,31214711,32708070,27542272,25592580	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	61742809	61742809	C	A	het	off-target	QUAL=39;DP=6;QD=6.50;AF=0.50;MQM=60;SAP=10;ABP=3;SAR=0;SAF=3	BRIP1	intron	BRIP1:ENST00000682755.1:intron_variant:MODIFIER:intron14/17:c.2157+204G>T::,BRIP1:ENST00000259008.7:intron_variant:MODIFIER:intron16/19:c.2379+204G>T::,BRIP1:ENST00000683039.1:intron_variant:MODIFIER:intron17/20:c.2379+204G>T::,BRIP1:ENST00000682453.1:intron_variant:MODIFIER:intron17/20:c.2379+204G>T::,BRIP1:ENST00000682989.1:intron_variant:MODIFIER:intron16/18:c.2379+204G>T::,BRIP1:ENST00000577598.5:intron_variant:MODIFIER:intron15/17:c.2379+204G>T::,BRIP1:ENST00000584322.2:intron_variant:MODIFIER:intron16/16:c.2379+204G>T::,BRIP1:ENST00000683381.1:intron_variant:MODIFIER:intron17/17:c.2439+204G>T::		605882_[GENE=BRIP1_PHENOS=Fanconi anemia, complementation group J, 609054 (3); {Breast cancer, early-onset, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	679668 [benign DISEASE=not provided];		Tigger1 (DNA/TcMar-Tigger)	rs12937232	0.77156	0.83320,0.57848,0.78186,0.76544,0.80639	45847,	25598	34728	-0.4190			7.14				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	61780448	61780448	C	G	het	off-target	QUAL=183;DP=14;QD=13.07;AF=0.64;MQM=60;SAP=23;ABP=5;SAR=0;SAF=9	BRIP1	intron	BRIP1:ENST00000682755.1:intron_variant:MODIFIER:intron10/17:c.1573-47G>C::,BRIP1:ENST00000259008.7:intron_variant:MODIFIER:intron12/19:c.1795-47G>C::,BRIP1:ENST00000683039.1:intron_variant:MODIFIER:intron13/20:c.1795-47G>C::,BRIP1:ENST00000682453.1:intron_variant:MODIFIER:intron13/20:c.1795-47G>C::,BRIP1:ENST00000682989.1:intron_variant:MODIFIER:intron12/18:c.1795-47G>C::,BRIP1:ENST00000577598.5:intron_variant:MODIFIER:intron11/17:c.1795-47G>C::,BRIP1:ENST00000584322.2:intron_variant:MODIFIER:intron12/16:c.1795-47G>C::,BRIP1:ENST00000683381.1:intron_variant:MODIFIER:intron12/17:c.1795-47G>C::	regulatory_region_variant:TF_binding_site	605882_[GENE=BRIP1_PHENOS=Fanconi anemia, complementation group J, 609054 (3); {Breast cancer, early-onset, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	262005 [benign DISEASE=not specified,not provided];		AluJb (SINE/Alu)	rs4988351	0.77773	0.85368,0.63270,0.82041,0.75632,0.79693	46452,	25274	33774	0.1520			3.79			COSV51993354	0.02	25741868,26790966	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2022-06-22 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2021-03-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	61799424	61799425	AG	-	hom	off-target	QUAL=284;DP=11;QD=25.82;AF=1.00;MQM=60;SAP=27;ABP=0;SAR=11;SAF=0	BRIP1	intron	BRIP1:ENST00000682755.1:intron_variant:MODIFIER:intron6/17:c.919-126_919-125del::,BRIP1:ENST00000259008.7:intron_variant:MODIFIER:intron8/19:c.1141-126_1141-125del::,BRIP1:ENST00000683039.1:intron_variant:MODIFIER:intron9/20:c.1141-126_1141-125del::,BRIP1:ENST00000682453.1:intron_variant:MODIFIER:intron9/20:c.1141-126_1141-125del::,BRIP1:ENST00000682989.1:intron_variant:MODIFIER:intron8/18:c.1141-126_1141-125del::,BRIP1:ENST00000577598.5:intron_variant:MODIFIER:intron7/17:c.1141-126_1141-125del::,BRIP1:ENST00000584322.2:intron_variant:MODIFIER:intron8/16:c.1141-126_1141-125del::,BRIP1:ENST00000683381.1:intron_variant:MODIFIER:intron8/17:c.1141-126_1141-125del::		605882_[GENE=BRIP1_PHENOS=Fanconi anemia, complementation group J, 609054 (3); {Breast cancer, early-onset, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	676467 [benign DISEASE=not provided];			rs5821340	0.98891	0.96069,0.99744,1.00000,0.99991,0.99979	74409,	1623	1687	0.0000			1.38				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	61801161	61801161	-	A	het	off-target	QUAL=117;DP=16;QD=7.31;AF=0.50;MQM=60;SAP=20;ABP=3;SAR=8;SAF=0	BRIP1	intron	BRIP1:ENST00000682755.1:intron_variant:MODIFIER:intron6/17:c.919-1863dup::,BRIP1:ENST00000259008.7:intron_variant:MODIFIER:intron8/19:c.1140+91dup::,BRIP1:ENST00000683039.1:intron_variant:MODIFIER:intron9/20:c.1140+91dup::,BRIP1:ENST00000682453.1:intron_variant:MODIFIER:intron9/20:c.1140+91dup::,BRIP1:ENST00000682989.1:intron_variant:MODIFIER:intron8/18:c.1140+91dup::,BRIP1:ENST00000577598.5:intron_variant:MODIFIER:intron7/17:c.1140+91dup::,BRIP1:ENST00000584322.2:intron_variant:MODIFIER:intron8/16:c.1140+91dup::,BRIP1:ENST00000683381.1:intron_variant:MODIFIER:intron8/17:c.1140+91dup::	regulatory_region_variant:open_chromatin_region	605882_[GENE=BRIP1_PHENOS=Fanconi anemia, complementation group J, 609054 (3); {Breast cancer, early-onset, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	1282406 [benign DISEASE=not provided];			rs11390869	0.79192	0.89559,0.63425,0.81959,0.75945,0.78533	48201,	23729	31565				3.00				0	26790966	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	2	"[2] auto-classification 20.11.2017  "			BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr18	22415790	22415790	T	C	hom		QUAL=428;DP=17;QD=25.18;AF=1.00;MQM=60;SAP=40;ABP=0;SAR=0;SAF=17	CTAGE1,ATP7BP1	synonymous,upstream_gene,downstream_gene	CTAGE1:ENST00000391403.4:synonymous_variant:LOW:exon1/1:c.2022A>G:p.Pro674=:,CTAGE1:ENST00000525417.1:upstream_gene_variant:MODIFIER::::,ATP7BP1:ENST00000603437.1:downstream_gene_variant:MODIFIER::::						rs9946145	0.75399	0.37231,0.84755,0.82150,0.91392,0.80079	47659,	19283	37391	-0.4070			0.74			COSV66942792	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CTAGE1 (inh=n/a oe_syn=1.20 oe_mis=1.39 oe_lof=n/a), ATP7BP1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr18	22416048	22416048	G	A	het		QUAL=1512;DP=133;QD=11.37;AF=0.46;MQM=60;SAP=5;ABP=5;SAR=34;SAF=27	CTAGE1,ATP7BP1	synonymous,upstream_gene,downstream_gene	CTAGE1:ENST00000391403.4:synonymous_variant:LOW:exon1/1:c.1764C>T:p.Leu588=:,CTAGE1:ENST00000525417.1:upstream_gene_variant:MODIFIER::::,ATP7BP1:ENST00000603437.1:downstream_gene_variant:MODIFIER::::						rs7227477	0.49190	0.47355,0.57435,0.61365,0.47606,0.44235	18446,	37818	77172	0.4950			0.33			COSV66942794	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CTAGE1 (inh=n/a oe_syn=1.20 oe_mis=1.39 oe_lof=n/a), ATP7BP1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr18	22975256	22975256	T	C	hom	off-target	QUAL=2154;DP=68;QD=31.68;AF=1.00;MQM=60;SAP=4;ABP=0;SAR=37;SAF=31	RBBP8	intron	RBBP8:ENST00000327155.10:intron_variant:MODIFIER:intron6/18:c.428+37T>C::,RBBP8:ENST00000399722.6:intron_variant:MODIFIER:intron6/18:c.428+37T>C::,RBBP8:ENST00000399725.6:intron_variant:MODIFIER:intron6/17:c.428+37T>C::,RBBP8:ENST00000360790.9:intron_variant:MODIFIER:intron6/18:c.428+37T>C::	regulatory_region_variant:enhancer	604124_[GENE=RBBP8_PHENOS=Seckel syndrome 2, 606744 (3), Autosomal recessive; Jawad syndrome, 251255 (3), Autosomal recessive; Pancreatic carcinoma, somatic (3)]	673936 [benign DISEASE=Jawad syndrome,Seckel syndrome 2,not provided];			rs2336916	0.94419	0.85740,0.96843,0.91766,0.98443,0.93251	68038,	7509	8487	-1.1550			0.79				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RBBP8 (inh=AR oe_syn=0.99 oe_mis=1.00 oe_lof=0.54)
chr18	22982555	22982555	G	A	hom	off-target	QUAL=212;DP=8;QD=26.50;AF=1.00;MQM=60;SAP=20;ABP=0;SAR=8;SAF=0	RBBP8	intron	RBBP8:ENST00000327155.10:intron_variant:MODIFIER:intron7/18:c.604+162G>A::,RBBP8:ENST00000399722.6:intron_variant:MODIFIER:intron7/18:c.604+162G>A::,RBBP8:ENST00000399725.6:intron_variant:MODIFIER:intron7/17:c.604+162G>A::,RBBP8:ENST00000360790.9:intron_variant:MODIFIER:intron7/18:c.604+162G>A::		604124_[GENE=RBBP8_PHENOS=Seckel syndrome 2, 606744 (3), Autosomal recessive; Jawad syndrome, 251255 (3), Autosomal recessive; Pancreatic carcinoma, somatic (3)]	669107 [benign DISEASE=not provided];			rs7407415	0.99797	0.99293,0.99935,1.00000,0.99999,0.99959	75809,	305	309	-0.2960			0.22				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RBBP8 (inh=AR oe_syn=0.99 oe_mis=1.00 oe_lof=0.54)
chr18	22984838	22984840	TCA	-	het	off-target;low_conf_region	QUAL=362;DP=32;QD=11.31;AF=0.47;MQM=60;SAP=3;ABP=3;SAR=7;SAF=8	RBBP8	intron	RBBP8:ENST00000327155.10:intron_variant:MODIFIER:intron7/18:c.605-41_605-39del::,RBBP8:ENST00000399722.6:intron_variant:MODIFIER:intron7/18:c.605-41_605-39del::,RBBP8:ENST00000399725.6:intron_variant:MODIFIER:intron7/17:c.605-41_605-39del::,RBBP8:ENST00000360790.9:intron_variant:MODIFIER:intron7/18:c.605-41_605-39del::		604124_[GENE=RBBP8_PHENOS=Seckel syndrome 2, 606744 (3), Autosomal recessive; Jawad syndrome, 251255 (3), Autosomal recessive; Pancreatic carcinoma, somatic (3)]	1263878 [benign DISEASE=Jawad syndrome,Seckel syndrome 2,not provided];			rs3052770	0.50561	0.22434,0.56519,0.46967,0.63856,0.54653	21813,	32989	74915	-0.3020			0.33				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RBBP8 (inh=AR oe_syn=0.99 oe_mis=1.00 oe_lof=0.54)
chr18	22996218	22996218	G	T	het	off-target	QUAL=79;DP=5;QD=15.80;AF=0.80;MQM=60;SAP=12;ABP=7;SAR=0;SAF=4	RBBP8	intron	RBBP8:ENST00000327155.10:intron_variant:MODIFIER:intron12/18:c.1940-156G>T::,RBBP8:ENST00000399722.6:intron_variant:MODIFIER:intron12/18:c.1940-156G>T::,RBBP8:ENST00000399725.6:intron_variant:MODIFIER:intron12/17:c.1940-156G>T::,RBBP8:ENST00000360790.9:intron_variant:MODIFIER:intron12/18:c.1940-156G>T::		604124_[GENE=RBBP8_PHENOS=Seckel syndrome 2, 606744 (3), Autosomal recessive; Jawad syndrome, 251255 (3), Autosomal recessive; Pancreatic carcinoma, somatic (3)]	673956 [benign DISEASE=not provided];		L1MB8 (LINE/L1)	rs4471804	0.51126	0.83826,0.44090,0.52256,0.36128,0.45219	23119,	31438	74254	-0.6430			1.93				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RBBP8 (inh=AR oe_syn=0.99 oe_mis=1.00 oe_lof=0.54)
chr18	22997493	22997493	T	A	het	off-target	QUAL=118;DP=18;QD=6.56;AF=0.44;MQM=60;SAP=20;ABP=3;SAR=0;SAF=8	RBBP8	intron	RBBP8:ENST00000327155.10:intron_variant:MODIFIER:intron13/18:c.2029-127T>A::,RBBP8:ENST00000399722.6:intron_variant:MODIFIER:intron13/18:c.2029-127T>A::,RBBP8:ENST00000399725.6:intron_variant:MODIFIER:intron13/17:c.2029-127T>A::,RBBP8:ENST00000360790.9:intron_variant:MODIFIER:intron13/18:c.2029-127T>A::		604124_[GENE=RBBP8_PHENOS=Seckel syndrome 2, 606744 (3), Autosomal recessive; Jawad syndrome, 251255 (3), Autosomal recessive; Pancreatic carcinoma, somatic (3)]	673333 [benign DISEASE=not provided];			rs2305886	0.48880	0.16198,0.55962,0.47281,0.63886,0.54805	21426,	31424	77680	-0.2240			1.11				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RBBP8 (inh=AR oe_syn=0.99 oe_mis=1.00 oe_lof=0.54)
chr18	23006282	23006282	C	T	het	off-target	QUAL=7038;DP=523;QD=13.46;AF=0.53;MQM=60;SAP=3;ABP=6;SAR=137;SAF=138	RBBP8,RN7SL745P	intron,downstream_gene	RBBP8:ENST00000327155.10:intron_variant:MODIFIER:intron15/18:c.2288-81C>T::,RBBP8:ENST00000399722.6:intron_variant:MODIFIER:intron15/18:c.2288-81C>T::,RBBP8:ENST00000399725.6:intron_variant:MODIFIER:intron15/17:c.2288-81C>T::,RBBP8:ENST00000360790.9:intron_variant:MODIFIER:intron15/18:c.2303-81C>T::,RN7SL745P:ENST00000484900.3:downstream_gene_variant:MODIFIER::::		604124_[GENE=RBBP8_PHENOS=Seckel syndrome 2, 606744 (3), Autosomal recessive; Jawad syndrome, 251255 (3), Autosomal recessive; Pancreatic carcinoma, somatic (3)]	673981 [benign DISEASE=not provided];			rs72889626	0.17751	0.05410,0.25663,0.39301,0.20368,0.19390	3064,	20796	124756	-3.4810			0.00				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RBBP8 (inh=AR oe_syn=0.99 oe_mis=1.00 oe_lof=0.54), RN7SL745P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr18	23006519	23006519	A	T	het	off-target	QUAL=29;DP=16;QD=1.81;AF=0.25;MQM=60;SAP=3;ABP=12;SAR=2;SAF=2	RBBP8,RN7SL745P	intron,downstream_gene	RBBP8:ENST00000327155.10:intron_variant:MODIFIER:intron16/18:c.2357+87A>T::,RBBP8:ENST00000399722.6:intron_variant:MODIFIER:intron16/18:c.2357+87A>T::,RBBP8:ENST00000399725.6:intron_variant:MODIFIER:intron16/17:c.2357+87A>T::,RBBP8:ENST00000360790.9:intron_variant:MODIFIER:intron16/18:c.2372+87A>T::,RN7SL745P:ENST00000484900.3:downstream_gene_variant:MODIFIER::::		604124_[GENE=RBBP8_PHENOS=Seckel syndrome 2, 606744 (3), Autosomal recessive; Jawad syndrome, 251255 (3), Autosomal recessive; Pancreatic carcinoma, somatic (3)]			AluJb (SINE/Alu)							-0.6550			0.70				0		0	1	0 / 1					RBBP8 (inh=AR oe_syn=0.99 oe_mis=1.00 oe_lof=0.54), RN7SL745P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr18	51046899	51046899	T	-	het	off-target;low_conf_region	QUAL=44;DP=42;QD=1.05;AF=0.19;MQM=60;SAP=20;ABP=38;SAR=0;SAF=8	SMAD4	splice_region&intron,upstream_gene	SMAD4:ENST00000398417.6:splice_region_variant&intron_variant:LOW:intron1/11:c.-127-10del::,SMAD4:ENST00000342988.8:splice_region_variant&intron_variant:LOW:intron1/11:c.-127-10del::,SMAD4:ENST00000588745.5:upstream_gene_variant:MODIFIER::::		600993_[GENE=SMAD4_PHENOS=Pancreatic cancer, somatic, 260350 (3); Myhre syndrome, 139210 (3), Autosomal dominant; Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant; Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3), Autosomal dominant]			(T)n (Simple_repeat)	rs745430558	0.00191	0.00336,0.00174,0.00321,0.00097,0.00065	0,	275	143405	-0.4070			0.53				0		0	205	0 / 22					SMAD4 (inh=AD oe_syn=0.93 oe_mis=0.34 oe_lof=0.07)
chr18	51058485	51058485	-	T	het	off-target;low_conf_region	QUAL=1509;DP=159;QD=9.49;AF=0.14;MQM=60;SAP=24;ABP=177;SAR=4;SAF=19	SMAD4	intron	SMAD4:ENST00000398417.6:intron_variant:MODIFIER:intron7/11:c.904+45dup::,SMAD4:ENST00000342988.8:intron_variant:MODIFIER:intron7/11:c.904+45dup::,SMAD4:ENST00000588745.5:intron_variant:MODIFIER:intron4/7:c.667+3508dup::		600993_[GENE=SMAD4_PHENOS=Pancreatic cancer, somatic, 260350 (3); Myhre syndrome, 139210 (3), Autosomal dominant; Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant; Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3), Autosomal dominant]	492739 [benign DISEASE=not specified,not provided];			rs386387676	0.03145	0.06922,0.02135,0.06385,0.01408,0.00808	105,	3792	123234				12.61			COSV61689656	0		8	664	0 / 51					SMAD4 (inh=AD oe_syn=0.93 oe_mis=0.34 oe_lof=0.07)
chr18	51058485	51058485	-	TT	het	off-target;low_conf_region	QUAL=1509;DP=159;QD=9.49;AF=0.31;MQM=60;SAP=101;ABP=54;SAR=1;SAF=48	SMAD4	intron	SMAD4:ENST00000398417.6:intron_variant:MODIFIER:intron7/11:c.904+44_904+45dup::,SMAD4:ENST00000342988.8:intron_variant:MODIFIER:intron7/11:c.904+44_904+45dup::,SMAD4:ENST00000588745.5:intron_variant:MODIFIER:intron4/7:c.667+3507_667+3508dup::		600993_[GENE=SMAD4_PHENOS=Pancreatic cancer, somatic, 260350 (3); Myhre syndrome, 139210 (3), Autosomal dominant; Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant; Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3), Autosomal dominant]	1227283 [benign DISEASE=not provided];			rs386387676	0.33482	0.20541,0.36070,0.40866,0.39245,0.23669	7119,	28217	84343				12.56			COSV61689656	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMAD4 (inh=AD oe_syn=0.93 oe_mis=0.34 oe_lof=0.07)
chr19	17268649	17268649	G	A	het	off-target	QUAL=34;DP=14;QD=2.43;AF=0.29;MQM=60;SAP=12;ABP=9;SAR=0;SAF=4	BABAM1,USHBP1	intron,upstream_gene	BABAM1:ENST00000447614.6:intron_variant:MODIFIER:intron1/5:c.-13-145G>A::,BABAM1:ENST00000359435.8:intron_variant:MODIFIER:intron1/8:c.-51-107G>A::,BABAM1:ENST00000598188.6:intron_variant:MODIFIER:intron1/8:c.-13-145G>A::,BABAM1:ENST00000601043.5:intron_variant:MODIFIER:intron1/8:c.-13-145G>A::,BABAM1:ENST00000595632.5:intron_variant:MODIFIER:intron1/5:c.-51-107G>A::,USHBP1:ENST00000252597.8:upstream_gene_variant:MODIFIER::::,USHBP1:ENST00000431146.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter				AluSp (SINE/Alu)	rs2004800	0.11154	0.06680,0.19908,0.51180,0.09389,0.16093	1555,	13831	134947	-0.2070			1.62			COSV53102212	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USHBP1 (inh=n/a oe_syn=0.93 oe_mis=1.02 oe_lof=0.79), BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07)
chr19	17268749	17268749	C	T	het	off-target	QUAL=1302;DP=108;QD=12.06;AF=0.47;MQM=60;SAP=5;ABP=4;SAR=29;SAF=22	BABAM1,USHBP1	intron,splice_region&intron,upstream_gene	BABAM1:ENST00000447614.6:intron_variant:MODIFIER:intron1/5:c.-13-45C>T::,BABAM1:ENST00000359435.8:splice_region_variant&intron_variant:LOW:intron1/8:c.-51-7C>T::,BABAM1:ENST00000598188.6:intron_variant:MODIFIER:intron1/8:c.-13-45C>T::,BABAM1:ENST00000601043.5:intron_variant:MODIFIER:intron1/8:c.-13-45C>T::,BABAM1:ENST00000595632.5:splice_region_variant&intron_variant:LOW:intron1/5:c.-51-7C>T::,USHBP1:ENST00000252597.8:upstream_gene_variant:MODIFIER::::,USHBP1:ENST00000431146.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter		1227766 [benign DISEASE=not provided];	CS1518199 [CLASS=DFP MUT=ALT PHEN="Breast cancer association with" GENE=BABAM1];		rs10424178	0.22499	0.34493,0.13827,0.00173,0.19930,0.11157	4469,	25223	117675	-0.3220			4.16		1.98>3.28		0.25	26472073,21431873,23805179,32601453	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USHBP1 (inh=n/a oe_syn=0.93 oe_mis=1.02 oe_lof=0.79), BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07)
chr19	17271696	17271696	A	T	het	off-target	QUAL=317;DP=46;QD=6.89;AF=0.35;MQM=60;SAP=4;ABP=12;SAR=9;SAF=7	BABAM1	intron	BABAM1:ENST00000447614.6:intron_variant:MODIFIER:intron3/5:c.344+41A>T::,BABAM1:ENST00000359435.8:intron_variant:MODIFIER:intron3/8:c.344+41A>T::,BABAM1:ENST00000598188.6:intron_variant:MODIFIER:intron3/8:c.344+41A>T::,BABAM1:ENST00000601043.5:intron_variant:MODIFIER:intron3/8:c.344+41A>T::,BABAM1:ENST00000595632.5:intron_variant:MODIFIER:intron3/5:c.344+41A>T::						rs10420922	0.49402	0.67572,0.37986,0.31887,0.43634,0.36640	19690,	35631	76827	-0.5940			0.97			COSV63921517	0	19572197,21431873	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07)
chr19	17273842	17273842	C	T	het	off-target	QUAL=201;DP=20;QD=10.05;AF=0.45;MQM=60;SAP=5;ABP=3;SAR=6;SAF=3	BABAM1	intron	BABAM1:ENST00000447614.6:intron_variant:MODIFIER:intron3/5:c.344+2187C>T::,BABAM1:ENST00000359435.8:intron_variant:MODIFIER:intron3/8:c.345-62C>T::,BABAM1:ENST00000598188.6:intron_variant:MODIFIER:intron3/8:c.345-62C>T::,BABAM1:ENST00000601043.5:intron_variant:MODIFIER:intron3/8:c.345-62C>T::,BABAM1:ENST00000595632.5:intron_variant:MODIFIER:intron3/5:c.344+2187C>T::					AluSg7 (SINE/Alu)	rs113272353	0.17102	0.18315,0.10688,0.00193,0.18686,0.10633	2390,	21179	125827	-0.8570			0.76				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07)
chr19	17276367	17276367	A	G	het	off-target	QUAL=1376;DP=96;QD=14.33;AF=0.54;MQM=60;SAP=3;ABP=4;SAR=26;SAF=26	BABAM1	intron	BABAM1:ENST00000447614.6:intron_variant:MODIFIER:intron3/5:c.345-128A>G::,BABAM1:ENST00000359435.8:intron_variant:MODIFIER:intron6/8:c.570-128A>G::,BABAM1:ENST00000598188.6:intron_variant:MODIFIER:intron6/8:c.570-128A>G::,BABAM1:ENST00000601043.5:intron_variant:MODIFIER:intron6/8:c.570-128A>G::,BABAM1:ENST00000595632.5:intron_variant:MODIFIER:intron3/5:c.345-128A>G::						rs34084277	0.17085	0.18287,0.10675,0.00154,0.18685,0.10581	2381,	21186	125932	-0.1090			8.99				0.03	26231170,28115406,29531215,28362817,28472234	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07)
chr19	17276445	17276445	G	A	het	off-target	QUAL=1356;DP=98;QD=13.84;AF=0.52;MQM=60;SAP=3;ABP=3;SAR=25;SAF=26	BABAM1	intron	BABAM1:ENST00000447614.6:intron_variant:MODIFIER:intron3/5:c.345-50G>A::,BABAM1:ENST00000359435.8:intron_variant:MODIFIER:intron6/8:c.570-50G>A::,BABAM1:ENST00000598188.6:intron_variant:MODIFIER:intron6/8:c.570-50G>A::,BABAM1:ENST00000601043.5:intron_variant:MODIFIER:intron6/8:c.570-50G>A::,BABAM1:ENST00000595632.5:intron_variant:MODIFIER:intron3/5:c.345-50G>A::						rs61634114	0.15960	0.14363,0.10253,0.00154,0.18691,0.10683	2114,	20019	127675	0.6530			5.51				0.23	21431873	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07)
chr19	17278839	17278839	C	T	het		QUAL=1227;DP=106;QD=11.58;AF=0.47;MQM=60;SAP=3;ABP=4;SAR=25;SAF=25	BABAM1,ANKLE1	splice_region&intron,upstream_gene	BABAM1:ENST00000447614.6:splice_region_variant&intron_variant:LOW:intron5/5:c.562-6C>T::,BABAM1:ENST00000359435.8:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::,BABAM1:ENST00000598188.6:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::,BABAM1:ENST00000601043.5:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::,BABAM1:ENST00000595632.5:splice_region_variant&intron_variant:LOW:intron5/5:c.562-6C>T::,ANKLE1:ENST00000394458.7:upstream_gene_variant:MODIFIER::::,ANKLE1:ENST00000594072.6:upstream_gene_variant:MODIFIER::::,ANKLE1:ENST00000652132.1:upstream_gene_variant:MODIFIER::::,ANKLE1:ENST00000404085.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer					rs10406920	0.17159	0.18507,0.10666,0.00154,0.18704,0.10759	2411,	21270	125970	0.7980			1.96		8.04>7.99	COSV63921267	0.01	26848770,28115406,19572197,21431873,23805179,32601453	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07), ANKLE1 (inh=n/a oe_syn=0.91 oe_mis=0.87 oe_lof=1.04)
chr19	17278895	17278895	G	A	het		QUAL=6272;DP=526;QD=11.92;AF=0.47;MQM=60;SAP=3;ABP=7;SAR=124;SAF=123	BABAM1,ANKLE1	synonymous,upstream_gene	BABAM1:ENST00000447614.6:synonymous_variant:LOW:exon6/6:c.612G>A:p.Lys204=:,BABAM1:ENST00000359435.8:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:,BABAM1:ENST00000598188.6:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:,BABAM1:ENST00000601043.5:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:,BABAM1:ENST00000595632.5:synonymous_variant:LOW:exon6/6:c.612G>A:p.Lys204=:,ANKLE1:ENST00000394458.7:upstream_gene_variant:MODIFIER::::,ANKLE1:ENST00000594072.6:upstream_gene_variant:MODIFIER::::,ANKLE1:ENST00000652132.1:upstream_gene_variant:MODIFIER::::,ANKLE1:ENST00000404085.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer			CM1010189 [CLASS=DP MUT=ALT PHEN="Ovarian cancer susceptibility to" GENE=BABAM1];		rs8170	0.17349	0.19136,0.10786,0.00154,0.18711,0.10716	2466,	21454	125702	3.0590			10.27			COSV63920809	0.05	23535729,23535825,23593120,24025454,24359602,24771903,24941967,26472073,26510858,27392074,22331459,23536562,27117709,27825120,27471560,26884359,21844186,22357627,23136140,24895409,25057183,25253900,25255808,25611573,26070784,31125336,20852633,23555315,28935272,26231170,24244489,20456938,22235027,22253144,24886216,25173882,21799032,26848770,24510657,18650832,25227710,26747452,27814745,28115406,23535730,29844822,23756864,20852631,29150481,21774837,27848153,27601076,22351618,23011509,19572197,21431873,23544013,29531215,23423317,29316957,22794196,23462924,28362817,28098224,27931260,27432226,25581431,28957321,26052370,25919761,22575968,27698005,25751625,23535733,24495414,23805179,23292081,31258768,25342391,23761956,23544012,31379942,24325915,22357538,24852375,28559747,25717406,33125686,29915430,26209509,32724790,27279675,32823908,32793750,32601453,25673085,29880983,24528085,32128252,33372680,35087569	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07), ANKLE1 (inh=n/a oe_syn=0.91 oe_mis=0.87 oe_lof=1.04)
chr20	14186437	14186437	T	C	hom	off-target	QUAL=444;DP=17;QD=26.12;AF=1.00;MQM=60;SAP=40;ABP=0;SAR=0;SAF=17	MACROD2	intron	MACROD2:ENST00000217246.8:intron_variant:MODIFIER:intron3/16:c.271+100709T>C::,MACROD2:ENST00000684519.1:intron_variant:MODIFIER:intron3/17:c.271+100709T>C::,MACROD2:ENST00000642719.1:intron_variant:MODIFIER:intron3/17:c.271+100709T>C::					L1PA16 (LINE/L1)	rs6042572	0.95247	0.93406,0.96718,0.98864,0.95205,0.95325	69018,	6857	7231	-0.6830			1.04				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MACROD2 (inh=AD oe_syn=0.89 oe_mis=0.87 oe_lof=0.22)
chr20	14186637	14186637	A	G	hom		QUAL=893;DP=30;QD=29.77;AF=1.00;MQM=60;SAP=4;ABP=0;SAR=17;SAF=13	MACROD2	intron	MACROD2:ENST00000217246.8:intron_variant:MODIFIER:intron3/16:c.271+100909A>G::,MACROD2:ENST00000684519.1:intron_variant:MODIFIER:intron3/17:c.271+100909A>G::,MACROD2:ENST00000642719.1:intron_variant:MODIFIER:intron3/17:c.271+100909A>G::					L1PA16 (LINE/L1)	rs6074704	0.52591	0.29618,0.57674,0.54509,0.62461,0.56669	22712,	34479	72029	-0.5390			9.31				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MACROD2 (inh=AD oe_syn=0.89 oe_mis=0.87 oe_lof=0.22)
chr20	49684453	49684453	C	T	hom	off-target	QUAL=479;DP=20;QD=23.95;AF=1.00;MQM=60;SAP=46;ABP=0;SAR=0;SAF=20	B4GALT5	intron	B4GALT5:ENST00000371711.4:intron_variant:MODIFIER:intron1/8:c.116-27751G>A::					AluY (SINE/Alu)	rs6019972	0.80943	0.83906,0.75923,0.82528,0.80174,0.87204	49762,	23193	28893	-2.1980			0.39				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					B4GALT5 (inh=n/a oe_syn=0.97 oe_mis=0.56 oe_lof=0.00)
chr20	49684609	49684609	G	A	hom		QUAL=39471;DP=1195;QD=33.03;AF=1.00;MQM=60;SAP=4;ABP=0;SAR=584;SAF=609	B4GALT5	intron	B4GALT5:ENST00000371711.4:intron_variant:MODIFIER:intron1/8:c.116-27907C>T::						rs6512586	0.49014	0.38771,0.46635,0.38801,0.54861,0.64963	18677,	36996	77340	-0.9890			0.26			COSV65493865	0	19956101,33230300	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					B4GALT5 (inh=n/a oe_syn=0.97 oe_mis=0.56 oe_lof=0.00)
chr22	28734312	28734312	C	T	het	off-target	QUAL=1766;DP=108;QD=16.35;AF=0.58;MQM=60;SAP=13;ABP=10;SAR=23;SAF=40	CHEK2	intron	CHEK2:ENST00000402731.6:intron_variant:MODIFIER:intron1/12:c.319+91G>A::,CHEK2:ENST00000425190.7:intron_variant:MODIFIER:intron1/13:c.-345+7457G>A::,CHEK2:ENST00000404276.6:intron_variant:MODIFIER:intron2/14:c.319+91G>A::,CHEK2:ENST00000348295.7:intron_variant:MODIFIER:intron2/13:c.319+91G>A::,CHEK2:ENST00000649563.1:intron_variant:MODIFIER:intron1/11:c.-72+7457G>A::,CHEK2:ENST00000405598.5:intron_variant:MODIFIER:intron3/15:c.319+91G>A::,CHEK2:ENST00000382580.6:intron_variant:MODIFIER:intron2/15:c.319+91G>A::,CHEK2:ENST00000650281.1:intron_variant:MODIFIER:intron3/15:c.319+91G>A::,CHEK2:ENST00000403642.5:intron_variant:MODIFIER:intron1/11:c.319+91G>A::		604373_[GENE=CHEK2_PHENOS={Colorectal cancer, susceptibility to}, 114500 (3), Somatic mutation, Autosomal dominant; Osteosarcoma, somatic, 259500 (3); {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Prostate cancer, familial, susceptibility to}, 176807 (3), Somatic mutation, Autosomal dominant; Li-Fraumeni syndrome 2, 609265 (3)]	1292603 [benign DISEASE=not provided];		MER51A (LTR/ERV1)	rs1033667	0.29468	0.34562,0.33862,0.21418,0.28069,0.15983	6910,	30945	107145	-0.4970			0.98			COSV60418297	0	30793520,31428123,24098683,30753320,25631615,32042192,35192695	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHEK2 (inh=AD oe_syn=0.86 oe_mis=1.07 oe_lof=1.15)
chr22	28734825	28734825	-	A	het	off-target	QUAL=721;DP=114;QD=6.32;AF=0.32;MQM=60;SAP=15;ABP=37;SAR=11;SAF=25	CHEK2	intron,upstream_gene	CHEK2:ENST00000425190.7:intron_variant:MODIFIER:intron1/13:c.-345+6943dup::,CHEK2:ENST00000404276.6:intron_variant:MODIFIER:intron1/14:c.-6-99dup::,CHEK2:ENST00000348295.7:intron_variant:MODIFIER:intron1/13:c.-6-99dup::,CHEK2:ENST00000649563.1:intron_variant:MODIFIER:intron1/11:c.-72+6943dup::,CHEK2:ENST00000405598.5:intron_variant:MODIFIER:intron2/15:c.-6-99dup::,CHEK2:ENST00000382580.6:intron_variant:MODIFIER:intron1/15:c.-6-99dup::,CHEK2:ENST00000650281.1:intron_variant:MODIFIER:intron2/15:c.-6-99dup::,CHEK2:ENST00000402731.6:upstream_gene_variant:MODIFIER::::,CHEK2:ENST00000403642.5:upstream_gene_variant:MODIFIER::::		604373_[GENE=CHEK2_PHENOS={Colorectal cancer, susceptibility to}, 114500 (3), Somatic mutation, Autosomal dominant; Osteosarcoma, somatic, 259500 (3); {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Prostate cancer, familial, susceptibility to}, 176807 (3), Somatic mutation, Autosomal dominant; Li-Fraumeni syndrome 2, 609265 (3)]	1292328 [benign DISEASE=not provided];		(A)n (Simple_repeat)	rs201340887	0.33970	0.44376,0.36723,0.23229,0.30285,0.18077	7808,	30724	90076				0.33						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHEK2 (inh=AD oe_syn=0.86 oe_mis=1.07 oe_lof=1.15)
